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ABSTRACT 
  
Purpose 
The purpose of this study was to explore the beliefs people with heart failure hold about 
their illness and its treatment and to determine any relationships between these beliefs 
and self-care using the Common Sense Model (CSM) of illness cognitions and behaviour 
as the theoretical framework (Leventhal et al, 1980).  
 
Methods 
Using a mixed methodology (Creswell and Plano Clark, 2007), findings from patient 
interviews were used to adapt the Revised Illness Perception Questionnaire (IPQ-R) 
(Moss-Morris et al, 2002) and the Beliefs about Medicines Questionnaire (BMQ) (Horne et 
al, 1999) in order to make them illness-specific. A questionnaire assessing self-care was 
developed based on the European Heart Failure Self-care Behaviour Scale (EHFScBS) 
(Jaarsma et al, 2003), the interview findings and a nominal group technique with specialist 
heart failure nurses. These questionnaires were used to determine beliefs and the 
relationship to behaviour in a cross-sectional survey of 169 patients with heart failure.  
 
Results 
A number of statistically significant correlations were found between beliefs and self-care. 
Most notably, perceived medication knowledge (r = 0.51, p ≤ 0.01), beliefs about the 
necessity of medication (r = 0.45, p ≤ 0.01) and illness coherence (r = 0.39, p ≤ 0.01). 
Multiple regression analysis revealed that 46% of the variance in self-care could be 
explained by illness representations and treatment beliefs (Adj. R2 = 0.46, F = 9.93, p = 
0.00). Three factors were significant predictors of self-care - medication knowledge (β = 
0.319, p = 0.003), a belief in the illness having serious consequences (β = 0.258, p = 
0.008) and the impact of medication use on lifestyle (β = -0.231, p = 0.03).  
 
Discussion 
The exploration of illness representations revealed a realistic picture of heart failure with a 
cluster of beliefs around a chronic illness with serious consequences and a high number 
of symptoms. There was a strong belief in the necessity of medication but for some, 
medication use had a negative impact on daily life. Patients were confident in their 
knowledge of medication but this was reduced when family members took control of 
medication management. A number of beliefs were predictive of self-care, suggesting that 
interventions designed to maximise these beliefs and correct any misconceptions may 
enhance self-care and potentially improve clinical outcomes in this population.  
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Be near me when my light is low, 
When the blood creeps and the nerves prick 
And tingle; and the heart is sick, 
And all the wheels of Being slow. 
 
Alfred, Lord Tennyson (1809-1892) 
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CHAPTER ONE: INTRODUCTION 
 
Heart failure is a collection of symptoms and signs that suggest impairment of the heart as 
a pump (National Institute of Clinical Health and Excellence (NICE), 2010). It is a 
prevalent condition affecting approximately 177,000 people in the United Kingdom (UK) 
(Scarborough et al, 2010). Although it is considered a chronic or long-term condition, 
those affected suffer frequent acute episodes and experience a high number of hospital 
admissions. The Department of Health (DH, 2000a) state that this pattern of illness is 
largely due to uncontrolled symptoms as a result of non-adherence to medication and 
lifestyle advice. Consequently, individuals with heart failure need to develop and maintain 
effective strategies and behaviours to care for themselves and manage their illness 
(NICE, 2003). This is supported by government policy, which has emphasised self-care as 
a key principle in the management of long-term conditions such as heart failure (DH, 
2005a).  
 
Enabling effective self-care is not simply a matter of enhanced patient education. Jaarsma 
et al (2000a) found that despite intensive education and support, patients with heart failure 
did not consistently demonstrate effective self-care. Many factors are thought to be 
involved in changing behaviour including demographic, social and psychological 
influences. Self-regulatory theory has provided a useful structure for advancing our 
understanding of how individuals make sense of their illness and respond in terms of 
behaviour (Leventhal et al, 1980).  
 
This chapter begins by explaining the significance of the topic and defines the key terms 
of „heart failure‟ and „self-care‟, as used in this thesis. It sets the context of the research in 
relation to the main areas of literature. The origins of the idea for the study and my 
background as the researcher are reflected upon. The setting for the research is 
discussed and an overview of the research design is presented including a statement of 
the research aims and objectives. The chapter concludes by outlining the content and 
structure of subsequent chapters.   
 
1.1 THE SIGNIFICANCE OF THE TOPIC, DEFINITION OF TERMS AND THE 
CONTEXT OF THE RESEARCH  
 
Heart failure has a significant impact on individuals, their families and on healthcare 
provision and resources. The disease accounts for approximately 5% of all emergency 
admissions to general medical or elderly care hospital beds in the UK and readmissions 
are common with one in four patients returning to hospital within three months (Cleland et 
al, 2003). The number of in-patient episodes in 2008/9 has been recorded as in excess of 
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100,000 (Scarborough, 2010). Annual mortality ranges from 10-50% depending on initial 
illness severity (Petersen et al, 2002).   
  
The term „heart failure‟ is defined in this thesis as: 
 
‘A complex clinical syndrome of symptoms and signs that suggest impairment of the 
heart as a pump supporting physiological circulation’  (NICE, 2010, p.19) 
 
The justification for the use of the term „heart failure‟, as opposed to other commonly used 
clinical terms, and the decision to apply this definition is discussed in section 2.1.1.  
 
There is now an established body of evidence for heart failure prevention, treatment and 
care. This is most notably reflected in the National Service Framework (NSF) for Coronary 
Heart Disease (CHD) (DH, 2000a) and Chronic Heart Failure: National Clinical Guideline 
for Diagnosis and Management in Primary and Secondary Care (NICE, 2010). Whilst this 
most recent publication emphasises the medical management of heart failure, lifestyle 
behaviours such as a reduced salt diet, have also been recommended (NICE, 2003). 
Supporting patients and their families is a key recommendation for practice and the 
management of heart failure is seen as a shared responsibility between the patient, family 
and health and social care professionals.   
 
Shared responsibility for care and the concept of self-care has been established 
government policy since 2000 when self-care was first introduced in the NHS Plan as ‘a 
key building block for a patient-centered health service’ (DH, 2000b, p.3). Since then, a 
number of key policy documents have driven the self-care agenda. These are discussed 
in detail in section 2.3.1. „Self-care‟ in long-term conditions is defined in this thesis as:  
 
„The activities that enable people to deal with the impact of a long-term condition on 
their daily lives, dealing with the emotional changes, adherence to treatment 
regimes, and maintaining those things that are important to them – work, socialising, 
family’              (DH, 2006a, p.2) 
 
Dickson et al (2006) conceptualise self-care in heart failure as a decision making process 
comprised of two elements - self-care maintenance and self-care management strategies. 
Self-care maintenance includes those actions believed to maintain a maximum level of 
health and functioning through adherence to medication regimes and recommended 
lifestyle advice such as reduced fluid intake and taking regular exercise. Self-care 
management includes recognising and monitoring symptoms such as fluid retention, 
through, for example, regular weighing and responding when symptoms worsen by 
seeking appropriate help.  
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Effective self-care is, therefore, important in terms of clinical management and 
government policy.  However, it has been suggested that self-care in this population is 
poor (Leventhal et al, 2005; Artinian et al, 2002).  A large number of studies have 
attempted to explain this by identifying factors that affect self-care, for example, Dunbar et 
al, (2005); Chriss et al, (2004) and Jaarsma et al, (2000b). Only a few studies have 
considered the influence of illness and treatment beliefs on self-care in heart failure.  
 
The common sense model (CSM) of illness cognitions and behaviour (Leventhal et al, 
1980) has provided a framework within which behavioural responses to a number of 
illnesses have been explained and predicted (Hagger and Orbell, 2003). Within this 
model, illness cognitions or representations inform the development of coping strategies 
or behaviours. Illness representations are defined as ‘an organised set of beliefs regarding 
illness’ (Cameron and Moss-Morris, 2004, p.85). Horne (1997) proposed an extended 
CSM which incorporated beliefs about treatment, specifically the necessity of medication 
and concerns about its use. 
 
Using the CSM, Horowitz et al (2004) in a qualitative study, described the relationship 
between illness representations and actions in heart failure as ‘a story of maladies, 
misconceptions and mishaps’ (p.631). Albert and Zellar (2007) similarly found inaccurate 
illness beliefs which had a negative impact on self-care. Morgan (2008) found mostly 
accurate illness representations in a Republic of Ireland population, with beliefs 
significantly predicting self-care. In contrast, Voelmeck (2006) found no significant 
correlations between illness representations and self-care. No published studies have 
been identified which consider the relationship between illness representations, treatment 
beliefs and self-care in a UK, heart failure population. This study attempts to do so.  
 
In summary, this study is important in that it addresses a significant clinical problem. Heart 
failure is a prevalent disease associated with poor clinical outcomes. Optimal 
management is dependent upon effective self-care which some authors suggest is limited. 
It is proposed here, that a greater understanding of the beliefs people hold about their 
illness and its treatment may help to explain and predict self-care in heart failure. The 
CSM model (Leventhal et al, 1980) has been useful in predicting illness behaviour in a 
number of illness groups and provides the theoretical framework for this research.  
 
This study should lead to a greater understanding of how patients make sense of their 
illness and respond in terms of adherence to medication and other self-care behaviours. It 
is envisaged that this may enable service providers, such as general practitioners (GPs), 
practice nurses, community matrons, specialist heart failure nurses (HFNs) and health 
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psychologists, for example, to develop targeted interventions aimed at promoting more 
effective self-care routines by addressing any misconceptions about the illness and its 
treatment. It is known that interventions which address illness representations can be 
effective in changing illness behaviour and improving outcomes for patients (Petrie et al, 
2002). It is hoped that this research may ultimately lead to improved outcomes for heart 
failure patients as measured by hospital admission rates, improved symptom control or 
prognosis, for example. 
 
Literature has primarily been drawn from the disciplines of health and social care policy 
and practice, health psychology and the sociology of health and illness. Four main topics 
have been explored in the literature namely, the nature and management of heart failure 
from a predominantly biomedical viewpoint, lay beliefs and social and psychological 
perspectives of health, illness and treatment, self-care within a health and social care 
policy framework and the factors believed to influence self-care in heart failure, including 
illness and treatment beliefs. The measurement of illness representations, treatment 
beliefs and self-care is also discussed. 
 
1.2  ORIGINS OF THE STUDY  
 
As a staff nurse in a coronary care unit with a remit for health education, I was frequently 
surprised that, despite suffering chronic or acute, life-threatening cardiac illnesses, many 
patients did not seem to alter their lifestyle as recommended by nursing and medical staff. 
Their willingness or ability to make recommended lifestyle changes, even after health 
education, seemed to be limited. Patients would often recite risk factors for heart disease 
but did not seem to personally identify with them. It seemed to me that they could tell me 
why other people developed heart disease but that this was not the case for them. Over 
time and through further study, I realised that changing behaviour is not simply a matter of 
knowing all the facts – it is much more complex than that, involving factors such as 
motivation, self-efficacy and social support, for example.  
 
Later, as a lecturer in cardiac nursing, I was recommended to read a book entitled 
„Perceptions of Health and Illness‟ edited by Keith Petrie and John Weinman (1997). In 
this book, the role of illness beliefs in changing behaviour was discussed and I felt that 
clues to why some people changed their behaviour in response to illness whilst others did 
not might be found in this area of study.  
 
In studying for an MSc. in Interprofessional Health and Social Care, I elected to do a 
dissertation on the illness representations of women following acute myocardial infarction 
(MI) as I wanted to apply my newfound interest in health psychology, specifically illness 
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representations, to this under-represented population. The experience of doing this small 
scale, qualitative study encouraged me to develop this area of interest further in a PhD.  
The increasing focus on heart failure and self-care within cardiac care practice expanded 
my area of interest. As well as exploring illness representations qualitatively, it also 
seemed to be important to determine possible relationships between beliefs and 
behaviour through quantitative methods. Despite a lack of formal training in health 
psychology and quantitative methods, my experience as a cardiac nurse coupled with my 
limited experience of research in illness representations, motivated me to pursue this area 
of study. This led to the development of the aims and objectives of the research, stated 
below.  
 
1.3 AIMS AND OBJECTIVES 
 
The aims of the research were: 
1. To explore illness representations, treatment beliefs and self-care in heart failure. 
2. To determine relationships between illness representations, treatment beliefs  
      and self-care in heart failure. 
 
The objectives were: 
1.  To conduct semi-structured interviews with a sample of heart failure patients to explore   
      illness representations, treatment beliefs and self-care. 
2.  To adapt or develop as necessary, questionnaires measuring illness representations,   
treatment beliefs, socio-demographic factors and self-care in heart failure. 
3. To use these questionnaires to determine relationships between these variables in a  
cross-sectional survey.  
 
1.4 THE RESEARCH SETTING AND AN OVERVIEW OF THE RESEARCH DESIGN  
 
The study was conducted in three NHS Primary Care Trusts (PCTs) in the South East of 
England, in a sample of community-based patients with heart failure. These sites were 
selected on the basis of convenience as they were local and easily accessible. 
Community heart failure patients, rather than those in acute services, were chosen as 
these patients were living with their illness on a day-to-day basis, reflecting routine self-
care rather than during brief episodes of acute exacerbation of symptoms. Ethically, it also 
seemed to be inappropriate to ask patients to participate in research when they were 
acutely unwell and physically and emotionally more vulnerable.  
 
A mixed methods research design was chosen using an exploratory, instrument 
development model as defined by Creswell and Plano Clark (2007). An exploratory model 
is described as occurring in two phases, where the results of the first, qualitative method 
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inform the second, quantitative method. The central premise of this design is that an initial 
exploration of the topic is necessary. In the instrument development model, phase one is 
the collection of qualitative data to explore a phenomenon which builds to a quantitative 
phase by developing instruments which are then used to collect quantitative data. 
 
This research, therefore, was conducted in two sequential phases. Phase one explored 
illness representations, treatment beliefs and self-care in heart failure from a patient 
perspective, using semi-structured interviews. Based on the findings of these interviews 
and using an expert group of HFNs, three questionnaires were adapted, largely from pre-
existing instruments, to measure illness representations, treatment beliefs and self-care. A 
questionnaire measuring socio-demographic characteristics was also developed. These 
four questionnaires were then used to collect quantitative data in phase two of the 
research, where relationships between illness representations, treatment beliefs, socio-
demographic factors and self-care were assessed in a cross-sectional survey.  
 
This research design was chosen as it was felt that illness representations, treatment 
beliefs and self-care had not been adequately explored in a UK population of heart failure 
patients. Although instruments have been developed to assess illness representations 
and treatment beliefs, most notably the Revised Illness Perception Questionnaire (IPQ-R) 
(Moss-Morris et al, 2002) and the Beliefs about Medication Questionnaire (BMQ) (Horne 
et al, 1999), these are not illness-specific. Albert and Zeller (2007) developed the Survey 
of Illness Beliefs in Heart Failure Tool (SIBHFT) based on the CSM but measuring the 
accuracy and certainty of illness beliefs rather than the nature of illness beliefs per se. 
Questionnaires measuring self-care in heart failure have been developed, most notably 
the European Heart Failure Self-care Behaviour Scale (EHFScBS) (Jaarsma et al, 2003), 
although it has been argued that its use should be further explored in a UK population 
(Shuldham et al, 2007). These instruments are discussed in Chapter two. 
 
1.5   STRUCTURE OF THE THESIS 
 
This thesis is organised into eight chapters according to the main arguments and 
processes of the research. Chapter two reviews the literature pertinent to the topic and 
provides the context for the study. Chapter three discusses the methodology and locates 
the research within the philosophical paradigm of pragmatism. The research design is 
identified as mixed methods and an overview of the methods is provided. Chapter four 
discusses the methods and results of phase one, the qualitative interviews. Chapter five 
describes the pilot study and the adaptation and testing of the questionnaires to be used 
in phase two, the quantitative survey. Chapter six discusses the methods and results of 
phase two. Chapter seven integrates the findings of the qualitative and quantitative 
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phases in an overall discussion according to the aims of the study. The strengths and 
limitations of the methodology are discussed and the implications for health and social 
care practice are considered before suggesting opportunities for future research. Chapter 
eight summarises the study and concludes by examining the extent to which the aims of 
the research have been met.  
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CHAPTER TWO:  LITERATURE REVIEW  
 
The previous chapter has given an overview of the design and aims and objectives of the 
research. The care of patients with heart failure has been identified as a significant clinical 
issue with self-care seen as an important aspect of management. This chapter explores, 
in more detail, the literature relating to key areas of the study, namely, the nature and 
management of heart failure from a biomedical viewpoint, lay beliefs and social and 
psychological perspectives of health, illness and treatment, self-care within a health and 
social care policy framework and factors known to influence self-care in heart failure 
including illness and treatment beliefs.  
 
In accessing the literature, the electronic databases of ASSIA, British Nursing Index, 
CINAHL, Cochrane, Medline, PsychINFO and ScienceDirect were searched using key 
terms of „heart failure‟, „lay beliefs‟, „Illness beliefs‟ „illness perceptions‟, „illness 
representations‟, „treatment beliefs‟, „self-care‟ and „self-management‟. These were used 
singularly and in combination. No limits were imposed in terms of publication dates in 
order to source all relevant articles.  Leading authors were searched for by name, for 
example, „Leventhal‟, „Weinman‟, „Horne‟, „Jaarsma‟ and „Riegel‟. Key journals were also 
selected individually and searched, for example, the British Journal of Cardiac Nursing, 
British Journal of Health Psychology, European Journal of Cardiovascular Nursing, 
Psychology and Health, and the Sociology of Health and Illness.  The abstracts of 
accessed articles were scrutinised for relevance to the topic and full text copies were 
obtained where appropriate. The reference lists of sourced articles were also checked for 
other relevant literature. The websites of the DH, NICE, the British Heart Foundation 
(BHF), local NHS Trusts, the British Society of Cardiology (BSC), the European Society of 
Cardiology (ESC), the American Heart Association (AHA), the British Psychological 
Society (BPS) and the European Psychological Society (EPS) were also accessed and 
searched. Relevant conference proceedings and theses or „grey literature‟ (Polit and 
Hungler, 2001) were accessed. Research supervisors and colleagues also recommended 
specific articles, topics and authors. ZETOC alerts were set up by e-mail so that newly 
published work by key authors and in key topic areas could be identified. In this way the 
literature was continuously updated. No new literature was included after December 2010 
when the thesis was in the final stages of completion.  
 
2.1 THE NATURE AND MANAGEMENT OF HEART FAILURE  
 
This section begins by defining the term heart failure and explores the difficulties this 
presents. The importance of heart failure in epidemiological terms, its presentation and 
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clinical management will then be discussed according to a predominantly biomedical 
model. The purpose of this is not only to justify the selection of heart failure as an 
important topic and the focus of this thesis but also to set out the dominant, established 
view of the disease against which the individual experience of the illness can be 
compared. By integrating professional and lay perspectives of heart failure in this way, it is 
hoped that a more inclusive representation of the illness emerges.  
 
2.1.1 Defining heart failure  
Defining what the term heart failure means is problematic not least because it is thought of 
as an umbrella term for a number of cardiac muscle abnormalities or cardiomyopathies 
(Nicholson, 2007). As stated in the previous chapter, the definition of heart failure by NICE 
(2010) has been adopted in this thesis as it is current and authoritative whilst being broad 
enough to include the many different forms of the condition:  
 
 ‘A complex clinical syndrome of symptoms and signs that suggest impairment of 
the heart as a pump supporting physiological circulation’ (NICE, 2010, p.19) 
 
Describing exactly how the heart is failing or identifying the specific cardiomyopathy can 
be useful in determining the cause of the illness and guiding clinical management. The 
World Health Organisation (WHO) brought together a list of the main cardiomyopathies 
which covered the majority of cases of heart failure. The American Heart Association 
(AHA) has since revised this list which is now used to describe the various types of heart 
failure in the UK, Europe and the US (Maron et al, 2006) (Table 2.1). 
 
According to the AHA (Maron et al, 2006), cardiomyopathies are classified as primary or 
secondary and can be characterised as structural or functional pathological changes. 
Terms such as „dilated‟ or „hypertrophic‟ cardiomyopathy define the structural changes 
that occur within the myocardium or heart muscle. Functional changes in cardiac 
performance such as „systolic‟ or „diastolic‟ failure can also be described whilst „left‟ and 
„right‟ ventricular failure specifies the location of the disorder. In addition, the duration of 
the abnormality can be described with the terms „acute‟ or „chronic‟ widely used. Most 
recently, NICE (2010) divides heart failure into Left Ventricular Systolic Dysfunction 
(LVSD), which accounts for approximately 50% of all cases of heart failure in the UK, and 
Heart Failure with Preserved Ejection Fraction (HF-PEF), based on echocardiographic 
findings. 
 
Heart failure is the preferred overarching clinical term in the UK (DH, 2000a), although 
other terms such „cardiac failure‟, „congestive cardiac failure‟ (CCF) and „left ventricular 
failure‟ (LVF) are still prevalent in the literature and used by clinicians. As a result, the 
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patient may be presented with an array of labels describing a complex condition which 
may make understanding the illness difficult for them and their families.  
Table 2.1 The American Heart Association (AHA) Classification of Cardiomyopathies 
Primary Cardiomyopathies 
Genetics  Hypertrophic Cardiomyopathy  Arrhythmogenic Right Ventricular Dysplasia (ARVD)  Conduction System Disease (Lenerge Disease)  Ion Channel Diseases (e.g Brugada Syndrome) 
Mixed (Genetic and Non-
genetic 
 Dilated Cardiomyopathy  Primary Restrictive Non-Hypertrophied Cardiomyopathy 
Acquired  Myocarditis  Stress (Tako-Tsubo) Cardiomyopathy  Peripartum Cardiomyopathy  Arrhythmia Induced Cardiomyopathy  Alcoholic Cardiomyopathy 
Secondary Cardiomyopathies 
Infiltrative  Amyloidosis  Gaucher Disease  Hurler‟s Disease, Hunter‟s Disease 
Storage  Haemochromatosis  Fabry‟s Disease  Glycogen Storage Disease  Nieman-Pick Disease 
Toxicity  Drugs, Chemicals  Heavy Metals 
Endomyocardial  Endomyocardial Fibrosis  Loeffler‟s Endocarditis 
Inflammatory  Sarcoidosis 
Endocrine  Diabetes Mellitus  Hyper/Hypothyroidism, Hyperparathyroidism  Phaeochromocytoma  Acromegaly 
Cardiofacial  Noonan Syndrome  Lentiginosis 
Neuromuscular/Neurological  Friedriech‟s Ataxia  Duchenne-Becker Muscular Dystrophy   Myotonic Dystrophy 
Nutritional Deficiencies  Beriberi, Scurvy  Pallagra  Selenium  Carnitine 
Autoimmune/Collagen  Systemic Lupus Erythema  Dermatomyositis  Rheumatoid Arthritis  Scleroderma  Polyarteritis Nodosa  Electrolyte Imbalance 
Post-Cancer Treatment 
 
Maron et al (2006, p. 8) 
 Radiation  Drugs (Anthracyclines, Cyclophosphamide) 
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The number of different ways in which heart failure can be defined is not simply an issue 
of semantics but has practical implications in terms of service development and delivery, 
the collection of epidemiological data and, not least, the patient and their family. In relation 
to GP funding, only the specific term Left Ventricular Systolic Dysfunction (LVSD) is 
currently recognised as heart failure. The likely outcome of this is to limit the number of 
people diagnosed, with subsequent limitation of resources. However, the inclusion of 
Heart Failure with Preserved Ejection Fraction (HF-PEF) in the new NICE (2010) guideline 
may go some way to redress this in the future.  
 
2.1.2 Epidemiology of heart failure  
Despite recent advances in the understanding of heart failure, it is not a new condition. 
Symptoms are described in classical literature and the Romans described the therapeutic 
and toxic effects of foxglove (digitalis) on the heart.  In 1795, a Birmingham physician, 
William Withering, published a case study on the treatment of a patient with „dropsy‟ 
(believed to be heart failure) with digitalis (Nicholson, 2007). 
 
Epidemiological data on heart disease is collated regularly by the British Heart Foundation 
(BHF) and published as „heartstats‟ (www.heartstats.org). The General Practice Research 
Database (GPRD) describes incidence increasing with age with a 60% higher incidence of 
heart failure amongst men, compared to women. 28,000 new cases of heart failure per 
year are estimated (Scarborough et al, 2010). 
 
In relation to prevalence, NICE (2003) gives prevalence rates of 3-20 people (0.3-2%) per 
1,000 in all age groups and 30-130 per 1,000 (3-13%) in those over 75 years of age. The 
Hillingdon Heart Study found a prevalence rate of 0.9% rising to 7.4% (Cowie et al, 1999). 
The MONICA study conducted in Glasgow, found a rate of 1.2-2.9% (McDonagh et al, 
1997). The Heart of England Study (Davies et al, 2001), conducted in the West Midlands, 
estimated the overall prevalence of heart failure to be over 2% with a further 1% with 
„probable‟ heart failure. Prevalence rates were between 6-7% in those aged 75 to 84 
years, increasing to between 12-22% in those aged 85 years and over. The GPRD 
estimates overall prevalence rates to be 0.9% in men and 0.7% in women. In those aged 
over 75 years, prevalence rates rise to 13.7% in men and 12.5% in women (Scarborough, 
2010). NICE (2010) predict that the number of people with heart failure will rise due to 
increasing survival rates for CHD, more effective treatments for heart failure and an 
ageing population. Added to this is the likelihood that more patients will be diagnosed with 
heart failure as the availability of diagnostic investigations increase (Nicholson, 2007).  
 
The total annual cost of heart failure to the NHS has been estimated at around 2% of the 
total budget with 70% of these costs due to hospitalisation (Petersen et al, 2002). The 
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number of in-patient episodes in 2008/9 has been recorded as in excess of 100,000 with 
associated high financial costs (Scarborough, 2010). Admission rates rise steeply in those 
over 85 years of age and readmission rates are high with one in four patients returning to 
hospital within three months (Cleland et al, 2003). Admission rates are predicted to rise by 
50% over the next 25 years as the prevalence of the disease increases (Petersen et al, 
2002).  
 
Primary care costs are also high with the cost of GP consultations estimated at £45 million 
per year. Community-based drug therapy is estimated to cost £129 million per year 
(Stewart and Horowitz, 2002). Financial costs to the individual are more difficult to quantify 
but may arise from prescription costs, attendance at clinics, hospital stays, loss of 
earnings and required modifications to the home (NICE, 2010). 
 
The prognosis for heart failure is poor. The Hillingdon Heart Study (Cowie et al, 1999) 
found that 40% of people died within the first year following diagnosis although there is 
evidence of an improving picture with six month mortality falling from 26% in 1995 to 14% 
in 2005 (Mehta et al, 2009).  Mortality is less than 10% per year, thereafter (Hobbs et al, 
2007). Within the context of other life-threatening illnesses, the prognosis in heart failure is 
worse than many types of cancers (Cowie, 2003). However, unlike cancer, prognostic 
markers are highly variable, making accurate prediction of prognosis difficult. The severity 
of the illness is best indicated by echocardiography findings. In addition, the New York 
Heart Association (NYHA) functional classification of heart failure (NYHA, 1984) (Table 
2.2), indicates decreasing functional ability from classes I to IV where class IV represents 
the most limited functional ability due to symptoms.  
 
Table 2.2 The New York Heart Association (NYHA) Functional Classification of Heart 
Failure 
 
Class Patient Symptoms 
Class I  
(mild) 
 
No limitation of physical activity. Ordinary physical activity does not cause 
undue fatigue, palpitations or dyspnoea. 
Class II  
(mild) 
 
Slight limitation of physical activity. Comfortable at rest, but ordinary 
physical activity results in fatigue, palpitations or dyspnoea. 
Class III 
(moderate) 
 
Marked limitation of physical activity. Comfortable at rest, but less than 
ordinary activity causes fatigue, palpitations or dyspnoea. 
Class IV 
(severe) 
 
NYHA (1984, p.254) 
 
Unable to carry out any physical activity without discomfort. Symptoms of 
cardiac insufficiency at rest. If any physical activity is undertaken, 
discomfort is increased. 
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However, the NYHA classification has limited ability to accurately predict prognosis with 
patients classified as IV being stable for many years or those classified at II or III dying 
earlier than expected. The reasons for this are complex, not least because of the high 
degree of subjectivity in assigning classification. It has been noted that the patient‟s view 
of the severity of their illness according to functional ability, is poorly correlated with their 
doctor‟s assessment of their NYHA classification (Subramanian et al, 2005). The risk of 
sudden death due to an arrhythmia at any stage of heart failure is also a complicating 
factor. 
 
Biochemical markers have some use in determining prognosis, specifically B-type 
Natriuretic Peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NTproBNP) as well 
as measures of end-organ dysfunction such as renal failure (Nicholson, 2007). Such 
difficulties in predicting an accurate prognosis may mean that clinicians are reluctant to 
discuss end of life care with patients and their families which may add to a belief that the 
condition is not serious (Barnes et al, 2006).  
 
The presence of co-morbidities is common in patients with heart failure. CHD is three 
times more common than in the wider population and diabetes is twice as common. 
Depression is also prevalent. The prognosis for those with multiple morbidities is worse 
than for those without co-morbidities (Thomas and Velazquez, 2005).  
 
The progression of heart failure can be unpredictable. Patients may have poor functional 
ability on diagnosis which may improve with treatment. Patients may also become acutely 
ill during periods of decompensation when the heart‟s ability to provide an adequate 
circulation is compromised. Although a recovery can be made, often individuals never 
quite regain their previous functional level. Functional level continues to deteriorate with 
more frequent periods of decompensation until eventually the heart cannot compensate 
and the patient dies. It has been suggested that given the poor functional level of patients 
with heart failure throughout their illness, their last day is often no different from any other 
(Cowie, 2008). 
  
2.1.3 Causes, symptoms and the diagnosis of heart failure – a health professional 
perspective  
 
Establishing the cause of heart failure is clinically important since some causes are 
reversible such as anaemia or thyrotoxicosis, or can be markedly improved by valve 
surgery, for example. Similarly, prognosis varies according to underlying pathology. 
Establishing a cause may also be important from a patient perspective in order to 
understand their illness. Many patients will have had chronic heart failure for a number of 
years and may also have co-morbidities which can make it difficult to establish an actual 
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or probable cause. As a result, the aetiology of heart failure is unknown in 20% of cases 
(Fox et al, 2001).  
 
Where the cause of heart failure is known, it is most commonly due to CHD, with 
hypertension, valve disease, cardiac arrhythmias, alcohol, infection, diabetes, genetic 
conditions and drug-induced heart failure also documented. Rare causes of heart failure 
include congenital abnormalities, pregnancy, amyloidosis and sarcoidosis (Cowie et al, 
1999).   
 
CHD, particularly myocardial infarction (MI), is the most common cause of heart failure by 
far. Fox et al (2001) found that heart failure was caused by CHD in 52% of cases in those 
less than 75 years of age. In this study, CHD was confirmed by angiography and the 
authors suggest that the diagnosis of CHD is underestimated in people who have not had 
angiograms carried out. Other studies suggest CHD accounts for between a half and 
three quarters of cases (Zannad et al, 1999; Mair et al, 1996). The DH (2003) suggests 
that in the UK, most cases of heart failure are due to CHD with about one third due to 
hypertension. An increasingly elderly population and advances in the management of MI 
has meant that more people are living longer with the effects of cardiac damage. The 
relationship between MI and heart failure is complex with pathological changes occurring 
over time leading to changes in the size and shape of the myocardium, known as cardiac 
remodelling. The result is a larger but less effective ventricular pump (Nicholson, 2007). 
The role of angina in the development of heart failure is less clear. Ongoing ischaemic 
episodes, characteristic of angina, may have a negative effect on cardiac contraction and 
precipitate heart failure (Elhendy et al, 2005). Furthermore, a number of established risk 
factors for CHD are also independent causes of heart failure, most notably diabetes and 
hypertension. As a result, multiple causes of heart failure may co-exist. The Framingham 
study, a large scale, US longitudinal study of heart disease, found that over 90% of 
patients with heart failure had CHD and/or hypertension (Kannel and Belanger, 1991).  
 
Hypertension is believed to be the second most common cause of heart failure in the 
developed world (Meredith and Ostergren, 2006). Fox et al (2001) found CHD to be the 
prime cause of heart failure but hypertension was present in 40% of patients. Whilst 
severe, malignant hypertension can occur, it is likely that chronic hypertension is the 
cause of most hypertension-related heart failure. In hypertension, the structure and 
function of cardiac muscle fibres is thought to be altered. Increased afterload or the 
pressure against which the heart has to pump is increased. This results in myocardial 
fibres becoming over-stretched and cardiac remodelling occurs (Nicholson, 2007).  
Hypertension may be more closely related to diastolic rather than systolic dysfunction 
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(Chinnaiyan et al, 2007). Hypertension is frequently „silent‟ with no symptoms and is 
thought to be under-diagnosed and sub-optimally managed. Even in a patient in whom 
hypertension has been controlled, damage to the myocardium may have occurred before 
treatment commenced. Furthermore, even if the blood pressure is normal, this may have 
fallen as a result of pump failure - so-called „burn-out‟ hypertension (Nicholson, 2007).  
Determining hypertension as a cause of heart failure can, therefore, be difficult.  
 
Valve disease is another significant cause of heart failure. Figures vary from 7% of cases 
in the Hillingdon Heart Study (Cowie et al, 1999) to 10% in the study by Fox et al (2001). 
However, establishing valve disease as a cause is also problematic as valve 
abnormalities can be a consequence of heart failure due to distortion of the valves leading 
to problems with the flow of blood through the heart. Valve disease caused by rheumatic 
fever, infection or MI, for example, can be a cause of heart failure as reduced efficiency of 
the valves leads to changes in pressures within the chambers of the heart which over 
time, leads to structural changes, hypertrophy and cardiac remodelling with resultant loss 
of function (Nicholson, 2007).  
 
Cardiac arrhythmias, like valve disease, can be both a cause and consequence of heart 
failure. Arrhythmias, especially atrial fibrillation, can cause permanent structural and 
functional abnormalities of cardiac muscle as turbulent blood flow through the heart 
reduces its efficiency. As a consequence of heart failure, atrial fibrillation is brought about 
by the abnormal structure and functioning of cardiac muscle leading to abnormal 
conduction and chaotic electrical activity. Fox et al (2001) identified lone atrial fibrillation 
as the cause of heart failure in 3% of cases. In the Hillingdon Heart Study up to 30% of 
people with heart failure had atrial fibrillation either as a cause or consequence of the 
illness (Cowie et al, 1999).  
 
Alcoholic cardiomyopathy may develop in patients with a history of excessive alcohol 
intake. Alcohol alone is believed to be the cause in 4% of cases of heart failure (Fox et al, 
2001). The mechanism is dependent on the toxic effect of alcohol on the heart causing 
cellular damage and cardiac dilation. With early abstinence from alcohol this damage may 
be reversible (Nicholson, 2007).  
 
Causes such as infection, diabetes, genetic illnesses and drugs make up approximately 
5% of heart failure cases (Fox et al, 2001). Though uncommon, acute viral myocarditis is 
the primary cause of heart failure in younger patients (Burian et al, 2005). The coxsackie 
virus is the most common agent but measles, mumps, rubella, and chickenpox are also 
potential causes. Other infective disorders are rheumatic fever, Chagas disease and 
human immunodeficiency virus (HIV) (Burian et al, 2005). Where infection is the cause, 
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patients may become very ill, very quickly with acute heart failure and life-threatening 
arrhythmias. Diabetes may be an independent cause of heart failure in that the metabolic 
effects of poor glycaemic control can cause remodelling of the myocardium and dilated 
cardiomyopathy (Bertoni et al, 2006).  
 
Some specific types of cardiomyopathy, such as Hypertrophic Obstructive 
Cardiomyopathy (HOCM), are due to a genetic abnormality and are hereditary. Patients 
often present at a young age with symptoms of heart failure or related complications such 
as arrhythmias. Unfortunately, the first indication of this may be sudden death. Individuals 
may be identified through family screening, especially when sudden cardiac death has 
occurred in the family. Heart failure may also be iatrogenic. Chemotherapy, for example, 
can cause damage to myocardial cells. Acute cytotoxicity in the first year following 
treatment is thought to occur in up to 50% of patients. Long-term effects are also 
observed (Nicholson, 2007).  
 
Although currently uncommon, the number of heart failure patients with congenital heart 
abnormalities is likely to increase. For the first time, there is now a population of young 
adults who have had cardiac surgery in infancy. The long-term consequence of this, for 
some patients, is heart failure (Nicholson, 2007). Heart failure in pregnancy is also rare 
occurring in 1 in 2,400 to 1 in 15,000 births in the western world. It is a recognised cause 
of maternal death before, during and in the first few months following delivery (Fox et al, 
2001). The mechanism is unclear although it may be due to the haemodynamic stress of 
pregnancy and birth or a response to an immunocological breakdown between the mother 
and the foetus leading to cardiac inflammation (Nicholson, 2007). Amyloidosis and 
sarcoidosis are systemic diseases which are also rare causes of heart failure occurring 
when amyloid or sarcoid tissue infiltrates the myocardium leading to fibrosis and impaired 
contractility (Nicholson, 2007).  
 
Given the difficulties in determining the cause of heart failure, recognising symptoms and 
clinical signs is especially important for diagnosis. Symptoms are the subjective 
experience of sensations as described by patients. In contrast, signs are objective, clinical 
observations. The recognition of signs and symptoms that have high sensitivity and 
specificity for heart failure is a key requirement for diagnosis and treatment.  A number of 
large studies have sought to identify symptoms relating to heart failure. In these studies, 
the most prevalent symptoms of heart failure were identified as breathlessness, 
particularly on exertion (Ahmed et al, 2004; Badgett et al 1997; Harlan, 1977) and 
peripheral, ankle oedema (Ahmed et al, 2004; Fonseca et al, 2004; Badgett et al 1997; 
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Davie et al, 1996; Harlan, 1977). NICE (2010) identify breathlessness, fatigue and ankle 
swelling as the most common symptoms of heart failure.  
 
Breathlessness, described as difficulty in breathing (dyspnoea) or shortness of breath, can 
occur on exertion or at rest and is commonly experienced when lying flat (orthopnoea). 
However, not all patients with heart failure experience breathlessness and this symptom 
may exist for many other reasons. The origin of breathlessness in heart failure is multi-
faceted. Impaired cardiac function means that the increased oxygen demands of the body 
during exercise cannot be met. As a result, the exercise threshold is reached early with 
increasing breathlessness and resulting poor exercise tolerance.  Breathlessness at rest 
occurs in severe heart failure and may result from the reduced ability of the left ventricle to 
empty, leading to a build-up of fluid and increased pressure in the lungs which forces fluid 
out of the pulmonary circulation into the alveoli with subsequently reduced gaseous 
exchange and hypoxaemia. Patients may be told they have „fluid on the lungs‟. The 
presence of white or blood-stained, frothy sputum and a cough is associated with 
dyspnoea as a result of fluid-build up.  
 
Alternatively, breathlessness at rest may be due to chronic increased pressure in the 
lungs causing the lungs to become inelastic. In this case the lungs may be described as 
„dry‟. A wheeze may be heard which can lead to a respiratory disorder being erroneously 
diagnosed. Worsening of dyspnoea in heart failure is often due to complicating factors 
such as a chest infection. Orthopnoea is a prevalent symptom in heart failure, 
consequently, patients may sleep upright with a number of pillows or sleep in an armchair. 
In severe heart failure, paroxysmal nocturnal dyspnoea may occur where patients report 
waking suddenly, a few hours after going to bed, in a state of extreme breathlessness and 
anxiety. Both orthopnoea and paroxysmal nocturnal dyspnoea are more specific 
symptoms of heart failure than breathlessness alone. Other sleep disturbances have been 
described, for example, insomnia and sleep apnoea have been linked with increased 
disease severity and poor prognosis (Merritt, 2004).   
 
Systemic fluid retention is another classical symptom of heart failure. Fluid retention 
occurs as a compensatory physiological response to a falling cardiac output. This excess 
fluid is forced into the tissues as a result of osmotic and hydrostatic forces. Commonly, 
this occurs in the ankles due to the effects of gravity. If fluid continues to build-up, it is 
forced higher into the sacrum and abdomen (ascites) leading to nausea and loss of 
appetite. The first detectable sign of fluid build-up is often weight gain. Patients may notice 
clothes feeling tight or difficulty in putting shoes on. Ankle oedema is bi-lateral and 
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described as „pitting‟ where the tissue is soft and can be compressed leaving an 
indentation which persists for several minutes (Nicholson, 2007).  
 
Ahmed et al, (2004) have documented fatigue or tiredness as a prevalent symptom of 
heart failure. The cause of fatigue may be due to a number of factors both physical and 
psychological. Reduced blood flow to skeletal muscle with resulting poor exercise 
tolerance may be one factor (Jackson et al, 2000). Depression, prevalent in heart failure, 
may also result in feelings of tiredness. Poor quality of sleep due to symptoms and the 
effects of medication, especially diuretics, may be contributing factors.  
 
Sexual dysfunction has been cited as a symptom of heart failure and it is likely that this is 
more common than documented due to a lack of reporting. Reduced peripheral circulation 
may impair sexual functioning. The use of drugs commonly used in heart failure such as 
Angiotensin Converting Enzyme Inhibitors (ACEI) and beta-blockers may further reduce 
blood supply or affect libido directly. Depression may be a contributing factor (Leventhal et 
al, 2005). Cognitive impairment is reported in heart failure due to chronic under-perfusion 
of the brain. Forgetfulness, difficulty in making decisions, light-headedness or dizziness 
are well documented (Bennett and Sauve, 2003).  
 
As well as symptoms which can be attributed to heart failure, a number of other symptoms 
frequently co-exist. Arrhythmias, experienced as palpitations, dizziness or blackouts 
(syncope) can be a cause or consequence of heart failure. The presence of CHD may 
mean that symptoms such as chest pain also occur.   
 
Clinical signs of heart failure include changes in haemodynamic parameters of pulse 
including rate, regularity, character and volume, changes in blood pressure and a raised 
jugular venous pressure. A third heart sound (S3), a gallop rhythm and a displaced apex 
beat may be heard on physical examination as well as lung crepitations and a wheeze 
(Ahmed et al, 2004; Fonseca et al, 2004; Drazner et al, 2003; Badgett et al, 1997; Davie 
et al, 1996; Harlan, 1977). Anaemia may be present as a consequence of reduced blood 
flow to the gut resulting in lack of iron absorption and signs of malnutrition.  
 
Along with an exploration of symptoms and physical examination, patients may undergo a 
number of investigations to confirm a diagnosis of heart failure. According to NICE (2010), 
those with a clinical history of heart failure and previous MI should be referred for an 
echocardiogram, reflecting the significance of MI as the most common cause of heart 
failure in the UK. In those without a previous MI, a blood test to detect BNP or NTproBNP 
is advocated which, if positive, should prompt a referral for an echocardiograph. Other 
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investigations include a 12-lead electrocardiogram (ECG), chest x-ray and further blood 
tests to monitor organ function.  
 
NICE (2010) emphasise that a full evaluation of the patient is required which includes the 
identification of the underlying abnormality of the heart, the severity of the illness, the 
cause, precipitating and exacerbating factors, identification of co-morbidities and 
estimation of prognosis. 
 
2.1.4 The management of heart failure 
The management of heart failure can be considered in terms of pharmacological 
interventions and invasive procedures. Medicines have been described as „The mainstay 
of heart failure management. They have a positive impact on symptoms, quality of life and 
prognosis’ (Nicholson, 2007, p.135).  
 
There is an extensive evidence base with explicit recommendations in England and Wales 
from NICE (2010), in relation to drug therapy. Angiotensin II converting enzyme inhibitors 
(ACEIs) and beta-blockers are advocated as first line treatment in heart failure. An 
angiotensin receptor blocker is recommended in those intolerant of ACEIs. Second line 
treatment includes aldosterone antagonists, diuretics and hydralazine in combination with 
nitrates and digoxin. The types of medicines, their actions and potential side-effects are 
outlined below.  
 
ACEIs have revolutionised the management of heart failure and are recommended in all 
patients due to their significant ability to improve symptoms, prognosis and reduce 
hospitalisation rates (Cowie et al, 1999). ACEIs competitively block the actions of 
angiotensin converting enzyme leading to vasodilation and reduced workload of the heart. 
The action of aldosterone is also blocked leading to salt and water excretion and reduced 
fluid build-up. As a result, ACEIs improve symptoms of breathlessness and oedema and 
also prevent cardiac remodelling in the longer term. The most significant side-effects of 
ACEIs are hypotension and resulting dizziness, renal dysfunction, electrolyte imbalances 
and a dry, irritating cough. ACEIs are started at a low dose and titrated upwards to a 
target dose as tolerated – a „start low, go slow‟ approach to medication management 
(NICE, 2010). Angiotensin receptor blockers work in a similar way to ACEIs but block 
angiotensin II receptors rather than angiotensin converting enzyme, producing fewer side-
effects. Angiotensin receptor blockers may be used in patients who cannot tolerate an 
ACEI or as second line treatment if symptoms persist (NICE, 2010). 
 
Like ACEIs, the evidence base for beta-blockers is extensive with proven mortality 
benefits (Cowie et al, 1999). Beta-blockers reduce the workload of the heart by 
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competitively blocking the receptor sites for adrenalin and reducing heart rate and blood 
pressure. Ventricular filling time is increased leading to improved contractility. The 
potential for arrhythmias is also reduced. Bronchospasm is a serious side effect and the 
heart rate may be slowed to such an extent that bradycardias and heart blocks develop. 
Hypotension, peripheral coldness, impotence and depression are recognised side-effects 
(British Medical Association, 2010). As with ACEIs, beta-blockers are commonly up-
titrated to a target dose as tolerated.  
 
Aldosterone antagonists block the effects of aldosterone, preventing fluid build-up and 
improving symptoms and prognosis in moderate to severe heart failure (Cowie et al, 
1999). Complications of aldosterone antagonists include a potassium imbalance with a 
resulting increased risk of cardiac arrhythmias. 
 
Diuretics are prescribed to remove excess systemic and pulmonary fluid and to prevent 
fluid retention. Hence, they improve symptoms of breathlessness and oedema. They also 
have a vasodilator effect so that preload and cardiac workload is reduced. Diuretics can 
cause renal dysfunction due to a primary effect on the kidneys and reduced blood 
pressure. Over-diuresis can lead to dehydration, electrolyte imbalance, postural 
hypotension and resulting dizziness (Nicholson, 2007). 
 
The combination of hydralazine and nitrates also has vasodilatory effects, reducing the 
work of the heart and improving symptoms and long-term mortality, especially in patients 
of African or Caribbean origin with moderate to severe heart failure (NICE, 2010). Digoxin 
is used to reduce heart rate and improve cardiac contractility. Historically the main drug 
used in heart failure, its use is now largely confined to patients with atrial tachycardias. 
 
A number of medicines are contra-indicated in heart failure, the most important of which 
are non-steroidal anti-inflammatory drugs (NSAIDs) which increase fluid retention. 
NSAIDs, for example, ibuprofen, are common analgesic, anti-inflammatory and anti-
pyretic drugs and are frequently found in over-the-counter analgesics and cold and flu 
remedies. 
 
Invasive treatments are becoming more frequently used in patients with heart failure. 
These can be summarised as either cardiac surgery or pacemaker devices. Cardiac 
transplant is the only curative procedure available for heart failure but has been likened to 
throwing a single lifeboat to a sinking Titanic! (Cowie, 2008). The lack of available donors 
and the unsuitability of most patients with heart failure to undergo major cardiac surgery 
mean that transplantation is not a realistic option for the majority of patients. Only 200-300 
patients underwent cardiac transplantation in 2009, of which only 14% of recipients were 
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over 60 years of age (www.uk.transplant.org). Valve repair or replacement with a synthetic 
valve is possible where valve disease is the cause of heart failure. Cardiac assist devices 
or intra-aortic balloon pumps are used mainly in patients with severe heart failure as a 
bridge to transplantation.  
 
The insertion of a permanent pacemaker to regulate the heart rhythm is a routine 
intervention in heart failure patients with arrhythmias. Increasingly, internal cardioverter 
defibrillators (ICDs) are inserted to terminate life-threatening arrhythmias. Cardiac 
resynchronisation therapy or bi-ventricular pacemakers are used to co-ordinate muscle 
contraction and enhance cardiac output in moderate to severe heart failure. Cardiac 
resynchronisation is now frequently combined with a defibrillator function (NICE, 2010). 
 
Recommendations for monitoring the patient with heart failure are also given by NICE 
(2010). These include an ongoing assessment of functional ability, fluid status, heart 
rhythm, cognitive and nutritional status, regular review of medication including side-effects 
and blood tests to monitor electrolytes and renal function. The frequency of monitoring is 
dependent on the clinical stability of the patient. Although monitoring is largely seen as the 
responsibility of the health professional, patient-initiated electronic telemonitoring, where 
physiological data are transferred from the patient‟s home to the healthcare provider is 
now becoming more common. However, NICE (2010) conclude that further research is 
needed to determine whether telemonitoring adds any benefit over care by a specialist, 
multi-disciplinary heart failure team.  
 
The involvement of specialists and the multi-disciplinary team in continuing care are 
pivotal in the management of patients with heart failure (NICE, 2010). The creation of the 
specialist heart failure nurse (HFN) role, largely funded and supported by the British Heart 
Foundation, through a £10 million grant from the New Opportunities Fund, seems to 
support this view.   
 
Sometimes, in spite of optimal management, there may come a point when patients reach 
the terminal or end-stage of their illness. The move to a palliative approach can be 
problematic as the course of the illness may be difficult to predict, as previously 
discussed. A palliative approach focuses on relieving symptoms, removing treatments that 
are no longer necessary and reducing suffering through physical, psychological and 
spiritual support. Diuretics, nitrates, opiate analgesics, saline nebulisers and breathing 
exercises can alleviate symptoms of breathlessness. Non-invasive ventilation may 
improve breathing if it can be tolerated by the patient. Sedatives aid sleep. Dietary 
modification, anti-emetics and laxatives alleviate symptoms of nausea and constipation as 
blood flow to the gut is reduced. Liquid food supplements may improve cachexia.  
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Issues of resuscitation need to be addressed, specifically, ICDs need to be de-activated. 
The psychological and spiritual needs of the patient should to be determined and 
addressed through advice, referral and actively sharing the experience of the patient and 
their family (NICE, 2003). Specialist palliative care services have largely been developed 
for patients with cancer and as such have traditionally been unavailable to patients with 
heart failure. However, this is changing with the recognition that access to palliative care 
should be available to all dying patients regardless of the disease pathology (NICE, 2003).  
 
Whilst medical, nursing and social care dominates the management of heart failure, there 
is growing recognition that patients should be involved in managing their illness. A 
partnership in care is envisaged with the patient, their family and health and social care 
professionals playing important roles. As well as adhering to medication regimes and 
monitoring and managing the effects of medication, it is advocated that patients adjust 
their lifestyle to take regular exercise, stop smoking, limit their alcohol intake, follow a 
balanced diet, reduce salt in their diet, limit fluid intake and monitor their fluid status 
(NICE, 2010; Nicholson, 2007). Exercise-based rehabilitation programmes and local 
support networks have been set up to facilitate this (NICE, 2010). The DH (2003), rather 
optimistically, suggests that patients who have a proper understanding of their condition 
and the role of different drugs are more likely to comply with their medication and to 
identify problems such as excessive weight gain early, and so are less likely to require 
admission to hospital.  
 
In conclusion, heart failure is a significant clinical condition which is predicted to become 
more widespread in the future. Healthcare costs are high and increasing. The level of 
functioning of patients with heart failure is poor and prognosis may be difficult to predict. 
Identifying the many types and causes of heart failure is difficult not least because of the 
relationship between cause and effect. Therefore, recognising the symptoms and clinical 
signs of heart failure is especially important. Management is mainly pharmacological 
although surgical and other interventions, such as pacemaker devices, are becoming 
increasingly common. There is an established evidence base, articulated by NICE (2003; 
2010) in relation to the diagnosis and management of heart failure. Within this, it is 
recognised that patients should play an active role in the management of their condition.  
 
In contrast to the biomedical view of the disease as discussed in this section, there follows 
a discussion of the literature regarding lay beliefs and social and psychological 
perspectives of health, illness and treatment.  
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2.2 LAY BELIEFS OF ILLNESS AND THE COMMON SENSE MODEL (CSM) OF 
ILLNESS COGNITIONS AND BEHAVIOUR 
 
This section begins by introducing lay beliefs about illness before discussing the common 
sense model (CSM) of illness cognitions and behaviour (Leventhal et al, 1980). The 
theoretical basis of treatment beliefs according to Horne (1997) and the relationship to the 
CSM will be analysed. The measurement of illness and treatment beliefs is also 
discussed.   
 
2.2.1 The experience of illness and the nature of lay beliefs 
Since the 1950s there has been a move away from a purely biomedical perspective of 
disease where there is an objective pathology and recognised signs, symptoms and time 
course, in favour of the concept of illness. 
 
Illness is defined by Kleinman (1988, p.3) as: 
 
‘The innately human experience of symptoms and suffering, referring to how the sick 
person and the members of the family or wider social network perceive, live with and 
respond to symptoms and disability’    
 
In sociological literature, a number of studies have been instrumental in contributing to the 
understanding of the illness experience from a social perspective. Glaser and Strauss 
(1967) described an illness trajectory which referred not just to the course of the illness 
but also to the work associated with it and the impact of this work on relationships. In long-
term conditions such as heart failure, the expectation of self-care and the need for 
frequent monitoring of the illness and its treatment may constitute a significant burden for 
the patient and their family.  
 
Bury (1982) described the experience of chronic illness in terms of biographical disruption, 
arguing that the experience of illness led to a fundamental rethinking of the individuals‟ 
biography and self-concept.  A biographical shift was described from a perceived normal 
trajectory with relatively predictable chronological steps to one which was abnormal and 
damaging. In heart failure and other long-term conditions, the presence of debilitating 
symptoms may require individuals to give up paid employment resulting in disruption to 
financial, social and psychological well-being. Bury (1982) also argued that biographical 
disruption affected not only the individual but also their relationships and practical aspects 
of life. Social networks and other resources were seen as crucial in determining how the 
illness was perceived. In heart failure, the effects of the illness may conceivably lead to a 
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greater reliance on close family members for emotional and practical support with a 
resultant change in social roles. 
 
Related to biographical disruption is the concept of loss of self, where former self-images 
are destroyed leading to restricted lives, social isolation and the feeling of being a burden 
to others (Charmaz, 1983). This theory was developed further by Williams (1983) who 
described the strategies people employed to create a sense of coherence and stability 
when faced with biographical disruption and loss of self. In heart failure, this search for 
stability is illustrated by Zambroski (2003) who described living with heart failure as 
navigating periods of turbulence before finding safe harbour through lifestyle changes and 
social re-adjustment. 
 
Viewing illness from an individual or „insider‟ perspective is integral to our understanding 
of the illness experience. Helman (1978) describes this as the „emic‟ perspective in which 
lay beliefs are central. Hughes (1968, p.88) defines lay beliefs about illness as: 
 
‘Those beliefs and practices relating to disease, which are the products of 
indigenous cultural development and are not explicitly derived from the conceptual 
framework of modern medicine’  
  
Russak and Friedman (1970) advanced this understanding by demonstrating that there 
were often fundamental differences between the biomedical and social understanding of 
illness in terms of causation, treatment and time-course, for example.  Similarly, 
Kleinman‟s work in the 1970s and 1980s challenged the biomedical view of what it means 
to be ill, highlighted cultural and societal beliefs in the illness experience (Kleinman, 
1988). Using case study examples, Kleinman argued that cultural influences and social 
norms helped shape individual beliefs about illness. This unique, personal understanding 
is in contrast to the view of disease as biologically determined and therefore, consistent 
and universal between individuals. As a result of these alternative viewpoints, there is the 
potential for conflict between the health professional and the patient in terms of the nature 
of the illness and the way in which it is best treated. This not only has implications for the 
relationship between the professional and the patient but also potentially, adherence to 
treatment. In recognition of this, Kleinman (1988) envisaged a model of clinical 
consultation consisting of an exploration of the patient‟s illness and treatment beliefs 
before the development of a negotiated treatment plan. Such a model illustrates the 
concept of concordance, or the process by which beliefs about the illness and its 
treatment are shared in an equal partnership between the individual and health 
professional (DH, 1997).  
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A number of explanatory models have been developed to categorise the nature of lay 
beliefs.   Blumhagen (1980) argued that people seek explanations for the illness in terms 
of aetiology, the timing and mode of onset, the pathophysiology, the time-course, the 
degree of sickness and its treatment. Similarly, Kleinman (1988) developed an 
explanatory model consisting of the nature of the illness or symptoms, reasons for the 
onset of symptoms at a particular time, causes of the illness, expected time-course, 
seriousness, the way in which the illness affected the patient‟s life and fears about the 
illness. Issues of perceived risk, vulnerability, compliance and satisfaction with care were 
seen as contributing factors to the development of beliefs. Rather than being formally 
organised, Kleinman (1988) argued that explanatory models were often incoherent and 
ambiguous and were time and context specific.  He argued that these models were often 
only constructed by the patient as a result of telling a narrative of their illness experience.  
 
Exploring lay beliefs is not, however, straightforward. Shaw (2002) argues that in western 
society, lay narratives of illness are in fact, accounts that have been filtered through 
medical or other health professionals and then owned by patients. That is, people re-
define their illness in line with professional definitions. He argues that in searching for 
meaning, people adopt expert, professional explanations and interpretations about their 
illness. Hence, patients may attempt to describe and explain their heart failure using 
medical terminology which may be poorly understood. Another difficulty in accessing lay 
beliefs, according to Cornwell (1984), is the disparity which may exist between patients‟ 
public and private accounts of their illness. Public accounts focus on widely accepted 
views which are likely to gain approval from, and be congruent with, the professional‟s 
viewpoint. Those opinions which might be considered unacceptable to the medical 
professional are not expressed, so that conflict is avoided.  
 
The assumption that the beliefs people hold about their illness relate to their behaviour or 
actions in some way, is important in terms of their influence on clinical outcomes. 
Although it has been suggested that beliefs may be employed as ex poste facto 
explanations of behaviour rather than as predictors of it (Dines, 1994), most authors, 
including Leventhal et al (1980), argue that beliefs influence and predict illness behaviours 
such as taking medication, visiting the doctor in response to symptoms or avoiding health-
damaging behaviours. As such, lay beliefs about health and illness form the foundation of 
a number of theoretical models which aim to explain and predict changes in health and 
illness behaviour.  
 
In summary, in contrast to a biomedical model of disease, the illness experience can be 
viewed from a sociological perspective in terms of biographical disruption and loss of self. 
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The study of lay beliefs enhances our understanding of the personal experience of illness 
or an emic perspective, and explanatory models such as that of Blumhagen (1980) and 
Kleinman (1988), have provided a general framework for examining lay beliefs. However, 
difficulties may exist in determining lay beliefs not least because of the prevailing medical 
culture in western society. Finally, lay beliefs are assumed to influence behaviour. The 
following section introduces the Common Sense Model (CSM) which has been developed 
from lay beliefs and used to explain and predict health and illness behaviour.    
 
2.2.2 The Common Sense Model (CSM) of illness cognitions and behaviour 
The common sense model (CSM) of illness cognitions and behaviour (Leventhal et al, 
1980) describes a process of self-regulation which involves goal setting, developing and 
enacting strategies to achieve these goals, appraising progress and revising goals and 
strategies (de Ridder and de Witt, 2006). Self-regulation is viewed as a dynamic, 
motivational system in which the management of emotional responses to the illness are 
also seen as important and intricately linked to cognitive processes.  
 
Historically, Leventhal and colleagues explored the concept of fear in influencing smoking 
behaviour. They found that whilst fear messages had some short-term effects in terms of 
behaviour, this was not maintained over time (Leventhal et al, 1997). They hypothesised 
that the processing of the health threat was separate from the processing of the fear 
emotion. The authors called this the „parallel response model‟. In the subsequently 
developed CSM, they explored the factors that led to the development of coping 
behaviours and called them „cognitive representations of illness‟ or „illness 
representations‟. They argued that these representations were generated in the minds of 
individuals and not imposed by the researcher. In this way, the CSM emphasises what the 
authors believe are intrinsic, personal, „common sense‟ beliefs about illness.  
 
The model is organised into three stages. Stage one is the „identification‟ stage which 
consists of illness representations and emotional responses. Stage two is „coping 
behaviours‟ which are generated in response to illness representations and emotional 
responses and stage three is the „appraisal‟ of these coping behaviours (Figure 2.1) 
 
The perception of stimuli, such as the occurrence of symptoms or health information, 
initiate illness representations so that the individual forms a picture of the condition based 
on current symptoms, contextual information and pre-existing beliefs. This guides the 
selection of coping responses, the outcomes of which are appraised in terms of 
eliminating the health threat, or controlling the illness or its consequences. Similarly, 
processing of the initial stimuli leads to the development of an emotional response which 
prompts the selection of coping responses aimed at controlling these emotions.  
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Figure 2.1 The Common Sense  Model (CSM) of Illness Cognitions and Behaviour  (Leventhal et al, 1980) 
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More recently, the concept of coherence is believed to be important within the model. 
Cameron and Leventhal (2003) describe this as the ‘if-then’ scenario. For example, ‘if I am 
suffering from a headache due to stresses at work today then taking two aspirin will 
eliminate the pain within 20-30 minutes’. In this way, a coherent picture of the illness and 
the behaviour is built up. If the illness representations, coping procedures and outcome 
enable the individual to form a consistent and coherent schema of the illness and its 
treatment, then beliefs and behaviour are reinforced.  
 
The model is self-regulatory in that it assumes that the individual is motivated to resolve 
the health threat and return to normality.  This is achieved through the existence of 
feedback processes where appraisal of coping responses feed back to the illness 
representations, modifying beliefs which may lead to the selection of alternative coping 
responses.  
 
A number of assumptions are inherent within the model. Firstly, that people are active 
problem solvers who use past experience and existing knowledge to formulate and 
respond to a health threat.  Secondly, many of the cognitive processes are not directly 
observable, rather observers make inferences based on what individuals say and do. 
Thirdly, the behaviour is both time- and situation-specific, that is, the process of 
constructing a representation of the illness and responding to it occurs within a specific 
time frame and contextual situation (Leventhal et al, 1980).   
 
In relation to the stages of the model, stage one, identification, consists of two sets of 
beliefs – illness representations and emotional responses to the illness. Illness 
representations are defined as ‘an organised set of beliefs regarding illness’ (Cameron 
and Moss-Morris, 2004, p.85). Scharloo and Kaptein (1997) propose that a number of 
other terms are synonymous with illness representations including illness cognitions, 
illness perceptions, illness beliefs and illness schemata. For the purpose of this thesis, the 
term illness representations will be used as they relate to the CSM.  
 
Lau and Hartmann (1983) identified five illness representations: identity, cause, timeline, 
consequences and cure and control.  Bishop (1991), cited by Leventhal et al (1997), found 
that, when patients were asked to describe their experience of illness, 90% of responses 
fell into these five categories.  The CSM incorporates these five key dimensions of illness 
representations as summarised in Table 2.3. 
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Table 2.3 Illness Representations According to the CSM (Leventhal et al, 1980) 
 
Illness Representation 
 
Definition 
Identity The illness label or diagnosis and perceived associated symptoms. 
 
Cause The factors or conditions believed to have caused the illness. 
 
Timeline The expected duration of the illness which may be acute and short 
term, cyclical or episodic, meaning the illness or its symptoms come 
and go, or chronic and long-term. 
 
Consequences The perceived effects of the illness on for example, physical, social, 
economic and psychological well-being and beliefs about the severity 
or seriousness of the illness. 
 
Cure and control The extent to which the illness can be controlled or cured through 
treatment measures and/or personal behaviours. 
 
 
 
Illness representations, it is suggested, are formed from a range of social and cultural 
influences such as media portrayal of illness, education, information from health 
professionals, personal and past experience of illness and the experience of illness of 
family or friends. Representations are not independent but related to each other (Cameron 
and Moss-Morris, 2004). Leventhal et al (1997) agrees that representations are organised 
into clusters or sets. For example, a strong belief that the illness can be cured or 
controlled is more likely to be associated with the belief that the illness will last a short 
time and have relatively minor consequences.  In contrast, the belief that the illness will 
last a long time is likely to be associated with a belief in more serious consequences and 
an illness which cannot be cured or controlled. 
 
Leventhal et al (1997) identify a number of „rules‟ in the construction of illness 
representations based on empirical studies.  These are the symmetry rule, the stress-
illness rule, the age-illness rule, and prevalence and duration rules. The symmetry rule 
states that each representation has two levels: concrete, perceptual codes, for example, 
the symptoms experienced, and abstract, linguistic codes, that is, the label or diagnosis 
given to the symptoms. Individuals try to link these perceptual and linguistic codes to have 
a clearly defined profile of the illness so the experience of symptoms creates a pressure 
for labelling or diagnosis and a diagnosis generates pressure for the identification of 
symptoms (Bauman et al, 1989; Easterling and Leventhal, 1989; Meyer et al, 1985). In 
this way, a coherent picture of the illness is constructed. 
 
The stress-illness and age-illness rules state that individuals will seek to determine if 
symptoms or functional changes reflect an underlying disease process or are stress or 
age related (Bauman et al, 1989). Hence, the symptom of tiredness may be attributed to 
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old age, headaches may be deemed the result of work stress. The duration and 
prevalence rules (Leventhal et al, 1997; Croyle and Jemmott, 1991) address the potential 
seriousness of symptoms. Symptoms of long duration and which are perceived as 
uncommon or rare are more likely to lead to the perception that they represent a serious 
illness.  
 
Leventhal et al (1997) acknowledge that representations may be further sub-divided. For 
example, Moss-Morris et al (2002) suggest that control can be divided into beliefs about 
personal control or the belief that one‟s actions will help control the illness, and treatment 
control, the belief that medication or other medical interventions will be effective in curing 
or controlling the illness. Cameron and Moss-Morris (2004) hypothesise that perceptions 
of high treatment control may predict adherence to medication whilst high personal control 
may predict lifestyle changes.  Cure and control beliefs are also related to the concept of 
self-efficacy or an individual‟s confidence in their ability to carry out health-promoting 
behaviours (Bandura, 1977), and outcomes efficacy or the belief that a particular action is 
effective in achieving the desired outcome. Attribution theory (Weiner, 1986), describes 
the processes by which individual‟s explain the causes of events which can be 
differentiated into intrinsic and extrinsic causes.  
 
Illness representations influence emotional responses and vice versa. For example, the 
discovery of a breast lump is likely to lead to an emotional response of fear and anxiety 
and the label „breast cancer‟ may further fuel these emotions. According to the CSM, 
mood directly influences illness representations. For example, a positive mood may make 
people feel that the illness is less of a threat and there is little need for concern. A 
negative mood may focus the individual on an awareness of symptoms with the potential 
for further worry. Whilst worry may motivate the individual to health protecting behaviours, 
if anxiety is high, individuals may avoid coping behaviours such as seeking advice from a 
health professional as doing so may further provoke feelings of anxiety.  
 
In stage two of the model, illness representations and emotional responses guide the 
selection of coping mechanisms or procedures to eliminate or control the illness threat. 
Leventhal et al (1997) tried to avoid a simple typology of „ways of coping‟ such as that of 
Lazarus and Folkman (1984) who describe „avoidance‟ or „approach‟ coping responses. 
Rather the model attempts to describe the factors involved in selecting and maintaining 
these coping responses.  
 
Coping responses or procedures deal with both the illness representations and the 
emotional response and are dependent on the formulation of an action plan which links 
illness representations and actions (Leventhal et al, 1997). The nature of these 
31 
 
procedures is numerous such as taking medication, resting or seeking advice.  Coping 
procedures are complex and like illness representations, can be classified into the 
dimensions of identity, timeline, causal mechanisms, consequences and control 
expectations. For example, ‘resting when I have chest pain due to my angina will relieve 
the pain within half an hour’. Coping procedures also specify a class of actions such as 
taking analgesics and a specific choice within that such as taking paracetamol.   
 
Stage three is the appraisal of coping procedures which completes the feedback system. 
If coping procedures are deemed to be effective in controlling the health threat, illness 
representations are reinforced. Alternatively, if coping procedures do not achieve the 
expected consequences within the expected timeframe for example, then the individual is 
motivated to reconsider both the illness representation and the coping procedures. As a 
result, illness representations, emotional responses and coping procedures may be 
altered. For example, in acute MI, chest pain may initially be attributed to indigestion and 
antacids taken.  An appraisal of this action may lead to the belief that antacids are 
ineffective in relieving the chest pain and the more serious and worrying identity of a heart 
attack may be constructed along with an alternative coping procedure such as calling for 
emergency help (MacInnes, 2006; Petrie et al, 1996).  
 
A number of moderators and mediators are identified within the model including socio-
economic and individual factors. Cultural influences and the social context within which 
behaviour takes place are considered to be important. Leventhal et al (1997) believe that 
whilst culture is undoubtedly important, analysis of cross-cultural beliefs in western 
societies reveals more similarities than differences. In the CSM, the influence of culture is 
confined to differences in language which affect the labelling of the illness. Cameron and 
Moss-Morris (2004) argue, like Kleinman (1988), that illness is, to a large extent, culturally 
defined and while the biological processes of disease may be universal, cultural 
differences exist in terms of social norms, traditions, customs and way of life which 
influence the perception of symptoms and the development of illness beliefs.  
 
The CSM has been criticised for its inability to articulate social influences except at the 
level of influencing illness representations (Ogden, 2003). Leventhal et al (1997, p.54) 
acknowledge that the model needs to be further extended into the social context but argue 
that „it is a gross misconception to think of self-regulation as a process carried out in 
solitude or to think of the individual as an isolated problem-solving machine’. They argue 
that social messages and relationships help shape not only illness representations but 
also emotional responses and coping behaviour. For example, media portrayal of illness 
and consultation with family and friends inform not only beliefs but also help to determine 
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the response such as the decision to seek medical help, make lifestyle changes or take 
medication. The illness may also be viewed in comparison to others of the same age (the 
age-illness rule) or the experience of others with illness. 
 
However, Cameron and Leventhal (2003) maintain that the „self‟ remains the primary 
agent of self-regulation in that the individual chooses whether to seek advice from others 
and decides whether or not to follow that advice. This may be especially true when input 
from social sources is inconsistent with their own beliefs and experience. Hence, although 
the social context influences the interpretation of symptoms and the specific responses, 
they do not define self-regulation entirely.   
 
It is also argued that theoretical ambiguities exist in the assignment of illness 
representations and coping procedures. For example, the belief that the illness has few 
serious consequences may be a coping procedure rather than an illness belief (Ogden, 
2003).  
 
Whilst such conceptual difficulties undoubtedly exist, the CSM has been shown 
empirically to be a useful framework for examining the complex nature of health and 
illness beliefs and behaviour. Hagger and Orbell (2003) conducted a meta-analysis of 45 
studies which used the CSM. They found support for the ability of illness representations 
to predict a range of outcomes such as physical functioning, psychological distress, 
psychological well-being, role functioning, social functioning and vitality. Pearson‟s 
correlation co-efficients (r) were calculated between illness representations and outcomes 
and found to be moderate but statistically significant (p ≤ 0.05), ranging from r = -0.56 to r 
= 0.50 in the reviewed studies. The following section examines the measurement of illness 
representations.  
 
2.2.3 The measurement of illness representations  
Leventhal et al (1980) used semi-structured interviews to explore illness beliefs in different 
illness populations. While this enabled in-depth explorations of beliefs, the small sample 
sizes and context-specific findings meant the results were not necessarily transferable to 
other populations or illnesses.   
 
Weinman et al (1996) developed the Illness Perception Questionnaire (IPQ) using the 
CSM as a theoretical basis. Unlike earlier methods, its purpose was to enable the 
assessment of illness representations in large populations across different illness groups 
and to determine relationships between illness representations and behaviour. The 
questionnaire was divided into five sub-scales or domains corresponding to the five illness 
representations. The identify domain was assessed by listing a number of common 
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physical symptoms such as nausea and fatigue, and asking respondents to rate them in 
terms of frequency on a 4-point scale. For all other domains, respondents were asked to 
rate the extent to which they agreed or disagreed with a series of statements using a 5-
point attitudinal scale. For example, cause: ‘family problems or worries caused my illness’, 
consequences: ‘my illness strongly affects the way others see me’, timeline: „my illness 
will pass quickly’ and cure/control: ‘there is little that can be done to improve my illness’. 
Analyses of causal attributes were treated as separate statements with all other domains 
analysed by summing the scores.  
 
The IPQ was evaluated for its psychometric properties in seven illness groups. Internal 
consistency was demonstrated by Cronbach‟s alpha (α). This ranged from α = 0.73 to α = 
0.82 across the different domains. Test-retest reliability was demonstrated at one, three 
and six months. In terms of concurrent validity, in an MI sample, the IPQ correlated with 
several other measures of health beliefs and behaviour, for example, the Sickness Impact 
Profile (Bergner et al, 1981). Concurrent validity was established in the diabetes sample 
using the IPQ and semi-structured interviews. Assessing scores across four different 
illness groups determined discriminant validity. Predictive validity of the IPQ was 
established by predicting attendance at cardiac rehabilitation within the MI group, at three 
and six months follow up (Petrie et al, 1996). 
 
Moss-Morris et al (2002) developed a revised IPQ (the IPQ-R, Appendix 1), which has 
improved measures of timeline and cure/control and includes additional domains of 
emotional response and illness coherence according to the CSM. Cyclical or episodic 
beliefs have been added as an additional dimension of timeline in statements such as, ‘I 
go through cycles in which my illness gets better and worse’.  Cure/control is divided into 
personal control relating to self-efficacy beliefs and treatment control as a measure of 
outcome expectancy. For example, „I have the power to influence my illness’ and „my 
treatment can control my illness’. Emotional responses are assessed through statements 
such as, ‘my illness makes me feel afraid’. The extent to which individuals‟ illness 
representations provide a coherent understanding of the illness or the extent to which it 
„makes sense‟ has also been added. For example, ‘my illness is a mystery to me’. The 
authors describe illness coherence as a meta-cognition as it is not specifically related to 
beliefs about illness but rather to personal understanding. Changes have also been made 
to the way in which the domain of identity is assessed. Respondents are asked whether 
the symptoms they have experienced are related to their illness. The authors argue that 
this now differentiates between a general somatic effect and specific perceptions 
regarding the illness identity. The IPQ-R has also been extended to include additional 
causal attributes and an open question to elicit the three most important causes of the 
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illness for that individual. In this way, causal attributes can be grouped into categories of, 
for example, lifestyle factors and hereditary factors.  
 
The IPQ-R has been psychometrically tested across eight different illness groups. 
Principal components analysis supported the existence of seven factors, namely, timeline 
(acute/chronic), timeline (cyclical), consequences, personal control, treatment control, 
illness coherence and emotional response. Internal consistency was improved from the 
original IPQ with Cronbach‟s alpha (α) ranging from α = 0.79 to α = 0.89 for the different 
sub-scales or domains. Test-retest reliability was established in the renal and rheumatoid 
arthritis samples at three weeks and six months with Pearson‟s correlation co-efficients 
generally over r = 0.5. The IPQ-R was also able to discriminate between the emotional 
response to the illness and affective traits. Discriminant validity was demonstrated by 
significant differences between scores in the chronic and acute pain samples. Predictive 
validity was established by the ability to predict adjustment to illness in the multiple 
sclerosis sample. In conclusion, the IPQ-R can be considered a valid and reliable 
measure in these samples. 
 
The IPQ and IPQ-R, whilst comprehensive in terms of their exploration of beliefs, are 
lengthy and may be difficult for some patients to self-complete. Arguably, they are most 
useful for research rather than for use in clinical practice. The Brief IPQ (Broadbent et al, 
2006) was designed as a short and simple measure of assessing illness representations. 
The Brief IPQ has reduced the domains of the IPQ-R to just nine questions with one 
question assessing each illness representation of consequences, timeline, personal 
control, treatment control, identity, coherence and cause. Emotional responses are 
divided into emotions and concerns about the illness. Unlike the IPQ and IPQ-R which use 
a Likert scale, the Brief IPQ assesses perceptions on a 0-12 continuous linear scale. For 
example, ‘how much control do you think you have over your illness”, where 0 = 
absolutely no control and 12 = extreme amount of control. Assessment of the causal 
domain is by an open question asking respondents to list the three most important causes 
for them. Data were collected from six illness groups to evaluate the psychometric 
properties of the questionnaire. Analysis showed good test-retest reliability in a renal 
disease group at three and six weeks. Concurrent validity with the IPQ-R was also 
established. Discriminant validity was demonstrated by the ability to differentiate between 
different illnesses. Predictive validity was established in the MI group in terms of a number 
of recovery outcomes such as return to work. 
 
The authors suggest that the Brief IPQ may be used in preference to the IPQ or IPQ-R in 
elderly or very ill patients or in those with more limited reading and writing ability. They 
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advocate its use where illness representations are only one of a series of measurements 
in large, population-based studies or where repeated measures are required. In this way, 
the burden on the patient is reduced. However, Broadbent et al (2006) recognise that the 
IPQ-R may be preferable where the identify domain is important. In addition, the Brief IPQ 
does not assess cyclical or episodic timeline beliefs which may make it less useful in 
chronic illnesses. Although patients with heart failure tend to be elderly with limited 
functional ability, given the nature of the illness in terms of the similarity between 
symptoms and the effects of medication and the prevalence of co-morbidities, the Brief 
IPQ may be less preferable than the IPQ-R in assessing illness identity in this population. 
  
The IPQ, IPQ-R and Brief IPQ have been developed as general questionnaires which are 
not illness-specific. The authors suggest that researchers adapt the scales to particular 
illness populations, as is the intention in this study. At the most superficial level this could 
be by simply changing the word „illness‟ to a specific named disease such as „asthma‟. 
However, Moss-Morris et al (2002, p.14) argue that more fundamental adaptations may 
be necessary in different illness groups due to the ‘powerful influence of unique 
characteristics of an illness’. They argue that causal and identity domains will be 
particularly unique.  
 
The IPQ, IPQ-R and Brief IPQ have been adapted for use in a number of specific illnesses 
and brought together on a website devoted to their application (www.uib.no/ipq). The IPQ 
appears in eight languages and has been adapted for use in four illness groups. The IPQ-
R has been translated into seventeen languages and adapted for use in thirteen illness 
groups. The Brief IPQ has similarly been translated into twenty-two languages. Over one 
hundred publications using the IPQ or IPQ-R are cited on the website. On further 
examination of the adapted versions of the questionnaires, they have either been 
translated without further amendment or the wording has been changed from „illness‟ to 
the specific condition.  
 
The HIV and Hypertension versions have, however, undergone more extensive changes.   
In the HIV scale (www.uib.no/ipq), there are additional timeline beliefs which explore 
perceptions of the illness trajectory or whether the illness is likely to get better, worse or 
stay the same over time, and the expected rate of improvement or deterioration. For 
example, „I expect my illness to get worse quickly’, and ‘I expect my state of health to 
remain how it is for the foreseeable future’. These items were included following 
qualitative interviews with HIV patients.  In relation to symptoms, additional items are 
included which are illness specific, for example, night sweats. The severity of symptoms is 
also assessed on a 5-point scale from „very mild‟ to „very severe‟.  In an extension of the 
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CSM, the HIV scale also assesses treatment beliefs. For example, ‘are you currently 
experiencing this symptom as a result of taking combination therapy?’ Similarly, the 
Hypertension scale (www.uib.no/ipq) combines illness representations with treatment 
beliefs. For example, „my treatment will be effective in curing my high blood pressure’. In a 
complex exploration of symptom beliefs, respondents are asked whether they have 
experienced a specific symptom, whether this symptom is related to their high blood 
pressure or whether the symptom is related to the medication.  
 
The HIV and Hypertension scales are consistent with the CSM but have been adapted to 
specific conditions following a qualitative exploration of beliefs in individual illness 
populations. The expansion of the CSM into treatment beliefs allows for the exploration of 
these beliefs and their relationship to medication regimes.  
 
No studies have been found which use a version of the IPQ-R adapted for use in heart 
failure, although the IPQ-R has been used unchanged in this population (Morgan, 2008; 
Cherrington et al, 2006; Voelmeck 2006.) The Survey of Illness Beliefs in Heart Failure 
Tool (SIBHFT) (Albert and Zeller, 2007) is illness-specific, and has a stated purpose of 
measuring the accuracy and certainty of illness beliefs in patients with heart failure, rather 
than measuring illness beliefs per se. Developed in the US using the CSM as the 
theoretical framework, this 14-item scale includes „accurate‟ and „inaccurate beliefs‟ about 
heart failure as determined by cardiology medical consultants and specialist nurses. An 
example of an accurate belief is, ‘heart failure is a threat to my health’ and an inaccurate 
belief, ‘heart failure requires me to drink fluids, especially when I am thirsty’. Respondents 
are asked to rate their agreement or disagreement with each statement on a 4-point Likert 
scale. The illness representation of causation is not assessed. Tested on a sample of 104 
hospitalised heart failure patients, internal consistency of the scale as a whole was good, 
α = 0.73. Factor analysis supported a 2-factor structure of accurate and inaccurate illness 
beliefs. However,  a number of theoretical difficulties exist, for example, the statement 
„heart failure can be cured with drugs and other therapies’ is identified as a belief about 
consequences when it appears to be more related to the dimension of treatment control. 
Similarly, the statement „heart failure may improve with drugs and a lot of time’ is 
described as a consequence rather than a treatment control or timeline item. Furthermore, 
since only specific, inaccurate beliefs are included, other misconceptions which might 
exist are not assessed. This may be especially problematic as the scale was developed 
by experts rather than from a lay perspective. It is quite possible that individuals with heart 
failure have different beliefs and misconceptions than those envisaged by health 
professionals, as suggested by Kleinman (1988). 
 
37 
 
In conclusion, the CSM appears to be a useful framework for examining illness beliefs in 
heart failure. The IPQ-R has been shown to be a valid and reliable instrument in other 
illnesses but might need to be adapted for use in heart failure to make it illness-specific. 
Although a scale exists for measuring illness beliefs in heart failure (the SIBHFT) 
theoretical difficulties are apparent. Therefore, in this study, an adapted version of the 
IPQ-R, developed from a patient perspective, is believed to the most appropriate measure 
for determining illness representations in a heart failure population.  
 
2.2.4 An extended CSM including treatment beliefs  
Horne (1997) proposed an extended CSM, incorporating beliefs about treatment as well 
as illness representations since, he argues, coping responses include making decisions 
about treatment. The assumption is that individuals search for a coherent explanatory 
model of both the illness and its treatment so that treatment beliefs are consistent with the  
individuals‟ representation of illness (Figure 2.2).  
 
According to this model, symptom experiences trigger treatment beliefs as well as illness 
representations. If symptoms are attributed to the illness, beliefs about the necessity of 
treatment may be re-enforced; conversely, the belief that symptoms are the effects of 
medication leads to the development of concerns about the treatment. Parallel processing 
of cognitive and emotional dimensions occurs so that the belief that medication has 
damaging effects results in worry and anxiety.  
 
The belief that the illness is cyclical rather than chronic, for example, may result in doubts 
about the necessity of taking regular medication. Cause and control beliefs are also 
expected to be important in that a belief that the illness is caused by poor diet for 
example, and can be controlled by dietary modification may result in low necessity beliefs 
about medication. Conversely, a belief that the illness has serious consequences may 
reinforce the necessity of medication. Treatment beliefs are described as influencing 
adherence to medication which is viewed as a behavioural response. The outcome of 
these responses is appraised with resulting reinforcement or a change in treatment beliefs 
and adherence behaviour.  
 
Contextual factors such as social and cultural norms, demographic factors and personality 
are thought to inform treatment beliefs and adherence behaviour. For example, spousal 
beliefs about the necessity of medication and their practical support in medication 
management may influence adherence. In addition, beliefs about medications generally, 
may inform beliefs about specific medicines. Perceptions of personal sensitivity and 
susceptibility to side-effects of medication (the sensitive soma) and perceptions of 
personal resilience or hardiness may also influence treatment beliefs (Horne, 1997). 
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Figure 2.2 An Extended CSM, Incorporating Treatment Beliefs (Horne, 1997) 
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2.2.5 The measurement of treatment beliefs  
The nature of lay beliefs about treatment was explored by Fallsberg (1991). Three sets of 
beliefs about medication were identified, a beneficial view of medication in promoting 
health, a harmful view of medicines as essentially „poisons‟ and a dual nature with 
medication having the potential for harm as well as benefit – a „double-edged sword‟. The 
potential for harm was expressed as fears about addiction and dependence and 
damaging side-effects either in the short or long-term.  
 
Horne et al (1999) conceptualised these beliefs in a model incorporating beliefs about the 
necessity of and concerns about medication in a „necessity-concerns framework‟. Beliefs 
about medication prescribed for a specific illness were differentiated from beliefs held 
about medicines generally. The „Beliefs about Medicines Questionnaire‟ (BMQ) (Horne et 
al, 1999) developed these core themes into a quantifiable form. The BMQ-Specific scale 
examines beliefs about medicines prescribed for a specific condition. It consists of two 
sub-scales, beliefs about the necessity and efficacy of medicines and concerns about their 
harmful effects. For example, ‘my medicines protect me from becoming worse’, and ‘I 
sometimes worry about the long-term effects of my medicines’. The BMQ-General scale is 
also divided into two sub-scales that assess the belief that medicines are generally over-
used by doctors and that medicines, in general, are harmful and addictive. For example, 
‘doctors use too many medicines’ and ‘most medicines are addictive’. Respondents are 
asked to rate eighteen items across the four sub-scales according to a 5-point Likert scale 
(Appendix 2). 
 
The BMQ was tested in over 500 patients across six chronic illness groups (asthma, 
diabetes, renal, cardiac, psychiatric and general medicine). Factor analysis supported the 
core themes in both the specific and general medication sub-scales. Internal consistency 
was considered acceptable in most sub-scales (α = 0.55 to α = 0.80) in all illness groups 
with the exception of the general-harm sub-scale. Here, internal consistency was limited in 
three illness groups with Cronbach‟s α ranging from α = 0.47 to α = 0.51. The authors 
recommend that the general-harm scale is used with caution and that the BMQ-Specific 
scale can be used separately. Test-retest reliability was confirmed in the asthma sample 
at two weeks. The BMQ was able to distinguish between the different illnesses 
(discriminant validity) and was able to predict the outcome measure of adherence to 
medication using the Reported Adherence to Medication (RAM) scale. 
 
The authors conclude that the BMQ can be adapted to assess beliefs about medicines for 
specific conditions or for individual medicines. This can be achieved by changing the 
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reference statements so that illnesses or medicines can be referred to by name, for 
example, ‘your views about medicines prescribed for your heart failure’ or ‘your views 
about your beta-blockers’. Additional items have been added to the specific-concerns sub-
scale based on qualitative findings in some illnesses. For example, the belief that regular 
use of analgesics will make them less effective in the future has been added to an 
analgesia version of the BMQ (Gill and Williams, 2001).  
 
The relationship between necessity and concern was further developed by Horne and 
Weinman (1999) where it was hypothesised that a cost-benefit analysis might be taking 
place in which strong perceptions of need might override perceptions of concern. 
Similarly, low concern might lead to non-adherence if necessity beliefs are also low. A 
necessity-concerns differential was devised by subtracting concerns from necessity 
scores. While the authors acknowledge methodological difficulties, in that the score on 
one scale does not necessarily correspond to the score on the other, the necessity-
concerns differential was a better predictor of adherence than either an isolated necessity 
or concerns score (Horne and Weinman, 1999). 
 
Other measures have been developed to assess beliefs about medication. Figueiras et al 
(2009) developed the „Generic Medicines Scale‟ which assesses lay beliefs about generic 
versus branded medicines. Instruments measuring treatment beliefs in relation to specific 
illnesses or medicines have also been developed, for example, Davidson and Fristad 
(2006) developed the „Treatment Beliefs Questionnaire‟ to measure beliefs about mood 
disorders and medication in children and their parents.  
 
In heart failure, Bennett et al (1997) developed the „Beliefs about Medication Compliance 
Scale‟ based on the Health Belief Model (Rosenstock, 1974). This was developed to 
assess the benefits of and barriers to medication compliance rather than beliefs about 
medication. Although individual items such as ‘taking my water tablets helps me breathe 
more easily’ and ‘taking water tablets is unpleasant’ are seemingly related to necessity 
and concern beliefs, the scale assesses a different, though probably related construct of 
beliefs about compliance. For this reason, the BMQ is considered to be more useful in 
assessing treatment beliefs than the Beliefs about Medication Compliance Scale, in this 
study. 
 
2.2.6 Illness and treatment beliefs in heart failure 
A number of qualitative studies have explored lay beliefs and the experience of heart 
failure. Mahoney (2001) interviewed 28 patients with heart failure and their families in the 
US, using an ethnographic approach. Living with heart failure was viewed as a disruption 
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to the normal life course causing disorder on physical, emotional, social, economic and 
spiritual levels. Viewing the illness in this way is consistent with the concept of 
biographical disruption suggested by Bury (1982). According to Mahoney (2001), lack of 
coherence or the illness not making sense often followed such a disruption which echoes 
the importance of illness coherence as assessed in the IPQ-R (Moss-Morris et al, 2002). 
The lived experience of heart failure was characterised by struggling, participating in 
partnerships, finding purpose and meaning in the illness experience and surrendering to, 
or coming to terms with the illness. The need to generate linguistic codes or labels, as 
suggested by Leventhal et al (1997), was also apparent in this study where participants 
attempted to reconcile their own beliefs about the labelling of the illness with medical 
terminology. For example, „an asthmatic heart‟ is described. Misconceptions were found in 
relation to the control of symptoms. For example, one participant describes sleeping on 
her stomach rather than on her back so that she would not drown. The cause of the illness 
was frequently attributed to God‟s will. The illness representations of identity, cause, and 
controllability according to the CSM were, therefore, articulated in this study, further 
supporting the applicability of this model in heart failure. 
 
Zambroski (2003) interviewed eleven patients with heart failure. In terms of the illness 
identity, the terms „wind‟ and „water‟ were frequently used by participants to describe 
problems of increased fluid and a feeling of being underwater or drowning. Terms such as 
gasping, puffing and blowing were described in relation to breathlessness. Continuing this 
metaphor, the author categorised the experience of living with heart failure as periods of 
turbulence, navigation and finding safe harbour. This supports the view that the illness can 
be described in terms of physical, emotional and social disruption (Bury, 1982).  
 
Illness beliefs and behaviour were influenced by ethnicity and culture in a study by 
Pattenden et al (2007). Here, 36 patients with heart failure and twenty family caregivers in 
the UK were interviewed. Differences were found in the way participants of South Asian 
origin described their heart failure. In this ethnic group, control of the illness was believed 
to be achieved by a combination of medication and prayer. Cleanliness and mobility were 
seen as important aspects of care as they related to religious practices. The findings of 
this study suggest that beliefs and behaviour are culturally influenced, as envisaged by 
Cameron and Moss-Morris (2004), Leventhal et al (1997) and Kleinman (1988). 
 
Jeon et al (2010) carried out a systematic, narrative review of qualitative studies 
concerning the experience of living with heart failure. The studies reviewed revealed that 
social isolation arising from lifestyle changes, medication regimes, the effects of 
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medication and physical restrictions due to breathlessness and tiredness were common. 
Strong emotions such as fear, distress and uncertainty was a key feature of living with the 
illness. A sense of control was also deemed important with loss of control connected with 
deterioration in symptoms, loss of independence and lifestyle restrictions. The most 
common coping strategies were sharing the illness experience through accepting practical 
and emotional help and adjusting to changing circumstances by accepting physical 
limitations and adjusting activities accordingly.  
 
Using the CSM as the theoretical framework, Horowitz et al (2004) carried out semi-
structured interviews with nineteen patients with heart failure in the US. They found that 
participants lacked a coherent model of heart failure and had inadequate knowledge about 
the causes, symptoms and the consequences of their illness. They often did not connect 
symptoms of heart failure to the condition. While most described fluid build-up, few 
labelled this as related to their heart and could not explain what caused their condition or 
its symptoms. Others attributed symptoms to conditions such as asthma or external 
causes such as stress. In relation to timeline, participants described an acute condition 
with few serious consequences. They did not recognise that their symptoms worsened 
over time and did not manage symptoms effectively so were unable to prevent acute 
exacerbations.  
 
A small number of studies have published quantitative findings on illness representations 
in heart failure. Albert and Zellar (2007) used the SIBHFT to measure illness beliefs in 104 
hospitalised patients in the US and, like Horowitz et al (2004), found that patients held 
inaccurate beliefs about heart failure and had little perceived control over their illness. In 
contrast, Voelmeck (2006), using the IPQ-R, studied 98 patients with heart failure in the 
US and found that the illness was believed to be chronic with serious consequences. The 
belief that the illness could be controlled by personal and treatment measures was also 
found.  
 
Cherrington et al (2006) also used the IPQ-R in a small study of 22 patients with heart 
failure, in the US. For the identity domain, participants experienced an average of 6.6 
symptoms which they believed were related to their heart failure. No causal factors could 
be identified. As the IPQ-R was used without making it specific to heart failure, the author 
acknowledges the need to revise the causal sub-scale to more accurately reflect the 
aetiologies in heart failure. The identity sub-scale may also require amendment for the 
same reason.  Consistent with the findings of Voelmeck (2006), a belief in a chronic 
timeline was found. There was a belief in the illness having serious consequences with a 
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high degree of personal and treatment control reported. Illness coherence was also high 
and there was a lack of a negative emotional effect. Morgan (2008), using the IPQ-R, 
found few symptoms were attributed to heart failure, a belief that the illness was a long-
term condition with serious consequences but one which could be controlled personally 
and through the use of medication. The illness was most commonly attributed to 
hereditary factors but stress and worry and ageing were also identified as causal factors. 
Few negative emotions were described. Hallas et al (2010) demonstrated the link between 
illness beliefs and emotional response in that those patients with more negative beliefs 
about the consequences of their illness and with less perceived control showed greater 
levels of depression and anxiety.  
 
Only three studies have been found which address treatment beliefs in heart failure. 
Ekman et al (2006) studied the medication beliefs of 302 Swedish heart failure patients as 
part of a large, 5-year randomised controlled drug trial. It was found that 94% of the 
sample believed that the study medication would make them feel better compared to 82% 
believing that that their regular heart failure medication would make them feel better. 69% 
of patients were knowledgeable about the names of their medication but only 16% of 
patients were aware of the need to take medication for the rest of their lives. Since this 
sample was drawn from patients undergoing a clinical trial, it might be expected that 
beliefs about the efficacy of medication and medication knowledge were high which may 
not necessarily be the case in a general heart failure population. De Smedt et al (2009) 
studied the perception of adverse effects of heart failure medication in a sample of 680 
hospitalised patients in Sweden; 17% reported at least one perceived adverse effect such 
as nausea, dizziness, itching or a rash.  
 
In a study by Rogers et al (2002), 27 heart failure patients were interviewed to examine 
their perceptions of symptoms and drug therapy. These authors found that patients had 
little understanding of what medications were intended to achieve. Patients expressed 
concerns about higher doses and interactions between drugs, especially after reading the 
patient information leaflets included in the drug packaging. Patients reported nineteen 
different symptoms which were attributed to old age, symptoms of heart failure or side-
effects of medication. Distinguishing the effects of medication and symptoms of the 
condition was especially problematic. This applied particularly to tiredness and a 
depressed or anxious mood. The authors assert that this lack of understanding posed a 
number of problems for patients in interpreting the significance of changing symptoms.  
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In conclusion, heart failure has a significant impact on physical, social and emotional well-
being and lay beliefs may be incongruent with the biomedical model. Using the CSM, 
there are conflicting findings between studies by Horowitz et al (2004) and Albert and 
Zellar (2007), who describe an acute or episodic model of the illness and a number of 
misconceptions, and the findings of Voelmeck (2006), Cherrington et al (2006) and 
Morgan (2008) who, using the IPQ-R, describe a chronic timeline and fewer 
misconceptions. However, it should be noted that these studies were conducted in the US 
and Republic of Ireland in relatively small samples in some cases, which may limit the 
generalisability of the findings. Data on treatment beliefs in heart failure is scarce, 
although it is suggested that there are strong beliefs about the necessity of medication but 
also concerns about its effects. Differentiating symptoms from the effects of medication 
may also be difficult for some patients. 
 
2.3 SELF-CARE POLICY AND PRACTICE  
 
This section discusses self-care in heart failure within the context of current UK health and 
social care policy. Policy initiatives are discussed and the definition of self-care as used in 
this thesis is re-stated. The nature, extent and measurement of self-care in heart failure 
are discussed. Finally, the factors influencing self-care are examined. 
 
2.3.1 Health and social care policy  
The concept of self-care in health and social care policy can be traced back to 2000 with 
the publication of the NHS Plan (DH, 2000b). Here, self-care was described as one of the 
„key building blocks for a patient-centred health service’ (DH, 2000b, p.3). Since 2000, a 
number of publications have driven the self-care agenda. In „The Expert Patient: A new 
approach to chronic disease management for the 21st century‟ (DH, 2001), the belief that 
patients could become experts in their own illness was articulated. „Expert Patient 
Programmes‟ (EPPs) were described as a way of enabling people with long-term 
conditions, such as heart failure, to self-care. In 2005, „Self-Care – A Real Choice‟ was 
published which defined self-care in operational terms (DH, 2005b). In this year, the 
National Service Framework (NSF) for long-term conditions was also published (DH, 
2005a). Here, supporting self-care was identified as a core quality requirement.  
 
The publication of „Supporting people with long-term conditions to self-care: A guide to 
developing local strategies and good practice‟ (DH, 2006a) brought together a number of 
policy strands to embed self-care in health and social care practice. The white paper, „Our 
health, our care, our say‟ (DH, 2006b), suggested that people with long-term conditions 
wanted more control over their care and led to the launch of „Your health, your way – a 
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guide to long-term conditions and self-care‟ (DH, 2008). The central focus was to promote 
discussion between health and social care professionals and individuals about the support 
and information available to enable self-care in the form of a „Patients‟ Prospectus‟. 
November 2009 saw the first national „Self-Care Week‟ which aimed to raise awareness of 
self-care, highlight the information available and encourage patients with long-term 
conditions to discuss a personal care plan with their healthcare provider.  
 
It is anticipated that voluntary or third sector organisations will play an increasing role in 
meeting the increased demand for self-care support (DH, 2010a), illustrating the coalition 
government‟s vision of a „Big Society‟. Most recently, the new Secretary of State for 
Health, described patients not as beneficiaries of care but as participants in shared 
decision-making (DH, 2010b). The recently published strategy for the NHS (DH, 2010c) 
emphasises an information revolution with greater choice and control for patients, 
suggesting an ongoing commitment to the principle of self-care. 
 
The DH (2006a) defines self-care as: 
 
‘the activities that enable people to deal with the impact of a long-term condition on 
their daily lives, dealing with the emotional changes, adherence to treatment 
regimes, and maintaining those things that are important to them – work, socialising, 
family’             (DH, 2006a, p.2)  
 
This broad definition of self-care is used in this thesis as it recognises emotional and 
social dimensions of self-care, rather than simply focusing on compliance or adherence to 
professionally determined medication and lifestyle regimes. The term „self-management‟ is 
also used in the literature although this has predominantly been applied to education such 
as the Expert Patient Programme (EPP) (DH, 2001). Self-care has been described as an 
umbrella term which includes self-management (DH, 2009). 
  
Central to the concept of self-care is the belief that patients with long-term conditions, 
through their experience, can become empowered to increase their knowledge and 
become key decision makers rather than passive recipients of care. It is suggested that 
patients expect to play a much greater part in managing their illness (DH, 2001). The 
concept of empowerment is explicit in self-care and requires a shift in the balance of 
power from health professionals to patients. Nettleton (2006) defines empowerment as 
‘the process of enabling people to have the power to take action to control and enhance 
their lives’ (Nettleton, 2006, p.239). The DH acknowledges that promoting self-care 
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‘requires a radical shift in the balance of power, with the patient at the centre’ (DH, 2006a, 
p.12).  
 
Although 82% of people with a long-term condition said they played an active role in 
caring for themselves (DH, 2007), levels of self-care were not consistent across different 
age groups, with younger people and those over 85 years of age described as less active 
in self-care. Deprived and minority ethnic groups were also less likely to engage in self-
care. Those groups least active in self-care also lacked confidence in their knowledge and 
understanding of self-care (DH, 2005c).  
 
The benefits perceived for effective self-care are considered to be numerous and include, 
rather ambitiously, better health and well-being for patients, reduced perceived severity of 
symptoms, improved adherence to medication, reduced need for emergency health and 
social services, prevention of unnecessary hospital admissions, better planned and co-
ordinated care, greater confidence and a sense of control and better mental health with a 
reduced incidence of depression (DH, 2006a). In addition, a number of studies have 
demonstrated potential service benefits including a 40% reduction in GP visits, a 17% 
reduction in outpatient appointments, a 50% reduction in visits to A&E and reduced drug 
expenditure (DH, 2007).   
 
However, in realising these benefits, a number of factors are recognised which may affect 
self-care. These include perceived or actual illness severity, the nature of the condition, 
the effect of symptoms, the short, medium and long-term impact of the condition on the 
individual‟s ability to undertake normal activities of daily living, the person‟s beliefs, 
understanding and expectations surrounding their condition, patients‟ morale and mental 
health and the perceived role of health and social care services in providing care, cure or 
support (DH, 2006a).  
 
Hence, five keys areas of support have been identified as essential to achieving the aim of 
effective self-care. These are information about the condition, services to support healthy 
lifestyle choices such as smoking cessation, skills training courses such as EPP, support 
networks and tools and equipment. Information prescriptions have been developed as a 
way to provide people with long-term conditions with individually tailored information on 
their condition and available services (DH, 2009b).  
 
The EPP (DH, 2001) has been developed as a formal education programme which aims 
to provide the patient with the skills necessary for self-care. Implemented widely in the 
UK, the EPP is highly structured and lay-led and may be generic or illness specific. For 
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example, programmes exist in diabetes, arthritis and asthma care (Wilson and Mayor, 
2005). The EPP is based on the Chronic Disease Self-Management Programme 
(CDSMP) developed at Stanford University based on the work of Kate Lorig. In this 
author‟s original study, the implementation of an arthritis self-management programme 
(ASMP) led to benefits in health outcomes such as reduced pain (Lorig et al, 1985). 
Furthermore, patients with reduced pain also reported greater control over their illness, 
leading to the hypothesis that changes in self-efficacy (Bandura, 1977) were partly 
responsible for the improvements reported in the ASMP (Lorig et al, 1989). A later version 
of the ASMP, incorporating efficacy-enhancing strategies, resulted in further improved 
health outcomes which were retained over time, including a reduced number of hospital 
visits (Lorig et al, 1993). 
 
In heart failure, Smeulders et al (2009) considered the impact of a self-management group 
programme on health behaviour and healthcare utilization among 317 heart failure 
patients in the Netherlands. They found that patients in the intervention group spent more 
time in physical activities such as aerobic, stretching and strength exercises, sports, and 
gardening, directly after the programme and at 6 months follow-up. However, the 
programme had no effect on drinking or smoking behaviour, body mass, or healthcare 
utilization. These authors conclude that there is limited evidence of a beneficial effect of 
the CDSMP on some health behaviours and healthcare utilization in this population. 
 
In addition to policy relating to the general principles of self-care, NICE (2009) has issued 
specific guidance on supporting medication adherence which is an important element of 
self-care. Non-adherence is described as intentional or unintentional and it is emphasised 
that non-adherence should not be seen as the patient‟s problem but rather a fundamental 
limitation in the delivery of healthcare through a failure to fully agree the prescription or 
provide ongoing patient support. Unintentional non-adherence occurs when the patient 
wants to follow the agreed treatment but is prevented from doing so by barriers beyond 
their control such as difficulty in understanding the instructions, inability to pay for 
treatment or simply forgetting to take medication. Intentional non-adherence occurs when 
the patient decides not to follow the treatment recommendations. Here, patient beliefs and 
preferences are seen as important in understanding the motivation to start and continue 
with treatment. The necessity-concerns framework (Horne and Weinman, 1999) is 
explicitly applied in that a key principle is „to be aware that patients’ concerns about 
medicines and whether they need them, affect how and whether they take their prescribed 
medicines’ (NICE, 2009, p.8). Healthcare providers are asked to assess, regularly review 
and address medication knowledge, concerns and necessity beliefs. A recommendation 
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by NICE (2009) is the need for further research to determine the most clinically and cost-
effective methods for identifying and addressing beliefs and concerns about medication 
that influence adherence.  
 
In conclusion, a definition of self-care has been given which encompasses emotional and 
social well-being as well as adherence to medication and lifestyle advice. Self-care has 
been presented as a cornerstone of health and social care policy in long-term conditions 
such as heart failure. There are a number of perceived benefits of self-care for the 
individual, their families and health and social care service. Although self-care is believed 
to be high in patients with long-term conditions, it is recognised that those in older age 
groups, ethnic minority and deprived groups may be less effective in engaging in self-
care. Five key areas have been targeted to support self-care in long-term conditions, most 
importantly support for enhancing knowledge and skills. NICE (2009) has issued clinical 
guidelines relating to medication adherence in which the identification of treatment beliefs, 
specifically necessity and concern beliefs is viewed as important in the assessment of 
adherence. The following section reviews the literature in relation to the specific nature 
and extent of self-care, including medication adherence, in heart failure. 
 
2.3.2 The nature and extent of self-care in heart failure  
A framework for conceptualising self-care in heart failure has been proposed by Dickson 
et al (2006) who describe self-care as a naturalistic decision-making process involving a 
choice of behaviours that maintain physiological stability (self-care maintenance) and 
recognising and responding to symptoms when they occur (self-care management). Self-
care maintenance includes adherence to medication and lifestyle advice. However, if the 
broad definition of self-care is used according to the DH (2006a), self-care maintenance 
also includes individuals maintaining those things that are important to them such as work, 
leisure activities and social networks.  Self-care management is seen as a process 
initiated by symptom recognition and evaluation. Table 2.4 summarises self-care 
maintenance and self-care management behaviours in heart failure. 
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Table 2.4 Self-Care Maintenance and Management Behaviours 
 
Self-Care Maintenance Self-Care Management 
Taking medications as prescribed 
Adhering to a low sodium diet 
Maintaining an ideal body weight 
Limiting alcohol intake 
Restricting fluid intake  
Taking regular exercise 
Flu and Pneumonia immunisation 
Smoking cessation 
Weighing oneself regularly 
Symptom recognition and evaluation 
Managing symptoms  
Seeking help and advice 
 
 
Based on Riegel et al (2009a); Dickson et al (2006); Jaarsma et al  (2000b)   
 
The terms compliance, adherence and, less commonly, concordance have been used in 
studies investigating self-care maintenance behaviour in heart failure. NICE (2009) and 
Sabate (2003) for the World Health Organisation (WHO), use the term adherence which is 
defined as: 
 
‘The extent to which a person’s behaviour – taking medication, following a diet 
and/or executing lifestyle changes, corresponds with the agreed recommendations 
from a provider’               (Sabate, for the WHO, 2003) 
 
In contrast to compliance, adherence implies a less powerful role for the health 
professional in that it requires the patients‟ agreement to the recommendation (Fraser, 
2010). The concept of concordance describes the process by which beliefs are shared 
and an equal partnership between the individual and health professional is envisaged 
(DH, 1997). In this study, since self-care is viewed as a behavioural outcome, according to 
the CSM, the term adherence will be used.   
 
Implicit in this research is the assumption that self-care affects clinical outcomes. 
However, few studies have conclusively demonstrated such a relationship. De Walt et al 
(2006) evaluated the effect of a self-care programme designed for heart failure patients 
with low literacy and found that the intervention group had lower mortality and fewer 
episodes of hospitalisation. Similar results were found by Lee et al (2007), who 
investigated the effect of self-management strategies on mortality and rate of 
hospitalisation and found that those with better self-management had lower mortality and 
fewer hospital admissions at one year. Falk et al (2009) also investigated self-care and 
survival in a sample of heart failure patients in Sweden, finding that poor self-care was an 
independent predicator of risk of death within twelve months, controlling for age and 
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NYHA classification. Grady (2008) in a literature review investigated the relationship 
between Health Related Quality of Life (HRQoL) and self-care and reported that whilst 
most studies suggested an improvement in HRQoL, the results were inconclusive.  An 
American Heart Association (AHA) statement (Riegel et al, 2009a) identifies a need to 
establish the direct effect of heart failure self-care on clinical outcomes including survival 
and HRQoL, as an urgent priority.   
 
There are wide variations in the reported extent of self-care in heart failure, especially in 
relation to medication adherence. The reasons for this are speculative although the 
different ways in which adherence and self-care are measured is likely to be a significant 
factor. Studies show that low levels of adherence to some aspect of self-care 
maintenance in heart failure is prevalent, ranging from 20-65% (Leventhal et al, 2005). 
Furthermore, self-care management behaviours such as managing and reporting 
symptoms have been found to be less frequently practised than self-care maintenance 
behaviours (Artinian et al, 2002).  
 
Using self-report measures, Van de Wal et al (2004) found adherence to medication to be 
96%, to diet, 80% and weighing at least once a week, 52%. Albert (2008) found that 
adherence to ACEI was just 39%.  The Carvedilol or Metoprolol European Trial (COMET) 
(Ekman et al, 2006) estimated a medication adherence rate of 76%. In the Candesartan in 
Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) trial (Granger 
et al, 2005), 89% of patients were over 80% adherent. In a review of adherence in the 
elderly, Van de Wal and Jaarsma (2007) cite rates from 10% to 99%. Adherence to a low 
sodium diet ranged from 13% to 75% and to a fluid restriction, 23% to 70%. Daily 
weighing ranged from 14% to 79% adherence. In conclusion, the findings from studies 
examining the extent of self-care and medication adherence in heart failure appear to be 
highly variable. The following section critiques the methods that have been used to 
measure adherence to medication and self-care in heart failure. 
 
2.3.3 Measuring medication adherence and self-care  
Medication adherence has been measured directly using a number of seemingly objective 
measures as well as the more subjective method of self-report. Commonly used 
measures include pill counts, the rate at which prescriptions are filled out or electronic 
Medication Event Monitoring Systems (MEMS). Here, the number of times a container is 
opened is recorded. However, although these methods are considered to be objective, 
there is no guarantee that medications are actually taken. Self-report measures are 
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considered to be more subjective and dependent upon accurate recall with some patients 
being tempted to exaggerate their adherence (Smith et al, 2009).  
 
Several studies have investigated the congruence between different measures of 
medication adherence in heart failure. Van De Wal and Jaarsma (2007) found a disparity 
between self-reported adherence to ACEI (99% adherence) and that recorded by MEMS 
(73%). In contrast, Chung et al (2006a) found broad agreement between self-reported 
medication adherence and MEMS. Smith et al (2009) aimed to identify a „gold standard‟ 
for measuring medication adherence in a UK population of elderly heart failure patients. 
Adherence to ACEI and diuretics over a six week period was measured using pill counts, 
MEMS and a self-report questionnaire. An adherence threshold of ≥ 80% was set which 
was considered an acceptable level of adherence. In relation to ACEI, 81% of patients 
were classified as adherent by self-report, 79% according to pill count but only 20% for 
electronic monitoring. For diuretics, 55% were classified as adherent by self-report, 63% 
by pill count and only 11% for electronic monitoring. On further analysis, the pattern of 
container opening as measured by MEMS was consistent with the use of a dosing aid 
such as a Dosette® Box where the container was opened weekly to fill the box. The 
authors conclude that it is not possible to select one method as the „gold standard‟ but pill 
counts and self-report, which were most closely correlated, are the most valid measures 
of adherence in heart failure.  
 
Adherence to a low salt or sodium diet can be measured using the objective method of 
urinalysis or self-report. Chung et al (2006b) investigated the ability of patients to 
accurately measure adherence to a low sodium diet using a combination of these 
methods. They concluded that patients found it difficult to accurately rate their adherence 
to a low sodium diet. Lennie et al (2008) also found a disparity between self-reported 
adherence (75%) compared to urinalysis (25%). These studies, conducted in the US, 
suggest that it may be more difficult for heart failure patient to accurately assess 
adherence to a low sodium diet compared to medication. The reasons for this are likely to 
be complex but may be related to a lack of information of what constitutes a „low salt‟ diet 
and difficulty assessing the sodium content of food, especially that which is pre-prepared 
or when dining out.   
 
Levels of self-care, including medication adherence have commonly been obtained by 
self-report questionnaires. Two widely cited examples are the Self-Care of Heart Failure 
Index (SCHFI) (Riegel et al, 2004) and the European Heart Failure Self-care Behaviour 
Scale (EHFScBS) (Jaarsma et al, 2003).  
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The SCHFI (Riegel et al, 2004) was developed in the US to measure self-care 
maintenance behaviour and the decision-making processes involved in managing the 
symptoms of heart failure.  Developed from the earlier Self-Management of Heart Failure 
Tool (Riegel et al, 2000), the SCHFI is a self-report measure of fifteen items rated on a 4-
point scale. The index is divided into three sub-scales – self-care maintenance in which 
respondents are asked to rate the frequency of carrying out individual behaviours, for 
example, ‘I weigh myself daily’; a complex self-care management sub-scale in which 
respondents are asked if they have had trouble breathing or experienced ankle swelling 
and if so, how quickly they recognised these as symptoms of heart failure, what remedies 
they tried, for example, ‘taking an extra water pill’, and how sure they were that the 
remedy worked (treatment efficacy). The final sub-scale assesses self-confidence (self-
efficacy), for example, ‘how confident are you that you can evaluate the importance of 
your symptoms?’ The index was used on 760 patients with heart failure. Reliability of the 
scale as a whole was described as adequate (Cronbach‟s α = 0.76) although the reliability 
of the self-care maintenance sub-scale was moderate (α = 0.56). Since only the 
symptoms of trouble breathing and ankle swelling are included, the scale is limited to 
patients who experience these symptoms. In addition some remedies are not advocated 
in all patients in the UK, taking an extra diuretic or water tablet, for example. Furthermore, 
since this index combines both behavioural and psychological processes, it is difficult to 
determine the relationship between beliefs and behaviour which is the aim of this current 
study. An update on the SCHFI (version 6) with added maintenance items and a modified 
response format has been issued (Riegel et al, 2009b), although the internal consistency 
of the scale is not significantly improved. 
 
The EHFScBS (Jaarsma, et al, 2003) (Appendix 3) was developed and piloted in a 
number of centres in Sweden and the Netherlands before being tested in 442 patients in 
Sweden, the Netherlands and Italy. It was developed in English with translation and back 
translated into Swedish and Dutch. Orem‟s model of self-care was used as the theoretical 
framework (Orem, 1995). The scale is a 12-item, self-administered questionnaire in which 
respondents are asked to rate the extent to which they agree or disagree with statements 
on a 5-point scale. Designed to measure only behavioural outcomes, the authors 
recognised a need for the scale to be able to measure the effects of interventions such as 
education programmes. The scale was developed by healthcare professionals and 
emphasises self-care maintenance behaviours, for example, ‘I restrict my sodium intake’. 
Although the scale claims to address healthy functioning and well-being, this is not evident 
in the questionnaire. In addition, monitoring and responding to symptoms are not 
differentiated in statements such as ‘If my shortness of breath increases, I contact my 
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doctor or nurse’. Furthermore, factor analysis failed to confirm the theoretically derived 
dimensions of complying with regimes, asking for help and adapting activities. Items 
loaded on more than one factor or could not be theoretically identified as separate factors. 
Internal consistency of the individual sub-scales was limited ranging from α = 0.46 - 0.67. 
In light of this analysis, the use of a total self-care score is advocated by the authors. 
Internal consistency of the questionnaire as a whole was good at α = 0.81. The authors 
conclude that although useful for research purposes, the scale requires additional testing 
before it can be used in clinical practice. The questionnaire has since been revised into a 
9-item scale and further tested (Jaarsma et al, 2009). Internal consistency was calculated 
as α = 0.80, with one reliable sub-scale identified (consulting behaviour). 
 
The EHFScBS has been translated into fourteen languages. A Japanese version (Kato et 
al, 2007), demonstrated acceptable but weaker internal consistency compared to the 
original questionnaire (α = 0.71). Shuldham et al (2007) tested the scale in 183 patients 
with heart failure in England and found the scale to be moderately reliable in this sample 
(α = 0.69). Again, principal components analysis did not confirm the theoretically derived 
factor structure. Furthermore, no correlations were found between the EHFScBS, the 
SCHFI and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) (Riegel et al, 
2002; Rector et al, 1997), a health-related quality of life (HRQoL) measure, suggesting 
that concurrent validity of the EHFScBS has not been established, which may limit its use 
in practice.  
 
In conclusion, a number of methods exist for measuring medication adherence such as pill 
counts, MEMS and self-report, although no gold standard exists between these methods. 
Adherence to a low salt diet may be more difficult to determine by self-report. In terms of 
self-care, the SCHFI (Riegel et al, 2004), though a valid and reliable measure, addresses 
the decision-making process of self-care not just the behaviours carried out by individuals. 
As such, its use is limited in determining the relationship between beliefs and behaviour. 
The EHFScBS (Jaarsma, et al, 2003) does assess behaviour, though emphasises self-
care maintenance or adherence behaviours. Factor analysis failed to confirm the 
theoretically derived constructs which made up self-care and the translated English 
version was less reliable than the original, Swedish version, suggesting a need for further 
exploration of this scale in a UK population. 
 
2.4 FACTORS INFLUENCING SELF-CARE IN HEART FAILURE 
 
The WHO (Sabate, 2003) developed a multi-dimensional model of factors influencing 
adherence behaviour in long-term conditions. Although devised as a framework for 
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adherence, this model is also useful for conceptualising factors influencing self-care. Five 
main influences are identified - socio-economic, healthcare system, condition, treatment 
and patient-related factors (Table 2.5).  
 
Table 2.5 Summary of Factors Influencing Self-Care in Heart Failure 
 
Socio-
economic 
Healthcare 
system 
Condition-
related 
Treatment-
related 
 
Patient-
related 
Education 
 
Financial 
constraints 
 
Level of social 
support 
 
Culture 
 
 
 
Patient support 
services 
 
Patient-Provider 
relationship 
 
Provider 
knowledge and 
skills 
 
Availability of 
resources 
Symptom 
severity 
 
Functional ability 
 
Presence of co-
morbidities 
 
Experience 
 
Cognitive ability 
 
 
 
Effectiveness  
of treatment 
 
Side-effects 
 
Complexity of 
regime 
 
Changes in 
regime 
 
 
 
Age 
 
Gender 
 
Knowledge 
 
Ability 
 
Beliefs, values 
 
Motivation 
 
Personality 
 
Self-efficacy 
Based on Leventhal et al (2005) and Sabate (2003).  
 
Many studies have considered the influence of these factors on self-care in heart failure. 
Socio-economic status including level of education, financial constraints, social support 
and culture, have been highlighted as influencing factors. Low socio-economic status and 
educational levels have been found to be important factors relating to non-adherence and 
poor self-care (Wu et al, 2007; Gary, 2006; Van der Wal et al, 2006). Supporting this, a 
higher level of education was found to be a significant predictor of adherence in studies by 
Rockwell and Riegel (2001) and Evangelista and Dracup (2000). This may be due, 
perhaps, to better health literacy in terms of understanding the illness, knowledge of 
lifestyle factors and an enhanced ability to manage complex treatment regimes.  
 
Financial constraints due to the cost of medication have been identified as a barrier to 
adherence (Wu et al, 2008; Horowitz et al 2004; Evangelista et al, 2003).  However, these 
studies were conducted in the US and generally relate to a lack of medical insurance with 
resulting increased personal costs of medication. Further research is needed to determine 
whether the cost of medication significantly influences adherence to heart failure 
medication in a UK healthcare setting. Since most research has been carried out on 
retired, elderly patients, little is known about the self-care behaviour of employed people. 
A number of studies suggest that self-care is limited in those who are employed (Kato et 
al, 2009; Dickson et al, 2008; Dickson et al, 2007a; Kato et al, 2007). It is suggested that 
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this may be due to better physical functioning and reduced severity of illness and 
symptom burden which may act to reduce the motivation to self-care.  
 
Social support has been found to be significant factor influencing self-care in many studies 
(Dunbar et al, 2008; Wu et al 2008; Riegel et al, 2007a; Ortega-Gutierrez et al 2006; 
Schnell et al, 2006; Scotto, 2005; Artininan et al, 2002; Ni et al, 1999). Chung et al 
(2006a) investigated the impact of marital status on medication adherence and found that 
married patients had substantially better adherence than those living alone. Patients with 
a spouse took more doses, understood the importance of taking medications on time and 
were more knowledgeable about names and doses. Sebern and Riegel (2009) found that 
shared communication and decision-making correlated with high levels of self-care. The 
nature of this support has been described in terms of practical assistance with medication 
management by giving partners their tablets at prescribed times (Stromberg et al, 1999), 
or collecting medications from the pharmacy and filling Dosette® Boxes (Wu et al, 2007). 
These authors conclude that without the active engagement of family members, some 
patients would have difficulty adhering to their medication regime. In contrast, Evangelista 
et al (2001) found no correlation between social support and adherence to medication and 
lifestyle behaviours which, it was suggested, was due to the high levels of social support 
reported in this sample. In relation to a low sodium diet, Chung et al (2009) found that 
adherence was improved in those where a spouse or family member also followed the 
diet.  
 
There is limited evidence on the influence of culture on self-care in heart failure. Wu et al 
(2007) and Riegel et al (2006) found that self-care practice amongst minority ethnic 
groups in the US, was poor compared to other groups, even when controlling for other 
socio-demographic factors. Riegel et al (2007) compared self-care in developed countries 
(the US and Australia) and developing countries (Mexico and Thailand) and found that 
self-care was highest in the Australian population and lowest in the Thailand population. 
No reasons are given to explain this except to suggest that further work is needed to 
determine the influence of culture on self-care. In contrast, Hebert et al (2010) found no 
difference in terms of adherence to heart failure medication between Hispanic, White and 
Black patients in the US.  
 
In summary, socio-economic factors, especially levels of social support are believed to be 
significant predictors of self-care in heart failure. However, these studies were conducted 
outside the UK so it is unclear whether these findings can be applied to a UK healthcare 
setting.  
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Considering healthcare system-related factors, support from healthcare providers has 
been found to enable self-care in a number of studies (Wu et al, 2008; Dickson et al, 
2006; Schnell et al, 2006; Leventhal et al, 2005; Scotto, 2005; Stromberg et al, 1999). 
This was due to positive relationships between patients and healthcare providers involving 
trust, professional knowledge and skill and time for consultations. Enabling skill 
development was also seen as important. Dissatisfaction with care and lack of physician 
support was detrimental to self-care in a study by Riegel and Carlson (2002). Though not 
explicitly stated in these studies, it seems likely that healthcare system-factors are most 
likely to be related to the self-care practice of seeking help and advice in response to 
deteriorating symptoms. 
 
A number of factors relating to the illness have been described as influencing self-care. 
These include the severity of symptoms and related functional ability, level of experience, 
prior hospitalisation, the presence of co-morbidities and cognitive functioning. Severity of 
symptoms and functional ability, as measured by the NYHA Functional Classification 
(NYHA, 1984), have been found to be important predictors of self-care in studies by Wu et 
al (2007) and Rockwell and Riegel (2001), with those patients with the most severe 
symptoms and limited functional ability having poorer self-care. However, this is more 
complex than it at first seems as poor functional ability may also be a motivating factor to 
self-care (Dickson et al, 2008). Hence, a balance exists between the motivation to self-
care and the ability to carry out self-care practices such as monitoring and managing 
symptoms. Prior experience of hospitalisation also seems to motivate individuals to self-
care as those with previous admissions were found to be more likely to care for 
themselves effectively in a study by Carlson et al (2001), presumably in an effort to avoid 
future hospitalisations. Similarly, level of experience of heart failure or time since 
diagnosis may be important in determining self-care ability as it is suggested that those 
with most experience of the illness have an enhanced ability to recognise changing 
symptoms and use tried and tested strategies to alleviate symptoms (Carlson et al, 2001).  
 
The presence of co-morbidities, especially if symptoms are similar to those of heart 
failure, makes the recognition and subsequent management of symptoms difficult for 
some patients. Chriss et al (2004) found that those with less co-morbidity had enhanced 
self-care. Given the prevalence of co-morbidities in heart failure, especially amongst older 
age groups, this suggests that many patients will experience some difficulty in recognising 
and managing symptoms. 
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Depression is a prevalent condition in patients with heart failure and can be considered a 
co-morbidity or an effect of the illness. It is suggested that at least 11% of ambulatory 
patients and over 50% of hospitalised patients with heart failure are depressed (Leventhal 
et al, 2005). Depression has been linked to poor self-care in studies by Holzapfel et al 
(2009), Riegel et al, (2007b), Dickson et al (2006) and Lesman-Leegte et al (2006). Non-
adherence is reportedly three times higher in depressed patients compared to those who 
are not depressed (DiMatteo et al, 2000). It seems likely that the motivation and ability to 
self-care is more limited in depressed patients so making it important that depression is 
diagnosed and treated in this population.    
 
Self-management requires that patients make decisions and take actions in response to 
symptoms. Cognitive deficits in heart failure are well documented (Nicholson, 2007; 
Bennet and Sauve, 2003; Ekman et al, 1998) with estimates of the prevalence of 
impairment between 30-50% (Leventhal et al, 2005). Wolfe et al (2005) found specific 
cognitive deficits in terms of memory, attention and executive functioning which were not 
related to illness severity.  Such deficits may impair the perception and interpretation of 
symptoms and the reasoning ability required for self-management.  This is supported by 
Dickson et al (2007b), who found a correlation between impaired cognition and individuals 
inconsistently demonstrating effective self-care. Similarly, Cameron et al (2010) found 
poorer self-management in those with mild cognitive impairment. Paroxysmal nocturnal 
dyspnoea, common in heart failure, deprives the body of sleep and may further impair 
cognitive functioning and decision-making ability (Trupp and Corwin, 2008). Perhaps as a 
result, the symptom of daytime sleepiness has also been linked to poor self-care (Riegel 
et al, 2009c).   
 
Adherence to medication has been linked to treatment-related factors such as the effects 
of medication, complexity of the regime and frequent changes to medication. It seems 
likely that the effects of medication, for example, the need for frequent urination as a result 
of diuretics, and side-effects of medication, such as dizziness, may reduce medication 
adherence (Cowie et al, 1999). The complexity of the treatment regime as indicated by a 
high number of administration times, for example, has been shown to decrease 
medication adherence (George and Shalansky, 2007; Van der Wal and Jaarsma, 2007; 
Riegel and Carlson, 2002). Furthermore, it can reasonably be assumed that the practice 
of up-titration of heart failure medication, that is increasing the dose to a target level, 
increases the day-to-day complexity of the regime with perhaps detrimental effects on 
adherence.   
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Individual patient characteristics have a role in self-care. Gender may influence behaviour 
although there is conflicting evidence. Lee et al (2009) found that gender was not a 
determinant of any aspect of self-care which is in contrast to the findings of Chung et al 
(2006b) who found that adherence to a low sodium diet was higher in women who were 
better able to make dietary decisions, perhaps due to increased knowledge. Conversely, 
Gary (2006) found that few women followed the recommended sodium restrictions, 
exercised or weighed themselves daily. However, as this was not a comparative study, it 
cannot be concluded that gender differences existed. Heo et al (2008) found higher 
perceived control and greater knowledge were associated with better self-care in men, 
whilst in women higher self-confidence and poorer functional status correlated with better 
self-care. It seems that gender differences may operate on factors influencing self-care as 
well as influencing adherence behaviours, such as diet, directly.  
 
The relationship between age and self-care behaviour is similarly unclear. Chriss et al 
(2004) and Evangelista et al (2003) found that increasing age was an independent 
predictor of self-care with elderly patients demonstrating greater adherence to medication, 
diet and exercise advice than younger patients. In contrast, Cline et al (1999) found that 
non-adherence to medication was more common in elderly patients who had limited 
knowledge regarding the names of the medication, their use and dosage. However, in this 
study it is not clear whether age was an independent predictor of self-care or related to 
other factors such as the presence of co-morbidities, for example.  
 
Another individual factor thought to influence self-care is knowledge about the medication, 
the condition and required behaviour. Medication knowledge including the names of the 
medication, mode and times of administration and the effects has been shown to impact 
on adherence (Ekman et al, 2006; Toren et al, 2006; Cline et al, 1999). Furthermore, 
knowledge about the relationship between the illness and medication was found to be 
important in a study by Wu et al (2008). Here, the ability to connect symptoms and the 
medications effectiveness in decreasing those symptoms enhanced medication 
adherence. In relation to lifestyle recommendations, Van der Wal et al (2006) found that 
patients did not regularly weigh themselves due to lack of knowledge of the reasons for 
weighing. Similarly, Ni et al (1999) and Riegel and Carlson (2002) found that a lack of 
knowledge of recommended self-care behaviour had a detrimental effect on adherence. It 
seems, then, that knowledge about the illness, its treatment and recommended 
behaviours is fundamental in enabling individuals with heart failure to self-care effectively.  
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Comparatively little is known about psychological factors such as personality and self-care 
in heart failure. One study by Schiffer (2007), found that individuals with type-D 
personality, characterised by negative affectivity and social inhibition (Denollet and 
Brutsaert, 1998), experienced symptoms which were more often appraised as worrying 
that those with other personality traits. However, they were also less likely to report these 
symptoms.  
 
A small number of studies have used the CSM to examine illness beliefs and predict self-
care behaviour in heart failure. Voelmeck (2006) explored illness representations, self-
care and HRQoL in a sample of 98 heart failure patients in the US. Using the IPQ-R, 
SCHFI and the Minnesota Living with Heart Failure Questionnaire (MLHFQ), no significant 
correlations were found between self-care scores and either illness representations or 
HRQoL. In a similar study, Morgan (2008) explored relationships between illness 
representations (IPQ-R), psychological well-being (Hospital Anxiety and Depression 
Scale, HADS), self-care (EHFScBS), and HRQoL (Kansas City Cardiomyopathy 
Questionnaire) in a sample of 161 heart failure patients in the Republic of Ireland. In 
contrast to the findings of Voelmeck (2006), illness representations explained a significant 
proportion of the variance in each of the study outcomes. More variance in self-care 
behaviour (8%) was explained by illness representations than illness-related or 
demographic factors. Albert and Zellar (2007) also found weak but statistically significant 
correlations between the accuracy of illness beliefs, as determined by the SIBHFT, and 
adherence (r = 0.12, p ≤ 0.05) and self-care management (r = 0.12, p ≤ 0.05). Fox et al 
(2001), using the IPQ-R, studied the congruence of illness representations between 60 
older heart failure patients and their spouses and the relationship to adherence behaviour. 
Adherence was increased when patients and their spouses held congruent beliefs in 
relation to the illness representation of control.   
 
In relation to treatment beliefs, only one study by Ekman et al (2006) was found that 
examined treatment beliefs and medication adherence in heart failure. Here, a strong 
belief that medication would improve symptoms was positively associated with medication 
adherence.  
 
In summary, published studies suggest that socio-demographic factors, the healthcare 
system, the illness and its treatment and patient-related factors influence self-care in heart 
failure although this evidence is, at times, inconclusive. The relationship between illness 
and treatment beliefs and self-care, which is the focus of this research, has been 
considered in only a few of studies, again with conflicting findings.  
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2.5 CONCLUSION 
 
In conclusion, four main areas of literature have been examined in this chapter: the nature 
and management of heart failure from a predominantly biomedical perspective, lay beliefs 
and social and psychological perspectives of health, illness and treatment, self-care policy 
and practice and finally, the factors influencing self-care in heart failure, including illness 
and treatment beliefs. 
 
In summary, heart failure is a prevalent clinical condition with wide ranging implications for 
the individual, their family and wider society. Defining heart failure can be problematic not 
only because of the many different types of failure but also because of the lack of a 
definitive diagnosis at times. Health and social care financial costs are high and are set to 
increase in the future. Clinical management presents a number of challenges not least 
because the cause of heart failure may be difficult to determine in many individuals and 
co-morbidities are common.  Management is predominantly through drug therapy but 
other treatments are becoming more widespread such as pacemaker devices. Prognosis 
is often difficult to predict which can mean that making the decision to move to a palliative 
care approach can be problematic.  
 
The experience of living with heart failure, from a patients‟ perspective, is also challenging 
and can be viewed as a major disruption in an individual‟s life course. A large number of 
relatively non-specific symptoms may be experienced by individuals and it is suggested 
that differentiating symptoms from the effects of ageing and medication may be difficult. 
Furthermore, the presence of a high number of co-morbidities in this population may make 
the construction of a coherent picture of the illness and treatment more difficult.  
 
Lay beliefs about illness have influenced the development of a number of models which 
attempt to explain and predict behaviour. The CSM (Leventhal et al, 1980) is widely used 
as a theoretical framework. Its main strengths are that it recognises an emotional 
influence on behaviour and views the interaction between beliefs and behaviour as a 
dynamic system involving a cognitive appraisal of outcomes which then feedback to 
influence beliefs. Illness representations, according to this model, have been measured 
extensively using the IPQ-R (Moss-Morris et al, 2002) and there is much support for its 
predictive ability of a number of health-related outcomes. It has been proposed by Horne 
(1997) that the CSM be extended to include treatment beliefs, involving beliefs about the 
necessary of and concerns about medication The BMQ (Horne et al, 1999) which 
measures treatments beliefs has been useful in predicting adherence to medication in 
some illnesses.  
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Self-care, including medication adherence, has been established health and social care 
policy in the UK for the past decade. Applied to heart failure, self-care has been visualised 
as a decision-making process involving making choices related to lifestyle behaviour and 
taking medication (self-care maintenance) and recognising symptoms and taking actions 
(self-care management). In UK policy, the definition of self-care also includes those 
actions taken to maintain emotional and social well-being, not just adherence to 
recommended lifestyle behaviour and medication. The reported level of self-care in heart 
failure varies widely and seems to be dependent on both context and methodology. In 
measuring self-care in heart failure, although other measures exist such as the SCHFI 
(Riegel et al, 2004), the EHFScBS (Jaarsma et al, 2003) has been used in a number of 
European studies and has been found to have an acceptable level of reliability in a UK 
population. However, there is an emphasis on adherence behaviours with more limited 
inclusion of self-management strategies or emotional and social activities. This may be 
because the development of this scale was led by expert nurses according to a 
biomedical model of illness rather than viewed from a patient perspective.  
  
Factors affecting self-care in heart failure have been extensively studied especially in 
relation to adherence behaviour. These factors can be categorised as socio-economic, 
healthcare, condition, treatment and patient-related. Of these, there is most evidence for 
the influence of social support, patient-provider relationships, the presence of co-
morbidities, the complexity of the drug regimes and the presence of cognitive impairment 
on self-care. However, there is more conflicting evidence in relation to age and gender, 
severity of illness and functional ability on self-care. Limited evidence exists for the 
influence of illness and treatment beliefs. Where evidence does exist, it is, again, 
conflicting. Voelmeck (2006) found no correlations between illness representations and 
self-care which is in contrast to the findings of Morgan (2008) and Albert and Zellar 
(2007), although only weak correlations were found in this earlier study.  Only Ekman et al 
(2006) suggest a possible association between beliefs about the necessity of heart failure 
medication and adherence.  
 
Arguably, a need exists to develop an understanding of illness and treatment beliefs in a 
UK, heart failure population and to determine any relationship between these beliefs and 
self-care behaviour. This understanding may mean that targeted interventions aimed at 
changing beliefs and enhancing self-care could then be developed.  
 
The CSM has proved to be a useful framework for exploring beliefs and their relationship 
to health outcomes in other illness populations. The measurement of illness 
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representations through the IPQ-R, and treatment beliefs through the BMQ, are generic 
questionnaires and so should first be adapted for use in heart failure. The use of the 
EHFScBS in measuring self-care, though illness-specific, needs to be scrutinised for its 
applicability to a UK, heart failure population. 
 
From this review, qualitative and quantitative studies have enhanced the understanding of 
the experience of living with heart failure and the relationship between beliefs and self-
care. Combining qualitative and quantitative approaches in a single study would enable 
both an exploration of the topic and allow relationships between illness representations, 
treatment beliefs and self-care to be determined. The following chapter discusses the 
methodology and methods used in this study. 
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CHAPTER THREE:   METHODOLOGY AND OVERVIEW OF METHODS 
 
This purpose of this chapter is to present the research design, analyse the methodology 
and present an overview of the methods employed in this study.  First, a reminder is given 
of the aims and objectives of the research before summarising the overall design. The 
philosophical basis of the dominant paradigms in health and social care research is 
discussed before defining mixed methods and briefly tracing the historical and 
philosophical development of this methodology. A typology of mixed methods is presented 
and the model used in this research is identified and discussed.  For clarity, although an 
overview of the methods is given here, detailed discussion of the methods and procedures 
is given in Chapters four, five and six in relation to each phase of the study.  Discussing 
the methods and results of each phase in sequence is a structure common in the write-up 
of mixed methods research (Creswell and Plano Clark, 2007). However, to avoid 
repetition, aspects of method which are common to both phases of the study, namely, the 
research setting, permissions and access to participants are discussed here.   
 
As stated in the introduction, the aims of the research were to explore illness 
representations, treatment beliefs and self-care in heart failure and to determine 
relationships between these variables. The objectives were to conduct semi-structured 
interviews with a sample of heart failure patients to explore illness representations, 
treatment beliefs and self-care; to adapt or develop as necessary, questionnaires 
measuring illness representations, treatment beliefs, socio-demographic factors and self-
care and to use these questionnaires to determine relationships between these variables 
in a cross-sectional survey.  
 
A mixed methods research design was chosen, using an exploratory, instrument 
development model as defined by Creswell and Plano Clark (2007).  The research was 
conducted in two sequential phases: Phase one explored illness representations, 
treatment beliefs and self-care in a sample of people with heart failure using qualitative 
methods. The findings from this phase were used to adapt and develop three 
questionnaires measuring illness representations, treatment beliefs and self-care. A socio-
demographic questionnaire was also developed. Following a pilot study, in phase two, 
illness representations, treatment beliefs and self-care were examined in a cross-sectional 
survey and relationships between these variables were determined using quantitative 
methods.  
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This design was chosen as it was thought necessary to first explore the phenomenon of 
beliefs and behaviour in this population from a patient perspective, best achieved using 
qualitative methods. Findings could be used to inform the development of measurement 
instruments, specific to heart failure. Relationships between beliefs and behaviour could 
then be tested in a larger sample, best achieved using quantitative methods. By 
integrating qualitative and quantitative findings in this way, it was anticipated that a more 
complete understanding of the topic could be achieved. 
 
3.1          THE DOMINANT PARADIGMS IN HEALTH AND SOCIAL CARE RESEARCH  
 
In order to locate this research within a philosophical paradigm, this section begins with a 
discussion of what is meant by the term „paradigm‟ and the different ways in which 
researchers have defined this. The development of the view that alternative paradigms 
are incompatible will be traced. The positivist or postpositivist and constructivist or 
interpretivist philosophical views will be compared and contrasted and the development of 
paradigms will be considered before discussing the view that we are now entering a third 
methodological movement – that of mixed methods research  (Tashakorri and Teddlie, 
1998). 
 
3.1.1 Defining paradigms and the incompatibility thesis 
The use of paradigms as a way of describing researchers‟ beliefs about their work can be 
traced from Kuhn (1970) in „The structure of scientific revolutions‟. Kuhn defined 
paradigms in a number of ways. A broad definition is that of a „worldview‟ or an all-
encompassing way of viewing and experiencing the world. In research terms, the most 
popular definition of a paradigm is „A basic set of beliefs that guide action‟ (Guba and 
Lincoln, 1995, p.105). Both these broad definitions emphasise what Morgan (2007) 
describes as the „metaphysical‟ basis of research, that is, abstract ideas about truth, 
reality and moral values. An acceptance of these broad definitions suggests that individual 
researchers hold a system of beliefs about the world which are so fundamental and 
integral to their thinking that it would be impossible to work within an alternative paradigm.  
 
According to Morgan (2007) it was this emphasis on metaphysical concerns that served to 
differentiate qualitative from quantitative research, leading to the belief that alternative 
paradigms and crucially, the research methods that they traditionally employ, are 
incompatible. That is, it is impossible to hold opposing paradigmatic views. Howe (1988) 
coined this „the incompatibility thesis‟. Advocates of these opposing paradigms, according 
to Gage (1989), have focused on debating the superiority of either a quantitative or a 
qualitative approach. As a result, researchers have been limited to single-method studies 
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in the belief that quantitative and qualitative techniques are incompatible due to 
fundamental and diametrically opposed differences in their philosophy (Tashakkori and 
Teddlie, 1998). 
 
Challenging this view, Morgan (2007), argued how Kuhn himself identified at least two 
other, more specific, definitions of the term paradigm. Paradigms can also be viewed as 
shared beliefs among members of a research community which determines what 
questions should be answered and the methods best employed in answering them. 
Alternatively, a paradigm can also be defined as an example or model of how research is 
carried out in a specific field. If these definitions of a paradigm are applied, it is suggested 
that researchers have the freedom to work with a number of different research methods, 
opening up the possibility of mixed methods research. 
 
3.1.2 Comparison of the dimensions of the dominant research paradigms  
Guba and Lincoln (1995) discussed the nature of the dominant paradigms in terms of 
ontology, epistemology, axiology and methodology. These authors define ontology as the 
study of the nature of reality, its form and what can be known about it. Epistemology is 
concerned with the nature of the relationship between the researcher and what can be 
known, and the nature of truth. According to Guba and Lincoln (1995), epistemology, 
therefore, is inexorably linked to ontology. For example, if one assumes that there is a 
single, external reality then the researcher remains detached and objective in order to 
discover that reality. Axiology is concerned with moral values and the importance of value-
free research. Again, this is linked to epistemology in practical terms, in that a researcher 
adopting a subjectivist stance would also presumably support a value-laden axiology.  
 
Finally, and arguably most significant, is the issue of methodology. This concerns the 
reasoning or logic of the research. Deductive reasoning is theory-driven and involves the 
testing of a priori hypotheses. Inductive reasoning begins with observation with a view to 
recognising patterns and developing theory. Methodology also includes the nature of the 
findings in terms of the extent to which they are context-dependent or generalisable and 
the justification for the research design and processes (methods). Ideas about ontology, 
epistemology and axiology are often seen as fundamental to the research process, 
underpinning methodological issues and, hence, determining the choice of methods 
(Crotty, 1998). 
 
The dominant paradigms of positivism/postpositivism and interpretivism/constructivism are 
discussed before identifying an alternative philosophical position. Positivism was 
developed by the logical positivists and later developed by Karl Popper to be called 
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postpositivism. According to Guba and Lincoln (1995) a postpositivistic stance 
emphasises a critical realism in that there is single, external reality but this can only be 
understood imperfectly. The researcher takes an objectivist stance and assumes findings 
are probably true but subject to falsification. This follows the assertion by Popper that 
knowledge develops not through proving an hypothesis, which is impossible, but by 
disproving or falsifying theory and presenting an alternative hypothesis. For Popper, the 
belief that a hypothesis is always subject to falsification defines the scientific method 
(Magee, 1985). Researchers strive for value-free inferences and the emphasis is on 
deductive logic and testing theory. The research design is largely experimental or quasi-
experimental using quantitative methods.  
 
Seemingly diametrically opposed to the positivist/postpositivist position is the 
constructivist or interpretivist viewpoint (originally called naturalism) by Guba and Lincoln 
(1995). The ontological basis is described as relativist in that realities are believed to be 
multiple and constructed by the individual. They are not held to be „true‟ in any absolute 
sense.  The researcher and the researched are inexorably linked so that the research is 
laden with the values and the subjective experience of the researcher. There is an 
emphasis on inductive reasoning and qualitative methods with the recognition that 
inferences are dependent on the context in which the research takes place. These 
philosophical positions are frequently presented as representing opposing points of view 
in terms of each paradigmatic dimension. 
 
These dominant paradigms are compared and summarised according to ontology, 
epistemology, axiology and methodology in Table 3.1, adapted from Creswell and Plano 
Clark (2007, p.24) and Guba and Lincoln (1995, p.164). For comparison, the dimensions 
of a pragmatic paradigm are included as this has been selected as the philosophical basis 
of this research (discussed in section 3.2.2).  
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Table 3.1:  Summary of the Paradigmatic Dimensions of Positivist/Postpostitivist,  
Constructivist/Interpretivist and Pragmatic Research 
 
Dimension Positivism/ 
Postpositivism 
Constructivism/ 
Interpretivism 
Pragmatism 
(section 3.2.2) 
Ontology  
The nature of reality 
 
A single reality 
 
 
Multiple realities – reality 
is socially constructed 
 
Singular and multiple 
realities 
Epistemology  
The relationship 
between the researcher/   
researched; 
The nature of truth 
 
Objective 
 
 
A single, absolute truth 
 
Subjective 
 
 
Multiple truths 
 
 
Objective and 
subjective 
 
Singular and multiple 
truths 
Axiology 
Moral values  
 
 
Value-free (unbiased) 
 
Value-laden (biased) 
 
Value-free and value-
laden 
Methodology  
Reasoning; 
Inferences 
 
Deductive reasoning;  
Inferences are 
generalisable 
 
Inductive reasoning; 
Inferences are context 
dependent 
 
Abductive reasoning; 
The degree of 
transferability  
 
3.1.3 Tracing the development of quantitative, qualitative and mixed methods  
Kuhn‟s (1970) description of how paradigms develop enables an exploration of the shift 
from a positivist/postpositivist paradigm employing largely quantitative methods, to a 
constructivist or interpretivist paradigm using qualitative methods and, arguably, to a 
mixed methods approach in health and social science research. Kuhn (1970) describes 
how a new idea is initially resisted as it threatens the established order. This idea is then 
gradually accepted until it too becomes institutionalised. A new, revolutionary idea then 
emerges. In nursing, research has been based on „borrowing‟ traditions from other 
disciplines, most notably medicine. Early nursing research was therefore, drawn from a 
positivist paradigm with research primarily focused on outcome measures using 
predominantly quantitative measures (Twinn, 2003). 
 
Since the 1980s, qualitative research has been in ascendance, establishing at least equal 
dominance in health research. Within nursing, the recognition that the complexity of health 
and illness and the nature of the human experience could not adequately be understood 
in purely scientific terms, led to a growing acceptance of qualitative research as a way of 
understanding health and nursing practice in terms of its social, behavioural, 
psychological, political, cultural and environmental influences (Twinn, 2003). In the social 
sciences, the paradigmatic shift was led by qualitative researchers, most notably, Lincoln 
and Guba (1985) who argued that the claims made by positivists and postpositivists were 
unrealistic and the alternative view of constructivism enabled a better understanding of the 
social world. 
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Tashakkori and Teddlie (2003) argue that we are currently experiencing a third paradigm 
shift to mixed methods research. Morgan (2007) also describes a move away from the 
metaphysical paradigms as there is an unclear relationship between metaphysical beliefs 
and the practical application of research methods. Guba and Lincoln (1995) agree that it is 
unlikely that the discussion of metaphysical dimensions closely describes what the 
researcher thinks or does and that „workaday scientists rarely have either the time or 
inclination to assess what they do in philosophical terms‟ (Guba and Lincoln, 1995, p.117).  
 
Mixed methods research is described by leading authors as in an adolescent stage with 
many unresolved issues, not least, its philosophical basis. The degree of acceptance of 
mixed methods as the dominant research paradigm, as envisaged by Tashakkori and 
Teddlie (1998) and Morgan (2007), remains to be seen. However, currently, interest in 
mixed methods research is evidenced by the proliferation of published research articles. 
Plano Clark (2005) found more than 60 published articles in health and social science 
journals employing mixed methods in 2004. The Journal of Mixed Methods Research was 
launched in 2005, the year which also saw the first international, multidisciplinary 
conference on mixed methods. A review of research commissioned by the Health 
Research and Development Programme in the UK found that 30% were mixed methods 
between 2000 and 2004 compared to 17% before this period (O‟Caithain et al, 2007). 
 
3.2 IDENTIFYING  MIXED METHODS AS THE RESEARCH DESIGN  
 
The section begins by defining mixed methods and presents a rationale for the selection 
of this design in this study. The historical and philosophical development of mixed 
methods will be briefly traced before analysing the different types or models of mixed 
methods. Finally, the rationale for the use of the specific model used in this research will 
be discussed. 
 
3.2.1 Defining mixed methods and the rationale for its use in this study  
Creswell and Plano Clark (2007, p.5) define mixed methods as: 
„A research design with philosophical assumptions as well as methods of inquiry. As 
a methodology, it involves philosophical assumptions that guide the direction of the 
collection and analysis of data and the mixture of qualitative and quantitative 
approaches in many phases of the research process. As a method, it focuses on 
collecting, analysing and mixing both quantitative and qualitative data in a single 
study or series of studies. Its central premise is that the use of quantitative and 
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qualitative approaches, in combination, provides a better understanding of research 
problems than either approach alone‟.  
 
This definition, although lengthy, has been selected as an operational definition as it 
brings together three main elements common in other definitions, for example, those of 
Greene and Caracelli (1997) and Tashakkori and Teddlie (1998; 2003). Namely, that 
mixed methods is a methodology not just a method, that it combines qualitative and 
quantitative methods in the same study and that this combination „adds value‟ to the 
research. A further advantage of mixed methods is that the strengths of one method may 
offset the limitations of the other. This is frequently referred to as „methodological 
triangulation‟ and is the historical basis of mixed methods research (Jick, 1979).  The main 
strengths and limitations of quantitative and qualitative methods are outlined below. 
 
Quantitative methods commonly involve large, representative samples so there is often a 
high degree to which findings can be generalised. In this way the research question is 
addressed in a broad, general sense not just in isolated circumstances (Miles and 
Huberman, 1994). It allows for greater objectivity as there is an effort to avoid personal 
bias so that researchers aim to keep a 'distance' from participants. Procedures are 
employed to maximise validity and reliability and described in detail so that the research 
may be replicated. Importantly, quantitative methods facilitate comparisons across 
categories and over time. In this way, the relationship between categories can be 
established (Kruger, 2003). However, this also means that quantitative methods often 
collect a much narrower and arguably, more superficial range of data. Results are limited 
to numerical descriptions rather than detailed narrative. The development of standard 
questions by researchers can lead to 'structural' bias, where the data actually reflected the 
view of the researcher instead of the participant. To some extent this can be overcome by 
deriving assumptions about which constructs are worth measuring, on qualitative data (De 
Vaus, 1996).  
 
In comparison, qualitative data provides depth and detail and can generate new theories 
or allow the description of existing phenomena and current situations. In doing so, it can 
facilitate a more complete understanding of the human experience (Denzin and Lincoln, 
2005). The collection and analysis of qualitative data is highly dependent upon the 
researcher‟s personal attributes and skills. This subjectivity, including personal experience 
and insight, is often described as a strength of qualitative data but also makes objectivity 
impossible so that results are less easily generalised and it may be difficult to make 
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systematic comparisons. Furthermore, it may be difficult to replicate a piece of qualitative 
research as data collection is highly context dependent.  
 
In this study, the main anticipated value of mixed methods is in providing a more complete 
understanding of the research problem. An understanding of the relationship between 
illness representations, treatment beliefs and self-care in heart failure requires the use of 
objective quantitative methods to determine those relationships and examine the extent to 
which findings can be generalised to the population of heart failure patients as a whole. 
The development of valid and reliable measures of these variables is best derived from 
the experience of people with heart failure in their own words, which is best determined by 
qualitative means. The interpretation of the quantitative data will also be enhanced by the 
rich description of the qualitative data so that the context within which results occur can be 
described. 
 
3.2.2 The historical and philosophical development of mixed methods – the    
            introduction of pragmatism 
 
The history of mixed methods can be traced from Campbell and Fiske (1959) who used 
multiple forms of quantitative data in a study of psychological traits. They used the term 
„multi-method‟ to describe this. The purpose of using more than one method was to 
ensure that it was the phenomenon in question that was being studied rather that the 
method used to study it. The term multi-method research has since been frequently used 
interchangeably with the term mixed methods. To differentiate these terms, Tashakkori 
and Teddlie (2003) defined multi-method research as the use of multiple qualitative or 
quantitative methods, for example, the use of a survey and experiment in a quantitative 
study or participant observation and a case study in a qualitative study. Jick (1979) 
discussed the triangulation of qualitative and quantitative data, the purpose of which was 
to offset the weaknesses of one method by the strengths of the other. Mixed methods 
research is, therefore, commonly described as evolving from multi-method research and 
triangulation which still represents one type of mixed methods design. Creswell and Plano 
Clark (2007) have called the emergence of multi-method and triangulation designs as the 
„formative period‟ in mixed methods research. 
 
The 1970s and early 1980s has been called the „paradigm debate period‟ by Tashakkori 
and Teddlie (2003), during which discussion took place on the philosophical basis of 
mixed methods. The debate focused on whether it was acceptable to use a number of 
paradigms or accept an alternative paradigm, most commonly the philosophy of 
pragmatism. Despite the assertion by Tashakkori and Teddlie (2003) that mixed methods 
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has moved on from this debate, determining the philosophical basis of this research 
design is ongoing. Greene and Caracelli (1997) argued that mixed methods can use 
different paradigms as long as it is explicit when each is used. This stance does not seek 
to reconcile alternative paradigms and accepts the incompatibility thesis, acknowledging 
the tensions and oppositions. Creswell and Plano Clark (2007) believe the choice of 
paradigm is dependent on the type or model of mixed methods design. Alternatively, 
many mixed method researchers, including Tashakkori and Teddlie (2003), call for 
„pragmatism‟ as the philosophical foundation for mixed methods research, arguing that the 
research question should be of primary importance rather than either the methods or 
philosophical paradigm. 
 
Pragmatism was first developed by the American philosopher and scientist Charles Peirce 
(1839-1914). Its meaning is derived from the Greek word „pragma‟, meaning action. It 
emphasises the practical relationship between humans and the world. In a discussion of 
pragmatism by Delanty and Strydom (2003), Cartesian dualisms such as subject and 
object, deduction and induction are rejected. Knowledge is grounded in real collective 
problems and the development of knowledge occurs in different ways and in a variety of 
contexts. The meaning of a concept can be understood by engaging in a „practical 
consideration‟, which takes account of the effects or practical consequences that might 
result from it. For Pierce, knowledge develops through „abduction‟ (inductive and 
deductive reasoning) which involves both feeling or intuition and experience or direct 
observation. The development of knowledge involves co-operative interpretation, 
discussion and argument within scientific communities.  
 
Dewey and Mead in the 1920s and 1930s, applied pragmatism to social science, rejecting 
the separation between theory and practice and claimed that in social inquiry, practice is 
intrinsic not extrinsic and determined by an „end-in-view‟ or the potential consequences of 
the inquiry. Maxcy (2003) described pragmatic research as that in which the methods are 
determined according to „what works‟. Rorty (1979) used the term „transcendental 
pragmatism‟ and called for the abandonment of the attempt to lift ourselves, in cognitive 
terms, to a position outside the world in order to view things from a purely ontological 
standpoint which separates us from the practical engagement with the world on which 
knowledge is based. For pragmatists, epistemological considerations are not ignored; 
rather the methodology is the prime consideration and connects the epistemology on the 
one hand and practical methods on the other (Figure 3.1). The top-down privilege of 
ontology in the constructivist/interpretivist paradigm is rejected.  
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Figure 3.1  Relationships between Metaphysical and Methodological Considerations in 
Pragmatic and Constructivist/Interpretivist Research 
 
 
    
 
 
 
 
 
 
 
 
 
Howe (1988) describes pragmatic philosophy as deconstructive in that it attempts to 
examine concepts such as „truth‟ and „reality‟ but prevents them from being turned into 
„super-concepts‟ and, thereby, generating problems that cannot be solved. In rejecting 
dualisms, complete objectivity or complete subjectivity is unrealistic. Pragmatic 
researchers move between these extremes in an intersubjective way.  Similarly, there is 
both a „real‟ world and a subjective reality. The issue of transferability rejects the notion of 
context-dependent or generalisable inferences. The important issue is the extent to which 
findings can be transferred and the factors which influence this (Morgan, 2007). 
Tashakkori and Teddlie (2003) go as far as to suggest that the dichotomy between 
positivism/postpositivism and constructivism/interpretivism should be abandoned along 
with the metaphysical constructs of truth and reality. Rather, pragmatism as a practical 
and applied research philosophy should guide methodological choices. Twinn (2003) 
acknowledges this but argues that that there has been little debate about the use of 
alternative philosophies, such as pragmatism, within nursing research.  
 
In this research, the philosophy of pragmatism is applied in terms of methodology, 
epistemology, ontology and axiology. Reasoning is both inductive and deductive in phase 
one (using qualitative methods) and deductive in phase two (using quantitative methods). 
The relationship between the researcher and the participant is largely subjective in phase 
one with attempts made to maximise objectivity in phase two, as such there is assumed to 
be both a „real‟ world and a subjective reality. The influence of the values of the 
researcher is recognised in phase one, with attempts made to minimise researcher bias in 
phase two.   
 
Pragmatism             Constructivism 
    Ontology            Ontology 
 
Epistemology                  Epistemology 
 
Methodology       Methodology 
 
Methods          Methods 
Adapted from Morgan (2007, p.69) 
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It could be argued that the use of qualitative methods in order to develop quantitative 
survey instruments sits within a postpositivist paradigm in that the ultimate aim of 
determining relationships between illness representations, treatment beliefs and self-care, 
assumes an external reality and emphasises the objective role of the researcher. Giddings 
and Grant (2007) might agree, when they describe the use of mixed methods in this way 
as „a Trojan horse for positivism‟.  However, the qualitative findings in this research are 
not only used to develop the questionnaires but also to illuminate the quantitative findings 
so that inferences are not made on the quantitative data alone. In this way, no data set 
has assumed preference over the other.  
  
Whilst the philosophical debate is still evident, it is argued that mixed methods has moved 
on to a third period in its history – namely the discussion of its methods and procedures 
(Tashakkori and Teddlie, 1998).  
 
3.2.3 A typology of mixed methods 
Many typologies or classifications of mixed method research designs have been 
proposed.  A seminal article by Greene et al (1989) described the first comprehensive 
classification system of mixed method designs. Since then, more than twelve classification 
systems have been developed by authors in a number of disciplines including nursing 
(Sandelowski 2000; Morse, 1991), health (Morgan 1998; Steckler et al 1992), social policy 
(Patton, 1990), education (Creswell and Plano Clark, 2007; Creswell et al 2003; Creswell, 
1999) and educational psychology (Tashakkori and Teddlie, 2003; 1993).  
 
Morse (1991) introduced a notational system, using the abbreviations „Qual‟ for qualitative 
and „Quan‟ for quantitative. Two types of mixed method design were identified - 
simultaneous and sequential triangulation. A simultaneous design is one in which 
qualitative and quantitative data are collected and analysed concurrently. In a sequential 
design, data are collected and analysed separately and in sequence. The symbol „+‟ was 
used to denote a simultaneous design and „‟ to denote a sequential design. Morse 
(1991) also introduced the concept of dominance in mixed methods research. Upper case 
letters were used to denote a dominant phase with lower case letters representing a less 
dominant phase. For example, QUAN + qual, describes a simultaneous design in which 
the quantitative data are given priority.  QUAL  quan, describes a sequential design in 
which qualitative data are dominant and collected first.  
 
In reviewing the typologies, Creswell and Plano Clark (2007) highlighted a number of 
difficulties. Firstly, the terminology was often discipline specific and used inconsistently. 
For example, Bryman (2007) argues that the term triangulation is now relatively 
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meaningless due to the many ways in which it has been defined in published work and 
has called for its use to be temporarily abandoned. Different terms have also been used to 
mean the same thing, for example, simultaneous (Morse, 1991) and concurrent (Creswell 
et al, 2003). Furthermore, the issue of dominance is now challenged with some authors 
questioning whether it is necessary to establish the relationship between dominant and 
less-dominant phases (Tashakkori and Teddlie, 2003). Typologies are also based on 
different criteria such as procedures (Tashakkori and Teddlie 1998) or purpose (Greene at 
al, 1989).  
 
The typology according to Creswell and Plano Clark (2007) has been selected as the 
methodological framework for this research and is outlined below. The rationale for this 
choice is that firstly, it represents the current thinking in mixed methods research and 
secondly, the typology is designed to be functionally useful to researchers undertaking 
mixed methods research which seems congruent with a pragmatic, philosophical position 
of „what works‟. Finally, the classification of an „exploratory design, instrument 
development model‟ accurately describes the research design applied here. The typology 
consists of four major designs – triangulation, embedded, explanatory and exploratory. 
Within these overall designs are a number of specific models (Table 3.2).  
 
Three key decisions are described in determining the specific design and model. These 
decisions involve timing, weighting and mixing. Timing refers to the sequencing of the 
study and the relationship between the quantitative and qualitative components. Timing 
can be concurrent or sequential. Concurrent timing occurs when the qualitative and 
qualitative data are collected in a single phase of the study. In sequential timing, data are 
collected in two distinct phases – collecting and analyzing one type of data before using 
the other. Either data type can be collected first. Weighting refers to the relative emphasis 
or priority of the approaches. Quantitative or qualitative data may be given priority or equal 
dominance is assumed. Morgan (1998) argues that weighting should be determined by 
the relative strength of the data set which is best suited to address the purpose and aim(s) 
of the study. Mixing is the explicit relationship between the two data sets. Three types of 
mixing exist; merging the data set during analysis, embedding one data set within a larger 
data set or connecting the data sets where the analysis of one type of data leads to the 
collection of the second type of data.   
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Table 3.2 Summary of a Mixed Method Typology  
 
Design Type Model Timing  Weighting Mixing Notation 
Triangulation 
 
 
 
 
 
 
Embedded 
Convergence; 
Data 
transformation; 
Validating 
quantitative data; 
Multilevel 
 
Embedded 
experimental; 
Embedded 
correlational; 
 
Concurrent: 
quan/qual at the 
same time 
 
 
 
 
Concurrent or 
sequential 
Usually 
equal 
 
 
 
 
 
Unequal 
Data merged 
during analysis 
 
 
 
 
 
Embed one 
data type 
within a larger 
design using 
the other data 
type  
 
QUAN + 
QUAL 
 
 
 
 
 
QUAN (qual) 
or QUAL 
(quan) 
Explanatory  Follow-up 
explanations; 
Participant 
selection; 
 
Sequential: 
quan followed 
by qual 
Usually 
quan 
Connect the 
data between 
the 2 phases 
 
QUAN  
qual 
Exploratory 
 
 
 
 
Instrument 
development; 
Taxonomy 
development 
Sequential: 
usually qual 
followed by 
quant 
Usually 
qual 
Connect the 
data between 
the 2 phases 
 
QUAL 
quan or 
qual 
QUAN or 
equal  
Creswell and Plano Clark (2007, p.85) 
 
3.2.4 The research design 
This study uses an exploratory design, instrument development model to explore illness 
representations, treatment beliefs and self-care in heart failure and to determine 
relationships between these variables according to the aims of the research.  
 
According to the typology (Creswell and Plano Clark, 2007), an exploratory design is 
conducted in two sequential phases where the results of the first, qualitative method 
develop or inform the second, quantitative method. The central premise is that an initial 
exploration of the topic is necessary. In the instrument development model, the topic is 
first explored with a small number of participants. These qualitative findings are then used 
to guide the adaptation or development of instruments to be used in a quantitative survey. 
In the second phase, these instruments are validated and implemented. The two phases 
are therefore, connected by the adaptation or development of the instruments.  
 
Here, the aim was to explore illness representations, treatment beliefs and self-care in a 
small sample of heart failure patients using qualitative methods. These results were then 
used to adapt or develop as necessary, existing questionnaires measuring illness 
representations (the IPQ-R, Moss-Morris et al, 2002), treatment beliefs (the BMQ, Horne 
76 
 
et al, 1999) and self-care in heart failure (the EHFScBS, Jaarsma et al, 2003). These 
questionnaires were then used in a cross-sectional survey to determine relationships 
between these variables according to the second aim of the study.  
 
This design was selected as it is proposed that there are some limitations in existing 
instruments used to measure illness representations, treatment beliefs and self-care in 
heart failure. Whist the IPQ-R and BMQ are considered reliable and valid, their use in a 
UK population of heart failure patients is unknown. The authors themselves assert that 
these instruments need to be adapted for use in specific illness populations (Moss-Morris 
et al, 2002; Horne et al, 1999).  The EHFScBS has been shown to be valid and reliable in 
a Swedish population although it has been suggested that it may be less reliable in a UK 
population (Shuldham et al, 2007).  Hence, it is argued that there is a need to first explore 
these variables qualitatively in order to adapt these instruments for use in this study 
population. 
 
Equal dominance is assumed between the qualitative and quantitative phases. Data are 
primarily connected through the adaptation of the questionnaires from the qualitative data. 
However, both qualitative and quantitative findings are both considered in an overall 
discussion of the results. Hence, this study is identified by the notation QUALQUAN. 
Figure 3.2 details this research design.  
 
Figure 3.2 An Exploratory, Instrument Development Model 
 
 
 
 
 
A strength of this model, according to Creswell and Plano Clarke (2007), is that since the 
phases are predominantly separate, the design is relatively straightforward. However, it is 
also time-consuming and it may be difficult to gain ethical permission for the study since 
the second phase cannot be described in detail at the outset. Furthermore, it may be 
difficult to decide which qualitative data to use in order to adapt or build the instruments 
(Creswell and Plano Clark, 2007). These issues are discussed further in Chapters four, 
five and six.  
 
 
 
 
QUAL 
data 
collection 
QUAL 
data 
analysis 
Instrument 
development; 
pilot study  
QUAN 
data 
collection 
QUAN 
data 
analysis 
Interpretation 
QUAL/QUAN 
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3.3 OVERVIEW OF METHODS AND GENERAL CONSIDERATIONS 
 
In this section, an overview of the methods employed is given followed by a discussion of 
aspects of method common to both phases of the research, namely, the research setting, 
access to participants and permissions.  
 
3.3.1 Overview of methods 
An overview of the methods and procedures in relation to the aims of the research is 
given in Figure 3.3. 
 
Figure 3.3. Overview of Methods and Procedures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHASE 1 
 
Aim: 
Exploration of illness representations, 
treatment beliefs and self-care 
 
Approach: 
Qualitative 
 
Method: 
Semi-structured interviews with up to 
30 heart failure patients 
Adaptation of the 
EHFScBS, from 
phase 1 data and 
NGT with expert 
HFNs 
Adaptation of the 
IPQ-R and BMQ 
from phase 1 data;  
 
Development of a 
socio-demographic 
questionnaire 
PILOT STUDY 
Aim: 
The further development of the 
questionnaires and testing of 
survey procedures 
 
Approach: 
Quantitative and Qualitative 
 
Method: 
Distribution, data collection and analysis 
of up to 30 sets of 
questionnaires; interviews with up 
to 6 heart failure patients 
 
PHASE 2 
 
Aim: 
Test the questionnaires; determine illness 
representations, treatment beliefs, socio-
demographic factors and self-care and the 
relationships between these variables 
  
Approach: 
Mainly Quantitative 
 
Method: 
Distribution, data collection and analysis of at 
least 150 questionnaires 
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As indicated in section 3.2.4, the research was conducted in two sequential phases. 
Phase one was the collection and analysis of qualitative data with a small sample of 
participants with heart failure, using semi-structured interviews. These data were then 
used to adapt three questionnaires, the IPQ-R, BMQ and the EHFScBS. The views of an 
expert group of heart failure nurses (HFNs) were also sought in the adaptation of the self-
care questionnaire using a nominal group technique (NGT). A questionnaire assessing 
socio-demographic characteristics was developed in order to accurately describe the 
sample. In the pilot study, the process of data collection and methods of data analysis to 
be used in the main survey were tested. The questionnaires were then further amended 
based on the pilot study and following discussion with a small number of heart failure 
patients (member checks). In phase two, quantitative data were collected in a larger 
sample of heart failure patients. The final questionnaires were tested for reliability and 
validity and data were analysed to determine illness representations, treatment beliefs and 
self-care in this sample and the relationships between these variables. Consideration was 
also given to the influence of socio-demographic factors on self-care. 
 
3.3.2 The research setting  
The research took place in three NHS Primary Care Trusts (PCTs) in one County of South 
East England. These PCTs were nearest, geographically to the researcher and so were 
chosen for convenience. For the purpose of this research, these PCTs have been labelled 
Sites A, B and C. Site A is the largest, serving a population of 710,000 people. Site B 
serves 655,700 people and Site C, the smallest, serves a population of 270,000 people 
(KCC website, 2010).  
 
Multiple sites were chosen in order to draw from a wider and potentially more diverse 
population and to offer a large sample size. This was important in terms of the 
generalisability of findings and statistical significance of the results. Accessing a number 
of sites also served to spread the workload of the HFNs whose support was necessary, 
not only to recruit participants, but also to develop the self-care questionnaire.  
 
A community or primary care setting was chosen rather than secondary or tertiary care, 
for a number of reasons. Firstly, it was felt that this was the most appropriate setting in 
which to study self-care which addresses the day-to-day actions of people who are living 
with illness who are supported, but not directly supervised by, healthcare professionals. A 
community setting also offered the opportunity for a much larger sample size compared to 
secondary care.  It was also felt that ethically, there was reduced potential for harm in 
selecting community-based patients as it was necessary to question them about some 
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potentially distressing aspects of their illness. Answering such questions whilst 
experiencing an acute exacerbation of symptoms may have caused additional distress for 
patients who might be physically and emotionally vulnerable when hospitalised.   
 
3.3.3 Permissions and access to participants  
The research was undertaken according to research governance procedures set out by 
Canterbury Christ Church University (CCCU) as the sponsors of the research. Procedures 
set out by the Research Governance Framework for Health and Social Care (DH, 2005d) 
were also followed. Research Governance identifies a number of key standards in relation 
to the ethical involvement of research participants, the scientific quality of the research, 
information in terms of dissemination of findings and public access, health and safety of 
the participant and researcher, legal issues, financial regulation and the prevention of 
misconduct (CCCU, 2006).  
 
Initially, the University Research Degrees Sub-Committee approved an outline proposal. A 
satisfactory peer review was obtained following some clarification of the procedures and 
broadening of the literature review. The procedure for ethical review was carried out 
according to CCCU regulations. Ethical permission was gained from the National 
Research Ethics Service (NRES) local committee following some clarification of 
procedures (Appendix 4). Creswell and Plano Clark (2007) recognise that gaining 
approval for phase two of an exploratory, instrument development model can be 
problematic as the data collection instruments are not available at the start of the study. In 
this case, a further approval by the NREC was required once the final versions of the 
questionnaires were developed (Appendix 5). The ethical principles which applied in this 
research are discussed in relation to each phase of the study in Chapters four, five and 
six. Permission for the research to take place within the PCTs was gained from the 
Research Management and Governance Centre for the locality (Appendix 6) following a 
required Criminal Records Bureau and occupational health check.  
 
In order to gain access to participants, the lead HFN in each of the three PCTs was 
initially approached by telephone. These nurses were seen as the gatekeepers to the 
heart failure patients and so their co-operation was crucial in terms of recruitment. 
Agreement in principle was sought to allow access to the heart failure patients registered 
to their service and for their assistance in recruitment. The researcher was known 
personally to two of these nurses either through involvement in earlier research or in a 
professional capacity. On reflection, this existing relationship of rapport and mutual trust 
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was instrumental in ensuring the early and ongoing support of the HFNs and the success 
of the study. 
 
Contributing to the relative ease of access was that the lead HFNs recognised a reciprocal 
benefit in supporting the research. The lead HFN in Site C saw supporting the research as 
an opportunity to educate her team in research methods, while at Site A, participating in 
the research allowed the team to achieve a strategic management target. The lead HFNs 
also supported the purpose of the study and saw the development of the self-care 
questionnaire, in particular, as potentially beneficial to their service. Beyond the initial 
access, the maintenance of the relationship between the researcher and the HFNs was 
dependent on regular contact through meetings, telephone calls and e-mails. Any 
changes to the procedures were first agreed with the HFNs. In conclusion, although 
gaining permissions for the research and allowing access to participants was a lengthy 
process, no significant difficulties were encountered.  
 
In conclusion, this chapter has identified mixed methods as the research design, located 
within the philosophical paradigm of pragmatism. Specifically, an exploratory, instrument 
development model has been selected where illness representations, treatment beliefs 
and self-care in heart failure are first explored qualitatively before the adaptation of the 
questionnaires. These questionnaires are used to determine the influence of beliefs on 
self-care, in a cross-sectional, quantitative survey. As such, the collection of qualitative 
and quantitative data is sequential. Co-dominance is assumed with both data sets 
integrated in an overall discussion of the results. 
 
An overview of methods and procedures has been presented and aspects of method 
common to both phases of the study have been discussed, namely, the research setting 
and permissions and access to participants. Detailed methods and procedures for each 
phase of the study in terms of sampling, recruitment and data collection and analysis 
methods are discussed in Chapters four, five and six. 
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CHAPTER FOUR: THE QUALITATIVE PHASE – METHODS AND RESULTS  
 
This chapter presents the methods and results of phase one, the collection and analysis 
of the qualitative data. The purpose of this phase was to explore illness representations, 
treatment beliefs and self-care in a sample of patients with heart failure in order to use 
these findings to inform the adaptation of the questionnaires used in the quantitative 
survey (phase two). Since relationships between these variables are measured 
quantitatively in phase two, the presentation of the qualitative data is primarily a 
discussion of the findings in relation to the literature and the theoretical framework. A 
secondary purpose was therefore, to test the applicability or „fit‟ of the data to the CSM. 
 
A summary of the procedures is given, followed by a discussion of the sampling strategy, 
recruitment of participants, data collection and analysis methods. Ethical considerations 
and the extent to which the data can be considered trustworthy is also discussed. In 
presenting the results, the characteristics of the sample are described before a discussion 
of the main findings.   
 
4.1 METHODS 
 
4.1.1 Procedures  
A summary of the procedures is given in Figure 4.1.  
 
Figure 4.1 Summary of the Qualitative Procedures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sampling and 
Recruitment: 
 
Participants 
identified by purposive 
sampling; Envelopes 
(containing a participant 
information letter, reply 
slip and stamped 
addressed envelope) hand-
delivered 
by HFNs. 
Data Collection: 
 
Semi-structured, 
audio-taped interviews 
conducted in 
participants‟ homes; 
field notes written; 
GPs informed. 
Data Analysis: 
 
Tapes transcribed 
and data analysed 
thematically using 
NVivo 7 
Member Checks: 
 
Transcripts sent to 
participants to check, 
amend and return 
Member Checks: 
 
Summary of findings 
sent to participants to 
comment upon and return 
82 
 
The heart failure nurses (HFNs) selected 30 patients according to a purposive sampling 
strategy. Envelopes containing a participant information letter, reply slip and stamped 
addressed envelope were hand-delivered to patients by the HFNs. The patients were 
instructed to complete and return the rely slip with their name, address and contact 
details, if they were willing to take part. They were then telephoned to set up a mutually 
convenient date and time when the data could be collected.  
 
Data were collected by semi-structured, audio-taped interviews in the participants‟ homes. 
On arrival, following introductions, the purpose of the study was explained and the 
participant information letter was reviewed. The nature and structure of the interview was 
outlined. Participants were asked to sign a consent form (Appendix 7) agreeing to take 
part in the research and for the interview to be audio-tape recorded. One copy of the 
consent form was left with the participant and one retained by the researcher as a record. 
Permission was sought from the participants‟ for their GPs to be informed of their 
involvement in the study, as requested by the NREC. A copy of the letter sent to GPs is 
given in Appendix 8.  
 
Following the interview the participant was thanked for their time and contribution to the 
research. They were then asked if they would like to receive a transcript of the interview to 
check, amend and return; whether they would like to receive a summary of the results to 
comment upon and return and whether they would like the audio-tape returned to them at 
the end of the study. Field notes were written immediately following the interview.  
 
The audio-tapes were transcribed verbatim by an experienced transcriber. These were 
then checked for accuracy by listening to the tapes and reading through the transcripts a 
number of times. Individual transcripts were then sent to those participants who requested 
it in order for them to check the transcript for accuracy, make any amendments and 
return. Data were analysed thematically using the framework method described by Miles 
and Huberman (1994). Computer-Assisted Data Analysis Software (CAQDAS), 
specifically NVivo 7, was used to aid this analysis. A summary of the results (Appendix 9) 
was sent to participants to comment upon and return.  
 
4.1.2 Sampling and recruitment  
The population from which the sample was drawn was considered to be all those patients 
with heart failure registered to one of the three PCT heart failure services. In relation to 
the inclusion and exclusion criteria, only patients diagnosed with heart failure were 
included. Diagnosis had been previously determined by the patient‟s GP or hospital 
consultant before referral to the heart failure services. No distinction was made between 
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different types or causes of heart failure and participants with co-morbid conditions were 
also included. Those patients newly diagnosed and those with long-standing heart failure 
were included since the purpose was to gain as wide a variety of patients with heart failure 
as possible.  
 
A number of exclusion criteria applied. Those unable to read or speak English were 
excluded as written information was not available in other languages. No translation or 
interpretation services were available so the interviews could not be conducted in other 
languages.  Whilst this was not desirable in terms of equality of access, it was deemed 
unavoidable given the resource constraints of the study.  The HFNs were also asked to 
exclude any patients who, in their view, were too ill to take part in an in-depth interview. 
Hence, those with the greatest severity of illness may have been excluded which may 
have implications for the findings.  
 
A non-probability, purposive sampling strategy was used. In purposive sampling, 
individuals are selected on the basis of their experience of the phenomenon to be 
investigated (Silverman, 2010). Sampling was purposive in terms of age and gender so 
that the views of both men and women from a range of age groups were sought. This was 
achieved by asking the HFNs to purposefully select participants from these groups. The 
intention was to select a sample to provide rich, dense description of the phenomenon 
(Denzin and Lincoln, 2005). Given the higher prevalence rates of heart failure in older age 
groups and amongst men (NICE, 2010), it was likely that, as a result of this sampling 
strategy, the sample would include a higher number of females and younger patients than 
would be typical of the general heart failure population.   
 
In terms of sample size, qualitative researchers vary widely in their recommendations. 
Authors advocate selection of a qualitative sample size based on time-constraints, the 
nature of the phenomenon under investigation, the nature of the sample or the concept of 
data saturation (Silverman, 2010).  Time-constraints, whilst relevant to any research, were 
not in themselves, considered to be adequate justification for the sample size in this study. 
In relation to the nature of the phenomenon, Morse (1991) suggests at least six 
participants are needed where the aim is to understand the essence of experience. Lay 
beliefs and self-care in heart failure have been explored by qualitative researchers with 
sample sizes of between six and twenty. From a previous study, a sample size of ten was 
found to be sufficient to explore a similar phenomenon of illness representations and 
behaviour in MI patients (MacInnes, 2006). In relation to the nature of the sample, 
Holloway and Wheeler (1996) suggest that between six and eight participants are needed 
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for a sample with homogenous characteristics while twelve to twenty is required for a 
heterogeneous sample. In this research, the sample was considered to be relatively 
homogenous in terms of the illness experience so a smaller sample size was anticipated.  
 
The concept of data saturation means that rather than determining a specific sample size 
a priori, on analysing the data, repetition and confirmation of previous findings determines 
the end point of data collection (Denzin and Lincoln, 2003). However, the concept of data 
saturation as an achievable aim is contentious. Miles and Huberman (1994) suggest that 
since analysis involves peeling away different layers of data to reveal deeper 
understanding, it is difficult to determine an endpoint. Morse (1991) also cautions that 
data saturation is both time and context dependent so that new data may be revealed with 
the same or a different sample at a different time. Although the use of data saturation may 
be imperfect, seeking repetition and confirmation of findings is believed to enhance the 
trustworthiness of the findings (Denzin and Lincoln, 2003), hence, this process was used 
in determining sample size in this study.  
 
Based on the nature of the topic and sample, in this study, a sample size of between six 
and twenty was estimated, with the final number being determined by data saturation. It 
was proposed that participants be approached in cohorts of 30 so that an estimated 
response rate of one third would enable ten participants to be recruited at a time. De Vaus 
(1996) suggests that in a specialised sample, a response rate of one third might be 
expected.  Following data analysis, this recruitment process could then be repeated as 
necessary to the point of data saturation.  
 
Initially, an attempt was made to recruit participants by postal invitation. Site C, which was 
ready to proceed with data collection earliest, posted the envelopes to patients identified 
according to the inclusion and exclusion criteria.  No date was given by which patients 
should reply, except to request it was returned within two weeks of receipt of the letter. 
Unfortunately, no responses were received. The reasons for this are speculative although 
it is suggested that the unsolicited postal method of recruitment might have resulted in this 
lack of response as this method typically results in a lower response rate (De Vaus, 1996). 
In addition, the lack of a specific deadline by which to reply may have negatively affected 
the response in that return of the envelopes may have been put off indefinitely.  
 
It was therefore, necessary to change the procedure by which participants were recruited. 
It was agreed with the HFNs that they would deliver the envelopes by hand to potential 
participants, either during home visits or at clinics. Personal introduction is suggested by 
De Vaus (1996) as a useful technique for improving response rates. In addition, a specific 
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return date was given on the participant information letter. The revised letter and reply slip 
are given in Appendix 10. Site A delivered the first 30 envelopes. Twelve participants 
responded indicating their willingness to take part. This represented a response rate of 
40% which is in line with that suggested by De Vaus (1996).  
 
Following collection and analysis of the data, saturation was believed to have occurred so 
no further interviews were conducted and this therefore, represented the final sample. The 
implication of this was that, in being drawn from one geographical area (PCT), a less 
diverse sample may have been selected than if participants were recruited from all three 
sites as originally proposed.  
 
4.1.3 Data collection methods  
While other qualitative methods are recognised such as focus groups or observational 
studies, interviews have the advantage of allowing in-depth exploration of the lived 
experience of people whilst also being practical to organise and conduct (Silverman, 
2010). Given that the focus of the research was on individual beliefs and experiences, 
rather than collective responses, one-to-one interviews seemed most appropriate. A semi-
structured format was used as it allowed phenomenon to be explored in-depth but remain 
focused on the topic under investigation (Fontana and Frey, 2005).  
 
Interviews took place in the participants‟ own homes in order to reduce any 
inconvenience, especially to those who may have been elderly or in poor health. This 
environment was also considered most appropriate to discuss the day-to-day experience 
of living with heart failure.  
 
An interview schedule (Appendix 11) was developed based on the components of the 
CSM and self-care literature. This served as a topic guide to enable all relevant areas to 
be addressed and helped maintain consistency between interview cases so that cross-
case analysis could be carried out. Silverman (2010) emphasises that the schedule 
should be used only as a guide as departures are both necessary and desirable. The 
interview schedule was checked to ensure that leading questions, which might influence 
responses, were avoided. The schedule commenced with some simple introductory 
questions in order to obtain demographic details, for example, ‘How old are you?’ These 
questions were largely closed, factual and easy to answer. The intention was to put the 
participant at ease and begin the development of rapport. Open questions followed in 
relation to illness representations, emotional responses, beliefs about medication and self-
care. For example, ‘What do you understand is wrong with your heart?’, ‘How does your 
illness make you feel?’ and ‘What do you do to care for yourself at home?’ The interview 
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schedule generally guided the order in which topics were discussed. However, if a 
participant brought up a topic at an earlier point in the interview, this was discussed at that 
point so that a conversational style was retained. In this way individuals were encouraged 
to tell their own personal stories or narratives (Oakley, 1993). However, sometimes it was 
necessary to gently re-focus the discussion on the topic if it was felt that the relevance of 
the conversation in relation to the aims of the research was being lost. For example, 
phrases such as „Thinking again about your heart in particular...?’ were used. Probing 
questions were used to follow up responses to more general questions.  For example, 
„Does your illness change or stay the same?’  ‘In what way?’  ‘Why do you think this is?’ 
This technique of using probing questions is advocated by Bryman and Burgess (1994).   
 
In terms of epistemology, the nature of the relationship between the researcher and the 
participant is important (Denzin and Lincoln, 2005). In this qualitative phase, a largely 
subjective relationship was apparent. Denzin and Lincoln (2005) recognise that it is 
neither realistic nor desirable to remain an objective outsider or observer when the aim is 
to encourage participants to speak openly. Oakley (1993) identifies a traditional interview 
approach where the researcher asks standardised questions of the respondent whilst 
refusing to give any personal information about themselves or allow any questions, in an 
effort to be objective. This denies the complex social interaction that occurs in the 
communication between the researcher and participant and lacks the acknowledgment 
that personal characteristics of age and gender, for example, influence the dynamics of 
the interaction.  
 
Holloway and Wheeler (1996) describe a need for reflexivity or self-examination by the 
researcher in terms of their own assumptions and values. It requires thoughtfulness and 
reflection on the relationship with the participant and reactions towards them. The 
researcher‟s age, gender, culture, personality and life experience also affect the research 
process and such influences or „biases‟ need to be recognised and acknowledged. 
However, it has been argued that these influences sensitise the researcher to the events 
and people in the investigation and can, therefore, be a resource as long as researchers 
are reflexive and aware of their own assumptions (Olese, 1994).  
 
As a female nurse with a young family, I was aware of the different nature of the 
relationship between, for example, myself and the elderly gentlemen in the study and the 
young mother, with whom I perhaps had greater empathy. Also, having knowledge of 
heart failure and having read the literature on beliefs and self-care, I may have had pre-
conceived ideas and expectations about the findings. An awareness of health damaging 
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behaviours such as smoking or intentional non-adherence to medication, for example, 
may also have made it difficult to be totally non-judgemental.   
 
According to Holloway and Wheeler (1996), health professionals‟ own assumptions can 
interfere with the study as they may feel they know the problems that patients‟ experience 
which prevents them from focusing on the patient‟s real concerns; a point acknowledged 
in this research. From previous experience of qualitative interviews, in introducing myself 
as a nurse, participants frequently regarded the interview as a clinical consultation by 
handing over their drug prescriptions and asking me questions about their health. In this 
research, I wanted to avoid this in order to try to get beyond ideas about the medically-
defined disease into lay beliefs and experiences. This seemed more likely if I could also 
be identified as a „lay person‟ in some way.  However, despite this, participants still 
sometimes asked me clinical questions about their heart failure to which I would refer 
them to their HFN as professionally, I did not have access to their clinical notes nor did I 
want to influence their responses. In this way, whilst the subjective nature of the interview 
was recognised, attempts were made to minimise 
 
The use of field notes are a mechanism whereby experiences, feelings and thoughts are 
written, which in themselves become objects of reflection. In this study, immediately 
following the interview, field notes were written. An excerpt of which is given in Appendix 
12. Hammersley and Atkinson (1983) suggest that field notes are a central research 
activity, enhancing the quality of the project. Schatzman and Strauss (1973) divide field 
notes into three areas: observational, theoretical and methodological notes. Observational 
notes consisted of those events that were primarily experienced through watching or 
listening. For example, notes on the participants‟ state of health such as breathlessness, 
social influences, interruptions such as the telephone ringing or the participant needing to 
interrupt the interview and emotional observations such as whether participants seemed 
anxious or depressed. Theoretical notes attempted to develop analytical concepts or 
make sense of the data as it occurred, for example, the idea that the management of the 
illness was a shared experience between the patient and spouse originated from the field 
notes. Hence, new ideas outside the theoretical framework were noted and cross-
references were made to previous cases.  
 
Methodological notes were made in an attempt to enhance the quality of the interviews. 
As well as the use of field notes, the audio-tapes and interview schedule were reviewed 
between each interview, where possible, to look for missed questions, leading questions 
or other methodological issues which could affect the findings. In light of this reflection it 
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was noted that one question, ‘How serious do you think your illness is?’ had been omitted 
on more than one occasion. On reflection, this seemed to be a question that had the 
potential to cause distress to participants and was perhaps avoided for this reason. A 
deliberate effort was made in subsequent interviews to address this question which, 
although thought-provoking, did not seem to cause undue distress to participants. 
 
From the first two interviews and field notes it became apparent that participants would 
frequently refer to their spouses to seek confirmation of factual information such as time-
scales, or clinical details such as medication names. However, spouses would also 
interrupt at times to give their own beliefs or interpretations, for example: 
 
What do you think caused your heart problem? [Res] 
I really don’t know [P3] 
I think, myself, I’m interrupting again, that the move up here was so horrendous, I’m 
sure this is what did it [P3, wife].   
 
It was recognised that this could potentially influence findings in that the data may not be 
accessing patient beliefs but those of their partner. Therefore, in subsequent interviews, if 
a spouse was present in the room at the start of the interview, it was explained to them 
that while their views were important, it was necessary to first establish the thoughts and 
feelings of their partner. At the end of the interview with the audio-tape still running, 
spouses were invited to add anything that they wanted to say. Although this was at times 
visibly difficult for both the participant and their spouse to adhere to, it seemed to be 
effective in focusing the discussion on the patient‟s beliefs and experiences. However, it 
must also be recognised that the mere presence of a spouse during the interview may 
have influenced the participant‟s responses to some degree.  On reflection, in order to 
reduce this potential bias, it might have been better if spouses had been asked to leave 
the room during the interview; however, as I was an invited „guest‟ in the participant‟s 
home, this did not seem to be appropriate. Furthermore, the finding that self-care, 
especially medication use, was socially influenced was, in part, derived from the observed 
interaction between the participant and their spouse (discussed in section 4.2.3). 
 
Although the interview technique was reviewed and refined during the process of data 
collection, it could be argued that pilot interviews would have been useful since 
conducting a research interview requires considerable skill and experience to develop 
good techniques (Denzin and Lincoln, 2003). Furthermore, pilot interviews would have 
enabled the interview schedule to be tested (Silverman, 2010). Although I had some 
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experience of conducting research interviews, it is acknowledged that pilot interviews may 
have been beneficial. This is discussed further in Chapter seven.  
 
4.1.4 Ethical considerations  
Consideration was given to ethical issues in this research, as required under the 
Research Governance Framework (DH, 2005d) and scrutinised by the NREC. As a 
registered nurse there was also a professional obligation, according to the Nursing and 
Midwifery Council (NMC) code of professional practice (NMC, 2008), to obtain consent 
and ensure confidentiality of patient information. The section discusses those ethical 
considerations specific to this phase of the research.  
 
The ethical principles of autonomy and veracity (truth-telling) underpin the concept of 
informed consent (Beauchamp and Childress, 2008) which, in research terms, is defined 
by Denzin and Lincoln (2003, p.89) as „receiving consent by the subject after having 
carefully and truthfully informed him or her about the research’. Informed consent 
comprises information, voluntariness and comprehension (Beauchamp and Childress, 
2008). Here, written information was given in the participant information letter and 
discussed at the time of the interview. This information consisted of the nature and 
purpose of the research, the procedures involved and the potential risks and benefits, how 
the individual was selected, the identity of the researcher and sponsor organisation and 
the mechanisms for the dissemination of findings. A minimum of two weeks elapsed 
between the participant being invited to participate and informed consent being sought at 
the time of the interview. This was believed to be sufficient time for the participant to 
consider the information and make an informed choice. That taking part in the research 
was voluntary was explained by the HFNs on introduction, written in the participant 
information letter and discussed at the time of the interview. It was stressed that refusal to 
take part would not affect the care received in any way. Participants were advised that 
they could withdraw at any time and no monetary or other award was offered. However, it 
could be argued that since participants were recruited directly by the HFNs there may 
have been an element of wanting to please the nurse who was known to them and whose 
care they were receiving. Cognitive impairment is a recognised, prevalent feature of heart 
failure (Cowie et al, 1999). Therefore, the ability of individuals to comprehend the 
information and give informed consent needed to be considered. Since the HFNs were 
asked to select individuals who were suitable, in their view, to take part in the research, 
there is an assumption that only those able to give informed consent were approached. 
Although no formal assessment of mental capacity was made, all participants appeared
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able to understand the information given to them by responding to questions 
appropriately. 
 
Research should also ensure that all individuals in society have equal access and 
opportunity to take part. That is, no group is excluded on the basis of gender, age, ethnic 
origin, socio-economic status, disability or other criteria (Beauchamp and Childress, 
2008). Here, applying the exclusion criteria meant that those unable to read and write a 
sufficient level of English were excluded, thus potentially compromising equality of access 
based on ethnic origin. 
 
Privacy, anonymity and confidentiality are related ethical concepts. Privacy refers to the 
right of an individual to decide the time, extent and circumstances under which they will 
share information (Guillemin and Gilham, 2004). As some interviews were conducted with 
family members present and consent to this was not expressly sought, it remains an 
assumption that this was with the participants‟ agreement, so maintaining privacy.  
Anonymity requires that individuals, their families and organisations cannot be identified in 
the research. Participants were informed in writing that they would not be able to be 
identified in the write-up of the study or any other publication. The names of family 
members and other identifiable data such as the names of GPs and local hospitals, have 
therefore, been omitted.  
 
Confidentiality requires that information and data relating to the individual and their family 
will not be shared with any third party without their knowledge or consent and that the data 
will not be used for any other reason than for the research. Only the researcher‟s 
supervisor was made aware of participant names, addresses and the date and time of the 
scheduled interviews. This was necessary to safeguard the researcher as discussed 
below. This information was destroyed following completion of the interviews. The 
transcriber also necessarily, had access to the names and some personal identifying data 
as recorded on the audio-tape. The tapes, transcripts, and other identifying documents 
were stored in a locked cabinet. Data stored electronically included the transcripts and 
analysed data. In this case, access was password protected. All data, including the 
remaining audio-tapes will be destroyed at the end of the study according to University 
regulations (CCCU, 2006).   
 
Non-maleficence or the ethical principle „to do no harm‟ is perhaps the over-riding ethical 
consideration in research (Beauchamp and Childress, 2008). The potential for harm must 
be minimised and any risks made clear to participants. In recognition of this, the HFNs 
were asked to exclude those who were, in their view, too ill to take part in an in-depth 
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interview. This minimised the potential for physical and psychological discomfort in those 
most vulnerable. Participants were also informed that they could contact a named HFN 
following the interview if they had any concerns or worries as a result of taking part 
(Appendix 13). It was anticipated that some participants might become distressed during 
the interview when talking about their illness. Some participants were visibly saddened 
during the interview and were empathetically listened to and given time to express their 
feelings. One participant became very distressed and cried on a number of occasions. At 
these points I offered to turn the tape-recorder off and allowed time for them to feel able to 
continue.  
 
Given the unpredictable and often severe nature of the illness, there was a possibility that 
some participants might die in the period following the interview before the transcripts, 
results or tape-recordings were returned to them. Clearly, it would be inappropriate and 
upsetting for the family if correspondence addressed to the participant was sent to them at 
this time. To avoid this, the HFNs were asked if it was still appropriate to contact the 
participant before any further correspondence was sent. This safeguard did, in fact, prove 
to be necessary as one participant died within two months of the interview. As a result, no 
further correspondence was sent and potential distress to the participant‟s family was 
avoided.  
 
The safety of the researcher was also of paramount importance. A small, potential risk 
was identified in visiting participants in their homes. This risk was either from the 
individuals themselves or more likely, the environment or neighbourhood.  To minimise 
this, the HFNs were instructed to only select individuals and areas they themselves would 
be willing to visit. Visits were only carried out during daylight hours. The researcher‟s 
supervisor was made aware of the time and location of the scheduled visits and the 
researcher telephoned a family member when going into and leaving the participants‟ 
homes.   
 
Related to non-maleficence is the ethical principle of beneficence or „doing good‟. That 
there was likely to be no direct benefit to the participant by taking part in the research was 
explained in writing, in the participant information letter. However, it is suggested that 
some participants might welcome the opportunity to talk about their experience of living 
with their illness and so may have received some benefit. A point acknowledged in 
qualitative research (Silverman, 2010). 
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4.1.5 Data analysis  
Computer Assisted Qualitative Data Analysis Software (CAQDAS), specifically the 
software package NVivo 7, was used for data analysis having first undertaken training in 
its use. NVivo 7, rather than alternative packages, was chosen simply due to convenience 
as it was the only software licensed to the University at the time and so was easily 
accessible.  Transcripts with accompanying field notes were loaded into NVivo 7 as 
individual cases in preparation for analysis. 
 
The decision to use computer software was primarily based on the opportunity to make 
data management easier. From previous experience of qualitative data analysis, the 
practical management of interview transcripts, field notes, rough notes and ideas, memos 
and conceptual maps is often difficult, involving unwieldy piles of paper which require 
frequent sifting and re-organising.  Bazeley (2007) identifies data management as one of 
the principal reasons for using CAQDAS and argues that by removing the laborious 
process of cutting, labelling and filing there is greater freedom to develop ideas as there is 
greater opportunity to reconceptualise data (Bazeley, 2007). Certainly, the ease with 
which segments of data could be grouped and re-grouped made data analysis easier.  
 
Bazeley (2007) also suggests that the use of software helps to ensure rigour through the 
ability to query the data so that every recorded case of a term or every coded instance of 
a concept can be retrieved. It is further suggested that the researcher works more 
methodically, more thoroughly and more attentively. In practice, this enhanced ability to 
analyse the data in a systematic and methodical way meant there was greater confidence 
that the data had been thoroughly interrogated. However, whether greater depth of 
analysis was achieved by using CAQDAS is difficult to judge. 
 
On reflection, although the use of NVivo 7 required an initial, substantial investment of 
time in learning its use, this was justified by the ease with which data were subsequently 
managed and reported. However, the instrument of analysis remains the researcher, that 
is, the computer does not do the analysis for you! The method of analysis must be 
established beforehand (Bazeley, 2007), as discussed below. 
 
A framework of qualitative data analysis based on that described by Miles and Huberman 
(1994) was used. This framework was selected because it clearly articulates the decision-
making process and procedures in thematic, qualitative analysis. These authors describe 
three concurrent activities: data reduction, data display and conclusion drawing and 
verification, illustrated in Figure 4.2.  
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Figure 4.2 Components of Data Analysis (Miles and Huberman, 1994, p.12) 
 
 
Data reduction concerns making analytical choices about which data to extract, code and 
summarise. According to Miles and Huberman (1994), data reduction sharpens, sorts, 
focuses, discards and organises data. Data display is the organised presentation of 
information that enables conclusions to be drawn. In common with much qualitative 
research, data display, here, is in the form of extended text. Drawing conclusions and 
verification consists of proposing explanations for and evaluating findings in a discussion 
of the results. These processes are inter-related in that the researcher moves between 
data reduction, display and conclusion drawing throughout the analysis. The process of 
data reduction, specifically coding, is discussed below, followed by an integrated display 
and discussion of the results. 
 
In data reduction, codes are described as abstract constructs that are identified before, 
during and after data collection. The process of coding as the search for contextual 
meaning has been described as „the heart and soul of whole-text analysis’ (Miles and 
Hubersman, 1994, p. 171). These authors differentiate between analysis of „words or 
phrases‟ using techniques such as word counts and analysis of „chunks‟ of text in which 
the contextual meaning is important, as in this study.  
 
Miles and Huberman (1994) suggest that researchers start with some codes derived from 
the literature or theory and add codes and sub-codes during the process of analysis. They 
describe a method ‘partway between a priori and inductive approaches, that of creating a 
general accounting scheme for codes that is not content specific but points to the general 
domains in which codes can be developed inductively’ (Miles and Huberman, 1994, p.61). 
This supports a pragmatic approach to data analysis, which allows freedom to work 
between an interpretivist and positivist/postpositivist epistemological position in terms of 
Data 
Collection 
Data 
Display 
Conclusion 
Drawing/ 
Verification 
Data 
Reduction 
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deductive and inductive reasoning. Fereday and Muir-Cochrane (2006) also support a 
hybrid approach of inductive and deductive coding with data and theory-derived code 
development.  
 
Analysis was theory driven in that themes were developed deductively according to the 
CSM and self-care literature, that is, illness representations, emotional response, 
treatment beliefs and self-care were set up a priori, as 1st level themes. Individual illness 
representations, treatment beliefs and self-care behaviours, such as identity, concerns 
about medication and adherence to medication were set up as 2nd level themes. Themes 
also „emerged‟ or were inductively derived from the data, for example, impact of 
medication use on lifestyle was identified as a 2nd level theme within treatment beliefs. In 
this way the theoretical framework was tested for its applicability in this sample.  
 
Coding was a mixed strategy of both within-case and between-case analysis. That is, 
efforts were made to develop themes that cut across cases or were common to a number 
of participants, as well as retaining the complex, narrative of each individual case, as 
illustrated in section 4.2.5. 
 
The process of coding requires that codes be assigned to marked text. It, therefore, 
required making choices about the meaning of any section of text. Here, each case was 
initially coded separately before looking for cross-case comparisons. Where codes were 
already set up according to the theoretical framework, text relating to that code was 
assigned, for example: „My breath gets short, I just got a job to breathe’ [P1], was coded 
as Illness Representation>Identity> Symptom. Where codes were developed inductively 
from the text, the development of new codes and marking text occurred concurrently, for 
example: „I’m not saying I’m always optimistic, but I hold on to that’ [P6] was coded as 
Self-care > Management > Positive Attitude, where positive attitude was a code derived 
from the data. 
 
Codes therefore, acted as tags for marked text as well as theoretical constructs. 
Consideration was given to the labelling of codes so that their name was as close as 
possible to the concept it was describing, for example, the explicit code 'support from 
counsellor' was used. Miles and Huberman (1994) describe a number of different types of 
code. Descriptive codes, or first level analysis, entail little interpretation and attribute a 
simple phenomenon to a section of text. For example, „The chest pain is so excruciating, I 
can’t move’ [P11] was coded under identity as ‘symptoms related to other cardiac 
conditions', Data were also assigned to more interpretive codes which conveyed more 
complex meaning. For example, „If I feel tired I can always sit, I can always relax, but 
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when you are with friends you can’t do that.  If I go to my friend’s house, it’s not nice to go 
there and fall asleep’ [P10] coded as ‘reduced social contact as a consequence of 
symptoms’, in the illness representation of consequences. Pattern codes group codes into 
a set of themes or constructs. According to Miles and Huberman (1994) these develop the 
cognitive map, forming an integrated system for understanding the phenomenon and 
interactions. For example, the theme treatment beliefs ultimately described a set of five 
inter-related themes of necessity, concerns, medication knowledge, social influences on 
medication use and impact of medication use on lifestyle. 
 
Codes and themes were organised into a hierarchical structure. This structure or 
„codebook‟ according to Ryan and Bernard (2003) includes a detailed description of the 
code or theme, its boundaries, and examples of text associated with it. For example, the 
theme ‘cause’ was labelled and described as „perceived cause of heart failure’ in order to 
distinguish it from causes of other conditions, with an example: „I wonder whether the fact 
that they put me on steroids for the asthma, whether it started it off’ [P12].  
 
NVivo 7, uses the term „node‟ rather than code and differentiates them into „tree nodes‟ 
describing codes organised into an hierarchical structure and „free nodes‟ which identify a 
code which has not yet been incorporated into this structure. Thus, data analysis 
progressed by codes being grouped together to develop themes which were further split 
or merged as analysis proceeded.  Figure 4.3 gives an example of the hierarchical 
structure of the 1st level theme, treatment beliefs. 
 
Memos were also used as part of the process of data reduction. Glaser (1978) defines 
memos as „the theorizing write-up of ideas about codes and their relationships as they 
strike the analyst whilst coding, providing a little conceptual elaboration’ (p.72). NVivo 7 
has the facility to write memos concurrently whilst coding and attach them to segments of 
text. Miles and Huberman (1994) advise that ‘when an idea strikes, stop coding and write 
the memo!” (p.72). For example, this memo, written concurrently whilst coding, described 
ideas about coherence, relating to a marked section of text: „Lack of coherence perhaps 
due to difficulties in determining the identity of the illness - what the illness actually is and 
how symptoms relate to this. Co-morbidites seem to add to the confusion’. Memos were 
revisited in the process of developing themes. 
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Treatment Beliefs 
Necessity of 
Medication 
Concerns about 
Medication 
Medication 
Knowledge 
Impact of 
Medication Use 
on Lifestyle 
Social Influences 
of Medication 
Use 
1st Level Theme 2nd Level Theme Code 
Frequent 
diuresis 
Effort in taking 
medication 
Effort in 
monitoring the 
effects of 
medication 
Text Example 
I don’t sleep well, I’m 
up and down to the 
toilet what seems 
like half the night, 
that’s the tablets 
[P6] 
Having to take 
tablets all the time 
is a real nuisance 
[P2] 
I always seem to 
have an 
appointment...to 
check the effects of 
the tablets [P1] 
Figure 4.3 Example of the Hierarchical Coding Structure 
The field notes were also included in the development of codes and themes. According to 
Denzin and Lincoln (2003) field notes serve to strengthen coding by pointing to deeper or 
underlying issues. For example the field note, „P11 found it really difficult to answer 
questions about his illness and referred constantly to his wife for information and 
confirmation of his ideas. The illness seems to be very much a shared experience’, helped 
develop ideas about social influences on beliefs and behaviour.  
 
Arguably, coding is complete when all incidents can be readily classified, categories are 
„saturated‟ and sufficient numbers of regularities occur (Denzin and Lincoln, 2003). No 
new codes or themes were added beyond the coding of Case 9, although additional 
examples of codes were found. It was decided that within this sample and context, data 
saturation had occurred and no further data were collected beyond the initial twelve 
interviews.  
 
4.1.6 The extent to which the data are trustworthy 
Rigour is an important concept in qualitative research. Quantitative data are subjected to 
tests of reliability and validity. In qualitative data these terms are replaced by the concept 
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of „trustworthiness‟ (Guba and Lincoln, 1995). Trustworthiness is said to exist when the 
findings of the qualitative study represent reality. Four criteria are proposed for 
establishing trustworthiness – credibility, transferability, dependability and confirmability.  
 
To establish credibility, participants need to be identified and described accurately. The 
characteristics of the sample are discussed in the following section. A further aspect of 
credibility is the use of member checks or the practice of allowing participants to check the 
findings to make sure they are true to their experience. Although this was attempted, few 
participants chose to make further comments beyond the initial interview. This may have 
been because participants were completely happy with the accuracy and interpretation of 
the data. However, what seems more likely is that participants were not particularly 
interested in contributing further to the research, which is a common experience according 
to Bryman and Burgess (1994). Participants seemed to be most interested in receiving the 
results in order to find out the extent to which their experience was similar to or different 
from that of others, rather than wanting to add further comments.  
 
Transferability is the degree to which findings can be transferred from the sample to the 
population as a whole. Since purposive sampling was used in this phase of the study, 
transferability was not a prime consideration. However, Holloway and Wheeler (1996) 
suggest that as long as the characteristics of the sample are described accurately and a 
clear decision trail is given in relation to data analysis, readers themselves can determine 
if the results can be applied to their own setting. In order for the research to be 
dependable, again a clear decision trail should exist, where theoretical and 
methodological choices are discussed throughout. Confirmability links the source of the 
data through to the conclusions. In this study, quotes from individual participants are 
linked to identified themes which are then used in the adaptation or development of the 
questionnaires (Chapter five) and considered in an overall discussion of the results 
(Chapter seven). By following these criteria it is anticipated that the results of this phase of 
the research may be considered trustworthy.  
 
4.2 RESULTS AND DISCUSSION 
 
This section presents the results and discussion of the interviews. First, the characteristics 
of the sample are described before discussing the findings in relation to published literature 
and the CSM.  
4.2.1 The Characteristics of the Sample 
The characteristics of the sample are presented in Table 4.1. 
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Table 4.1 Characteristics of the Interview Sample  
 
Number of Range  Mean  SD (±) 
Responses 
(n) 
 
Age (years)     12    37-85    70.08  12.84 
Time with Illness (years)   12    <1-15      4.16    3.85    
  
Number of  Frequency % 
Responses  
(n)    
 
Gender      12 
     Male    7  58.3   
     Female    5  41.7 
 
Ethnic Origin     12 
     White, British              11  91.6 
     White, Other    1    8.4 
 
Social Situation     12 
     With partner/family   9  75.0 
     Lives alone      3  25.0 
    
Qualifications     12 
     None    9  75.0 
     GCSE/O‟Level   3  15.0 
 
Occupation     12 
     Retired    11  91.6 
     Employed      1    8.4 
   
Co-morbidities     12  12             100.0 
 
 
Seven men and five women were interviewed. This represents slightly more women than 
would be expected in the heart failure population as a whole with national prevalence 
rates of 3.0% in men and 1.7% in women (Davies et al, 2001). The mean age was 70.08 
years (SD ± 12.84, range 37-85) although younger participants were represented. That 
most participants were from older age groups is consistent with the disease trajectory 
(Cowie et al, 1999). The purposive sampling strategy can, therefore, be considered 
successful in meeting the intended aim of recruiting men and women from a range of age 
groups.  
 
All participants were of „White, British‟ or „White, Other‟ (in this case, Western European), 
ethnic origin as defined by the Office for National Statistics (ONS, 2008). No participants 
were drawn from Black Minority Ethnic (BME) groups which, given that the population in 
this locality is predominantly white (94%) with only 6% of the population of BME origin 
(KCC website 2008), might be expected. Similarly, the proportion of BME patients with 
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heart failure in the locality is estimated to be only 6% (PCT heart failure service 
databases, 2010). Caution should; however, be exercised in extending conclusions to 
other ethnic groups.  
 
Nine participants lived with their spouse or family with three living alone, all of whom were 
women. Few participants (n = 3) had formal qualifications at GCSE/„O‟ level equivalent or 
above.  Most participants were retired which again, would be expected in these age 
groups. Only one participant was in paid employment but had not returned to work 
following the onset of her heart failure. Participants had been living with heart failure for an 
average of mean 4.16 years (range <1-15 years, SD ± 3.85). All participants had co-
morbidities, most commonly CHD which might also be expected since CHD is three times 
more common in those with heart failure (Thomas and Velaquez, 2005).  
 
4.2.2 Illness representations and emotional response  
Illness representations comprise beliefs about illness identity, cause, timeline (acute, 
chronic or cyclical), consequences, the extent to which the illness can be cured or 
controlled (personally or through treatment) and coherence. According to the CSM, illness 
representations and the emotional response to the illness are processed in parallel hence 
emotional response is also discussed here.  
 
IDENTITY 
 
The identity domain is composed of an understanding of the nature of the illness, the 
diagnosis or „label‟ attached and associated symptoms (Cameron and Moss-Morris, 
2004). In terms of the nature of the illness, differentiating heart failure from other cardiac 
conditions was difficult: 
 
I collapsed in the doctor’s surgery and they rushed me into hospital and I had a 
pacemaker fitted [P6]  
 
I’ve got a couple of blocked arteries and I’ve got one that’s OK [P5] 
 
These examples seem to describe an arrhythmia and CHD, respectively, rather than heart 
failure.  
 
The symptom of breathlessness was frequently attributed to an acute or chronic 
respiratory condition which may have been due to an inability to correctly identify 
breathlessness as a symptom of heart failure or could describe the presence of 
respiratory co-morbidities. For example: 
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My problems are not my heart. I don’t feel that my heart is a major problem. 
Obviously, you get to a position, which for medical reasons, they call chronic heart 
failure and I’ve no doubt reached that stage but my problem is that I’m very prone to 
getting pneumonia [P1]  
 
    I get puffed out because I’ve got asthma [P6]  
 
For one participant, a number of labels made identifying the illness difficult:  
 
It was ‘left ventricular systolic dysfunction’ then I got a letter saying ‘dilated 
cardiomyopathy, ischaemic heart disease’ and I thought ‘that’s a bit different from 
what I’ve heard’ [P8] 
 
Differentiating symptoms, the effects of medication and the emotional response to the 
illness was also problematic: 
 
I’ve got no appetite now, eating is just something that has to be done. I still don’t 
know the cause of that. I know the digoxin made me continuously nauseous with no 
appetite but the digoxin has been stopped and I still haven’t got the appetite. I don’t 
know why [P11] 
 
I get light-headed, dizzy sometimes. I don’t know if I get a few panic attacks. I don’t 
know if it’s the panic attacks I’m getting or if it’s to do with the medication or the 
condition. Probably after I get the feeling, I do panic but I don’t know if it’s the actual 
condition that’s giving me the funny turn [P8] 
 
The hope that greater experience of the illness would improve understanding was 
expressed by one participant which suggests that greater length of time with the illness 
may be related to a clearer illness identity: 
 
It’s a new learning thing for me. Maybe in a few years I’ll think, ‘oh, I know this is to 
do with my heart condition, or medication or whatever’ [P8] 
 
Where heart failure could be differentiated from other conditions it was described in terms 
of the heart not pumping blood effectively:  
 
The problem is the heart won’t pump blood fast enough. The walls are weak so 
they’re not pumping the blood [P3]  
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I would say my pump doesn’t work 100%, like normal people. I’ve got a bit less 
pumping action. The left ventricular side of my heart, that’s a bit like jelly [P8] 
 
This is broadly congruent with the biomedical view of heart failure although most 
participants were unable to define their condition in this way, referring largely to the 
symptoms and their effects.  
 
In summary, identifying the nature of the illness was difficult for most participants. This 
may have been due to the presence of other illnesses particularly other cardiac 
conditions, changing labels or diagnosis and difficulties differentiating symptoms from the 
effects of medication and emotional responses. Where heart failure could be identified it 
was most commonly described in terms of the heart‟s failure to pump blood effectively. 
The difficulty in connecting symptoms of heart failure to the condition was also found by 
Horowitz et al (2004). Similarly, Rogers et al (2002) found that symptoms were frequently 
attributed to the effects of medication.  
 
The symptoms of heart failure were described, in order of frequency, as breathlessness, 
tiredness and daytime sleepiness, sleep difficulties, dizziness or light-headedness, 
forgetfulness, loss of appetite, cold fingers and toes and sexual difficulties. The number of 
symptoms varied with most participants describing at least three symptoms.  
 
Depression was frequently described and could be categorised as a symptom, emotional 
response, consequence of the illness or co-morbidity. In this analysis, depression is 
discussed in terms of the emotional response as this was the context in which most 
participants described it. Similarly, tiredness and sleep difficulties could be conceptualised 
as either a symptom or a consequence of the illness. As both are recognised symptoms of 
heart failure in the literature, they have been categorised as such. 
 
All participants described breathlessness: 
 
My breath gets short. I’ve just got a job to breathe [P6] 
 
I’m a little bit breathless but only if I go upstairs carrying things [P9] 
 
Tiredness and daytime sleepiness were also frequently described: 
 
I get tired, sometimes very tired. I get tired very easily [P10] 
 
The thing I do suffer from now is tiredness. I never used to sit down in the afternoon, 
now I have to sit down and have a nap for half an hour, 45 minutes [P12] 
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Difficulty sleeping at night was also commonly associated with the illness: 
 
I can’t sleep. I have to have three pillows now.  I can’t sleep flat. My sleep pattern is 
completely a sham. I can have a night when I’ll go to bed and fall asleep straight 
away and the other night I was awake until 4 o’clock in the morning [P8] 
 
I haven’t slept in a bed for about five years because if I lie down flat I can’t breathe. I 
gave up in bed and now I just sit in a chair [P1] 
 
Dizziness and light-headedness: 
 
It’s a funny feeling in your head. It’s like a drained feeling and you tend to lose your 
balance. My head is all over the place [P3] 
 
Sometimes when I’m walking, I just feel like I’m going to pass out.  I just feel really 
funny, really light-headed and floaty [P8]  
 
Forgetfulness: 
 
Sometimes even reading a book, I can’t remember what I’ve just read or I can be 
talking and all of a sudden I think, ‘what were we talking about?’ [P8] 
 
Loss of appetite: 
 
I’ve got no appetite now, eating is just something that has to be done [P11] 
 
One participant described peripheral coldness: 
 
I get blue fingers, white fingers, tingling cold toes [P11]  
 
Sexual difficulties were also described by one participant: 
 
I’d probably have more sex if I didn’t have a heart problem! [P5] 
 
The symptoms described are broadly consistent with documented heart failure symptoms 
(Nicholson, 2007). Breathlessness, particularly on exertion is considered to be a classical 
sign of heart failure (Ahmed et al, 2004; Badgett et al, 1997; Harlan, 1977). Tiredness and 
daytime sleepiness are non-specific, prevalent symptoms of heart failure but which may 
be experienced in older age groups and related to depression (Ahmed et al, 2004). 
Insomnia, orthopnoea and loss of appetite are widely described (Nicholson, 2007; Merritt, 
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2004) and light-headedness and dizziness are commonly experienced and related to poor 
cerebral perfusion (Cowie et al, 1999). Cognitive impairment, which may manifest as 
forgetfulness, is increasingly recognised as a symptom of heart failure with an estimated 
30-50% of heart failure patients having some degree of deficit (Leventhal et al, 2005). 
Although sexual dysfunction has been reported in the literature as a symptom of heart 
failure, this may also be related to treatment or psychological factors such as depression 
(Nicholson, 2007). A number of these symptoms such as tiredness, dizziness, loss of 
appetite and sexual difficulties, are recognised effects of heart failure medication 
particularly beta-blockers, ACEI and diuretics so it is perhaps unsurprising that some 
patients find it difficult to differentiate symptoms from the effects of medication (Nicholson, 
2007).  
 
Interestingly, peripheral oedema, most commonly ankle swelling, which is considered a 
classical symptom of heart failure (Ahmed et al, 2004; Fonseca et al, 2004; Badgett et al, 
1997; Davie et al, 1996; Harlan, 1977), was not identified by participants in this sample. 
This may be because it was either not experienced, perhaps due to optimal medication 
management, or it may have been considered of limited consequence or was not 
recognised as a symptom of heart failure. Paroxysmal nocturnal dyspnoea, also 
considered to be a specific symptom of heart failure (Merritt, 2004), was not explicitly 
described in this sample but may have been categorised more generally as sleep 
difficulties. 
 
CAUSE 
 
Beliefs about causation are considered to be important components of explanatory 
models of illness, including the CSM. Although causes can be considered individually, 
beliefs can be grouped into external and internal causative factors. External causes are 
those perceived to be outside the influence of the individual while those internal are 
believed to be influenced by personal processes (Leventhal et al, 1997).  
 
Although one participant was unable to suggest a cause: 
 
I can’t think of anything. No idea at all. I’ve never been ill before. No, I can’t think 
why [P9] 
 
The belief that the illness was caused by external factors or stressors was prevalent with a 
minimal role perceived for internal causes. Family history, other illnesses and treatment 
for other illnesses were identified:  
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The only thing I can think of is that my mother died of a heart attack. Her brother had 
a heart problem so I think it’s been passed on like that [P11] 
  
Other illnesses, including a genetic condition and a virus were cited: 
 
What do you think caused the problem with your heart? [Res] 
Pseudoxanthoma elastica [P5] 
 
It was down to a viral infection that attacked my heart [P8] 
 
Two participants believed that their heart failure was due to drugs given to treat other 
illnesses, namely, cancer and asthma:  
 
I was told by Dr (name) that the chemo had enlarged it (the heart) and it wasn’t 
working particularly well [P7]  
 
For years they’d been treating me for asthma and as things got worse they were 
increasing the dose of steroids, and, in fact, at the end of the day, I hadn’t got 
asthma, I’d got this heart problem. I wonder whether the fact that they put me on 
steroids for the asthma, whether that started it off [P12] 
 
Stress, particularly due to external stressors was commonly viewed as the cause of the 
illness. According to Lazarus and Folkman (1984) stress is described as an internal 
process consisting of a stressor (which may be external or internal to the individual), an 
appraisal of that stressor and a subsequent coping response. In this sample, overwork, a 
specific stressful event or family conflict were identified: 
 
Obviously, I’d been abusing myself. I’d been overactive. I’ve been self-employed all 
my life and you work at a totally different pace when you’re self-employed. You’re 
not a nine-to-five person. I mean, I could be in Cologne at 1.30pm and say, ‘I must 
get back to watch Coronation Street’ and you drive all the way, non-stop. Always 
rushing about and I suppose that’s probably the reason [P12]  
 
We put the house on the market in the morning and sold it in the afternoon. We had 
to get out. I was all right before I came here. I think it was the stress really [P3]  
  
To be the black sheep of the family as they called me. They don’t seem to 
understand me, it’s like I don’t fit in with them and I’m not the same family. My health 
is because of everything to do with that [P10] 
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Lifestyle factors were not commonly identified as potential causes of heart failure in this 
sample. Two participants identified smoking as a potential cause but this was externalised 
and moderated against a background of environmental factors or stress. 
 
I think quite honestly it’s smoking but I was also working in coal burning ships where 
you go inside a bunker and you’d be black and the inside of your mouth would be 
black with coal dust and you’re breathing all the dust. You’re pulling asbestos apart 
and the air’s full of it so all these things together no doubt, have played some part 
[P1] 
 
I smoke but I’m not blaming the cigarettes for my illness. Partly, yes, but I think it’s 
the stress and the cigarettes as well. I should say 90% was the stress and 10% was 
the cigarettes [P10]  
 
In summary, the cause of the illness was attributed to largely external factors such as 
family history, genetic illnesses, infections, drugs or environmental factors. Although, 
these agents are medically recognised causes of heart failure (Cowie et al, 1999), they 
are all relatively uncommon. In the UK, most cases of heart failure are due to CHD with 
about one-third due to hypertension (DH, 2003). In this sample, nine participants 
mentioned previous heart attacks, angina, hypertension or interventions for CHD, such as 
coronary artery bypass grafting (CABG), but did not make the connection between these 
conditions and their current symptoms or diagnosis of heart failure. That is, they failed to 
identify CHD as the cause of their illness even though, for most, this was probably the 
most likely cause according to a biomedical model of the illness. This may be because, as 
discussed in relation to identity, some participants had difficulty differentiating heart failure 
from other cardiac illnesses so may have been referring to the cause of their heart 
problems generally and not specifically heart failure. The influence of lifestyle factors, 
such as smoking, were minimised within the context of external factors. 
 
This belief in stress as a causative factor was also prevalent and supports the findings of 
Baumann et al (1989) who argued that the presence of life-stress led people to attribute 
unusual symptoms to stress rather than to the illness (the stress-illness rule). Stress was 
found to be the most commonly perceived cause of other cardiac conditions including MI 
(Petrie et al, 1996) and angina (Furze et al, 2001). In heart failure, Horowitz et al (2004) 
and Morgan (2008) also found that the illness was frequently attributed to stress.  
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TIMELINE 
 
Timeline refers to beliefs about whether the illness is acute and short-lasting or chronic 
and long-lasting and describes the expected illness trajectory or whether the illness is 
expected to improve, stay the same or get worse in time. The pattern of illness or whether 
the illness or its symptoms are cyclical or episodic is also considered a dimension of 
timeline in the CSM.  
 
Heart failure was most frequently described as a chronic condition which was expected to 
stay the same or get worse in the future. For example: 
 
I think it will stay the same or get a bit worse. It won’t get any better will it? [P4] 
 
It will probably get progressively worse [P5] 
 
Advancing age was seen as an influencing factor in the progression of the illness: 
 
Getting old, usually things don’t get better. It’s like arthritis; it doesn’t get better with 
age does it? If it’s the heart that’s tired or worn out or failing in whatever way, it’s not 
going to get better [P1] 
 
Two participants tentatively expressed a belief in an acute illness which might be cured or 
at least improved. One described an enlarged heart as a result of recent chemotherapy 
improving while another expressed faith in medication: 
 
It (the heart) has probably gone back down again now. I think it was enlarged but I 
think it’s improved [P7] 
 
These drugs that will strengthen the walls of the heart and do this and do that, if they 
do what they say they do, then yes, it’s got to get better hasn’t it? [P12] 
 
Both participants held strong beliefs about the powerful nature of medication as illustrated 
by the belief that the heart failure was caused by medication and could therefore, be 
improved by stopping that medication or by taking heart failure medication. 
 
A number of participants perceived a cyclical or episodic timeline in relation to symptoms 
and emotional response to the illness rather than the illness as a whole with „good‟ and 
„bad‟ days described: 
 
Well, some days I feel better than others [P3] 
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I get good days and then I get a few bad days [P4] 
 
Overall, viewing heart failure as a chronic illness which was likely to stay the same or get 
worse in the future was the most prevalent belief and represents an accurate illness 
trajectory. This belief is consistent with patient studies by Morgan (2008), Cherrington et al 
(2006) and Voelmeck (2006) but in contrast to the findings of Horowitz et al (2004) where 
a prevalent belief in heart failure as an acute condition was described.  
 
CONSEQUENCES 
 
The illness representation of consequences describes the extent to which the illness is 
believed to be have serious consequences and the nature of these, for example, physical, 
psychological, social and financial effects.  
 
In this sample, the illness was generally viewed as having serious consequences: 
 
To me, it’s very serious. The way I feel, it’s bad [P10] 
 
I suppose it is serious, really [P9] 
 
Physical consequences were most frequently described, mostly in relation to poor 
exercise tolerance and the symptoms of tiredness or fatigue:   
 
It takes so much effort to get anywhere in the mornings, I haven’t got the energy 
[P2] 
 
I used to walk two or three miles a day. I can’t do that anymore. I find now I just 
haven’t got the energy.  It seems that I’ve got no energy at all. I mean even walking 
across the room is not as easy [P1] 
 
Similarly, carrying out household chores and climbing stairs was problematic, particularly 
in terms of provoking symptoms: 
 
If I give a hand to make the bed, if I bend down to tuck the sheets in, then very often 
I’ve got to sit down [P3] 
  
That’s why I came to live here in a bungalow because stairs are very bad for me, I 
just can’t do it. I start to puff, puff [P6] 
 
For some, physical consequences were moderated by age and exacerbated by co-
morbidities: 
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I couldn’t change a light bulb now, I’ve got a problem climbing up but I think that’s 
probably something that happens to all 80 year olds [P1]  
 
I’ve arthritic knees, one hip and lower spine and I can’t have the operations because 
of the anaesthetic and my heart, so because of my mobility problems, if my knees 
and back are too bad, I don’t get around the corner [P11]  
 
Social consequences, specifically reduced social contact due to symptoms was described:   
 
If I feel tired I can always sit and relax but when you are with friends you can’t do 
that. If I go to my friend’s house it’s not nice to go there and fall asleep! I used to call 
my friend and we used to go out. We used to go shopping or go for a meal. Not any 
more [P10] 
 
I can’t go out the way I used to. When our little granddaughter was one year old I 
used to take her out. We used to go all over the place and drive and that, and I just 
can’t do it. The last year or so, I just can’t do it. I get too tired [P1] 
 
Concerns about the reactions of others to the illness were also described by women in 
this sample:  
 
I was in a shop one day and I fainted, I just felt funny. I knocked against these two 
people and they laughed and said ‘it’s a bit early to be drunk. That woman is drunk!’ 
It did upset me [P6] 
 
Other people don’t understand. I mean, before I had this, if I’d seen someone in the 
playground having a funny turn, I’d think, ‘Tut! What’s she on about!’ You do get 
bitchy people that think, ‘Oh God, pull yourself together!’ [P8] 
  
As this view was only expressed by two women in this sample, it is difficult to draw reliable 
conclusions on the influence of gender in relation to concerns about the reactions of 
others. However, it suggests that women are more keenly aware of how having heart 
failure might be perceived by those who are „well‟. 
 
In summary, there was a prevalent belief that the illness had serious consequences, a 
finding echoed by Cherrington et al (2006) and Voelmeck (2006). Consequences were 
predominantly physical, although this was viewed within the context of advancing age. A 
tendency to attribute the effects of illness to increasing age is recognised by Bauman et al 
(1989) and termed the „age-illness‟ rule. In addition, in this sample, negative social 
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consequences were described in terms of reduced social context and concerns about the 
opinions and reactions of others. This last finding may be a gender-specific concern as 
this view was only expressed by women in this sample. Overall, these findings are 
supported by Mahoney (2001), who described the consequences of heart failure as 
disorder on physical, emotional and social levels. The Department of Health (DH, 2007) 
also describe the consequences of living with long-term conditions in these terms. 
 
CURE AND CONTROLLABILITY 
 
Cure and controllability describes beliefs about the extent to which the illness can be 
cured or controlled and by what means, personally or by treatment. Beliefs about control 
rather than cure were described, which is consistent with the belief that the illness had a 
chronic timeline. 
 
For some, a lack of illness control was described: 
 
The illness controls me, I don’t control it [P10] 
 
I just have to accept it, there’s nothing I can do about it [P3]  
 
For one participant, this lack of control was related to increasing age and beliefs about the 
side-effects of the medications:  
 
They say ‘there’s nothing we can do about your heart’. My doctor’s actual words 
were ‘you’re 85, you’ve got a dicky heart, your kidneys aren’t all that clever, so make 
the most of it!’ [P3] 
 
Where some degree of control over their illness was described, this was most commonly 
believed to be achieved through the use of medication. This belief seemed to be related to 
a perceived improvement in symptoms as a result of taking medication.  
 
I was short of breath but since I came under Dr (name), she’s done a lot with my 
tablets and I’m 50 times better. I’ve seen a vast improvement through the tablets 
[P4] 
 
I’ve seen a big improvement with the tablets. I can walk further. I don’t get out of 
breath so much [P11] 
 
In terms of maintaining personal control, a positive attitude and exercise were seen as 
important: 
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You’ve got to be cheerful, if you can be cheerful that helps your health a lot. People 
can help themselves get better. Some people feel sorry for themselves, it’s no good. 
There’s always a blue sky to look at. I’m not saying I’m always optimistic but I hold 
onto that. I think that’s the important thing [P6] 
 
Exercise controls it definitely. Got to keep exercising every day, keep it working 
hard. Work your heart hard, it’s a muscle, it needs stimulation. My main exercise is 
the bike. I’ve got strong legs and I think I’ve got a strong heart [P7] 
  
Overall, although lack of control was described by some participants, there was a 
prevalent belief in treatment control. A degree of personal control was also described and 
believed to be best achieved through the emotional factor of maintaining a positive 
attitude and the lifestyle factor of exercising. Other lifestyle factors, for example, a low 
sodium diet, were not identified as controlling factors. Although lack of control is described 
by Horowitz et al (2004), Morgan (2008), Cherrington et al (2006) and Voelmeck (2006) 
found strong beliefs in both personal and treatment control. However, in these studies, the 
belief in personal control was stronger than treatment control which is seemingly in 
contrast to the findings in this sample.  
 
COHERENCE 
 
Coherence or beliefs about the degree to which the illness makes sense was difficult to 
analyse in that, when asked directly, most participants agreed, albeit tentatively, that their 
illness made sense to them: 
 
Yes, I think I understand it all, really [P1]  
 
However, this was frequently not demonstrated in other responses. For example, lack of 
coherence was demonstrated through an uncertain cause or illness identity: 
 
I really don’t understand much. I can’t think why I collapsed in the garden; it’s a 
mystery really [P9]  
 
Where the water comes from, I don’t know. I don’t understand that bit of it [P5] 
 
My diagnosis has changed somewhat, so I’m getting a bit confused. When I came 
out of hospital I thought I had one thing and then they’re saying ‘no, it might be…’ 
My head’s a bit of a buzz. I get puzzled because you get told one thing and then 
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halfway through you get told something else and then you’re back to square one 
again and there are so many technical terms [P8] 
 
According to the CSM, coherence relates to the belief that the illness makes sense. 
However, this appears to be a different concept from that of a demonstrated coherent 
view of the illness in terms of other illness representations. This may explain why in 
studies using the IPQ-R (Cherrington et al, 2006; Voelmeck, 2006), where coherence is 
assessed through statements such as „I have a clear picture or understanding of my 
condition’, a coherent picture of the illness is reported but in qualitative studies by 
Horowitz et al (2004) and Mahoney (2001) inconsistencies and misconceptions in relation 
to other individual illness representations, lead the authors to conclude that there is a lack 
of illness coherence.  
 
EMOTIONAL RESPONSE 
 
Whilst one participant reported no negative emotions, most participants described one or 
more feelings of depression, anxiety, panic, loss of confidence, anger, frustration or 
feelings of guilt.  
 
In relation to depression, this ranged from feeling down or „fed up‟ which seemed to be 
due to poor exercise tolerance, to desperation and suicidal thoughts: 
 
I feel fed up really. I’d like to do lots of things but I can’t [P5] 
 
I just had difficulty breathing; no matter what you do you can’t breathe. I felt so down 
and that was not like me. You almost get in a depressive state and I felt as if I was 
really pushing my luck and I really couldn’t see that I could keep overcoming the 
problem. I mean, it kept coming back and coming back and coming back. I had 
difficulty to struggle out of it that time [P1] 
 
To be quite serious, there’ve been one or two times when I’ve thought, ‘if I had the 
guts I’d end this...’, but I’ve not got the guts to do it [P3]  
 
Anxiety or panic and resulting loss of confidence were also expressed: 
 
My breath gets short and I’ve just got a job to breathe so what I have to do is.... I 
have to stop myself because if you’re not careful you start panicking [P1]  
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I have to think before I go anywhere because I think, ‘Oh, am I going to have one of 
my funny turns?’ Like my son was at a birthday party and I had a funny turn in there 
and I had to leave. I’ve lost my confidence going places [P8] 
 
I still haven’t walked 18 holes. I probably could do it without any problems but you’re 
a bit wary aren’t you, especially in the winter, pulling a trolley [P12]  
 
Anger and a sense of frustration were also prevalent responses: 
 
Any little thing will irritate me and I get angry for nothing. Stupid things and I should 
laugh about it but it just makes me feel angry [P10] 
 
 I get so frustrated because I was going to do so much [P4]  
 
One participant reported feelings of guilt: 
  
I feel guilty with the kids. You’ve got to say, ‘Mum can’t do that today’, and you feel 
quite bad. I feel bad for my husband because he’s such a good support and he’s 
done everything. I feel bad for him. I’m relying on him a lot and he never moans but I 
feel bad [P8] 
 
In summary, negative emotional responses to the illness were frequently and often 
powerfully described by both men and women of all age groups. Depression is recognised 
as a prevalent experience of patients with heart failure with at least 11% of heart failure 
patients feeling depressed (Leventhal et al, 2005). Anxiety and panic have also been 
described in qualitative studies by Rogers et al, (2002) and Mahoney, (2001). In contrast 
studies using the IPQ-R report a neutral emotional response to heart failure (Morgan, 
2008; Cherrington et al, 2006). 
 
In conclusion, in relation to illness representations and emotional response, there was for 
many, a lack of a clear illness identity often due to the presence of other illnesses, 
particularly other cardiac conditions. Differentiating between heart failure symptoms, the 
emotional response to the illness and medication effects was also problematic. This is 
consistent with qualitative studies on lay beliefs by Horowitz et al (2004), Rogers et al 
(2002) and Mahoney (2001). Symptoms described were generally typical of the 
biomedical view of heart failure with breathlessness and tiredness most frequently 
experienced. Peripheral oedema and paroxysmal nocturnal dyspnoea, also commonly 
cited symptoms of heart failure were not described in this sample. 
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The illness was most commonly attributed to external factors such as family history or 
stress due to external stimuli. Stress as a causative factor in illness is consistent with the 
theory of Baumann et al (1989). Lifestyle factors were not generally recognised as 
causative factors. Although many of the participants in this sample described symptoms of 
CHD, this was not recognised as a possible cause of the heart failure possibly due to the 
failure to differentiate heart failure from other cardiac diseases. The illness was commonly 
perceived as a chronic or long-term condition which was likely to deteriorate over time, 
which describes an accurate illness representation. This is in contrast to the findings of 
Horowitz et al (2004) but supported by Cherrington et al (2006) and Voelmeck (2006). 
Although symptoms were at times, described as coming and going (cyclical), the illness 
itself was not viewed in this way. 
 
The illness was described as having serious consequences which were predominantly 
physical, although reduced social contact and concerns about the reactions of others were 
also described. There was a strong, prevalent belief in the control of the illness by 
medication with a less powerful role for personal control. This is in contrast to the findings 
of Cherrington et al (2006) and Voelmeck (2006) where strong, personal rather than 
treatment control beliefs were most prevalent. Illness coherence was reportedly high in 
this sample with participants in broad agreement that the illness „made sense‟, however, 
this was not necessarily evident in other illness representations. Negative emotional 
responses to the illness were widespread with depression and anxiety most prevalent. 
Depression especially, is well documented in heart failure (Leventhal et al, 2005). 
 
Few differences were observed in terms of socio-demographic characteristics of age, 
gender, social situation, education level or time with illness. In some older participants, 
advancing age was seen as a moderating factor in determining the physical 
consequences of the illness and re-enforced beliefs about a chronic timeline. Concerns 
about the reactions of others to the illness were only expressed by women in this sample 
which may reflect a gender-specific finding requiring further investigation.   
 
In applying the CSM as the theoretical framework, the existence of the five illness 
representations and the emotional response to the illness was supported by the data 
which could readily be assigned to these constructs. Coherence, described as a meta-
cognition by Moss-Morris et al (2002), was more difficult to describe which, it is 
hypothesised, may be related to the different ways in which this term is used in published 
studies. No new or additional representations or cognitions were identified from this 
analysis, rather, heart failure-specific symptoms were highlighted, for example, 
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„forgetfulness‟ and „daytime sleepiness‟. Beliefs about causation, for example „medical 
treatment for other illnesses‟ and „other heart problems‟ were identified as specific causes 
of heart failure. 
 
4.2.3 Treatment beliefs 
Treatment beliefs can be seen as an extension of the CSM (Horne, 1997) and comprise 
beliefs about the necessity of and concerns about treatment (Horne et al, 1999).  
 
NECESSITY AND CONCERNS  
 
Only two participants expressed some doubt about the necessity of their medication: 
  
I don’t know whether they’re essential or not because I’ve been taking them since 
day one when I came out of hospital [P12]  
 
I’d like to stop all of them and see what happens and if necessary come back on 
them again [P2] 
 
Most participants held the view that medication was necessary often due to the perception 
that symptoms improved as a result of taking medication: 
  
I have to take them because if I didn’t take them, I’d probably feel worse than I do 
now, so I have no choice but to take them [P10] 
 
I take them because obviously they do improve my life a lot, they do help [P8] 
 
My tablets probably keep me alive [P5] 
 
Although one participant had no concerns about their medication, most were concerned 
about drug interactions and side–effects: 
 
The blood pressure medication is interacting with the chemotherapy which also 
lowers the blood pressure so basically at one stage, my blood pressure was 80-
something over 50-something and I was falling over [P7]  
 
It’s hard to know what you can take with your medication. When I came out of 
hospital I had a cold and I took ibuprofen and I don’t think you can take that. And 
Lemsip, on the box it says ‘if you have a heart condition or take beta-blockers…. ’ 
[P8]  
 
Negative or „side-effects‟ of medication were of widespread concern:  
115 
 
 
One of them, the water tablets, when they clear out the water they clear out the salt 
as well and my potassium level was low so I had to take tablets to crack that! [P3] 
 
Aspirin.  I’ve got terrible stomach aches with it [P10] 
 
I know the digoxin made me continuously nauseous and no appetite [P11] 
 
I had this cough, I knew what tablet was doing it [P4]  
 
I was on one that caused problems for my liver and I had to stop that and other ones 
cause other side-effects. I have insomnia, I have all sorts of things really, which you 
could attribute to the tablets, side-effects of the tablets [P5] 
 
Information given in patient information leaflets seemed to add to these concerns:  
 
I’m terrible with the leaflets you get. I read them all and what they can do. One of my 
tablets, I have to have my kidneys checked because they can affect your kidneys 
and that’s all I need! [P8] 
 
Concerns about side-effects seemed to be particularly related to higher doses: 
 
I did ask the doctors to cut down because I was fainting all the time, in the street 
everywhere. They have reduced the amount and I’m OK up to now.  High doses 
seem to be dodgy to me [P6] 
 
I think there is a possibility that the tablets may be too strong for me and that’s 
what’s making me feel tired [P12]  
 
I’d had these incredibly painful cramps caused by the increase in dose [P12] 
 
Balancing necessity and concerns was described by some participants: 
 
With every medicine there is a side-effect and you have to weigh up whether you’re 
being helped or not, considering the side-effects [P5]  
 
You have to weigh up how much good the tablets are doing you as opposed to if 
you’ve got any problems with side-effects [P1]  
 
In summary, there was a strong, prevalent belief in the necessity of medication which was 
seemingly related to the perception of improved symptoms. However, concerns about 
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drug interactions and side-effects were also widespread. Concerns about side-effects 
were also found to be important to patients in studies by Riegel and Carlson (2002) and 
Stromberg et al (1999). Higher doses of medication seemed to increase these concerns, 
in this sample. Since heart failure medication management includes the practice of up-
titration or increasing dosage in a step-wise fashion to a target dose, this finding may be a 
specific concern in this illness group.  Concerns about side-effects also seemed to be 
increased by reading the patient information leaflets contained in the medication 
packaging. This was also found by Rogers et al (2002) where higher doses and patient 
information leaflets added to concerns. A cost-benefit analysis, as described by Horne 
and Weinman (1999), was found in this study where strong beliefs about necessity were 
balanced against concerns. 
 
MEDICATION KNOWLEDGE  
 
In addition to necessity and concern beliefs, participants described their perceived 
knowledge about the actions, doses and timing of medication. As the accuracy of this 
knowledge was not verified by prescriptions, this theme describes perceived knowledge or 
the confidence in one‟s ability to understand the use of medication. In terms of drug 
actions, most participants were confident in their knowledge. For some, this information 
was gained from the patient information leaflets:  
 
Atorvastatin, that’s for my cholesterol, the aspirin’s to keep the blood thin, atenolol, 
the beta-blocker, that slows my heart down a little bit and then I’m on a couple of 
other things – I think there’s a water tablet in there as well just to help with fluid 
retention [P7] 
 
I’ve read up on every one of them, one’s for blood pressure, one’s for doing this and 
that. I’ve actually gone through all those papers [P8] 
 
In contrast, one participant did not believe they had a clear understanding of the actions of 
their medication: 
 
I wake up in the night because I’m going to the toilet all the time and then I go back 
to bed and lay there and think, ‘I’ll make a cup of tea’. I don’t think any of my tablets 
are what they call water tablets, I don’t know what water tablets are, whether they 
stop you or make you go, I don’t know, but I don’t think I’m on water tablets [P9] 
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In terms of doses and the times of administration, again, most participants were confident 
in describing their medication regime. Doses were commonly described in terms of the 
number of tablets rather than their strength:  
 
I take four altogether in the morning, another one at lunchtime and then the same 
again at teatime, then my night-time one [P1] 
 
Changing tablets or brand names seemed to impact on knowledge confidence:  
 
I know what each one is supposed to do really. Well, one or two I’m not absolutely 
certain about.  They’ve changed my tablets so much in the last three or four months 
that some that I was taking, I’m now not taking [P3] 
 
You go to get them from the doctor or chemist and they’re in different boxes each 
time and they’re different colours. When you’ve taken some tablets for so many 
years one colour and you go back and they’re another colour it’s confusing. I think 
they buy them cheaper, don’t they? [P5] 
 
In summary, most patients were reasonably confident about their knowledge of their 
medication, although threats to this knowledge, through changes to the regime were also 
described. The accuracy of knowledge about the use of medication has been studied, 
especially in relation to medication adherence (George and Shalansky, 2007; Van der Wal 
and Jaarsma, 2007; Riegel and Carlson, 2002), but no studies have been found which 
address individual confidence in understanding the actions of and use of heart failure 
medication. However, it is acknowledged that the accuracy of knowledge might be 
expected to relate to knowledge confidence.  
 
SOCIAL INFLUENCES ON MEDICATION USE  
 
The belief that family or friends influenced medication use through practical assistance 
with medication management was described:   
 
My wife gives them to me in a container with each meal and when I go to bed, she 
gives them to me and says, ‘here you are, take that’ [P5]  
 
My daughter-in-law bought me this thing with seven or eight drawers in it, one for 
each day of the week [P3] 
 
However, confidence in medication knowledge was poor when others took responsibility 
for medication management: 
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My wife could tell you all about the tablets I’m on, because, I don’t take much notice 
of that. My wife does it [P5] 
 
I have to admit I’ve switched my brain off to a lot of it; my wife deals with most of 
that, fortunately. God knows how people deal with it when they’re on their own [P7] 
 
The nurse says to my wife, ‘take him off this, put him on half of that, do this, do that’ 
and between them they sort me out [P7] 
 
Gender differences were observed in that assistance with medication management was 
exclusively described by men in this sample. Men in partnerships tended to describe their 
wife managing their medication whilst women in partnerships did not describe any 
assistance with medication. However, this could be related to advancing age as women in 
partnerships, in this sample, tended to be younger. 
 
The beliefs and advice of friends was noted to be a potential, negative influence on the 
use of medication: 
 
It’s been suggested by friends of mine to reduce the dose and see what effect it has 
on me but I haven’t tried [P12] 
 
None of my family take as many tablets, none of my brothers and sisters have any, 
and then sometimes my friend says to me, ‘why do you take so many tablets?’ [P10] 
 
Social influences on the development of illness and treatment beliefs have been described 
by Horne et al (1999) and Leventhal et al (1997). Here, social influences seemed to have 
a largely positive effect on medication use through practical support, which may be related 
to gender. This influence is consistent with the findings of Stromberg et al (1999), who 
described the important role a spouse played in medication management by giving their 
partners their tablets at prescribed times. Wu et al (2007) also found that family members 
assisted with medication use by filling Dosette® Boxes. However, knowledge about 
medication may be negatively affected when medication is managed by others. A further 
finding is that beliefs about medication and potentially, adherence may be influenced by 
the beliefs and suggestions of others.   
 
IMPACT OF MEDICATION USE ON LIFESTYLE  
 
The use of heart failure medication was described as interfering with aspects of lifestyle. 
Although, conceptually, this may be related to concerns about medication it seemed to 
119 
 
describe the more practical consequences of taking medication such as diuretics, and the 
time and effort involved in taking medication regularly and monitoring its effects: 
 
I am on water tablets but once you’re getting rid of it, you go to the toilet every half 
hour or something like that, which is difficult when you are out [P3] 
 
I don’t sleep well. I’m up and down to the toilet what seems like half the night, that’s 
the tablets [P6] 
 
Having to take tablets all the time is a real nuisance [P2] 
 
We used to visit my son in Herefordshire, but I don’t drive there now. It’s not so 
much the driving it’s that I always seem to have an appointment with the nurse or 
doctor to check the effects of the tablets [P1] 
 
The unwanted effects of drug actions, particularly diuretics are well documented in heart 
failure (Nicholson, 2007; Cowie et al, 1999). The view that the management of a long-term 
condition involves substantial work effort by the individual is also supported here (Glaser 
and Strauss, 1967; DH, 2006b). 
 
Overall, in addition to beliefs about the necessity of and concerns about medication, 
perceived knowledge about medication, social influences on medication use and the 
impact of medication use on lifestyle were also described.   A strong, prevalent belief in 
the necessity of medication was found which seemed to be related to the belief that 
symptoms improved as a result of taking medication. However, concerns, particularly in 
relation to drug interactions and side-effects, especially at higher doses, were also 
prevalent as described in other studies (Riegel and Carlson, 2002; Stromberg et al, 1999). 
Concerns were enhanced by reading the patient information leaflets in the medication 
boxes.  
 
Knowledge about medication was perceived to be high which was enhanced by reading 
the patient information leaflets. However, changes to the medication regime seemed to 
have a negative impact on perceived knowledge, similarly, when family members took 
responsibility for medication management, knowledge of medication seemed to be 
reduced. Medication use was believed to be influenced by friends and family with wives, in 
particular playing an important role in practical medication management through filling 
Dosette® Boxes and administering tablets. However, the beliefs of friends were found to 
have a potentially negative effect on medication use. The impact of heart failure 
medication on lifestyle, which can be considered a specific, practical medication concern, 
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was identified as a potential barrier to adherence as frequent diuresis and the time and 
effort involved in taking regular medication and monitoring its effects were highlighted.  
 
In relation to the extended CSM (Horne et al, 1999), the existence of treatment 
representations of necessity and concern beliefs were supported in this study. That 
individuals viewed the use of medication as a balance between necessity and concerns 
was also supported. Social influences on medication use and the impact of medication 
use on lifestyle were themes developed inductively from the data, which although 
documented in the literature, have previously not been considered within the construct of 
treatment beliefs. Perceived confidence in medication knowledge, which may be related to 
the accuracy of knowledge, was also described in this sample and appears to be an 
original finding in relation to treatment beliefs. 
 
4.2.4 Self-care 
Self-care in heart failure has been conceptualised as consisting of self-care maintenance 
and self-care management behaviours (Dickson et al, 2006). Self-care maintenance 
includes adherence to recommended lifestyle behaviours and medication adherence. Self-
care management strategies include symptom recognition, monitoring and management 
and the actions taken in response to those symptoms, such as seeking help.   
 
ADHERENCE TO RECOMMENDED LIFESTYLE BEHAVIOURS  
 
In this sample, the following changes to lifestyle were described: 
 
Reducing alcohol consumption: 
 
I’ve cut the drinking down.  I used to have a regular sort of drink of an evening, gin 
and tonic or maybe a scotch but I don’t do that anymore. I’ve certainly stopped the 
regular habit of drinking every evening [P12] 
  
I’ve never drunk a lot but I used to have a glass of wine or so at the weekends. I 
don’t drink now, I’ll probably have one glass of wine Christmas day just with my 
dinner but other than that I don’t drink [P8] 
 
The importance of eating a low fat diet: 
 
We have skimmed milk or semi-skimmed milk now and we also have Bertolli which 
is olive oil [P1] 
 
Avoiding caffeine was reported: 
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I have cut out all caffeinated drinks [P12] 
 
We have decaffeinated tea and coffee now [P2] 
 
One participant described her efforts to reduce smoking: 
 
I’m doing very well because since Christmas I have had four cigarettes a day, roll-
ups, the fine, fine ones. I managed to stay four days without cigarettes [P10]   
 
Weight loss was mentioned:  
 
I’ve lost over a stone. If I was a bit stronger and lost another stone in weight that 
would do me good, which I’ll try and do [P12]  
 
Exercise was seen as important in a physical sense and also as a social activity: 
 
I know exercise is important and what I’ve been doing is walking as fast as I can and 
I can feel my heart going but it’s normal, it’s like it used to, like when you run, it 
beats a bit faster and it’s a good feeling [P11]  
 
I go to town on Monday mornings. It gives me a chance to walk around and so I 
suppose that in the process of doing that I probably do a half a mile or something 
and I enjoy seeing people, getting out and about [P1]  
 
Changes in lifestyle were also influenced by other illnesses:  
 
You should exercise regularly if you can but you can only do what you can do and I 
can’t exercise. I can’t take things with sugar because of my diabetes. I’ve got a 
hiatus hernia which if I eat fat gives me a painful stomach and also I’ve got 
gallstones which if I eat fatty foods are very painful [P5] 
 
These behaviours are consistent with recommended self-care behaviour in heart failure 
(Riegel et al, 2009a; Dickson et al, 2006; Jaarsma et al 2000b). However, other 
behaviours such as limiting salt (sodium) intake and restricting fluids were not generally 
described with only one participant mentioning a reduction in their salt intake and no 
participants reportedly restricting their fluid intake. This finding is in contrast to a review of 
studies by Van de Wal and Jaarsma et al (2007) where adherence to a low sodium diet 
ranged from 13% to 75% and to a fluid restriction from 23% to 70%.  
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Lifestyle changes, such as taking a low fat diet, were not specifically discussed in relation 
to controlling heart failure but rather seemed to be described as part of an overall „healthy 
lifestyle‟ or in response to co-morbidities. That spouses were also described as making 
dietary changes seems to support the lack of specificity of this behaviour to heart failure. 
Those behaviours which might be considered most specific to heart failure, namely 
reducing salt and fluid intake were infrequently described, suggesting a lack of 
understanding of the purpose of these lifestyle changes in relation to the illness.  
 
ADHERENCE TO MEDICATION  
 
Adherence to medication was reportedly high with many participants describing full 
adherence:  
 
I never miss doses I’m very, very vigilant [P7]  
 
I’m on lots of tablets and I take them without fail. I don’t forget [P9] 
 
Strategies to maintain adherence such as Dosette® Boxes and other aide memoir were 
frequently described, particularly when forgetfulness was also apparent:  
 
I take them altogether in the morning. I’ve got a little pillbox because I’d just forget. 
sometimes they all look the same, especially when you’re half asleep so they’re all 
set out and then I know. Sometimes like today, I nearly forgot to take them and if I 
hadn’t had that pillbox, especially with my memory, I would have stood there and 
thought ‘have I taken them?’ Whereas, I just went over and thought, ‘Oh no, I 
haven’t taken them’ [P8] 
 
I fill the things up every morning, and the water tablets, if I don’t take one in the 
morning because I’m going out, I lay the mop on the floor to remind me so that when 
I come home I take one as soon as I get in, so I’ve got my own system for doing it 
[P11] 
 
At times, incomplete adherence was unintentional through forgetfulness or due to the 
complexity of the treatment regime:  
 
I sometimes forget to take one of them, my night-time beta blocker [P8] 
 
Sometimes when I come to take them in the mornings, if there’s one tablet missing, I 
haven’t a clue which one. I try to compare them to the next day and sometimes I find 
it, and sometimes I don’t [P3]  
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When you go to hospital they’ve got a tendency to take you off all your tablets and 
change them all; I don’t know why that is. That completely destroys my routine for 
about a month or two and I have trouble getting them right [P1]  
 
Intentional non-adherence was described by two participants through adjusting doses to 
avoid side-effects or omitting specific tablets: 
 
Aspirin gives me a terrible stomach ache so I just take a quarter of one [P10]  
 
This same participant described omitting specific tablets as a way of dealing with a 
negative emotional response to the illness: 
 
When you take medications it is because you are not well and when you are not well 
you don’t like it. The tablets always remind you that you are ill so it makes me feel 
better not taking so many, so I try to skip some of them. I will skip the lunchtime 
ones. One of them is three times a day; I just take one in the morning and in the 
night, not the lunchtime one. I skip the tablet for cholesterol, I think I will escape 
[P10] 
 
A second participant omitted specific tablets due to doubts about necessity:  
 
My cholesterol was coming down because of it (the tablet) and then it was holding 
steady at, I think it was 4.2 or something like that, so I thought, ‘now I’m at a 
reasonable level, I’ll come off, and if I go up I’ll start on them again’ [P2] 
 
I’d like to stop all of them and see what happens and if necessary come back on 
them again. That to me would be a reasonable thing to request or expect. I’d like to 
come off the tablets, maybe one by one and see, with regular check-ups, if I need to 
go back on them again [P2] 
 
High levels of medication adherence, as reported in this sample are in line with those 
reported by Ekman et al (2006), Van de Wal et al (2004) and Granger et al (2005). 
Adherence was enhanced by the use of medication aids such as Dosette Boxes®. 
Threats to unintentional non-adherence were the symptom of forgetfulness, the 
complexity of the treatment regime, as indicated by a high number of tablets and 
administration times and frequent changes to the treatment regime. Forgetfulness, which 
may be related to cognitive deficits in heart failure, was also found to be related to non-
adherence by Dickson et al (2007b). The complexity of the treatment regime has been 
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linked to medication non-adherence in studies by George and Shalansky (2007), Van der 
Wal and Jaarsma (2007) and Riegel and Carlson (2002).  
 
In terms of beliefs, Ekman et al (2006) found that a strong belief that medication would 
improve symptoms was positively associated with medication adherence. Doubts about 
the necessity of medication seemed to be related to intentional non-adherence by one 
participant in this study. The presence of side-effects was also a barrier to adherence for 
one participant which may indicate a specific concern about medication. Intentional non-
adherence was also described as a coping strategy to manage the negative emotional 
effects of the illness which seems to be an original finding, though one which is consistent 
with the CSM. 
 
MONITORING SYMPTOMS AND THE EFFECTS OF MEDICATION  
 
Monitoring changes in symptoms requires that they are first recognised as symptoms of 
heart failure. As discussed in identity, differentiating heart failure symptoms from other 
illnesses, emotions and the effects of medication was difficult for some participants. An 
awareness of changing symptoms was however, described by a small number of 
participants:  
 
In the morning when you get up, usually you don’t feel in the mood… you feel so 
tired that, ‘here we go again!’ You get tired, you sit, you are uncomfortable, you go 
to the settee, you’re uncomfortable and… it starts like that. You’re lying in bed, you 
can’t breathe, so you get up…that’s how the routine starts [P10] 
 
I know when my blood pressure goes up and I know when it goes down. I notice 
pretty well straight away. It’s just this funny head, really, that’s the signal [P7] 
 
Monitoring of blood pressure was carried out by this participant‟s wife: 
 
Every day my wife does it; she’s my personal nurse! She checks my blood pressure 
in the morning and then if I’m…..whoa…during the day, she’ll check it again [P7] 
 
However, most commonly monitoring the condition was seen as the responsibility of the 
HFN or GP: 
 
The nurse calls on a regular basis and I see a doctor. He has a clinic every month, 
usually I see him once every three months. They check you over, make sure you’re 
OK [P1] 
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The cardiac nurse calls on me once a month to take my blood pressure and things 
like that [P2] 
 
Monitoring by health professionals was also to check for the negative effects of 
medication: 
 
Every three months I have a blood test to check the liver and the kidneys [P10] 
 
I have to have my kidneys checked because one of the tablets I’m on can affect 
your kidneys [P8] 
 
Overall, most participants were unable to recognise changing or deteriorating symptoms. 
Monitoring the condition and the effects of medication was seen as the responsibility of 
health professionals, sometimes assisted by a spouse. Active self-monitoring of 
symptoms such as ankle oedema and assessing fluid status through daily or regular 
weighing were not reported in this sample. Daily or regular weighing was found to be 
carried out by 52% of patients in a study by Van de Wal et al (2004) and ranged from 14% 
to 79% in a review of the literature by Van de Wal and Jaarsma (2007). In this sample, as 
oedema was not a reported symptom of the illness, assessment of fluid status through 
regular weighing perhaps explains the absence of this monitoring behaviour.  
 
MANAGING SYMPTOMS  
 
The management of symptoms was largely passive in that resting was most frequently 
described: 
 
If I get this funny head, I have to go to sit down or lie down. I go and sit down and 
after three, four or five minutes, it clears [P3] 
 
When my breath gets short I deliberately stand still or sit down and expel all the air 
out of my lungs so that I’ve got to take a deep breath and then that makes me 
breathe in and out and I can do that for five minutes and sort of come back to 
normal [P1]  
 
Related to the suggestion that rest was seen as a remedy for symptoms, avoidance of 
lifting or straining as provoking factors was described: 
  
I’ve got to be very careful what I do. Not strain for everything [P3]  
 
Anything heavy, I don’t lift [P9] 
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As with medication management, the protective influence of female family members was 
described: 
 
She won’t let me lift anything heavy. I’d have a go at anything really but she won’t let 
me do it. She won’t let me lift anything [P4] 
 
The ability to manage symptoms was described as a learning process gained by 
experience. These participants had heart failure for three and five years respectively:  
 
I’m learning to control it now. Yes, I’m learning [P10] 
 
You learn, after a time, how to help yourself, I think [P1] 
 
In summary, symptoms were managed by resting and those behaviours thought to 
provoke symptoms, namely lifting and straining, were avoided. This was often „enforced‟ 
by spouses. Managing symptoms was seen as learning process, implying that experience 
of the illness is important for this aspect of self-care. Level of experience or time since 
diagnosis was found to be an important factor in determining self-care ability by Carlson et 
al (2001) through an enhanced ability to recognise changing symptoms and the use of 
tried and tested management strategies. 
 
MANAGING THE EMOTIONAL AND SOCIAL EFFECTS OF THE ILLNESS 
 
Managing the negative emotional and social effects of the illness was a theme developed 
inductively from this analysis. The following behaviours are not recognised in existing 
heart failure self-care checklists such as the EHFScBS or the SCHFI, but are consistent 
with the DH definition of self-care of „dealing with the emotional changes…and 
maintaining those things that are important – work, socialising, family’ (DH, 2006a, p.2). 
Managing the emotional response to the illness is also explicit in the CSM. 
 
Managing depression through activity and making an effort to maintain a positive attitude 
was described: 
 
I say to myself, ‘it’s no use being miserable, there’s nobody to help you’ and I take 
my bike and I ride around the block, around the park and come back and I feel 
better [P6] 
 
You’ve got to say to yourself, ‘get up off your backside and do something about it 
rather than sit there and feel sorry for yourself’ [P12] 
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Others described strategies to manage anxiety: 
 
I say to my husband, ‘Right just talk to me for a minute, so I can pass it’. If my 
brain’s thinking of something else I won’t think of me panicking [P8] 
 
I read, I watch TV. It relaxes me, keeps my mind occupied [P10] 
 
Making an effort to go out was reported as a means of managing emotions and 
maintaining social networks: 
 
We’ve started to go out to eat because we were just stuck here within the four walls 
all the time, which is great because it rallies you because you have to see people 
and speak to them [P12]  
 
I make an effort to be sociable. My friend just rung and said, ‘Would you like to come 
to the meeting this afternoon?’ I said, ‘Yes, I would’. It’s not my church but they’re 
very friendly. You’re an hour or two out of the house and you meet people. I make 
an effort to get out [P6] 
 
One participant saw support groups as useful in terms of making social contacts: 
 
I belong to a scheme called the Rhythm of Life. It’s just that people like this all get 
together. I’ve only been once and met a man that had it done (insertion of an 
internal cardioverter defibrillator, ICD) and I’d like to meet more people. I’m thinking 
about going back to some exercises where they sit down all the time. It might get me 
out a bit more. It’s only once a week but you meet people and then you go out with 
them during the week so I have them here or go to their places [P11] 
 
The ability to go out was facilitated or hindered by the level of social support:  
 
 I suddenly get the urge to see a bit of sky and sea and so my son took me down to 
the coast just so I could see a horizon, it was lovely [P1] 
 
If I had someone to come out with me it might help, the right person, somebody that 
didn’t panic, it would make it easier [P11] 
 
Making an effort to go out was most prevalent in those living alone who, in this sample, 
were women.  
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In summary, maintaining a positive attitude through keeping active, managing emotions 
such as anxiety and making a deliberate effort to go out were described. Qualitative 
studies such as Zambroski (2003) and Mahoney (2001) have also identified these 
behaviours in describing the experience of patients with heart failure. These behaviours 
could be described as actions to maintain HRQoL (Dunderdale et al, 2008). However, 
they could also be categorised as self-care behaviours according to the DH definition.   
 
REPORTING AND SEEKING HELP  
 
Reporting symptoms and seeking help were described in urgent and non-urgent 
situations. In many cases, seeking emergency help was prompted by the presence of 
severe symptoms, particularly breathing difficulties: 
 
I can’t control the breathing. That’s when I have to call up and ask for assistance so 
I’ll land up in hospital [P1] 
 
I couldn’t breathe, I rang the surgery and they said ‘we’ll get an ambulance straight 
away for you’, because I didn’t know what to do. I’m suffocating. I’ve been in three or 
four times like that [P11] 
 
Seeking help and reassurance from a GP or HFN was also described:  
 
I’ll get a bit of a tummy ache or something like that. I just feel generally lethargic and 
down and I don’t feel right so I’ll go along and see the doctor and half the time it’s 
just you want someone who knows what they’re talking about to give you a word of 
advice [P1]  
 
I can pick the phone up and she (the HFN) can give me an answer. You know, if 
there’s always somebody at the end of the phone then you shouldn’t have to worry 
about anything should you? [P12] 
 
For participants who experienced panic attacks a counsellor was important in managing 
the emotional response to the illness: 
 
She helped me a lot. She helped me understand what happened to me. She 
showed me how to deal with the panic attacks [P10] 
 
In summary, seeking help as an emergency with resultant hospital admission was 
reported in this sample which is consistent with the documented high admission rates in 
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heart failure (Petersen et al, 2002).   This may be due to an inability to recognise and 
manage deteriorating symptoms as described by Horowitz et al (2004).  
 
When the GP or HFN was contacted, this was primarily to seek advice or reassurance in 
response to worry or anxiety, a behaviour which can be viewed as a way of managing the 
emotional effects of the illness. That a counsellor was also an important resource for 
some, seems to support this. 
 
In conclusion, adherence to a number of recommended lifestyle changes was described.   
Limiting alcohol intake, taking regular exercise, smoking reduction or cessation, making 
dietary changes such as eating a low fat diet and avoiding caffeine and losing weight were 
reported changes. These behaviours can be considered part of a „healthy lifestyle‟ and 
relatively non-specific to heart failure.  Behaviours such as adhering to a low sodium diet 
and restricting fluid intake, which can be considered most specific to heart failure (Dickson 
et al, 2006; Jaarsma et al 2000b), were mentioned infrequently or not at all. Adherence to 
heart failure medication was reportedly high with Dosette® boxes used to facilitate this. 
Incomplete adherence was also described through forgetfulness and the complexity of the 
treatment regime as found in studies by George and Shalansky (2007), Van der Wal and 
Jaarsma (2007) and Riegel and Carlson (2002). Intentional non-adherence appeared to 
be a coping mechanism for anxiety or due to weak beliefs about the necessity of 
medication or concerns about side-effects, in some participants.  
 
Although deteriorating symptoms were recognised by some, monitoring the illness and the 
effects of medication were seen as the responsibility of health professionals. The practice 
of regular weighing, an important aspect of self-care monitoring (Dickson et al, 2006; 
Jaarsma et al 2000b), was not evident in this sample. Managing symptoms was largely a 
passive process involving resting and avoiding activities perceived to provoke symptoms. 
Managing symptoms was also described as a learning process, gained through 
experience and so may be related to length of time living with the illness. As well as 
managing physical symptoms, managing negative emotions and the social consequences 
of the illness were described. This included maintaining a positive attitude, keeping active, 
managing emotions, such as anxiety, and making an effort to go out. This is consistent 
with the Department of Health (DH, 2006a) definition of self-care and the CSM, in that 
coping behaviours are directed at both symptoms and emotions.  
 
In terms of reporting, seeking emergency help in response to deteriorating symptoms, 
especially breathlessness was evident, perhaps as a consequence of the inability to 
monitor and manage symptoms as described above and supported by Horowitz et al 
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(2004). Non-urgent help was sought from GPs, HFNs and a counsellor, largely to seek 
reassurance and manage the emotional effects of the illness. 
 
In relation to the domains of self-care described by Dickson et al (2006), the existence of 
self-care maintenance behaviours including adherence to lifestyle factors and medication, 
were apparent from this data. Self-care management strategies including monitoring and 
managing symptoms, reporting and seeking help were also described in this sample. 
However, an additional theme of managing the emotional and social consequences of 
heart failure was also identified.  
 
One purpose of the interview data was to test the use of the CSM as the theoretical 
framework. The following section draws together illness representations, treatment beliefs 
and self-care in a case study example which illustrates the „fit‟ of this data to the CSM.  
 
4.2.5  Application of the CSM  
 
A case study of P10, a 59 year old woman, is presented in Figure 4.4. This participant 
was chosen as she demonstrated limited self-care and a complex system of beliefs.  
 
Overall, there was a lack of a clear illness identity as she could not explain what was 
wrong with her heart and did not differentiate between symptoms of angina and heart 
failure. Although breathlessness was recognised as being due to the condition, it could not 
be differentiated from panic attacks. The illness was attributed primarily to family stress 
but smoking was also identified as a potential cause although its contribution to the 
development of the illness was perceived as limited. A total lack of control over the illness 
was described and there was a belief that the illness had serious consequences which 
were mainly physical, although a reduction in social activities was also reported. This 
participant described her illness as „puzzling‟, demonstrating a lack of illness coherence. A 
strong, negative emotional response to the illness was apparent with anger, fear, anxiety 
and depression experienced. She was too fearful to think about the future, so beliefs 
about timeline were difficult to assess. There were doubts about the necessary of 
medication and concerns about side-effects. Confidence in her knowledge of the actions 
of medication was limited and the views of friends were important in determining her 
attitude to medication.  
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Figure 4.4  Case Study Illustration of the CSM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Illness Representations 
  Lack of a clear illness identity  Timeline (avoidance)  Cause: stress, smoking  Serious consequences (physical, social)  Lack of personal or treatment control 
Self-Care  Limited adherence to heart failure-specific lifestyle 
behaviours  Intentional non-adherence to medication –  
changing doses and omitting tablets  Lack of symptom monitoring  Passive management of symptoms   Managing the emotional response to the illness  Lack of reporting and help seeking, except in an  
emergency 
 
Negative Emotional Response  
  fear, anxiety, depression, anger 
Treatment Beliefs  
 Weak necessity beliefs   Concerns about medication side-effects  Limited medication knowledge  Negative social Influences on medication use 
132 
 
In terms of self-care maintenance behaviours, reducing but not stopping smoking was 
reported and as she believed she already eat a healthy diet, no further lifestyle changes had 
been made. This is consistent with the belief that the illness was not caused or controlled by 
lifestyle behaviours. Intentional non-adherence to medication was described in terms of 
reducing doses and skipping selected tablets due to concerns about medication side-effects, 
particularly those attributed to aspirin, and as a strategy to reduce the emotional impact of the 
illness, as taking medication was seen as a reminder of that she was ill. This behaviour is 
also consistent with the belief that stress was the main cause of the illness. The active 
monitoring of symptoms, through for example, regular weighing was not described, illustrating 
a lack of a clear illness identity as the purpose of regular weighing was not known.  
Symptoms such as breathlessness and tiredness were managed by resting and relaxing, 
which represents a coherent view of stress as the cause of the illness. Strategies aimed at 
managing negative emotions were described, namely, keeping occupied, trying not to think 
about the illness and by avoiding the use of medication. Help was sought only as an 
emergency when symptoms worsened, highlighting a lack of control over the illness. 
 
4.3 CONCLUSION  
 
In conclusion, the purpose of the qualitative data was to inform the adaptation or 
development of the questionnaires and to test the application of the CSM.  In summary, while 
no new themes were identified from these data in terms of illness representations, a need 
was identified to make symptoms and causes specific to heart failure in the IPQ-R (Moss-
Morris et al, 2002). Three additional domains of treatment beliefs were added to necessity 
and concern beliefs as described in the BMQ by Horne et al (1999). These were perceived 
knowledge about medication, social influences on medication use and the impact of 
medication use on lifestyle. In terms of self-care, the concepts of self-care maintenance and 
self-care management (Dickson et al, 2006) could be applied to these data with specific 
behaviours in heart failure identified. In addition, managing the emotional and social 
consequences of the illness was identified as an important aspect of self-care by participants 
and could be described as a coping strategy according to the CSM.  
 
An extended CSM including treatment beliefs could, therefore, be usefully applied to this 
data. However, some difficulties were apparent. A lack of a clear illness identity meant some 
participants described other cardiac conditions along with heart failure so that, at times, it was 
difficult to isolate beliefs about different conditions. Depression could theoretically be 
categorised as an emotional response to the illness, a symptom of heart failure or a co-
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morbidity. Here, it has been categorised as an emotional response as this was the context in 
which the participants described it and consistent with the CSM. Illness coherence could be 
defined not only as the belief that the illness makes sense but also in terms of the ability to 
demonstrate this through the consistency between other illness representations and few 
misconceptions. This is discussed further in Chapter seven.   
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CHAPTER FIVE:  THE ADAPTATION AND DEVELOPMENT OF THE 
QUESTIONNAIRES AND THE PILOT STUDY 
 
In this chapter the adaptation of the questionnaires assessing illness representations, 
treatment beliefs and self-care is discussed.  The development of a socio-demographic 
questionnaire is also described. This adaptation or development was based on the qualitative 
findings, published literature and the expert opinion of HFNs. The pilot study is then 
presented, the purpose of which was to test the recruitment, data collection and data analysis 
procedures to be used in the main survey (phase two). Further amendments to the 
questionnaires in the light of the pilot study and through discussion with a small number of 
heart failure patients, are finally described. 
 
From the analysis of the interview data, discussed in the previous chapter, the IPQ-R was 
found to accurately describe the illness representations of heart failure patients, although 
there was a need to make the identity (symptoms) and causal sub-scales specific to heart 
failure. Beliefs about the necessary of medication and concerns about its use were themes in 
the BMQ and were also described by the heart failure patients. In addition, three new 
constructs were identified – perceived medication knowledge, social influences on medication 
use and the impact of medication use on lifestyle. Self-care was described by the heart failure 
patients in terms of adherence to lifestyle behaviours, adherence to medication, monitoring 
and managing symptoms and reporting and help-seeking behaviour, as defined in a model of 
self-care maintenance and self-care management strategies according to Dickson et al 
(2006). In addition, patients described the use of strategies to manage the emotional and 
social consequences of the illness, as articulated by the CSM and the DH definition of self-
care (DH, 2006a).  
 
5.1 THE INITIAL ADAPTATION AND DEVELOPMENT OF THE QUESTIONNAIRES  
 
The original, validated questionnaires (the IPQ-R, BMQ and EHFScBS) are given in 
Appendices 1-3. The adapted versions, as used in the pilot study, are each labelled „Version 
1 (Pilot)‟ and given in Appendices 14-16. Changes made from the original questionnaires 
have been tracked and highlighted. The pilot version of the questionnaire assessing socio-
demographic characteristics is given in Appendix 17. 
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In adapting or developing the questionnaires, general principles of questionnaire design 
according to Oppenheim (2002) were followed.  Font size was maximised to make the 
questionnaires as easy to read as possible without excessively increasingly the number of 
pages which might be a barrier to completion. Attention was paid to layout to try to make the 
questionnaires visually appealing and to provide sufficient space for respondents to record 
their answers. Shading was used to highlight instructions and differentiate between the 
columns of the response grids. The Arial style was chosen as this was believed to be most 
easily readable. The „texture‟ of the questionnaire was varied using both open and closed 
questions, as Oppenheim (2002) suggests responses may be better when different types of 
question are used. Attention was paid to the order of questions so that, generally, questions 
on a similar theme were grouped together. Questions were kept as short and simple as 
reasonably possible with a maximum word limit of twenty words (Oppenheim, 2002). 
Questions were phrased to try to avoid jargon, unfamiliar words, leading questions, 
ambiguity, multiple ideas and double-negatives. The option for the response „other‟ was made 
available where relevant and the instructions for completing the questionnaires were made as 
clear as possible. Reversed questions and „filler‟ questions were used in order to minimise 
acquiescence bias or the tendency to agree to all statements (Oppenheim, 2002) This was 
especially important in assessing self-care behaviour where respondents might be tempted to 
state that they carried out recommended behaviour in order be seen as compliant and 
present themselves in a positive light, so-called social desirability bias. The following sections 
discuss, in detail, the initial adaptation or development of each of the four questionnaires.  
 
5.1.1 Initial adaptation of the IPQ-R  
Moss-Morris et al (2002), advocate that the IPQ-R should be adapted to make it illness 
specific. Permission to use the IPQ-R and amend it if necessary was gained from Professor 
John Weinman, author of the IPQ and the IPQ-R. This adapted questionnaire is hereafter 
referred to as the IPQ-R (heart failure) (HF) (Appendix 14). 
 
The qualitative data indicated that a number of changes to the IPQ-R were needed, although 
no new themes were identified. In summary, the term „illness‟ was changed to „heart failure’ 
throughout; the assessment of the identity and causal domains were made heart failure 
specific; a minor wording change was made to one statement assessing the emotional 
response to the illness and two additional timeline items were added. The New York Heart 
Association (NYHA) Functional Classification (NYHA, 1984) was added as a measure of 
illness severity. These changes are summarised in Table 5.1 and discussed below. 
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Table 5.1 Summary of Changes to the IPQ-R  
Change 
The term “Illness” changed to “heart failure” throughout 
NYHA Functional Classification scale added 
Domain Deleted Items Additional Items 
Identity 
(symptoms) 
pain; stiff joints;  Weight gain; forgetfulness; chest pain; 
palpitations; loss of appetite, swollen ankles; 
sexual difficulties; daytime sleepiness; fatigue; 
light-headedness; 
Open question 
Timeline None “my heart failure will get worse in time”;  
“I expect my heart failure to stay the same in the 
future” 
Cause A germ or virus; pollution in the 
environment; my own behaviour; my 
mental attitude; my emotional state; 
accident or injury; my personality; 
altered immunity 
an infection; being overweight; a previous heart 
attack; other heart problems; other illnesses; 
medical treatment for other illnesses; high blood 
pressure 
Emotional 
Response 
None “my illness makes me feel angry or frustrated” 
 
The first section of the IPQ-R addresses the illness representation of identity and consists of 
a list of symptoms. Respondents are asked firstly, whether these symptoms have been 
experienced and secondly, whether they are believed to be due to the identified illness. From 
the qualitative findings and the heart failure literature, those symptoms not commonly 
recognised as symptoms of heart failure were removed, for example, „stiff joints’. Commonly 
identified symptoms of heart failure, not already included, were added These were: „weight 
gain’, ‘forgetfulness’, ‘daytime sleepiness’, ‘loss of appetite‘, ‘swollen ankles’ and ‘sexual 
difficulties’. Symptoms more typical of other cardiac conditions - „chest pain’ and „palpitations‟ 
- were also added as it was thought that this might determine the ability of respondents to 
differentiate the symptoms of heart failure from other cardiac conditions, as this had been 
problematic for some interviewees and described in the studies reviewed by Jeon (2010).Two 
other symptoms listed in the IPQ-R were amended in order to use the language of heart 
failure patients. The term „tiredness‟ was added to „fatigue‟ and „light-headedness’ was added 
to „dizziness‟. Given the high number and diversity of heart failure symptoms, an open 
question was added for respondents to list any other symptoms that they believed were 
related to their heart failure.  
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The assessment of the causal domain was also adapted to be specific to heart failure. Like 
identity, those items not identified as potential causes by either the literature or the qualitative 
data were removed, for example, „altered immunity’ and „accident or injury’. Items added were 
„being overweight’, ‘a previous heart attack’, ‘other heart problems’, ‘medical treatment for 
other illness’ and ‘high blood pressure’. The item „a germ or virus’ was changed to „an 
infection’ to better reflect the terminology of heart failure patients and include bacterial 
infections, for example.   
 
In the IPQ-R, the illness representations of timeline, consequences, cure/control, coherence 
and emotional response are assessed as separate domains or sub-scales using a 5-point 
Likert scale. The qualitative data and literature indicated that these statements were 
applicable to heart failure so only minimal changes were made. The statement „my illness 
makes me feel angry’ was amended to „my heart failure makes me feel angry or frustrated’ as 
frustration was frequently described by the interview participants and was considered to be 
related to anger. The IPQ-R includes a timeline item of „my illness will improve in time’. 
However, alternative statements in relation to the perceived future progression of the illness 
are not included. The interview data suggested that the statements of „my heart failure will get 
worse in time’ and „I expect my heart failure to stay the same in the future’ were recognisable 
to heart failure patients and so were added.  
 
It has been suggested that the severity of the illness may influence illness beliefs and 
behaviour (Cameron and Moss-Morris, 2004). In heart failure, the severity of the illness has 
been found to influence self-care in studies by Wu et al (2007) and Rockwell and Riegel 
(2001). The „gold standard‟ in determining illness severity in heart failure is the 
echocardiogram, which quantifies the ejection fraction or the effectiveness of the cardiac 
pump (NICE, 2010). Since ethical permission to access the patients‟ medical notes was not 
sought and the questionnaires were completed anonymously, this measure was not available. 
Therefore, a measure of functional ability was used rather than a direct measure of disease 
severity. The NYHA Functional Classification (NYHA, 1984), discussed in Chapter two, is a 
widely used self-report measure which asks patients to assess the perceived level of physical 
activity needed to provoke symptoms, primarily breathlessness (Wu et al, 2007). Functional 
ability is ranked by Roman Numerals I to IV where IV represents the most severe impairment. 
Although, functional ability can be considered an illness-related factor rather than a belief, its 
dependence on perceived symptoms meant that it seemed appropriate as part of the IPQ-R 
(HF). 
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5.1.2 Additions to the BMQ  
Permission to adapt the BMQ was sought from the author, Professor Robert Horne. However, 
despite a number of attempts to contact him by e.mail and telephone, no response was 
received. In hindsight, other methods might have been tried, for example, a letter or a third-
party introduction.  Although published work by Horne et al (1999) suggest the BMQ can be 
adapted to make it illness and/or drug specific, without explicit permission, the decision was 
made to keep the BMQ intact but to make it heart failure specific by adding items and 
domains which could be analysed separately. This questionnaire is now referred to as the 
„Medication Use in Heart Failure Questionnaire‟ or MUHFQ, which incorporates the BMQ 
(Appendix 15). A summary of these additions is given in Table 5.2. 
 
Table 5.2 Summary of Additions to the BMQ 
Domain Additional items 
Necessity “my symptoms improve when I take my tablets” 
Concerns “I sometimes worry about the effect of taking lots of different tablets” 
Medication Knowledge 
(New) 
“I understand why I need specific tablets”;  
“I know when to take my tablets”;  
“I know the dose (strength) of my tablets”; 
“I am unsure whether I should take medicines that I buy myself, with 
the tablets prescribed for me”; 
“I know which symptoms are due to my heart failure and which are the 
effects of my tablets”; 
 
Social Influences on 
Medication use (New) 
“my family or friends help me to take my tablets”; 
“I would find it difficult to take my tablets without help from my family or 
friends”; 
“I follow the advice of my family or friends about taking my tablets”; 
 
Impact of Medication Use on 
Lifestyle (New) 
“taking my tablets is influenced by my religious beliefs”;  
“I find it difficult to take my tablets when I go out” 
 
 
The MUHFQ assesses beliefs about the necessity of and concerns about medication (the 
BMQ), together with three additional domains of medication knowledge, social influences on 
medication use and the impact of medication use on lifestyle, as identified from the qualitative 
data.  It was hypothesised that, along with necessity and concern beliefs, these factors may 
influence adherence to heart failure medication. Attitudinal statements were assessed on a 5-
point Likert scale. The statement ‘my symptoms improve when I take my tablets’ was added 
as a necessity item and „I sometimes worry about the effect of taking lots of different tablets’ 
was added as a concern as these items were identified in the interview data but not 
addressed in the BMQ.  
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In developing the new domains, an item pool was generated since, according to Oppenheim 
(2002), there are inherent risks associated with assessing the complex phenomenon of 
attitudes in a single item. The medication knowledge domain consisted of five items which 
aimed to assess perceived knowledge of the purpose of the medication, the dosage and 
timing of medication, differentiating the effects of medication from the illness and the 
concurrent use of prescribed and over-the-counter (OTC) medication, as suggested by the 
qualitative data. Three items assessed the perceived influence of family members and friends 
in terms of their treatment beliefs and practical medication management. Finally, the impact 
of medication use on lifestyle was assessed in general terms and in relation to going out, also 
identified from the qualitative data. The impact of religious beliefs on medication use was also 
included as according to Sabate (2003), this may also influence adherence to medication. 
 
5.1.3 Initial adaptation of the EHFScBS 
Permission to adapt if necessary and use the European Heart Failure Self-Care Behaviour 
Scale (EHFScBS) was gained from the author, Professor Tiny Jaarsma. However, since this 
questionnaire was developed in Sweden, it was recognised that the self-care behaviours 
identified may not be those recommended in a UK healthcare system, operating under 
different clinical guidelines and organisational structures. The reliability of the EHFScBS in a 
UK population has also been questioned (Shuldham et al, 2007). The interview data and the 
DH definition of self-care (DH, 2006a) also suggest that self-care includes more than 
adherence behaviour, which is the focus of the EHFScBS. Therefore, the decision was made 
to develop a self-care questionnaire using findings from the qualitative data, the literature 
(including the EHFScBS) and behaviours identified by HFNs. The reason for using an expert 
group of HFNs in addition to the patient perspective was the belief that to be meaningful, self-
care should include behaviours believed to improve clinical outcomes. For example, the self-
care behaviour of restricting sodium intake is believed to prevent fluid overload and resulting 
exacerbation of symptoms (Nicholson, 2007). It was felt that in addition to published 
evidence, specialist HFNs were best placed to identify those behaviours. 
 
A nominal group technique (NGT) was chosen as the method of collecting data from a group 
of thirteen specialist HFNs and one heart failure Nurse Consultant, representing four PCTs 
and one Acute NHS Hospital Trust in the locality. NGT is described as a group-based method 
of data collection which explores a specific question, in-depth, among a target population 
(Delbecg and Van de Ven, 1971). The purpose of the technique is to generate information in 
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response to a specific issue which can then be prioritised. By presenting results qualitatively 
and quantitatively, NGT is a mixed methods approach which is consistent with the philosophy 
of this research. A number of advantages are noted by Potter et al (2004). These include 
time-efficiency, cost-effectiveness and easy implementation through minimal pre-meeting 
preparation time. Time-efficiency was particularly important as the data were collected at a 
regional heart failure service meeting with only a limited amount of time allocated in the 
agenda. A further advantage was that most members of the group had had some experience 
of the process as it is a common method of evaluation used in nursing education, locally. 
 
Potter et al (2004) describe a 5-step process for conducting a nominal group which was 
followed here. First, the purpose and procedures of the meeting were explained. The 
definition of self-care according to the DH (2006a) was given and the nurses were asked to 
identify specific, self-care behaviours in heart failure by individually generating items for a few 
minutes before sharing these ideas on a flipchart. When no new items were identified, a copy 
of the EHFScBS was presented and the nurses were asked to review their list of self-care 
behaviours in the light of this validated questionnaire, making any additions or deletions to 
their list. From this, only the EHFScBS item „I get a flu and pneumonia vaccine’ was added. It 
was interesting to note that adherence to recommended advice and help-seeking behaviour 
were emphasised by the HFNs, suggesting these nurses held a predominantly biomedical 
model of self-care. The self-management of symptoms and behaviours aimed at promoting 
emotional and social well-being were important to the interviewees but not identified by the 
HFNs. The nurses were then asked to individually rate the items in terms of importance using 
a 7-point scale where 1 = „not important‟ to 7 = „very important‟, thus prioritising behaviours.  
 
The findings were then collated and analysed using descriptive statistics. The mean score 
and standard deviation for each item was calculated and the items were ranked in order of 
importance (Table 5.3). All items were highly scored (mean score, 5.00 or above). Those 
items ranked most highly were weighing oneself regularly, monitoring changes, reporting 
changes and medication adherence. Those with the lowest rank were avoiding non-steroidal 
anti-inflammatory drugs (NSAIDs), consuming alcohol within government recommended 
limits, having flu and pneumonia vaccinations, following a healthy cardiac diet and taking 
appropriate exercise. On reflection, these items are either least specific to heart failure or 
most dependent on individual patient characteristics and hence, least universal.  
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Table 5.3 Nominal Group Technique (NGT) Results  
 Item E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 E13 E14 Mean SD (±) 
1 Take appropriate exercise 3 4 5 5 6 5 4 7 6 6 4 4 6 5 5.00 1.21 
2 Maintain level of activity 2 5 6 6 6 5 7 7 6 6 5 6 6 6 5.64 1.07 
3 Weigh yourself regularly 7 7 7 7 7 6 7 6 7 6 5 7 7 7 6.64 1.21 
4 Monitor changes in: sleep pattern;  
exercise tolerance; breathing (notice if 
you: have a cough; start waking at 
night; become more short of breath); 
fluid retention; have palpitations or 
falls; monitor effects of medications 
7 7 7 7 7 7 7 7 7 7 7 7 7 7 7.00 1.21 
5 Report changes in above;  
report chest pain; 
6 7 7 7 7 7 7 6 7 7 6 7 7 7 6.78 0.43 
 
6 Maintain fluid intake of 1.5-2l 6 7 7 6 5 6 7 6 6 6 4 6 6 5 5.92 0.80 
7 Take a low salt diet 4 6 7 6 4 7 6 6 6 7 4 6 7 7 5.92 1.10 
8 Follow a healthy cardiac diet 2 6 6 6 4 5 5 5 6 6 3 5 6 6 5.07 1.22 
9 Take medications as prescribed;  
Alter medications as advised 
3 7 7 7 7 7 6 7 7 6 6 7 7 7 6.50 1.05 
10 Report side-effects of medication 6 7 7 7 3 5 6 6 6 7 6 6 7 6 6.07 1.03 
11 Keep a current list of medications 2 6 5 5 5 7 7 5 7 7 6 5 7 5 5.64 1.34 
12 Stop smoking 3 6 6 6 4 6 5 5 6 6 4 6 7 7 5.50 1.12 
13 Avoid NSAIDs 3 6 4 6 4 6 4 6 6 6 4 5 5 5 5.00 1.00 
14 Seek advice on OTC drugs 5 7 7 6 4 5 5 5 7 6 6 5 5 5 5.57 0.90 
15 Seek help if unsure 5 7 7 7 3 6 7 7 7 7 7 5 7 7 6.35 1.17 
16 Maintain drug refills 7 7 6 6 3 7 7 7 7 7 6 7 7 6 6.42 1.04 
17 Drink alcohol within recommended 
limits 
4 5 5 7 5 5 5 5 6 5 5 5 6 6 5.28 0.67 
18 Have Flu and pneumonia vaccinations 3 6 6 5 4 5 6 5 6 5 5 6 6 6 5.28 0.88 
 
KEY  E= Expert Nurse Scores 1 = not important to 7 = very important 
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Using the nominal group data and the qualitative findings, the pilot version of the self-care 
questionnaire was developed. Items were worded as statements and assessed using a 5-
point Likert scale. From the expert data, „monitoring changes’ consisted of more than one 
element and was separated into monitoring changes in sleep patterns, exercise tolerance, 
and breathing, for example. Some items were merged. For example, „avoiding NSAIDs’ and 
‘seeking advice on over-the-counter (OTC) drugs’ were merged into the single item „If I need 
to take medicines which are not prescribed, I check with my pharmacist, doctor or nurse’. 
From the qualitative data, the self-management item of resting when needed was added as 
this was commonly described in the interviews. Items addressing the management of the 
emotional and social consequences of the illness such as making an effort to go out and 
maintaining social networks, were also included. 
 
The questionnaire, therefore, consisted of five domains: adherence to lifestyle advice, 
adherence to medication, monitoring changes, managing symptoms and the emotional and 
social consequences of the illness and reporting and seeking-help. These are broadly 
consistent with the concepts of self-care maintenance and self-care management behaviours 
according to Dickson et al (2006) and reflect self-care as defined by the DH (2006a). 
 
A draft of the developed questionnaire was sent to the nurses who had participated in the 
nominal group, for comment. Three responded with one suggesting no changes. This low 
response may have been due to satisfaction with the questionnaire or a reluctance to engage 
further in its development, perhaps due to competing work demands. One comment received 
from two nurses was to omit the statement „I eat a low fat diet’ as it was felt to be 
inappropriate for patients in the final stages of their illness with cachexia. The phrase 
„vigorous exercise’, it was suggested, should be avoided as patients would be recommended 
to only exercise until they were „slightly breathless but able to speak in sentences’. Specifying 
the frequency of flu and pneumonia vaccinations was also thought to be necessary. The 
questionnaire was amended accordingly and resulted in Version 1 (Pilot) (Appendix 16). 
 
Since the researcher and the local heart failure services, rather than the EHFScBS, drove the 
development of this questionnaire - and the pilot version was considerably different from the 
EHFScBS - it was decided that this was effectively a new questionnaire although 
acknowledging the use of the EHFScBS in its development. This questionnaire is now 
referred to as the, „Looking After Yourself with Heart Failure Questionnaire‟ or LAYHFQ and 
was evaluated during the course of this work. 
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5.1.4 Initial development of the Socio-Demographic Questionnaire (SDQ)  
A socio-demographic questionnaire (SDQ) was developed to describe the characteristics of 
the sample (Appendix 17). A secondary purpose was to be able to determine the influence of 
socio-demographic characteristics on self-care since Sabate (2003) describes socio-
demographic and illness-related characteristics as related to adherence behaviour. From the 
literature, age, gender, economic status, ethnic origin, education level, the presence of co-
morbidities, social support and the duration of the illness are suggested to be influencing 
factors on self-care in heart failure. In the SDQ, open questions assessed age, income, time 
since heart failure diagnosis and co-morbidities. Gender, ethnic origin as categorised 
according to the ONS (2008), social situation, educational qualifications and occupation 
required respondents to choose from a list of options.  
 
5.2 THE PILOT STUDY  
 
A pilot study is described by Polit and Hungler (2001) as a small scale version or trial-run 
done in preparation for the main study. In addition to testing the adequacy of the procedures, 
these authors suggest that the principle focus of a pilot study is the assessment of the 
adequacy of the measurement instruments. In this section, the design of the pilot study and 
an overview of the procedures are given. As the procedures for sampling and recruitment, 
data collection, data analysis and ethical considerations remained the same for the main 
survey, these are discussed in detail, in Chapter six. The response rate and characteristics of 
the pilot sample are described before evaluating the study in terms of its overall aims. 
Changes made to the questionnaires in the light of the pilot analysis are discussed in section 
5.3.  
 
5.2.1 Design and procedures 
The design of the pilot study and an overview of procedures are given in Figure 5.1. In terms 
of sampling and recruitment, each of the three heart failure services were asked to distribute 
ten envelopes (30 in total) to the first patients who met the inclusion and exclusion criteria as 
described for the qualitative phase in Chapter four, section 4.1.2. Therefore, the sample was 
one of convenience and hence not necessarily representative of the heart failure population. 
A response rate of one-third was estimated (De Vaus, 1996) so that a sample size of 
approximately ten participants would be used to test the procedures, gauge the likely 
response rate in the main survey, allow preliminary analysis and enable changes to be made 
to the questionnaires (Cormack et al, 2006). The sample was kept relatively small as those 
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participating would be excluded from taking part in the main survey as their responses may 
have been influenced by having previously completed the pilot questionnaires. Hence, too 
large a pilot sample would have reduced the number of available participants for the main 
survey.  
 
The envelopes given out by the HFNs contained a participant information letter (Appendix 
18), the pilot questionnaires (Appendices 14-17) and a stamped, addressed reply envelope. 
As in the qualitative study, the HFNs were briefed on the verbal information to be given to 
patients to minimise selection bias. 
 
Figure 5.1 Pilot Study Design and Procedures 
 
 
Participants were given three options by which to complete the questionnaires: to complete 
and return them by post in the pre-paid envelope (self-completion), to complete them in a 
telephone interview with the researcher or to complete them, in their own homes, in a face-to-
face interview with the researcher. The purpose of offering these options was twofold; firstly, 
to try to maximise the response rate and secondly, in recognition of the characteristics of the 
Sampling and Recruitment 
 
Envelopes containing the 4 pilot questionnaires, a participant 
information letter and a stamped-addressed envelope were 
hand-delivered by the HFNs to a convenience sample of 30 
heart failure patients 
 
Data Collection  
 
Option 1 
 
Participant self-
completes the 
questionnaires and 
returns them in the 
stamped addressed 
envelope 
Data Collection 
Option 2 
Participant completes 
the questionnaires with 
the researcher in a 
telephone interview 
Data Collection  
  Option 3 
Participant completes 
the questionnaires 
with the researcher in 
a face-to-face 
interview  
Data Analysis 
Data inputted into a SPSS (version 16.0) datafile, 
checked for missing data and analysed using 
descriptive and inferential statistics 
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respondents since some participants were likely to be elderly or in poor health, for example, 
and may have found self-completion difficult given the length and complexity of the 
questionnaires. 
 
A date of two weeks was given during which participants were requested to respond. This 
was considered a reasonable length of time in which to consider whether or not to participate, 
and to complete the questionnaires. If an interview was requested, participants were 
instructed to return the reply slip with their telephone number so that they could be contacted 
to arrange a convenient date and time for the interviews to be conducted.  
 
In preparation for analysis, a datafile was set up in SPSS (version 16.0) according to the 
processes described by George and Mallery (2005). Each question was identified as a 
separate variable and labelled, for example, „gender‟ and „timeline‟. The type of variable was 
then identified as either a numerical or string variable and defined as a nominal, ordinal or 
scale variable. This is discussed further in Chapter six. 
 
5.2.2 Results  
In terms of recruitment, no difficulties were reported by the HFNs in delivering the envelopes, 
suggesting that the procedures were satisfactory. Twenty sets of questionnaires were 
returned, representing a response rate of two-thirds which was higher than anticipated (De 
Vaus, 2006). No participants selected the option of either the telephone or face-to-face 
interview as a means of completing the questionnaires, the consequences of which are 
discussed in section 5.4. This established that self-completion was achievable and the 
favoured method of completion. However, it was recognised that in a larger sample, some 
participants might still elect to complete the questionnaires in an interview. 
 
Individual cases were coded and identified according to site and case number for example, 
B2 (Site B, Case 2,) and C4 (Site C, Case 4). Data from each case was then inputted into the 
datafile. The data were first scrutinised for missing responses which were then traced back to 
the individual questions for further reflection (discussed in section 5.3). The socio-
demographic characteristics of the sample were descriptively analysed for means, ranges, 
standard deviations and frequencies. These results are presented in Table 5.4.  
 
The mean age of the pilot sample was 68.6 years (range 31-89, SD ± 16.64). Average 
household income was £24,722 (range 8,500 – 60,000, SD± 17.00). The mean time with the 
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illness was 5.9 years (range 0.25-27.00, SD ± 7.70). 70% of the sample were men and 30% 
were women. 95% of participants described themselves as of White, British ethnic origin with 
5% (n = 1) described as Asian, British.  The majority of the sample (65%) lived with a partner 
or family with 35% living alone. Half the sample had no formal qualifications. Most (94.7%) 
were retired with 5.3% in paid employment. A high proportion (65%) reported having co-
morbidities. According to the NYHA functional classification, most participants were classified 
as either class II or III, which describes moderate severity of heart failure.   
 
Table 5.4 Socio-Demographic Characteristics of the Pilot Sample 
 
(n) Range Mean SD (±) 
Age 20 31-89   68.60 16.64 
Household Income (£/yr)   5 8,500-60,000   24,722 17.00 
Time since diagnosis (yrs)                  20         0.25-27.00                      5.90                              7.7 
________________________________________________________________________________ 
 
 
(n) 
 
Frequency  
 
% 
 
Gender 
     Male 
     Female 
20  
14 
  6 
 
70.0 
30.0 
 
Ethnic Origin 
     White, British 
     Asian, British 
20  
19 
  1 
 
95.0 
  5.0 
 
Social Situation 
     Lives alone 
     Lives with partner/family 
      
20  
  7 
13 
 
35.0 
65.0 
 
Qualifications 
     None formal 
     GCSE/‟O‟Level or Equivalent 
     „A‟ Level or Equivalent 
     Degree 
     Professional 
      
18  
  9 
  4 
  2 
  1 
  2 
 
50.0 
22.2 
11.1 
  5.5 
11.1 
 
Occupation 
     Employed 
     Retired 
19  
  1 
18 
 
  5.3 
94.7 
 
Co-morbidities 
     Yes 
     No 
20  
13 
  7 
 
65.0 
35.5 
 
NYHA 
     Class I 
     Class II 
     Class III 
     Class IV 
15  
  1 
  7 
  6 
  1 
 
  6.7 
46.6 
40.0 
  6.7 
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In order to test the feasibility of the data analysis methods, statistical tests which were to be 
used in the main survey were carried out.  These results have not been reported in this thesis 
since their purpose was to test the feasibility of data analysis, rather than determine 
preliminary results. Internal consistency of the questionnaires was tested using Cronbach‟s 
alpha (α). Frequencies, means and standard deviations were used to describe the data and 
inferential statistics of chi-squared (X2), one way analysis of variance (ANOVA), Pearson‟s 
correlation co-efficient (r) and multiple regression were carried out to determine relationships 
between variables. The use of these tests in relation to the main data is discussed in Chapter 
six.  
 
5.3 FINAL DEVELOPMENT OF THE QUESTIONNAIRES 
 
The final development of the questionnaires was based on analysis of the pilot data and a 
process of member checking (Guba and Lincoln, 1995), the purpose of which was to enhance 
the validity of the questionnaires and to determine the ease with which the questionnaires 
could be completed.  
 
All patients attending a clinic appointment with a HFN at Site A were approached and invited 
to participate in a one-to-one discussion on the use of the questionnaires. This clinic and site 
were chosen for convenience. Verbal consent was obtained following an explanation of the 
purpose of the research and what participation would involve. All patients attending the clinic 
agreed to participate. The sample consisted of three men and one woman. Participants were 
first asked to self-complete the questionnaires. One patient requested that the questionnaire 
was read out as he had poor vision. They were then asked the extent to which the 
instructions for completion were clear and to identify any questions which they found difficult 
to answer and for what reason.  How the questions were being interpreted was also probed to 
make sure they were being answered in the way the researcher intended. All comments were 
noted and summarised (Appendix 19) and were considered in the final development of the 
questionnaires. 
 
As a result of scrutinising the pilot questionnaires for missing data and following the member 
checks, a number of amendments were made to the pilot questionnaires. The final versions, 
as used in the main survey are given in Appendices 20-23 and labelled Version 2 (Final). 
Changes from the pilot versions have been tracked and highlighted. A discussion of the 
reliability and validity of the questionnaires is given in Chapter six. 
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5.3.1 Final amendments to the IPQ-R (HF) 
The title of the questionnaire was changed to be more „user-friendly‟, avoiding the use of 
complex acronyms which would not be relevant to the participant. The title „Your Views About 
Your Heart Failure’ replaced the term IPQ-R (HF) for the purpose of data collection. On 
analysis of the pilot data it was noted that two items in the coherence domain of the IPQ-R 
had been inadvertently omitted in the development of the IPQ-R (HF) –‘my illness is a 
mystery to me’ and ‘my illness doesn’t make any sense to me’. These were re-instated in the 
final version of the questionnaire.  
 
Missing data in the pilot study were concentrated in three main areas: the identification of 
symptoms in the identity domain, the NYHA scale and the assessment of beliefs about 
causation. Analysis of the identity domain was problematic in that, while most participants 
were able to identify the symptoms they had experienced since having heart failure, most (n = 
15, 75%) did not complete the second part of the question asking them to identify which of 
these symptoms were related to their heart failure. This may have been due to difficulty 
differentiating heart failure symptoms from other co-morbidities as suggested by the 
qualitative data. However, it was suggested by the clinic patients that they were not able to 
clearly differentiate between what was being asked in the first and second parts of the 
question. For the final version, the identity domain was simplified into a one-part question 
asking participants to identify those symptoms which they believed were due to their heart 
failure, as in the original IPQ (Weinman et al, 1996). The consequence of this was that the 
IPQ-R (HF) was not able to differentiate between beliefs about the symptoms of the illness 
and a general somatic effect, as described by Moss-Morris et al, (2002). From discussion with 
the clinic patients, one participant sought clarification for the term ‘palpitations’ which was 
subsequently further defined as ‘an awareness of my heart beating’. 
 
There was also some missing data for the NYHA scale (n = 5, 25%). Again, the reasons for 
this are speculative but on reflection, the instructions may not have been clear. This was 
confirmed by two clinic patients who said they were not sure what was being asked in this 
section.  The use of the terms „maximal and minimal exertion’ were also thought to be unclear 
and were subsequently reworded to give examples of levels of exertion, for example, ‘I 
experience symptoms when I carry out any physical activity, for example, getting up from a 
chair’. In addition, this scale may have been inadvertently missed out as it was a small 
section and presented as free-text. It was consequently presented as a grid, as other 
sections, to order to make it more visible. Respondents had been asked to circle their 
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response in a yes/no format which was unlike the rest of the questionnaire. It was therefore, 
put in the same „tick-box‟ format as in other questions for ease of completion.  
 
Missing data were also apparent in the assessment of beliefs about causation. Missing data 
were spread evenly with no one item consistently missed. It is suggested that those 
statements which were not relevant to an individual were simply skipped rather than 
answered „disagree‟ or „disagree strongly’. The instructions for completing this section were 
strengthened in the final version of the questionnaire by asking participants to respond to all 
statements.   
 
Clinic patients found it necessary to read some questions a number of times in order to make 
sense of them. Lengthy, reversed questions in particular, required more careful reading which 
might have implications for the accuracy with which these questions were answered in the 
main survey. One participant commented that they found it more difficult to write „free-form‟ in 
the open questions. As a result, open questions were kept to a minimum. The final version of 
the questionnaire is given in Appendix 20. 
 
5.3.2 Final amendments to the MUHFQ 
On analysis of the pilot questionnaires, missing data were minimal. As in the IPQ-R (HF), the 
title was described in lay terms as „Your views about your heart failure medication’ for the 
purpose of data collection.  In relation to the domain of social influences on medication use, 
on reflection, an item assessing the influence of the views of others replaced a more general 
item so as to better reflect the findings of the qualitative study. 
 
From discussion with the clinic patients, the statement relating to religious beliefs (part of the 
impact of medication use on lifestyle sub-scale) was not well understood with most 
participants seeking clarification of its meaning. This item was omitted in the final 
questionnaire as it was not based on either the qualitative findings or empirical research but 
on a general theory of adherence (Sabate, 2003) and so may not have been relevant in heart 
failure. A more general question assessing this domain  - ‘taking my tablets is part of my daily 
routine’ - replaced it. The final version of the MUHFQ is given in Appendix 21. 
5.3.3 Final amendments to the LAYHFQ 
No consistently missing data were identified from the analysis of the pilot data. However, on 
reflection, five additional medication adherence items were added to the final version to better 
reflect the complexity and diversity of medication adherence behaviour, which it was felt, had 
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not been adequately addressed in the pilot questionnaire.  For example, changing the dose or 
time of medication was added and non-adherence was differentiated into intentional and 
unintentional non-adherence by including an item on forgetting to take medication. In 
addition, questions assessing the uptake of flu and pneumonia vaccines were combined for 
simplicity. 
The discussion with the clinic patients raised other issues. One patient sought a reminder of 
what was meant by alcohol units. A definition was, therefore, added in the final questionnaire. 
Three patients asked for clarification on the meaning of the term to „check‟ for changes in 
symptoms. Following discussion with these patients and the clinic HFN, the term „recognise‟ 
rather than „check‟ was agreed upon and amended for the final questionnaire. The final 
version of this questionnaire is given in Appendix 22. 
5.3.4 Final amendments to the SDQ 
From the pilot study data only five respondents (25%) answered the question on income. 
From the discussion with the clinic patients, one participant commented that that they never 
answer questions about income. In gaining ethical approval, the NREC also commented that 
asking participants about income might negatively affect the response rate. This question was 
therefore, omitted in the final version of the questionnaire. As a result, neither the economic 
characteristics of the sample nor the economic influence on self-care could be assessed. This 
is discussed further in Chapter seven.  
 
In response to a comment made by one clinic patient, the term „wife/husband’ was included 
as an alternative to „partner‟ since this participant objected to the use of this term. One patient 
was unable to identify a point of diagnosis but was able to give an approximate length of time 
with the illness. Other patients also found this question difficult.  As a result, the term ‘length 
of time with heart failure’ replaced ‘time since diagnosis’, in the final version of the 
questionnaire.   
 
Oppenheim (2002) suggests that providing the participant with an explanation of the purpose 
of collecting socio-demographic data is beneficial in terms of response. An introductory 
statement was added to the questionnaire to facilitate this. On reflection, the question relating 
to co-morbidities was believed to be over-complicated and so was simplified to asking 
participants to just list any other illnesses. The opportunity to state „equivalent‟ qualifications 
was also added. This final version of the SDQ is given in Appendix 23.  
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5.4 CONCLUSION 
 
In summary, this chapter has discussed the initial adaptation or development of 
questionnaires assessing illness representations - the IPQ-R (HF), treatment beliefs - the 
MUHFQ, self-care - the LAYHFQ and socio-demographic characteristics - the SDQ. The pilot 
study has been described which tested the procedures of sampling and recruitment, data 
collection and analysis. The final amendments to the questionnaires, based on missing pilot 
data and member checks, have also been discussed. 
 
Creswell and Plano Clark (2007) describe the difficulty in making decisions about what 
findings to use in the development of questionnaires in a mixed method, exploratory, 
instrument development model. Here, the adaptation of the IPQ-R (HF) was relatively 
straightforward in that minimal changes were required from the IPQ-R, largely consisting of 
adding specific symptoms and causes of heart failure. Since the SDQ mostly consisted of 
closed, factual questions based on published literature, this too was relatively straightforward. 
In relation to the MUHFQ and the LAYHFQ, the main themes identified in the interview data 
were used to establish the additional domains of medication knowledge, the impact of 
medication use on lifestyle, social influences on medication use and the management of 
emotional and social effects of the illness. The nature of the items within these domains 
required critical appraisal of the relative strength of the evidence in order to justify the 
inclusion of items. That is, the qualitative findings, published literature and, in the case of the 
LAYHFQ, expert group opinion were used to make judgments about what was important and 
needed to be included in the questionnaires. A NGT was an effective method of gaining the 
views of an expert group of HFNs in a short time and achieved its aim of identifying self-care 
behaviours from a health professional perspective. Although the generalisability of the 
findings was not a major consideration in the pilot study, the decision to use a convenience 
sampling strategy had implications for the generalisability of the findings in the main survey, 
discussed in Chapter 6. In relation to recruitment, no difficulties were encountered by the 
HFNs in delivering the envelopes and a good response rate was achieved, suggesting that 
the recruitment procedures were satisfactory. 
 
No participants in the pilot study chose to complete the questionnaires in a telephone or face-
to-face interview; however, face-to-face interviews were carried out with clinic patients. This 
meant that the telephone interview method of data collection was untested which may have 
implications for the quality of some data in the main survey (discussed further in Chapter 
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seven). Setting up the datafile and the use of selected statistical tests suggested that the data 
analysis procedures were feasible in relation to the aims of the study.  
 
In the final development of the questionnaires, analysis of the pilot data enabled missing data 
to be identified so that the questions to which this data referred could be scrutinised and the 
questions revised or omitted. In addition, the completion of the questionnaires with heart 
failure clinic patients was worthwhile in that some ambiguities and difficulties with completion 
were highlighted and corrected.  However, on reflection, these member checks might have 
been carried out before the collection of the pilot data so that the pilot questionnaires might 
then have been more similar to the questionnaires used in the main survey. With hindsight, it 
may have been beneficial to carry out a second pilot study, using the final versions of the 
questionnaires. However, this in itself may have led to further changes and would have 
further reduced the population available for the main survey.  
 
Overall, the pilot study was generally effective in achieving the aim of testing the procedures 
to be used in the main survey and enabling the final development of the questionnaires (Polit 
and Hungler, 2001). The final versions of the questionnaires were used to collect the data in 
phase two, the quantitative phase of the research which is discussed in the next chapter.  
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CHAPTER SIX:  THE QUANTITATIVE PHASE - METHODS AND RESULTS 
 
This section discusses the methods and results of phase two, the main survey. An overview 
of the procedures is given followed by a discussion of sampling and recruitment, data 
collection methods, ethical considerations and data analysis. The internal consistency and 
construct validity of the questionnaires is then considered. In the results, the response rate is 
discussed and the socio-demographic and illness-related characteristics of the sample are 
presented. Illness representations, treatment beliefs and self-care are described before, 
presenting the relationships between these variables, according to the main aim of the 
research.  
 
6.1 METHODS 
 
The procedures were as described for the pilot study in Chapter five, Figure 5.1.  In summary, 
the three heart failure services were asked to distribute, by hand, envelopes containing a 
participant information letter (Appendix 18), the questionnaires (Appendices 20-23) and a 
stamped, addressed reply envelope to patients who met the inclusion and exclusion criteria 
as described for the qualitative phase (Chapter four). Participants were given three options by 
which to complete the questionnaires: to self-complete and return them by post in a pre-paid 
envelope or to complete them in either a face-to-face or telephone interview. If an interview 
was requested, participants were instructed to return the reply slip with their telephone 
number so that they could be contacted to arrange a convenient time. A date of two weeks 
was given by which participants were requested to respond. Structured interviews were 
carried out either face-to-face in the participants homes or over the telephone, as requested 
by participants.  
 
An SPSS (Version 16.0) data file was set up, based on that used in the pilot study, so that 
each question represented a single variable. Cases were labelled according to site, case 
number and method of data collection. For example, Site A, Case 11, face-to-face interview 
was identified as A11F. Data were inputted and analysed using descriptive and inferential 
statistics. The following sections discuss sampling and recruitment, data collection methods, 
ethical considerations and data analysis. 
 
6.1.1 Sampling and recruitment 
Personal introduction by the HFNs was considered to be the most effective method of 
recruitment and was successful in the pilot study. This was especially important given the 
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lack of the initial response in the qualitative phase when invitations were posted. Oppenheim 
(2002) agrees that personal contact by an „official‟ yields a higher response rate. This 
decision, however, had implications for the sampling strategy as the number of potential 
participants was now significantly reduced since, although the HFNs had a large number of 
patients registered to their service (in excess of 900 patients across the three sites), many 
were not in face-to-face contact with the HFNs through home or clinic visits. This significantly 
reduced the available population by approximately half so that a probability sample was not 
feasible based on the required sample size (discussed below). Therefore, a non-probability, 
convenience sampling strategy was used. 
 
Polit and Hungler (2001) describe a convenience sample as the selection of the most readily 
available subjects.  However, it is considered a weak form of sampling in that the sample may 
not be representative of the population. Patients visited by the HFNs or seen in clinic may 
have been more likely to be newly diagnosed, in poorer health or required more complicated 
management, for example. However, all heart failure patients were reviewed annually so 
patients likely to be more typical of the heart failure population would also be included. The 
characteristics of the sample are described in section 6.4.2.  
 
Sample size was determined according to a Cohen‟s d power calculation based on the 
number of cases needed to produce statistically significant results in multiple regression. 
Potentially up to twenty predictor variables were identified – namely, all socio-demographic 
characteristics, illness representations and treatment beliefs. If all were included in the 
regression, to produce a statistical power of 0.8, with a medium effect size of 0.15 and a 
significance level of p = 0.05, a sample size of 156 would be needed (www.statsdirect.com). 
 
Although Oppenheim (2002) suggests that a response rate of one-third or less is realistic for 
self-completed questionnaires, the pilot study suggested that a response rate significantly in 
excess of this was likely (66%). However, the number of questionnaires distributed in the 
main survey was based on this published estimate to try and ensure an adequate response. 
Therefore, it was calculated that 468 envelopes would need to be distributed to achieve a 
target sample size of 156. Essentially, this meant that the sample was equivalent to the total 
available population. 
 
Sites A, B and C were unequal in terms of staffing levels. Sites A and C had a team of six 
HFNs with administrative support. Site B had only three nurses without administrative 
support. For this reason, the questionnaires were not distributed evenly across the three sites 
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but according to workload, as requested by the teams. The period of data collection was 
three months which, following discussion with the HFNs, was thought to be a sufficient length 
of time to distribute the questionnaires. Site A estimated that they could distribute 150 sets of 
questionnaires in this period, Site B, 90 and Site C, 180.  This gave a total of 420 envelopes. 
Following this, further questionnaires could be distributed, if necessary, as new patients were 
registered to the service. The HFNs were asked to keep a record of those patients who had 
received the questionnaires so that reminder letters could be sent in the event of the target 
sample size not being achieved. 
 
The HFNs were carefully briefed about the information that was to be verbally given to 
patients so that any bias in terms of recruitment was minimised. Oppenheim (2002) describes 
the necessity of giving consistent information where personal introductions are made so that 
individuals have equal information on which to decide whether or not to participate. The HFNs 
were instructed to briefly state the purpose of the research, what participation would involve, 
to emphasise that involvement was voluntary and to instruct patients to contact the 
researcher with any queries.  
 
6.1.2 Data collection  
Self-completion of the questionnaires was the anticipated, primary method of data collection 
based on the findings of the pilot study. In addition, a structured interview was used to collect 
data from those participants selecting either face-to-face or telephone interviews. The 
purpose of this standardised approach was to ensure responses were as consistent as 
possible between individuals and the different methods of data collection. This comparability 
of response is considered by Polit and Hungler (2001) to be one of the main advantages of 
structured interviews.  
 
For the interviews, following introductions, the purpose of the research was explained as in 
the participant information letter and the opportunity was given to ask questions. The 
approximate length of time needed to complete the questionnaires was stated so that 
participants were able to allow sufficient time. In completing the questionnaires, the 
instructions and statements were read out exactly as written on the questionnaires and 
responses were recorded by the researcher. Clarification of the instructions or questions was 
given where requested. In this way it was hoped that participants were not inadvertently 
directed to any specific response. In contrast to the data collected in phase one, where the 
objective was to explore patient narratives, an objective approach was sought in this second 
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phase in order to minimise researcher bias. However, it is recognised that the relationship 
between the researcher and participant can never be free of biographical or social influences 
and complete objectivity is unobtainable (Denzin and Lincoln, 2005; Oakley, 1993).  
 
Field notes were written immediately following the interviews. Comments were mainly in 
relation to methodological issues (Miles and Huberman, 1994). For example, the ease with 
which questions were answered was noted and those questions which needed to be 
explained were identified. The purpose of this was so that any missing data in the self-
completed questionnaires might perhaps, be explained.  
 
6.1.3 Ethical considerations 
Ethical review of the final questionnaires and the revised sampling strategy was sought from 
the NREC prior to commencement of the survey. Approval was gained following some 
clarification of the procedures (Appendix 5). Informed consent, access to participation, 
anonymity and confidentiality, and the ethical principles of non-maleficence and beneficence 
are discussed in relation to this phase of the study. 
 
Written information was given in the participant information letter (Appendix 18) with informed 
consent being assumed by return of the completed questionnaires, as recommended by the 
NREC (www.nres.org.uk). Where data were collected by interview, informed consent was 
verbally obtained. However, as in phase one and the pilot study, it could be argued that since 
participants were recruited directly by the HFNs, there may have been an element of wanting 
to please the nurse who was known to them. 
 
In terms of equal access to participation, applying the exclusion criteria, as discussed in 
Chapter four, meant that those unable to read and write a sufficient level of English were 
excluded, thus potentially compromising equality of access based on ethnic origin or level of 
education. 
 
Participants were informed that the questionnaires were anonymous and it would be 
impossible to be identified from them. There was, however, a potential for anonymity to be 
compromised in the interviews since personal information (name, address or telephone 
number) were known. Therefore, at the time of data collection, the questionnaires were 
labelled according to site, number and method of data collection only. On completion of the 
interview, personal information was separated from the questionnaires and destroyed. 
Although the researcher‟s supervisor was made aware of the names, addresses, date and 
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time of the scheduled face-to-face interviews in order to safeguard the researcher, this 
information was destroyed on completion of the interview. Confidentiality was assured by not 
passing on the data to any third party and using it only for the stated purpose of the research.  
 
In terms of non-maleficence, the HFNs were asked to exclude patients who were, in their 
view, too ill to take part in the study. This minimised the potential for physical and 
psychological discomfort in those most vulnerable. Participants were also given the contact 
details of a named HFN should they have any worries or concerns as a result of taking part. 
The HFNs were instructed to only select individuals and neighbourhoods they themselves 
would be willing to visit to minimise the risks to the researcher, should interviews need to be 
carried out in the participants‟ homes. It was stated in writing that there was likely to be no 
direct benefit to the participant by taking part (beneficence).  
 
6.1.4 Data analysis 
Variables were either described numerically or, less commonly, using words (string 
variables). For example, open questions on the questionnaire asked participants to list co-
morbidities. Numerical variables were differentiated into continuous or discrete (categorical) 
variables. Continuous variables were those which could be assigned any value. The variable 
of „time with illness‟ was therefore defined as a continuous variable since values were given 
in years and months. Discrete variables were those which could only be assigned certain 
values, in this case whole numbers. In this sample, all other variables were defined as 
discrete variables, for example, gender and social situation. Age was also defined as a 
discrete variable as values were given as whole numbers (years). However, in large samples, 
as in this case, age may be considered a continuous variable for the purpose of analysis 
(Coolican, 2009). 
  
Numerical variables were further categorised as scale, ordinal or nominal measures. Scale 
variables have intrinsic numerical meaning and allow traditional mathematical manipulation. 
Here, age and time with illness were categorised as scale variables, for example, an 
individual who has had heart failure for two years has had the illness twice as long as 
someone who has had heart failure for one year. Ordinal variables also have intrinsic order 
but the numerical value is relatively meaningless. For example, variables which were 
assessed by responses on the Likert scales from -2 = strongly disagree through to +2 = 
strongly agree were categorised as ordinal variables. Nominal variables have no intrinsic 
order and the numerical values are merely used as labels, for example, gender, where 1 = 
male and 2 = female and social situation where 1 = lives alone, 2 = lives with partner/family, 3 
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= lives in nursing or residential home and 4 = other. Missing data were given a value of 9999 
so that it could be easily identified and excluded from the analysis.   
 
The questionnaires were evaluated for internal consistency and factorial validity. Internal 
consistency, or the degree to which individuals responded in a consistent way, was 
determined using Cronbach‟s alpha (α). Factorial validity was determined using prinicipal 
components analysis, where the aim was to establish the degree to which the theoretical 
constructs of treatment beliefs and self-care were supported.  
 
The questionnaires were examined for missing data and normal distribution. This was 
important in terms of the use of parametric tests such as t-tests and analysis of variance 
(ANOVA), described below, which assumes that scores are normally distributed. Descriptive 
statistics of frequencies, percentages, means, standard deviations and ranges were 
calculated in order to describe the socio-demographic characteristics of the sample, illness 
representations, treatment beliefs and self-care.  
 
The degree of association between socio-demographic variables and self-care was tested 
using Chi-squared (X2) or ANOVA, depending on the type of variables. In determining the 
relationships between illness representations, treatment beliefs and self-care, Pearson‟s 
correlation co-efficients (r) were calculated. Finally, multiple regression analysis was carried 
out in order to assess the extent to which the criterion variable (self-care) could be 
determined by the predictor variables (socio-demographic variables, illness representations 
and treatment beliefs).  
 
In interpreting the results of these relationships, statistical significance was noted. Probability 
values (p) indicated the likelihood of any observed differences happening by chance. The 
lower the p value, the less likely the difference occurred by chance and so the higher the 
significance of the finding. p ≤ 0.05 was considered an acceptable level of significance while 
p ≤ 0.01 was considered highly significant (Coolican, 2009). 
 
6.2 RELIABILITY AND VALIDITY  
 
The consideration of the validity and reliability of the questionnaires is important in 
determining the overall value and the strength of the findings. Validity is the degree to which 
an instrument measures the attribute it was designed to measure. Reliability is the accuracy 
with which the instrument measures that attribute (Polit and Hungler, 2001). 
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Bannigan and Watson (2009) describe the measurement of reliability in terms of stability, 
internal consistency and equivalence. Stability describes the extent to which the same results 
are obtained on repeated administrations of the instrument – commonly assessed as „test-re-
test reliability‟. Internal consistency considers the extent to which respondents answer related 
items in a similar way. Cronbach‟s alpha (α) is frequently used for measuring internal 
consistency. Equivalence describes the use of the scale by different administrators at the 
same time (inter-rater reliability) or administration of two forms of the scale to the same 
sample, successively (alternative form reliability).  
 
There are a number of different ways by which validity can be determined (Coolican, 2009; 
Tashakkori and Teddlie, 1998; De Vaus, 1996) and it is recommended that a variety of 
approaches are used (McDowell and Newell, 1996).  Most simply, face validity is the extent to 
which the instrument „looks like‟ it measures the intended attribute. However, this is 
considered a weak form of validity and other methods are favoured (Tashakkori and Teddlie, 
1998). These are commonly referred to as content, criterion, and construct validity.   
 
Content validity is the extent to which the instrument covers the area or content it is intended 
to cover. That is, it includes all relevant issues and excludes those that are not relevant. It is 
commonly assessed through a critical review by an expert panel or in comparison to the 
literature (Bannigan and Watson, 2009). Criterion validity is demonstrated when findings 
relate to other known data in a predictable way. It includes concurrent and predictive validity. 
Concurrent validity is the extent to which scores on an instrument are similar to scores on 
other established measures administered at the same time (for example, agreement between 
scores on the LAYHFQ and the EHFScBS). Predictive validity considers the extent to which 
the results of the scale predict expected future outcomes.  
 
Construct validity evaluates how well the instrument conforms to theoretical expectations or 
constructs (De Vaus, 1996). Construct validity can be accessed through 
convergent/divergent, factorial and discriminant validity. Convergent/divergent validity 
involves formulating hypotheses about whether the scale will correlate (or not) with other 
measurement scales and then testing these hypotheses. Factorial validity uses the statistical 
procedure of factor analysis which describes the underlying or latent conceptual structures of 
an instrument. Factorial validity is demonstrated when items in the scale group together in a 
consistent and coherent way (Bowling, 1995). Discriminant validity describes the scales 
ability to differentiate or discriminate between groups which are expected to differ. For 
example, it should be able to differentiate between scores in those with different illnesses.  
160 
 
 
In this study, internal consistency was calculated for the IPQ-R (HF), the MUHFQ and the 
LAYHFQ using Cronbach‟s α. Factorial validity was determined using principle components 
analysis (PCA). The following section presents the methods and results of this analysis. An 
overall evaluation of the extent to which the questionnaires can be considered reliable and 
valid is given in Chapter seven.  
 
6.3 INTERNAL CONSISTENCY AND FACTORIAL VALIDITY OF THE 
QUESTIONNAIRES 
 
The internal consistency of the IPQ-R (HF), MUHFQ and the LAYHFQ was determined using 
Cronbach‟s alpha (α). This was calculated for the questionnaires as a whole and also the 
theoretically derived domains, for example, the illness representations of consequences, 
timeline (acute/chronic), timeline (cyclical), personal control, treatment control, and 
coherence. In this analysis α > 0.70 was described as „good‟ and α = 0.50 to 0.70 was 
described as „moderate‟ (Coolican, 2009). Internal consistency was improved, where 
necessary, by deleting selected items in a stepwise fashion through a process of item 
analysis (Coolican, 2009). This involved identifying those items which, if deleted, most 
improved the Cronbach‟s α. The tables in the section present the final Cronbach‟s α values 
following any described deletions.  
 
Exploratory factor analysis was carried out to determine the underlying or latent constructs of 
the MUHFQ and LAYHFQ. In factor analysis, correlations between variables are calculated 
so that „clusters‟ of items may be identified and reduced to a smaller number of factors. 
Principal components analysis (PCA) was used as the extraction method. PCA identifies the 
number of factors and assigns individual items to these dimensions (Watson and Thompson, 
2006).  
 
Prior to conducting PCA, an assessment of the suitability of the data is first required (Pallant, 
2010). Sample size is important since correlations are considered to be less reliable in small 
samples. Specifically, the ratio between the number of cases and the number of items in the 
scale is important. Whilst authors vary in their recommendations, 5 cases for each item are 
generally considered adequate (Pallant, 2010). In the MUHFQ, the number of items is 19 so 
that the calculation of 5 x 19 gives a required sample size of 95, which is well within the 169 
cases in this analysis. The LAYHFQ has 28 items, the calculation 5 x 28 gives a required 
sample size of 140, which again suggests that the sample size was sufficient. The second 
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consideration is the strengths of the correlations between variables. A preponderance of 
correlations above r = 0.3 is considered sufficient according to Pallant (2010).  A review of the 
correlation matrix of the MUHFQ identifies a number of correlations above r = 0.3. However, 
the LAYHFQ has fewer correlations of this strength. Bartlett‟s test of sphericity and the 
Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy are further tests for the suitability 
of the data for factor analysis. Pallant (2010) suggests Bartlett‟s test should be statistically 
significant (p ≤ 0.05) and the KMO index should be above 0.6. This analysis is summarised in 
Table 6.1 and suggests that the data from both the MUHFQ and the LAYHFQ are suitable for 
factor analysis. 
 
Table 6.1 Suitability of the Data for Factor Analysis 
 
Questionnaire Bartlett’s test of 
Sphericity 
 
Kaiser-Meyer-
Olkin index 
MUHFQ p < 0.001 0.76 
LAYHFQ p < 0.001 0.69 
 
Kaiser‟s Criterion, Catell‟s Scree test and Horn‟s parallel analysis were used in combination 
to determine the number of factors in this analysis. Using Kaiser‟s criterion, eigenvalues 
represent the amount of the total variance explained by any factor. An eigenvalue >1.0 
indicates that the factor explains more of the variance than the original items. Therefore, only 
those factors with an eigenvalue >1.0 should be retained. The scree test plots each of the 
eigenvalues against the number of items. The point at which the slope breaks (the „elbow‟) is 
identified and all factors above this point should be retained. However, both Kaiser‟s criterion 
and the scree test have been criticised for their tendency to overestimate the number of 
factors (Pallant, 2010). 
 
Parellel analysis is considered to be a more accurate method of determining factors (Pallant, 
2010). This involves comparing the size of the actual eigenvalues against those of randomly 
generated data sets of the same size. In this case, 100 data sets were generated using the 
parallel analysis software MonteCarloPA (www.softpedia.com). Only those factors with 
eigenvalues above the corresponding values of the generated data set should be retained. 
 
Although Kaiser‟s criterion, the scree test and parallel analysis were used to estimate the 
number of factors, the final number was determined according to the judgement of the 
researcher as advocated by Watson and Thompson (2006). 
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The process of rotation was used to assist in the interpretation of the number of factors. The 
purpose of rotation is to maximise the loadings or correlations of items. In this study, Varimax 
rotation was used which attempts to minimise the number of variables that have high loading 
on each factor (Pallant, 2010). This is a commonly used orthogonal approach, meaning that 
is assumed that the factors derived are not correlated with each other. The aim was to 
identify a simple structure with each item loading strongly on only one factor, whilst 
minimising the loading of items onto other factors (cross-loading). Loadings above 0.45 were 
considered significant (Dancey and Reidy, 2007). 
 
The final step in PCA was to describe and label the resulting factors. Here, themes developed 
from the qualitative interviews were used to describe the underlying constructs as indicated 
by factor analysis. 
 
6.3.1 The IPQ-R (HF) 
 
Table 6.2 presents the internal consistency of the domains of the IPQ-R (HF) and the 
questionnaire as a whole.  
 
Table 6.2 Internal Consistency of the IPQ-R (HF) 
 
Domain Number of items 
(n) 
Cronbach’s 
α 
Timeline (acute/chronic) 6 0.80 
Consequences 6 0.70 
Personal control 6 0.78 
Treatment  control 4 0.70 
Timeline (cyclical) 4 0.82 
Coherence 5 0.71 
Emotional response 
 
6 0.88 
IPQ-R (HF) (Total) 37 0.74 
 
Internal consistency of the timeline (acute/chronic) domain, using the original IPQ-R items 
was good at α = 0.80. The additional timeline items, ‘My heart failure will get worse in time’ 
(IPN1) and ‘I expect my heart failure to stay the same in the future’ (IPN2), were added 
separately and together but reliability was not improved (IPN1 only, α = 0.79, IPN2 only, α = 
0.71, IPN1 plus IPN2, α = 0.71).  Therefore, in the subsequent data analysis only the 6 
original IPQ-R timeline items were included.  
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The domains of personal control (α = 0.78), timeline (cyclical) (α = 0.82), coherence (α = 
0.71) and emotional response (α = 0.88) also demonstrated good internal consistency. The 
consequences sub-scale demonstrated moderate but acceptable internal consistency (α = 
0.70). 
 
Treatment control, on initial analysis, demonstrated only moderate internal consistency (α = 
0.57). In order to improve the reliability of this sub-scale, inter-item correlations were 
calculated. The item „My treatment will be effective in curing my heart failure’, had limited 
correlation with other items. Theoretically, in chronic illness, the term „cure‟ may be 
inappropriate and may explain the lack of correlation between this and other items in this sub-
scale.  Internal consistency was improved to an acceptable level of α = 0.70 when this item 
was deleted. This item was therefore, excluded in subsequent analysis.  
 
Reliability of the IPQ-R (HF) as a whole was good (α = 0.74). Factorial validity was not 
assessed in this questionnaire as changes from the IPQ-R were minimal and this 
questionnaire has been extensively psychometrically tested in a number of illness groups 
(Moss-Morris et al, 2002). 
 
6.3.2 The MUHFQ 
Table 6.3 presents the internal consistency of the domains of the MUHFQ.  
 
Table 6.3 Internal Consistency of the  MUHFQ 
 
Domain Number of items 
(n) 
Cronbach’s 
α 
Necessity 5 0.74 
Concerns 4 0.76 
Medication knowledge 4 0.73 
Social influences on 
medication use 
3 0.74 
Impact of medication 
use on lifestyle 
3 0.56 
 
Necessity of medication using the original items from the BMQ achieved good internal 
consistency (α = 0.74). When the additional necessity item, „My symptoms improve when I 
take my tablets’, was added, reliability was not improved (α = 0.73) so this item was not 
included in further analysis.  
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On reflection, the BMQ concern item, „My tablets disrupt my life‟, seemed to relate more to 
the impact of medication use on lifestyle sub-scale and so was analysed as such. The 
concerns sub-scale, therefore, consisted of the remaining BMQ concern items and the 
additional item, „I sometimes worry about the effect of taking lots of different tablets’.  Internal 
consistency using these items was good at α = 0.76.  
 
The medication knowledge sub-scale initially showed moderate internal consistency of α = 
0.65. Determination of inter-item correlations showed that the item, „I am unsure whether I 
should take medication that I buy myself with my heart failure tablets‟ had limited correlation 
with the other items. The reason for this may be that this question was complex and reversed 
and so may have been poorly understood. This is supported by the discussions with the heart 
failure clinic patients who reported that they found complex, reversed questions more difficult 
to answer.  Alternatively, as this question relates to other medications, not just those for heart 
failure, it may not be measuring the same construct as the other items in this domain which 
relate specifically to knowledge about heart failure medication. With this item deleted, 
reliability of this sub-scale was improved to α = 0.73. This item was therefore, excluded in 
further analysis.  
 
Social influences on medication use showed good internal consistency of α = 0.74. However, 
the impact of medication use on lifestyle scale demonstrated only moderate internal 
consistency (α = 0.52). Inter-item correlations showed that reliability was improved to a small 
degree by excluding the item, „Taking my tablets is part of my daily routine‟ (α = 0.56). As the 
only reversed item in this sub-scale this may have been answered inconsistently. This item 
was subsequently omitted in further analysis.  Further step-wise deletions did not improve the 
reliability and it should, therefore, be noted that this sub-scale achieved only moderate 
reliability in this sample and so the conclusions drawn in relation to these findings are 
necessarily tentative.  
 
Internal consistency of the whole questionnaire was not calculated as the necessity and 
concerns domains could be viewed as opposing beliefs and so tended to cancel each other 
out. Horne et al (1999) similarly, did not report the internal consistency of the BMQ as a 
whole.  
 
Principal components analysis (PCA) of the MUHFQ revealed the presence of 5 factors with 
eigenvalues >1.0 according to Kaiser‟s criterion - F1, 4.21; F2, 3.13; F3, 2.02; F4, 1.23; F5, 
1.17. These factors explained 62.22% of the variance in the MUHFQ scores. F1, the first 
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principal component, explained 22.18% of the variance, F2 16.47%, F3 10.63%, F4 6.80% 
and F5 6.14%.  
 
The scree test illustrates a break after the fourth component (Figure 6.1), Suggesting a 4-
factor structure. 
 
Figure 6.1 Scree Plot of the MUHFQ 
 
Parallel analysis showed 3 components with eigenvalues exceeding the corresponding 
values from 100 randomly generated data set (Table 6.4) 
 
Table 6.4 Parallel Analysis of the MUHFQ 
 
Component 
Number 
Actual 
Eigenvalue 
Eignenvalue from 
parallel analysis 
1 4.214 1.663 
2 3.129 1.518 
3 2.020 1.423 
4 1.292 1.341 
 
In determining the number of factors, a judgement needed to be made about the meaning of 
these constructs. The 5 factors corresponded to the theoretical domains of the MUHFQ 
derived from analysis of the interview data. Factor 1 corresponded to the domain of 
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medication knowledge, Factor 2 to the concerns domain of the BMQ, Factor 3 to necessity 
beliefs, Factor 4 to social influences on medication use and Factor 5 to the impact of 
medication use on lifestyle domains. Therefore, the decision was made to adopt this 5-factor 
structure, although the factors of social influences of medication use and the impact of 
medication use on lifestyle, especially, should be viewed with some caution. Table 6.5 shows 
this 5-factor structure using Varimax rotation.  
 
Table 6.5  Principal Components Analysis of the MUHFQ 
 
Item Communality First 
Unrotated 
Principal 
Component 
Derived varimax factor solution factors 
 
 
  1 2 3 4 5 
My health depends upon my tablets 
 
0.53 0.52 0.22 -0.09 0.68 -0.06 0.01 
Life would be impossible without my tablets 
 
0.65 0.28 0.11 0.22 0.72 0.24 -0.05 
Without my tablets I would be very ill 0.66 0.28 -0.05 0.20 0.72 0.12 -0.28 
My future health depends on my tablets 0.52 0.40 0.14 0.04 0.69 -0.06 0.15 
My symptoms improve  0.53 0.63 0.43 -0.11 0.56 -0.12 0.02 
I worry about long-term side-effects  0.64 -0.20 0.012 0.77 0.01 0.17 -0.06 
I worry about becoming dependent  0.48 -0.14 -0.01 0.67 0.09 0.01 0.13 
My tablets protect me from becoming worse 0.61 -0.26 -0.28 0.71 0.05 -0.12 -0.02 
I worry about the effects of lots of tablets 0.68 -0.15 0.06 0.82 -0.02 -0.01 0.07 
I understand why I need my tablets 0.74 0.76 0.80 -0.09 0.24 -0.12 -0.05 
I know when to take my tablets 0.71 0.76 0.77 0.04 0.19 -0.26 -0.10 
I know the dose of my tablets 0.74 0.77 0.76 0.04 0.16 -0.34 -0.09 
I am clear about my symptoms/tablets 0.46 0.42 0.59 -0.12 0.05 0.22 -0.18 
I am influenced by my family or friends  0.50 -0.36 -0.00 0.05 -0.01 0.66 0.24 
I would find it difficult without help  0.69 -0.46 -0.30 0.01 0.10 0.76 -0.07 
I follow the advice of family or friends  0.70 -0.42 -0.08 0.06 0.00 0.83 0.03 
My tablets disrupt my life 0.58 -0.30 -0.03 0.53 0.11 0.24 0.46 
I find it difficult to take tablets when I go out 0.71 -0.37 -0.22 0.08 0.05 0.00 0.80 
My lifestyle prevents me from taking my tablets 0.61 -0.59 -0.15 0.05 -0.36 0.36 0.57 
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Cross-loading was apparent with the item ‘My tablets disrupt my life’ loading onto F3 - 
concerns (0.53) and F5 - impact of medication use on lifestyle (0.46). As this item was part of 
the original concerns sub-scale on the BMQ, this is perhaps not surprising and demonstrates 
a close relationship between general concerns about medication and the impact of 
medication use on lifestyle which may be considered to be a specific, practical concern. 
 
6.3.3 The LAYHFQ 
Table 6.6 presents the internal consistency of the domains of the LAYHFQ and the 
questionnaire as a whole. 
 
Table 6.6 Internal Consistency of the LAYHFQ
 
Domain Number of 
items (n) 
Cronbach’s 
α 
Lifestyle adherence 5 0.13 
Medication adherence 7 0.54 
Monitoring 7 0.76 
Managing symptoms, social 
and emotional effects  
5 0.48 
Reporting and seeking help 
 
4 0.50 
LAYHFQ (Total) 28 0.77 
 
 
Medication adherence (α = 0.54), reporting and seeking help (α = 0.50) and monitoring (α = 
0.76), demonstrated moderate to good internal consistency. Adherence to recommended 
lifestyle behaviours and managing symptoms and the social and emotional effects of the 
illness, did not demonstrate satisfactory internal reliability (α < 0.50). Step-wise deletion did 
not significantly improve this. As a result, overall, the individual domains of the LAYHFQ 
cannot be considered sufficiently internally reliable for use in this analysis. However, the 
internal consistency of the LAYHFQ when taken as a whole was good at α = 0.77. Therefore, 
in subsequent analysis, a total self-care score was used rather than individual domains. The 
implication of this is that relationships between beliefs and specific self-care behaviours, such 
as medication adherence, could not be determined. However, it is worth noting that internal 
consistency of the EHFScBS was also only demonstrated when self-care was taken as a total 
score (Jaarsma et al, 2003). 
 
Principal components analysis (PCA) of the LAYHFQ revealed the presence of 9 factors with 
eigenvalues >1.0. (F1, 4.94; F2, 2.31; F3, 1.90; F4, 1.72; F5, 1.67, F6 1.42, F7, 1.27, F8, 
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1.16, F9, 1.02). These factors explained 62.12% of the variance in the LAYHFQ scores. F1, 
the first principal component, explained 17.63%, F2 8.23%, F3 6.77%, F4 6.15%, F5 6.01%, 
F6 5.96%, F7 5.07%, F8 4.52% and F9 3.61%.  
 
The scree test is difficult to more interpret but indicates a break after the second component 
(Figure 6.2) with a smaller break after the fifth component.  
 
Figure 6.2 Scree plot of the LAYHFQ 
 
Parallel analysis showed 6 components with eigenvalues exceeding the corresponding 
values from 100 randomly generated data set (Table 6.7).  
 
Table 6.7 Parallel Analysis of the LAYHFQ 
 
Component 
Number 
Actual 
Eigenvalue 
Eigenvalue from 
parallel analysis 
1 4.936 1.837 
2 2.305 1.718 
3 1.896 1.620 
4 1.722 1.530 
5 1.668 1.460 
6 1.419 1.397 
7 1.163 1.270 
 
Based on Kaiser‟s criterion, Table 6.8 presents the 9 factor solution. 
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Table 6.8 Principal Components Analysis of the LAYHFQ 
Item Communality First 
Unrotated 
Principal 
Component 
Derived varimax factor solution factors 
 
 
 
1 2 3 4 5 6 7 8 9 
 
Exercise 
 
0.54 
 
0.05 
 
0.05 
 
-0.08 
 
0.56 
 
0.17 
 
0.30 
 
-0.08 
 
-0.11 
 
0.07 
 
-0.05 
Smoking 0.51 0.04 0.04 -0.11 0.30 0.36 0.42 0.28 0.10 0.04 0.07 
Fluids 0.54 0.16 0.16 -0.01 -0.06 -0.19 0.22 0.26 0.45 -0.38 -0.05 
Salt 0.75 0.35 0.35 0.16 0.31 0.05 -0.13 0.29 -0.32 -0.49 0.20 
Alcohol 0.64 0.22 0.22 0.10 0.45 0.22 -0.23 -0.32 0.36 0.05 -0.15 
Flu Jab 0.57 0.43 0.43 0.29 0.17 0.12 -0.31 -0.15 -0.00 -0.33 -.013 
Forget to take 
tablets 
 
0.66 0.39 0.39 0.18 0.22 0.29 -0.13 0.19 0.22 -0.01 -0.48 
Choose not to 
take tablets 
 
0.47 0.43 0.43 0.24 -0.12 0.35 0.08 -0.22 0.01 0.13 -0.11 
Change dose 
as instructed 
 
0.63 0.57 0.57 -0.42 -.012 0.23 0.11 0.06 -0.03 -0.15 0.04 
Change dose 0.63 0.50 0.59 -0.29 -0.27 0.22 0.01 -0.24 0.01 -0.05 0.04 
Change time 0.68 0.67 0.67 -0.35 -0.15 0.24 0.08 -0.10 0.01 0.02 -0.08 
Collect 
prescriptions 
 
0.63 0.62 0.62 -0.22 -0.31 0.19 0.08 0.07 0.19 0.07 0.08 
Weighing 
 
0.56 0.57 0.57 -0.18 -0.02 -0.05 0.17 -0.25 -0.02 -0.15 0.14 
Monitor 
sleeping 
 
0.67 0.38 0.38 -0.28 0.32 -0.47 0.10 -0.07 -0.07 0.30 0.04 
Monitor 
tiredness 
 
0.74 0.43 0.43 -0.42 0.20 -0.03 0.10 0.18 0.07 0.40 -0.16 
Monitor 
breathing 
 
0.61 0.59 0.59 -0.30 0.20 -0.10 0.01 0.23 -0.16 -0.14 0.07 
Monitor cough 0.58 0.62 0.62 0.01 0.01 -0.18 -0.31 -0.20 -0.02 -0.01 0.13 
Monitor fluid  0.50 0.41 0.41 0.33 0.09 -0.19 -0.21 -0.34 0.04 -0.05 0.02 
Recognise 
tablet effects 
 
0.60 0.45 0.45 0.23 0.09 -0.18 -0.42 0.05 0.09 0.30 0.12 
Keep active 0.61 0.55 0.55 0.07 0.23 -0.03 -0.12 0.29 -0.05 -0.03 0.05 
Go out 0.57 0.13 0.13 0.24 -0.22 0.08 -0.15 0.52 0.36 0.08 0.05 
Postive 
attitude 
 
0.61 0.28 0.28 0.34 -0.18 0.34 -0.06 0.05 -0.16 0.34 0.32 
Meet family/  
friends 
 
0.61 0.28 0.28 0.51 -0.22 -0.18 0.36 -0.01 0.23 0.01 -0.01 
Rest 0.63 0.37 0.37 0.48 -0.17 0.05 0.15 0.25 -0.26 0.22 -0.11 
Report 
changes  
 
0.67 0.43 0.43 0.44 0.01 -0.01 0.29 0.10 -0.40 -0.01 -0.12 
Report effects  
 
0.69 0.15 0.15 0.27 -0.20 -0.39 0.46 -0.27 -0.09 -0.11 -0.28 
Report OTC  
 
0.72 -0.08 -0.08 0.18 0.53 0.30 0.33 -0.18 0.01 0.05 0.40 
Seek advice 0.63 0.17 0.17 0.26 0.20 -0.20 .034 -0.09 0.44 -0.04 0.35 
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Reduction to 5 factors, according to the proposed theoretical domains of self-care, did not 
significantly improve loading. This analysis is presented in Appendix 24.  
 
Jaarsma et al (2003) also found that the theoretical domains of self-care were not supported 
by factor analysis of the EHFScBS. It is, therefore suggested from the analysis of the 
LAYHFQ and the EHFScBS, that the behaviours that make up self-care may be separate, 
from a patient perspective.  For example, taking regular exercise or making dietary changes 
may be perceived as being part of a healthy lifestyle and not necessarily behaviours carried 
out in response to the heart failure. This was also suggested by the qualitative data. As a 
result, such behaviours may not be easily grouped together as they are likely to be influenced 
by a range of individual factors. This is discussed further in Chapter seven.  
 
6.4 RESULTS  
 
6.4.1 The response rate 
At the end of the data collection period, Site A had delivered 180 questionnaires as 
anticipated. At Site B, distribution was more problematic as due to staff changes and 
holidays, only 25 of the 90 allocated questionnaires were distributed. Site C distributed 130 of 
the 180 allocated which was the total available population at that time. This meant that 
overall, a total of 335 sets of questionnaires were delivered, 133 fewer than anticipated.  
 
However, 169 sets of questionnaires were completed representing a response rate of 50.4%. 
The target sample size of 156 responses was, therefore, achieved. This response rate, 
though lower than in the pilot study (60%) was nevertheless sufficient according to the power 
calculation and higher than the one-third suggested by De Vaus (1996).  
 
The majority (n = 152, 89.9%) of participants elected to self-complete the questionnaires, as 
indicated by the pilot study. This suggests that participants were able to understand the 
instructions for completion and were able to answer the questions. However, it does not 
guarantee that family members or friends did not complete the questionnaires or that the 
questions were fully understood. Fourteen participants (8.3%) chose to complete the 
questionnaires by face-to-face interview, (thirteen in Site A, one in Site C), with three 
participants in Site A (1.8%) opting to complete the questionnaires by telephone.  Differences 
in socio-demographic characteristics between these three sites are presented in the following 
section.  
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6.4.2  Socio-demographic and illness-related characteristics of the sample 
In describing the socio-demographic and illness-related characteristics of age and time with 
the illness, the mean or average score,  standard deviation (SD) or spread of dispersion 
around the mean and range (maximum and minimum scores) were calculated (Harris and 
Taylor, 2008). Gender, ethnic origin, social situation, education, occupation, the presence of 
co-morbidities and functional ability as classified by the NYHA, were described in terms of 
frequencies or the number of times an observation occurred, and presented as percentages 
(Table 6.9)  
 
The mean age of the sample was 70.89 years (range 30-91, SD ± 11.99). The mean time 
with the illness was 7.34 years (range 0.1-70, SD ± 9.39). 74.1% of the sample were men and 
25.9% were women. All participants described themselves as of White, British ethnic origin.  
The majority of the sample (79.5%) lived with a partner or family with 19.3% living alone. Just 
over half the participants (54.9%) had no formal qualifications. Most were retired (80%). A 
high proportion, 71.6%, had co-morbidities such as renal disease or diabetes, for example. 
According to the NYHA functional classification, most participants classified themselves as 
either class II or III which represents moderate severity of heart failure.   
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Table 6.9 Socio-Demographic and Illness-Related Characteristics of the Sample 
 
Number of Range  Mean  SD (±) 
Responses 
(n) 
 
Age (years)  165  30-90  70.89  11.99 
Time with Illness (years) 157  0.1-70    7.34    9.39 
  
Number of  Frequency % 
Responses  
(n)    
 
Gender   166 
     Male    123  74.1   
     Female      43  25.9 
 
Ethnic Origin  165 
     White, British   165  100.0 
 
Social Situation  166 
     With partner/family   132  79.5 
     Lives alone        32  19.3 
     Residential/nursing       2    1.2 
 
Qualifications  162 
     None    89  54.9 
     GCSE „O‟level    31  19.1 
     „A‟ level     11    6.8 
     Degree     14    8.6 
     Post-graduate      6    3.7 
     Other       11    6.8 
 
Occupation  165 
     Retired    132  80.0 
     Employed      20  12.1 
     Homemaker        7    4.2 
     Unemployed        3    1.8 
     Medically retired       3    1.8 
 
Co-morbidities  169 
     Yes     121  71.6 
     No       48  28.4 
 
NYHA classification 146 
     I       28  19.2 
     II       38  26.0 
     III       52  35.6 
     IV       28  19.2 
 
 
 
The socio-demographic and illness-related characteristics of participants from each of the 
three sites were examined to determine the extent to which the sample could be considered 
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homogenous or coming from a single population.  The degree of association between the 
categorical variables of site and gender, social situation, level of education, occupation, 
presence of co-morbidities and NYHA classification was tested using Chi-Squared (X2). X2 
measures the difference between observed and expected frequencies with the assumption 
that there is no difference between the variables - the null hypothesis. In this case the null 
hypothesis was that there was no difference in terms of socio-demographic or illness-related 
characteristics between the different sites.  
 
However, with the exception of gender and co-morbidities, there were too few cases to 
include Site B in this analysis (n = 7). At Sites A and C, there were too few cases in some 
categories of social situation, occupation and qualifications to make X2 analysis reliable. 
Therefore, those categories were either omitted from the analysis or categories were 
combined as follows: The social situation category of ‘live in a nursing or residential home’ (n 
= 1) was excluded. Similarly, in terms of occupation, the categories of ‘unemployed’ (n = 2) 
and ‘homemaker’ (n = 3) were also excluded. Qualifications were grouped into two categories 
- those with and those without formal qualifications. On interpretation of this analysis an 
associated p value gave the statistical significance or likelihood that the difference could have 
occurred by chance. Degrees of freedom (df) indicated the number of independent variables 
(Table 6.10).  
 
There were no statistically significant differences in terms of gender, social situation, 
qualifications, the presence of co-morbidities or NYHA scores between Sites A and C. In 
terms of occupation there was a statistically significant difference, with Site C having a higher 
than expected number of employed respondents (X2 = 4.32, df = 1, n = 146, p = 0.04).  
 
Table 6.10 Differences Between Sites in Terms of Socio-Demographic and Illness-Related 
Characteristics 
 
In relation to the continuous variables of age and time with illness across the three sites, one 
Variable Number of 
Responses (n) 
Chi-Square (X2) df p 
Gender 
Social Situation 
Qualifications 
Occupation 
Co-morbidities 
NYHA 
166 
157 
149 
146 
169 
143 
0.78 
1.02 
1.42 
4.32 
3.09 
0.14 
2 
1 
2 
1 
2 
3 
0.67 
0.30 
0.49 
0.04* 
0.21 
0.99 
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way Analysis of Variance (ANOVA) was carried out. Unlike X2, in ANOVA the variation 
around the means are compared rather the frequencies. The F value gives a measure of the 
variance between groups, compared to within groups. On analysis, there were no statistically 
significant differences in terms of age (F, 0.40, p = 0.67) or time with illness (F, 0.08, p = 
0.92) across the three sites (Table 6.11). 
 
Table 6.11 Differences Between Sites in Terms of Age and Time with Illness 
  
Variable Sum of 
squares 
df Mean square F p 
Age (years)  
Time with Illness (years) 
117.07 
14.35 
2 
2 
58.54 
7.18 
0.40 
0.08 
0.67 
0.92 
 
Although, methodologically, it may have been useful to determine if there were differences in 
socio-demographic or illness-related characteristics between participants opting for different 
methods of data collection, too few interview cases were available for meaningful analysis.  
 
In conclusion, with the exception of occupation, no significant differences were found in the 
socio-demographic or illness-related characteristics of participants in Sites A and C, so that it 
can be concluded that these samples can be considered to come from a single population.  
 
6.4.3 Illness representations and emotional response 
The domains of illness representations were described in terms of mean scores, standard 
deviations, and ranges. One-sample t-tests (2-tailed) were carried out to determine whether 
the means were statistically different from the neutral score of zero. A value of p ≤ 0.05* was 
considered significant. This analysis is presented in Table 6.12.   
 
Table 6.12 Illness Representations and Emotional Response 
 
Domain Number of 
Responses 
(n) 
Mean Score Range    SD (±)       p 
Identity 96 9.14  0 to 15 2.99 n/a 
Timeline (acute/chronic) 136 6.09           -12 to 12 3.88 <0.001* 
Consequences 138 2.98 -12 to 12 3.89 <0.001* 
Personal Control 138 3.20           -12 to 12 4.08 <0.001* 
Treatment Control 144 2.35    -8 to 8 2.63 <0.001* 
Timeline (cyclical) 145 -0.96    -8 to 8 2.48 <0.001* 
Coherence  147 2.40          -10 to 10 3.87 <0.001* 
Emotional response 146 -0.17 -12 to 12 5.33 0.698 
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In the identity domain, a high number of symptoms were believed to be associated with heart 
failure (mean number of symptoms 9.14, SD ± 2.99). There was a strong belief that the illness 
had a chronic timeline (mean 6.08, SD ± 3.88, range -12 to +12, p = <0.001), and had serious 
consequences (mean 2.98, SD ± 3.89, range -12 to +12, p = <0.001). The degree of control 
over the illness was reportedly high both in terms of personal control (mean 3.20, SD ± 4.08, 
range -12 to +12, p = <0.001) and treatment control (mean 2.35, SD ± 2.63, range -8 to +8, p 
= <0.001). There was a high level of reported illness coherence, indicating agreement that the 
illness „made sense‟ (mean 2.40, SD ± 2.43, range -10 to +10, p = <0.001). Symptoms were 
not viewed as cyclical or episodic (mean -0.96, SD ± 3.87, range -8 to +8, p = <0.001) and 
although few negative emotional responses were reported, this was not statistically significant 
(mean -0.17, SD ± 5.33, range -12 to +12, p = 0.698).  
 
In relation to symptoms, breathlessness and fatigue were most widely described with 96.3% 
of the sample reporting these symptoms. Daytime sleepiness (86.2%), loss of strength 
(83.6%), swollen ankles (74.5%), dizziness (61.2%), palpitations (60.3%), sleep difficulties 
(57.6%), wheeziness (57.4%), weight gain (55.5%), sexual difficulties (52.3%) and 
forgetfulness (50.0%) were described by at least half the participants. Chest pain (43.8%) and 
loss of appetite (35.8%) were least frequently experienced (Figure 6.3).  
 
Figure 6.3 Percentages of Specific Symptoms Attributed to Heart Failure 
 
 
From the open question, other diverse symptoms of heart failure were reported including 
hallucinations, cramp, numbness in the arms, heaviness in the legs, tremors, hot sweats and 
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loss of appetite 
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sleep difficulties 
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daytime sleepiness 
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breathlessness 
Percentage   
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falls. A cough was reported by three participants. Negative emotions such as depression, 
anxiety, panic attacks and ill temper were also identified as symptoms by ten participants, 
indicating the difficulty in categorising negative emotions as either symptoms or responses.  
There was an overall lack of agreement that the heart failure was due to the suggested 
causes (Table 6.13).  
 
Table 6.13 Beliefs about Causation 
 
 
The only statistically significant cause which was positively identified was ageing (mean 0.27, 
range -2 to +2, SD ± 1.09, p = 0.002). There was also agreement that the illness was caused 
by stress or worry, but this was not statistically significant (mean 0.07, SD ± 1.21, range -2 to 
+2, p = 0.455). Most other causes such as a previous heart attack or smoking, for example, 
were not perceived as the cause of the illness. Two additional causative factors were 
identified in the open question, pregnancy and loneliness, each of which was cited only once.  
 
In summary, heart failure was seen as a long-term condition with serious consequences. 
Participants believed that the illness could be controlled by medication as well as reporting a 
high degree of personal control. The illness was described a „making sense‟ and participants 
Cause Number of 
Responses (n) 
Mean SD (±) p 
Ageing 
Stress or worry 
High blood pressure 
Hereditary 
Other illnesses 
Chance/bad luck 
Overwork 
Other heart problems 
Overweight 
Previous heart attack 
Diet/eating habits 
Smoking 
Family problems/worries 
Treatment for other illnesses 
An infection 
Poor medical care in the past 
Alcohol 
154 
148 
149 
148 
146 
146 
148 
147 
148 
147 
146 
150 
146 
143 
140 
146 
150 
0.27 
0.07 
-0.01 
-0.15 
-0.20 
-0.23 
-0.28 
-0.29 
-0.32 
-0.35 
-0.36 
-0.42 
-0.52 
-0.63 
-0.66 
-0.80 
-0.93 
1.09 
1.21 
1.24 
1.21 
1.11 
1.04 
1.06 
1.14 
1.15 
1.28 
1.07 
1.30 
1.02 
1.00 
0.95 
0.97 
0.97 
0.002* 
     0.455 
     0.895 
     0.121 
0.033* 
0.008* 
0.001* 
0.002* 
0.001* 
0.001* 
<0.001* 
<0.001* 
<0.001* 
<0.001* 
<0.001* 
<0.001* 
<0.001* 
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did not commonly experience negative emotions such as depression or anxiety as a result of 
having heart failure, which is in contrast to the interview findings. However, these emotions 
were described as a symptom rather than a response to the illness by a small number of 
participants (n = 10). A high number of diverse and debilitating symptoms which were 
believed to be due to heart failure were reported, with breathlessness and fatigue almost 
universally cited. In contrast to the biomedical model of heart failure, lifestyle factors and CHD 
were not perceived to be the cause of the illness with only ageing and stress or worry, 
positively identified as causative factors. These results are discussed in Chapter seven. 
 
6.4.4  Treatment beliefs  
Treatment beliefs are described in Table 6.14. 
 
Table 6.14 Treatment Beliefs 
 
Domain Number of 
Responses 
(n) 
Mean Range SD (±) p 
Necessity 159 4.96 -10 to 10 2.56 <0.001* 
Concerns 153 0.17 -8 to 8 3.14 0.016* 
Medication Knowledge 156 4.21 -10 to 10 2.59 <0.001* 
Social influences on 
medication use 
154 -2.74 -6 to 6 2.40 <0.001* 
Impact of medication 
use on lifestyle 
154 -2.40 -6 to 6 1.96 <0.001* 
 
 
Overall, there was a positive attitude to the use of medication with strong necessity beliefs 
(mean 4.96, SD ± 2.56, range -10 to +10, p = <0.001), reportedly good medication knowledge 
(mean 4.21, SD ± 2.59, range -10 to +10, p = <0.001), few concerns (mean 0.17, SD ± 3.14, 
range -8 to +8, p = 0.016) and limited impact on lifestyle reported (mean -2.40, SD ± 1.96, 
range -6 to +6, p = <0.001). Medication use was not believed to be influenced by family or 
friends (mean -2.74, SD ± 2.40, range -6 to +6, p = <0.001). These results are discussed in 
Chapter seven.  
 
6.4.5 Self-care 
Self-care behaviours were descriptively analysed for means and SD. Scores for all items 
ranged from -2 to +2. Again, one-sample t-tests were used to determine statistical 
significance from the neutral point of zero (Table 6.15)  
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Table 6.15 Individual Self-Care Behaviours 
 
Domain Behaviour Mean 
Score 
SD (±) 
 
p 
Lifestyle adherence 
    
 Taking regular exercise 0.13 1.12   0.886 
 Not smoking  1.55 0.92 <0.001* 
 Restricting fluid intake 0.48 1.07 <0.001* 
 Limiting salt intake  0.91 0.92 <0.001* 
 Restricting alcohol  1.26 1.01 <0.001* 
Medication adherence 
    
 Flu and pneumonia vaccination 1.05 0.94 <0.001* 
 Forgetting (unintentional non-adherence) -0.83 1.03 <0.001* 
 Choosing not to take medication -1.23 0.84 <0.001* 
 Choose to change the dose -1.32 0.71 <0.001* 
 Choose to change the time -0.67 1.11 <0.001* 
 I collect my prescriptions so I do not run out of 
tablets 
1.30 0.61 <0.001* 
Monitoring 
    
 Regular weighing 0.98 0.82 <0.001* 
 Recognising changes in sleep patterns 0.81 0.80 <0.001* 
 Recognising if more tired than usual 0.99 0.59 <0.001* 
 Recognising changes in breathing 1.06 0.56 <0.001* 
 Recognising the development of a cough 1.03 0.69 <0.001* 
 Recognising signs of fluid retention 1.07 0.69 <0.001* 
 Recognising the effects of tablets 0.63 0.87 <0.001* 
Managing symptoms, 
emotions and social 
effects 
    
 I am not as active as I could be  0.67 1.00 <0.001* 
 Going out as much as I can 0.80 0.82 <0.001* 
 Positive outlook 1.02 0.74 <0.001* 
 Making an effort to see family and friends 0.97 0.71 <0.001* 
 Rest when I need to 1.08 0.56 <0.001* 
Reporting and seeking 
help 
    
 Reporting changes in health 0.41 1.08 <0.001* 
 Reporting effects of medication 0.74 0.78 <0.001* 
 Checking before taking other medication 0.85 0.84 <0.001* 
 Seeking advice if questions or concerns 
 
1.08 0.66 <0.001* 
 
There was a high level of agreement for all recommended self-care behaviours in all 
domains. Only the lifestyle adherence item of taking regular exercise was not significantly 
significant (p = 0.886).  Participants reported high levels of medication adherence with 
forgetfulness, choosing not to take medication or changing the dose or time, infrequently 
described. As a result, the total self-care score was high in this sample (mean 24.64, SD ± 
8.75, range -52 to +52, p = <0.001). These results are discussed further in Chapter seven. 
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6.4.6 Relationships between socio-demographic and illness-related characteristics 
and self-care 
 
From the literature a number of relationships between socio-demographic and illness-related 
factors and self-care were hypothesised. Higher education level and high levels of social 
support were expected to enhance self-care. Conversely, low economic status and the 
presence of co-morbidities may limit self-care. Gender and age may be related to self-care 
but there is conflicting evidence in relation to the nature of the relationship. Similarly, 
increased severity of heart failure, as measured by the NYHA, may be either a motivating or 
limiting factor in self-care.  
 
In this analysis, categorical variables of socio-demographic and illness-related characteristics 
were analysed for their relationship to self-care using Chi-squared (X2). Self-care was first 
converted into a categorical variable by dividing total scores either side of the median of 
23.00. Scores ≤ 23.00 were categorized as low self-care and those >23.00, high self-care. 
The median was chosen so that categories were equal and frequencies were sufficiently high 
for X2 analysis.  As described in section 6.4.2, socio-demographic categories with too few 
cases were excluded or combined.  
 
Following this analysis, no statistically significant relationships were found between self-care 
and gender (X2 = 0.10, df = 1, p = 0.75), the presence of co-morbidities (X2 = 0.59, df = 1, p = 
0.44), NYHA classification (X2 = 2.04, df = 2, p = 0.56), social situation (X2 = 0.13, df = 1, p = 
0.720, qualifications (X2 = 0.56, df = 1, p = 0.45) or occupation (X2 = 0.01, df = 1, p = 1.00). 
 
In relation to the continuous variables of age and time with the illness and self-care, 
Pearson‟s correlation co-efficients (r) were calculated. Correlation considers the extent to 
which there is a linear relationship between two variables, although it does not indicate cause 
and effect. An example of a parametric test, normal distribution is assumed. The strength of 
the relationship is given by the correlation co-efficient (r).  A positive correlation means that 
as one variable increases the value of the other also increases. Conversely, a negative 
correlation means that as the value of one variable increases, the other decreases.  In a 
perfect correlation, r = ± 1.0. No association is indicated by r = 0.  The meaning of the size of 
the correlation varies between authors but generally, r = ± 0.2-0.4 is considered a weak 
correlation, r = > ± 0.4-0.6 a moderate correlation and r = > ± 0.6-0.8, a strong correlation 
(Coolican, 2009). P values indicate the statistical significance of any relationships. In this 
analysis, no statistically significant correlations were found between age (r = -0.04, p = 0.78) 
or time with illness (r = -0.15, p = 0.19) and self-care. 
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In conclusion, no relationships were found between socio-demographic or illness-related 
characteristics and self-care in this sample which in general, is in contrast to other published 
studies. The reasons for this are discussed in Chapter seven, however, it is speculated that 
as the main purpose of the SDQ was to describe the characteristics of the sample, rather 
than determine relationships between these variables, the study may have not been 
adequately powered to determine these relationships.  
 
6.4.7 Relationships between illness representations and treatment beliefs  
The CSM assumes that beliefs are not independent but related to each other and organized 
into clusters (Cameron and Moss-Morris, 2004; Leventhal et al, 1997). For example, the 
belief that the illness will last a long time is likely to be associated with a belief in more 
serious consequences and an illness which cannot be cured. In relation to treatment beliefs, 
concerns may be expected to correlate with the belief that medication use impacts on 
lifestyle. Illness representations are also expected to be related to treatment beliefs according 
to Horne (1997), for example, a belief in the necessity of medication may be related to a 
strong belief that the illness can be controlled by medication.  
 
In order to determine any relationships between beliefs, Pearson‟s correlation co-efficients (r) 
were calculated and presented in Table 6.16. It can be seen that a large number of 
statistically significant correlations were found which were moderate (r > ± 0.4 – 0.6) or weak 
(r = ± 0.2 - 0.4) in strength. Although all statistically significant correlations are presented 
here, only those correlations described as moderate are discussed, as Harris and Taylor 
(2008) argue that even very weak correlations can achieve statistical significance in large 
samples. Therefore, the question arises about whether such weak correlations are 
meaningful. Those relationships, which are believed to be most important, are discussed 
further in Chapter seven. 
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Table 6.16 Correlations Between Illness Representations, Treatment Beliefs and Self-Care 
 
 
 
 
** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-tailed)
Identity 
Timeline 
(acute/ 
chronic) 
Con-
sequences 
Personal 
control 
Treatment 
control 
Timeline 
(cyclical) Coherence Emotional  
   
Necessity  Concerns Knowledge 
Social 
Influence 
Impact 
on 
Lifestyle  
Self-
care  
Identity 1              
Timeline 
(acute/chronic) 
 
0.12 1             
Consequences 
 
0.47** 0.45** 1            
Personal control 
 
-0.19 -0.04 0.03 1           
Treatment 
control 
 
-0.24* -0.15 -0.21* 0.40** 1          
Timeline 
(cyclical) 
 
0.28** -0.03 0.15 -0.15 -0.28** 1         
Coherence 
 
0.16 0.30** 0.06 0.23** 0.33** -0.14 1        
Emotional 
 
0.60** 0.09 0.40** -0.17 -0.20* 0.38** -0.04 1       
Necessity 
 
0.37** 0.35** 0.28** 0.04 0.04 -0.04 0.24** 0.19* 1      
Concerns 
 
0.32** 0.05 0.31** -0.28** -0.29** 0.30** -0.21* 0.50** 0.09 1     
Knowledge 
 
0.17 0.21* 0.02 0.23** 0.25** -0.14 0.36** -0.03 0.34** -0.33** 1    
Social Influence 
 
0.26* -0.17 0.03 -0.18* -0.23** 0.09 -0.16 0.22* 0.02 0.20* -0.33** 1   
Impact on 
lifestyle 
 
0.09 0.01 0.15 -0.16 -0.19* 0.32** -0.01 0.18* -0.08 0.50** -0.36** 0.29** 1  
Self-Care 0.17 0.21* 0.25** 0.18 0.27** -0.22* 0.39** 0.07 0.45** -0.14 0.51** -0.23* -0.39** 1 
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A number of moderate and weak correlations were found between illness representations, 
which were statistically significant. The number of symptoms (identity) correlated with a 
negative emotional response (r = 0.60, p ≤ 0.01).  That is, the higher the number of 
symptoms, the greater the emotional impact, indicating the emotional burden associated with 
this complex condition. However, it may also suggest that those individuals with depression 
or anxiety, for example, attribute more symptoms to their illness. Similarly, the number of 
symptoms correlated with the belief that the illness had serious consequences (r = 0.47, p ≤ 
0.01), indicating that the presence of a high number of symptoms which could be attributed to 
heart failure, resulted in the construction of a serious model of the illness. The belief that the 
illness had serious consequences was also correlated with a belief that the illness was a 
chronic or long-term condition (r = 0.45, p ≤ 0.01) again, describing the serious nature of the 
illness. All correlations are illustrated in Figure. 6.4. 
 
Figure 6.4 Relationships Between Illness Representations 
Key 
 
p ≤ 0.01    
              weak correlation (r = ± 0.2-0.4),                 
              moderate correlation (r ± >0.4-6.0) 
 
 
As with illness representations, a number of correlations were found between treatment 
beliefs (Figure 6.5). A moderate correlation was found between concerns about medication 
and the impact of medication use on lifestyle (r = 0.50, p ≤ 0.01). This is not surprising given 
Emotional Response 
Identity 
Coherence Cyclical Timeline 
Treatment Control Personal Control 
Consequences 
Chronic Timeline 
r = 0.38 
r = 0.40 
r = 0.47 
 r = 0.45 
r = 0.28 
r = 0.30 
r = - 0.28 r = 0.33 r = 0.23 
r = 0.40 
r = 0.60 
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Chronic Timeline 
Identity 
Emotional Response 
Necessity 
Concerns 
Medication Knowledge 
Consequences 
Personal Control 
Treatment Control 
Cyclical Timeline 
Impact of Medication 
Use on Lifestyle 
r = 0.36 
r = 0.24 
r = 0.28 r = 0.35 
r = 0.37 
r = 0.32 
r = -0.28 
r = 0.32 
 r = 0.30 
r = 0.50 
r = -0.29 
r = 0.25 
Coherence 
that this domain can be considered a practical, „real-life‟ example of concerns, as suggested 
by the Factor analysis of the MUHFQ with one item cross-loading with these two domains.   
 
Figure 6.5 Relationships between Treatment Beliefs 
 
 
One moderate, positive correlation was found between illness representations and treatment 
beliefs. A negative emotional response to the illness correlated with concerns about 
medication (r = 0.50, p ≤ 0.01) indicating that worries about side-effects and drug interactions 
for example, may result  in  more general fears and anxieties about the illness or vice versa. 
All relationships are summarised in Figure 6.6. 
 
Figure 6.6 Relationships between Illness Representations and Treatment Beliefs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medication Knowledge 
Necessity 
Social Influences on 
Medication Use 
Concerns 
Impact of Medication on 
Lifestyle 
 r = 0.34 r = - 0.33 
 r = 0.50 
r = - 0.36 r = -0.33 
r = 0.29 
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6.4.8  Relationships between gender and treatment beliefs 
From the qualitative data, discussed in Chapter four, it was hypothesised that social 
influences on medication use were influenced by gender in that men reported greater spousal 
influences in practical medication management. It was further suggested that this influence 
had negative implications for perceived medication knowledge. To determine the influence of 
gender on social influences on medication and medication knowledge, independent t-tests 
were carried out. An independent t-test assumes that there is no difference between the 
means of two populations. That is, there is no difference between men and women in relation 
to social influences on medication use and perceived medication knowledge. The results of 
this analysis are presented in Table 6.17. 
 
Table 6.17 Relationships Between Social Influences on Medication Use, Medication 
Knowledge and Gender 
 
 Number of 
Participants (n) 
Mean SD (±) t df p 
 
Social Influences on medication use 
 
Male 111 -2.46 2.50 2.25 151 0.03 
Female 42 -3.43 1.99    
 
      
Medication Knowledge 
 
Male                            113                      3.78               2.14               -0.54                 154                0.59 
Female                          43                      3.98               1.80 
 
Male participants reported greater social influences on medication use (mean = -2.46, range -
6 to +6, SD ± 2.50) than did females (mean = -3.43, range SD ± 1.99) and this difference was 
statistically significant (t = 2.25, 151 df, p = 0.03). This supports the findings of the interview 
data than men may be more reliant on family members, especially spouses for medication 
management.  
 
However, this did not impact significantly on perceived medication knowledge since, although 
females reported greater knowledge (mean = 3.98, range -10 to +10, SD ± 1.83) than men 
(mean 3.78, ±SD, 2.14), this difference was not statistically significant (t = -0.54, 154 df, p = 
0.59).  
 
6.4.9 Relationships between illness representations, treatment beliefs and self-care 
From the literature and according to the CSM, it was hypothesised that the beliefs that the 
illness has a chronic timeline, can be controlled and has serious consequences might result 
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in enhanced self-care in heart failure. A high number of symptoms (identity) may reduce self-
care. The specific symptom of daytime sleepiness was predicted to reduce the ability to self-
care. Lack of illness coherence and negative emotions such as depression or anxiety may 
also result in poor self-care.  
 
There is limited published evidence for the influence of treatment beliefs on self-care in heart 
failure although it is hypothesised, here, that strong necessity beliefs, few concerns, high 
perceived medication knowledge and limited impact of medication use on lifestyle may be 
related to enhanced self-care. Social influences on medication use may enhance adherence 
through practical support in medication management or conversely, may negatively influence 
self-care when family and friends hold more negative views of medication.  
 
In this analysis, two factors were moderately, positively correlated with self-care: knowledge 
about medication (r = 0.51, p ≤ 0.01) and a belief in the necessity of medication (r = 0.45, p ≤ 
0.01). A number of other weak but statistically significant correlations were noted. All 
correlations are presented in Figure 6.7. A necessity-concerns differential was calculated 
(necessity minus concerns) since Horne et al (1999) suggest this may be a better predictor of 
behaviour that either necessity or concern beliefs alone. The correlation with self-care was r = 
0.38 (p ≤ 0.01), that is, weaker than necessity beliefs alone. From this analysis, treatment 
beliefs appeared to have greater influence on self-care than illness representations, although 
illness coherence was the next most strongly correlated belief with self-care (r = 0.39, p = 
0.01). 
  
In relation to specific symptoms, only sexual difficulties was weakly, negatively correlated with 
self-care (r = -0.22, p ≤ 0.05), that is, the perception that sexual difficulties was a symptom of 
heart failure was related to poor self-care. Although this weak correlation might have occurred 
by chance, this is a finding which has not been documented in other studies. There were no 
significant correlations between beliefs about specific causes of the illness and self-care 
which is consistent with the finding that participants were unable to identify causative factors. 
Those relationships which are most strongly correlated with self-care are discussed, in detail, 
in Chapter seven.  
 
186 
 
 
 
 
 
Figure 6.7 Relationships between Illness Representations, Treatment Beliefs and Self-Care 
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Stepwise multiple regression was used to determine those factors most strongly predictive 
of self-care. Unlike correlation co-efficients, regression assumes one variable precedes 
another. In stepwise regression, a list of independent (predictor) variables are entered and 
the program selects the order in which the variables are added (Pallant, 2010). Before 
analysis, the adequacy of the sample size was considered. Tabachnick and Fiddell (2007) 
suggest that the sample size should be greater than 50 + (8 x the number of predictor 
variables). In this analysis 9 predictor variables were included, as discussed below. 
Therefore, 50 + (8 x 9) = 122, which is within the sample size of 169 in this analysis.  
 
Those illness representations and treatment beliefs which had been found to correlate 
significantly (p < 0.05) with self-care in earlier analysis were included in the regression. 
First, the illness representations of consequences, coherence, treatment control, timeline 
(acute/chronic) and timeline (cyclical) were included. This constituted model 1 of the 
regression. The treatment beliefs of necessity, medication knowledge, social influences on 
medication use and the impact of medication use on lifestyle were then also added (model 
2). Model 2, therefore consisted of both illness representations and treatment beliefs.  
 
From this analysis, illness representations alone (model 1), accounted for 23% of the 
variance (Adjusted R2 = 0.23, F = 6.77, p = <0.001). Model 2, the final regression model 
was highly significant and explained 46% of the variance (Adj. R2 = 0.46, F = 9.93, p = 
<0.001) (Table 6.18).   
 
Table 6.18 Regression Analysis of Factors Predictive of Self-Care 
 
 
Model R R 
Square 
Adjusted 
R Square 
F p 
1 0.52 0.27 0.23 6.77 <0.001 
2 0.71 0.51 0.46 9.93 <0.001 
 
 
The standardised coefficients (Beta) showed that three of the variables were also 
significant. These were perceived medication knowledge (β = 0.319, p = 0.003), the belief 
in the illness having serious consequences (β = 0.258, p = 0.008) and the impact of 
medication use on lifestyle (β = -0.231, p = 0.03) (Figure 6.8).  
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Figure 6.8 Beliefs Predictive of Self-Care 
 
 
This analysis demonstrates that both illness representations and treatment beliefs are 
significant predictors of self-care, which confirms the main hypothesis of the study. In 
particular, self-care is enhanced when perceived knowledge about medication is high, 
when there is a belief that heart failure has serious consequences and when there is 
minimal impact of medication use on lifestyle. The implications of these findings are 
discussed in Chapter seven. 
 
6.5 CONCLUSION 
 
In conclusion, this chapter has considered the methods and results of phase two, the main 
survey. 169 sets of questionnaires were completed, representing a response rate of 
50.4%, suggesting the study was sufficiently powered to achieve statistically significant 
results. The questionnaires were examined for internal consistency using Cronbach‟s 
alpha (α). In the IPQ-R (HF), all domains demonstrated satisfactory reliability. In the 
MUHFQ, again all domains demonstrated satisfactory reliability, although it should be 
noted that the impact of medication use on lifestyle domain demonstrated only moderate 
reliability of α = 0.56. Factor analysis supported the proposed 5-factor structure of the 
MUHFQ. In the LAYHFQ, internal consistency was demonstrated for the questionnaire as 
a whole but not for a number of individual domains, with lifestyle adherence (α = 0.13) and 
managing symptoms and the emotional and social consequences of the illness (α = 0.48), 
demonstrating unsatisfactory internal consistency. Factor analysis also failed to support 
the proposed 5-factor structure. The overall reliability and validity of the questionnaires is 
discussed further in Chapter seven. 
 
The socio-demographic and illness-related characteristics of the sample have been 
described. The extent to which the sample is representative of the heart failure population 
is considered in the following chapter.  
ENHANCED  
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Illness representations, treatment beliefs and self-care have been described, which 
addresses the first aim of the study which was to explore these beliefs and behaviours in 
this population. In summary, a high number of symptoms were reported with the illness 
being described as a chronic or long-term condition, with serious consequences. A high 
degree of both personal and treatment control was described with participants agreeing 
that the illness „made sense‟ to them. However, participants were largely unable to 
positively identify the cause of their heart failure with only ageing and stress or worry 
identified as a likely causes. Participants did not report negative emotions, such as 
depression or anxiety, as a result of the illness. A strong belief in the necessity of 
medication was described with few concerns. Social influences on medication use and the 
impact of medication use on lifestyle were also infrequently described. Total self-care was 
reportedly high for all behaviours, with the exception of taking regular exercise. Non-
adherence to medication, both intentional and unintentional was infrequently described. 
 
A number of moderate, positive correlations between beliefs were found, namely, the 
perceived number of symptoms and a negative emotional response; the number of 
symptoms and the belief that the illness has serious consequences; a chronic timeline and 
the belief that the illness has serious consequences; a negative emotional response to the 
illness and concerns about medication and finally, the belief that medication use impacted 
on lifestyle correlated with concerns about medication. In relation to self-care, a belief in 
the necessity of medication and perceived medication knowledge were most strongly 
correlated with self-care. A number of other weak, but statistically significant correlations 
were found, most notably the symptom of sexual difficulties was related to poor self. No 
relationships were found between socio-demographic and illness-related factors and self-
care, although men reported greater social influences on medication use, compared to 
women.   
 
Using multiple regression, illness representations and treatment beliefs were both 
significantly predictive of self-care. Of greatest significance were perceived medication 
knowledge, the belief that heart failure had serious consequences and the impact of 
medication use on lifestyle. The following chapter discusses these findings in relation to 
the literature, the CSM and the interview findings and considers the implications for 
practice. 
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CHAPTER SEVEN:  DISCUSSION OF RESULTS AND CRITIQUE OF THE 
METHODOLOGY 
 
The purpose of this chapter is to discuss the results of the study in relation to the literature 
and the aims of the research and to critique the methodology and methods employed. In 
summary, the aims of the research were to explore illness representations, treatment 
beliefs and self-care in heart failure and to determine any relationships between these 
beliefs and behaviour. In relation to the methodology, the strengths and limitations of the 
mixed method research design, sampling strategies, data collection and methods of 
analysis are discussed. A judgement is made on the reliability and validity of the 
questionnaires and suggestions are given for their further development. The use of the 
theoretical framework (the CSM) and the concept of self-care according to Dickson et al 
(2006) are also considered. Finally, the implications for nursing and healthcare practice 
and opportunities for future research are discussed. 
 
7.1 ILLNESS REPRESENTATIONS, TREATMENT BELIEFS AND SELF-CARE  
 
7.1.1 Illness representations 
Participants reported an average of over nine symptoms believed to be due to heart 
failure. This is consistent with the qualitative findings and characteristic of the nature of 
the condition which affects almost all body systems. Such diverse and debilitating 
symptoms impact on the patient and their families in many areas of daily living such as 
physical activity and emotional and social well-being. Cherrington et al (2006), using the 
IPQ-R, found an average of 6.6 symptoms which patients believed were related to their 
heart failure, although as the IPQ-R was not adapted for use in heart failure the number of 
symptoms reported here may be an underestimate. Similarly, Morgan (2008) using the 
IPQ-R, concluded that patients with heart failure experience fewer symptoms than those 
with other long-term conditions. Again, that the identity scale in this study was not specific 
to heart failure, may explain this lower score. 
 
Breathlessness and fatigue were the most prevalent symptoms reported although daytime 
sleepiness, loss of strength, swollen ankles, dizziness, sleep difficulties, wheeziness, 
weight gain and sexual difficulties were reported by over half of the respondents. This is 
consistent with the findings of Morgan (2008) who, using the IPQ-R, found that loss of 
strength, breathlessness and fatigue were the most commonly reported symptoms. 
 
All of these are recognised symptoms of heart failure (Ahmed et al, 2004; Fonseca et al, 
2004; Badgett et al, 1997; Davie et al, 1996; Harlan, 1977) and, with the exception of 
swollen ankles, were also described by the interview participants. Interestingly, the high 
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prevalence of sexual difficulties in the survey might suggest under-reporting of this 
potentially sensitive symptom by the interview sample. It is important, therefore, that 
healthcare professionals actively seek to assess the presence of this symptom and its 
impact on the individual and their partners as patients may be reluctant to bring this 
subject up themselves during a clinical consultation. 
 
Chest pain and palpitations are generally considered to be symptoms of CHD and cardiac 
arrhythmias but were commonly identified as symptoms of heart failure by the survey 
participants. This suggests a high incidence of cardiac co-morbidities and perhaps more 
importantly, a limited ability to differentiate between the symptoms of heart failure and 
other cardiac conditions. A high incidence of cardiac co-morbidities is reported by Thomas 
and Valezquez (2005) and Cowie et al (1999) who found that CHD is three times more 
common in those with heart failure than in the wider population with atrial fibrillation (AF) 
found in 30% of patients. In this sample it was not possible to confirm the presence of co-
morbidities without access to medical notes. Since many participants described symptoms 
of CHD and arrhythmias but did not list these conditions as co-morbidities, a lack of a 
clear illness identity is suggested. This is supported by the qualitative data where some 
participants were unable to differentiate symptoms of their illness from other co-
morbidities, particularly those of a cardiac nature, the effects of medication or an 
emotional response such as panic attacks.  
 
According to the CSM, identity not only relates to the symptoms associated with the 
illness but also to the illness diagnosis or label. From the interview data, most participants 
were unable to clearly relate the label „heart failure‟ to their understanding of their 
symptoms or were confused by a number of complex labels. This unclear illness identity is 
also suggested by Horowitz et al (2004) who describe few patients labelling their illness as 
heart failure and an inability to isolate symptoms of heart failure from other conditions. 
Since there are significant differences in the aetiology, symptoms and management of 
different cardiac conditions, this lack of a clear illness identity may lead to the 
development of misconceptions about heart failure and its treatment, which may result in 
disagreement or conflict between patients and healthcare professionals (Kleinman, 1988). 
  
In relation to causal representations, there was a general lack of agreement that the 
illness was caused by the factors listed in the IPQ-R (HF). Only ageing and stress or 
worry were positively identified as causes with only ageing statistically significant.  This 
supports the assertion by Bauman et al (1989) and Leventhal et al (1997) that individuals 
seek to determine if symptoms or functional changes reflect a disease process or can be 
attributed to age or stress – the so-called „age-illness‟ and „stress-illness‟ rules. It seems 
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that, perhaps due to the presence of some relatively non-specific symptoms such as 
fatigue and loss of strength, and the disease trajectory, heart failure can reasonably be 
attributed to advancing age.  According to Leventhal et al (1997), stress is a widely 
accepted cause of disease amongst patients and ambiguous or non-specific symptoms in 
the presence of life stress are readily associated, as found in both the survey and 
interview data in this study. Stress as a cause of heart failure was also cited in the study 
by Horowitz et al (2004). In contrast, Morgan (2008), using the IPQ-R, found that the belief 
that the illness was hereditary was identified as the most likely causative factor, although 
stress and worry and ageing were the next most frequently cited causes.  
 
The DH (2003) suggests that most cases of heart failure in the UK are caused by CHD. In 
this study, the inability of patients to differentiate CHD from heart failure, meant, 
unsurprisingly, that they also failed to recognise CHD as a potential cause of their illness, 
as indicated by the lack of agreement that the illness was caused by „A previous heart 
attack’. Similarly, in the interview sample, CHD was not identified as a causative factor.  
 
The overall lack of agreement that the illness was caused by the suggested factors might 
indicate that some items were missing from the IPQ-R (HF).  All causes identified by the 
interview participants were included in the scale, as well as those commonly recognised 
from a medical perspective or identified in other published studies. The IPQ-R (HF) also 
included an open question giving the opportunity for participants to identify any factors 
which were not listed. From this analysis, only two further causative factors were identified 
- pregnancy and loneliness, each of which was cited only once. It seems unlikely, then, 
that any important causative factors were omitted in the IPQ-R (HF). The inability of heart 
failure patients to identify causal factors was also found by Cherrington et al (2006) using 
the IPQ-R and Horowitz et al (2004). It is apparent, therefore, that there is a difference 
between the biomedical view of heart failure, which is caused primarily by existing CHD, 
and the patient perspective where advancing age and stress or worry are seen as the 
most likely causes. However, in general, the cause of the illness largely remains a 
mystery for most patients.  
  
In relation to timeline, there was a strong belief that heart failure was a chronic illness 
which, given that the average time with the illness was 7.34 years, is perhaps 
unsurprising. The belief that heart failure is a long-term condition represents an accurate 
understanding of the nature of the illness according to a biomedical model and is 
consistent with the qualitative findings and those of Morgan (2008), Cherrington et al 
(2006) and Voelmeck (2006). In contrast, Horowitz et al (2004) found a belief in an acute 
timeline with participants not recognising that their illness deteriorated over time.  
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The illness was not generally seen as cyclical although some interview participants 
described „good days and bad days‟ in relation to worsening symptoms or negative 
emotions. That symptoms did not entirely disappear might explain the lack of agreement 
with a cyclical timeline. This represents an accurate and realistic view of the nature of the 
illness. In contrast, Cherrington et al (2006) concluded that heart failure was perceived to 
be cyclical in nature. However, it should be remembered that this study included a very 
small sample (n = 22), a point acknowledged by the authors. 
 
The illness was perceived to have serious consequences which is supported by the 
qualitative findings and consistent with the findings of Cherrington et al (2006) and 
Voelmeck (2006). The interview findings here, revealed that the nature of these 
consequences was largely physical and social. Although negative emotions were 
described, these were categorised as an emotional response rather than consequences, 
according to the CSM.  In terms of physical consequences, poor exercise tolerance due to 
symptoms of breathlessness and fatigue were described with a resulting inability to carry 
out household chores. Mahoney (2001) also identified physical disruption as a significant 
consequence of the illness. Similarly, Jeon et al (2010) in a systematic review of the 
literature found that physical restrictions due to breathlessness and fatigue where 
commonly identified in qualitative studies. Withdrawal from social situations and 
subsequent social isolation was described by the interview participants. Mahoney (2001) 
and Jeon et al (2010) similarly describe a reliance on close family members but 
disengagement from wider social networks. The implications of living with heart failure for 
the individual and their family and friends can therefore be wide-ranging and disabling, 
affecting many aspects of life.  
 
There was a strong belief in both personal and treatment control in this study, as also 
described by Morgan (2008), Cherrington et al (2006) and Voelmeck (2006). Although a 
belief in medication controlling the illness and its symptoms was described in the interview 
data, personal control was less well articulated with few participants describing a high 
degree of control over the illness. Rather, personal control was described in terms of 
maintaining a positive attitude which suggests a strategy for controlling negative emotions 
rather than the illness itself. It may be that the belief in personal control describes 
strategies to control negative emotions rather than symptoms or the illness itself, which is 
best controlled by medication. This may explain the contrasting findings of Albert and 
Zellar (2007) who, using the SIBHFT, found patients had little perceived control over their 
symptoms, and Horowitz et al (2004) who also concluded that participants had little 
personal control as demonstrated by an inability to prevent exacerbation of symptoms.  
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There was a high level of reported illness coherence which was also found by Cherrington 
et al (2006), using the IPQ-R. However, when data are collected by qualitative methods, 
the opposite conclusion seems to be reached. From the interview data, although most 
participants agreed that their illness made sense to them, this was frequently not 
demonstrated in other responses. For example, a lack of illness coherence was 
demonstrated through an inability to identify the cause of the illness and a lack of a clear 
illness identity. Other qualitative studies (Horowitz et al, 2004 and Mahoney, 2001) 
similarly report a lack of illness coherence. It may be that two subtly different concepts of 
coherence are being described – the belief that the illness makes sense and 
demonstrable illness coherence. The belief that the illness makes sense, as measured by 
the IPQ-R, seems to be more related to self-efficacy beliefs (Bandura, 1977) or the 
confidence in one‟s ability to understand the illness through agreement with statements 
such as „I have a clear picture or understanding of my illness’. Illness coherence may also 
be demonstrated through the accuracy of beliefs linked to behaviour. Horowitz et al (2004) 
describe participants not recognising heart failure as a chronic illness and not being able 
to minimise fluid-build up through specific self-management behaviours as an illustration 
of a lack of illness coherence. This may explain the different findings according to the 
methodology used, where a coherent picture of the illness is reported in quantitative 
studies using the IPQ-R, but in qualitative studies there is a lack of demonstrable 
coherence. It may be important, therefore, to know how illness coherence is defined and 
measured in published studies. Perhaps more importantly, the relationship between the 
different definitions of coherence and self-care behaviour should be examined as different 
interventions may be needed to promote self-efficacy beliefs or correct misconceptions. 
 
In relation to the emotional response to the illness, few negative emotions were reported 
in the survey, although this was not statistically significant. Morgan (2008) and 
Cherrington et al (2006) similarly reported neutral feelings about the illness. The survey 
findings are in contrast to the interview data where negative emotions such as depression, 
anxiety, panic, loss of confidence, anger, frustration and guilt were widely reported. Strong 
negative emotions were also found in qualitative studies by Jeon et al (2010), Horowitz et 
al (2004), Zambroski (2003) and Mahoney (2001). The reasons for these different findings 
are speculative but may reflect a degree of self-selection by the interview participants in 
that those experiencing negative emotions perceived some benefit in talking about their 
illness and so were more likely to agree to take part in the interview. Alternatively, it is 
possible that talking about the experience of living with heart failure in an in-depth 
interview may have facilitated the expression of more negative emotions. It might be that 
uncovering deep, personal emotions is more likely when individuals are given time to 
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express how they feel in a safe environment in the presence of a sympathetic, active 
listener.  
 
It is difficult, therefore, to accurately determine the extent of the emotional response to the 
illness as it seems to be dependent on the methodology, to some extent. However, what 
is clear is that a wide range of emotions may be experienced with some patients 
experiencing severe emotional distress. Depression has been widely cited in the literature 
either as a symptom, a co-morbidity or an emotional response (Holzapfel et al, 2009; 
Riegel et al, 2007b; Dickson et al, 2006; Lesman-Leegte et al, 2006; Leventhal et al, 2005 
and Cowie et al, 1999). Other emotions such as anxiety and panic may be highly disabling 
with significant social consequences, as described by some interview participants. 
 
In conclusion, from an integrated discussion of the qualitative and quantitative findings, 
participants attributed a high number of symptoms to heart failure which represents a 
significant symptom burden. Those symptoms identified were largely consistent with the 
medically defined disease. Sexual difficulties may be being under-reported with patients 
finding it difficult to talk about this sensitive issue. This has implications for practice in that 
open discussion may need to be facilitated by healthcare professionals.  
 
There was a lack of a clear illness identity, particularly in relation to other cardiac 
illnesses, with individuals unable to clearly differentiate between CHD, arrhythmias and 
heart failure in terms of diagnosis, symptoms and causative factors. In addition, other co-
morbidities, the effects of medication and emotional responses, especially panic attacks, 
made the identification of the illness difficult. There was a lack of certainty in relation to the 
cause of the illness with advancing age and stress or worry seen as the most likely 
causative agents. This is in keeping with other long-term conditions and articulated by the 
age-illness and stress-illness rules (Leventhal et al, 1997).  
 
The illness was believed to be chronic in nature with serious consequences which is 
consistent with the medically defined view of heart failure. Consequences were physical, 
social and psychological in nature, reflecting a significant impact on the lives of patients 
and their families. A high degree of both personal and treatment control was reported 
although personal control was less clearly described in the interview sample where it was 
described in terms of controlling negative emotions rather than physical symptoms. 
Survey participants described a high degree of illness coherence although this was not 
generally demonstrated in the interview sample or reported in other qualitative studies. It 
is suggested that illness coherence may be described as a self-efficacy belief or 
demonstrated through the relationships between illness representations and behaviour.  
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Few negative emotions were reported by the participants in the survey which may reflect 
the methodology used either due to selection bias in the interview sample or the increased 
likelihood of deep emotions being expressed in a qualitative interview. This is supported 
by published literature where negative emotions are vividly described in qualitative studies 
but few negative emotions are reported in questionnaire surveys. As such, the prevalence 
of negative emotions, such as depression or anxiety in heart failure, may be difficult to 
determine. However, what is clear is that the emotional impact of the illness can be severe 
and debilitating for some patients.  
 
7.1.2 Treatment beliefs  
From the interview data, five domains of treatment beliefs were identified. Necessity and 
concern beliefs, as described by Horne et al (1999) in the BMQ, and three additional 
domains relating to perceived knowledge about medication, social influences on 
medication use and the impact of medication use on lifestyle.  
 
In relation to necessity beliefs, there was a strong belief in the necessity of medication. 
This is supported by the interview data where there was a perception that symptoms 
improved as a result of taking medication. Although few studies have addressed treatment 
beliefs in heart failure, Ekman et al (2006) found that 82% of patients believed that taking 
medication would make them feel better, which also suggests strong necessity beliefs.  
 
However, these beliefs were also accompanied by some concerns about medication. In 
the interview data, concerns appeared to be more widespread than in the survey, 
suggesting that the interview participants either held a more negative view of their 
medication or were more likely to express concerns in an interview. This is consistent with 
the discussion above, relating to the prevalence of negative emotions, in that a more 
negative view of the illness and its treatment was expressed in the qualitative interviews.  
 
Concerns assessed in the survey included general worries about medication and fears 
about side-effects, drug interactions and dependency. Drug dependency was not 
identified as a concern in the interview sample and is not generally seen as an issue 
related to heart failure medication by healthcare professionals. However, this item was 
included due to the decision to retain the BMQ intact. The nature of concerns, in the 
interview sample, focused on perceived medication side-effects and drug interactions with 
other prescribed medication and medications bought „over the counter‟. Concerns about 
the side-effects of heart failure medication were also found by Riegel and Carlson (2002), 
Rogers et al (2002) and Stromberg et al (1999). In the interview sample, these concerns 
were enhanced by reading the patient information leaflets contained within the medication 
boxes, a finding echoed by Rogers et al (2002). Higher doses also seemed to be related 
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to more concerns in the interview sample. The practice of up-titration of many heart failure 
drugs, described by NICE (2010) as a „start low, go slow‟ approach to medication 
management, may mean that negative effects were more likely to be associated with an 
increased dose. Psychological support and education about the effects of medication 
would, therefore, seem to be especially important during the process of up-titration. 
 
Perceived knowledge about medication including drug actions, names, doses and timing 
of administration was reportedly good. It is important to emphasise, however, that the 
accuracy of this knowledge was not assessed in the questionnaire which would have 
required cross-checking with medication prescriptions, for example. Medication 
knowledge as assessed here, has more to do with confidence in one‟s ability to 
understand the use of medication, and so may be related to self-efficacy beliefs. 
Perceived medication knowledge has not been assessed in published studies although 
Ekman et al (2006) found that 69% of heart failure patients were knowledgeable about the 
names of medication. It is likely that a relationship exists between the accuracy of 
medication knowledge and self-efficacy beliefs relating to that knowledge, although this 
requires further investigation. 
 
From the survey data, few social influences in terms of practical help with medication 
management or the beliefs of others were reported. Although, therefore, not a widespread 
influence, the interview findings highlighted a group of patients who were dependent on 
others, particularly wives, for medication management. This hypothesis was tested in the 
quantitative survey where men reported significantly more social influences on medication 
use than women. This supports the view that the management of the illness can be a 
shared responsibility between husband and wife and highlights the reliance some men 
with heart failure have on their partners in order to take their medication appropriately. 
This has implications for clinical practice in that the loss of that partner, which might be 
expected in older age groups, may make patients particularly vulnerable to unintentional, 
non-adherence as a result of a reduced ability to take medication as prescribed. Additional 
support from other family members, pharmacists and healthcare professionals may, 
therefore, be essential.  
 
A limited impact of medication use on lifestyle was reported in the survey, however, since 
the internal consistency of this domain was only moderate at α = 0.56, this result should 
be interpreted cautiously. Although related to concerns about medication, this specific, 
negative effect of medication use was reported by some participants in the interview 
sample. Impact on lifestyle primarily related to difficulties in the ability to take medication 
when going out, disruption to sleep and social activities due to the effects of diuretics and 
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the need to frequently monitor the effects of medication, through clinic appointments and 
blood tests. Mahoney (2001) also described the experience of living with heart failure as a 
disruption to daily life, although this was not explicitly related to the use of medication. 
Glaser and Strauss (1967) recognised the work involved in living with long-term conditions 
which can be seen in the effort involved in taking medication frequently and monitoring the 
effects, both of which require adjustments to lifestyle. Although managing the effects of 
diuretics is recognised as disruptive for patients (Nicholson, 2007), no studies have been 
found which address other implications of heart failure medication use on lifestyle. Some 
aspects of the impact of medication are, however, described in HRQoL studies, for 
example Dunderdale et al (2008). It may be that some overlap exists between the social 
and emotional impact of medication use and HRQoL. 
 
In summary, there was a strong belief in the necessity of medication with few concerns 
apparent in the larger sample. Where concerns were described, these were mostly related 
to side-effects, especially at higher doses and enhanced by patient information leaflets. 
Perceived medication knowledge was reportedly high, although it is acknowledged that 
the accuracy of knowledge has not been measured. Although social influences on 
medication use were modest, gender differences were apparent with men being 
particularly reliant on family members. Similarly, the impact of medication use on lifestyle 
was reportedly low, although the need to take medication frequently, the effects of 
diuretics and regular monitoring of the illness and the effects of medication, may be 
particularly problematic for some patients. Overall, this represents a generally positive 
view of medication but one which is balanced against specific medication concerns and 
difficulties in managing the medication regime for some patients. In terms of professional 
practice, the recognition of the burden of the use of medication in heart failure should not 
be underestimated.  
 
7.1.3 Self-care 
Adherence to recommended lifestyle behaviours and medication, monitoring symptoms, 
managing symptoms and the social and emotional effects of the illness and reporting and 
seeking help, were themes derived from the literature and the qualitative data. However, 
with the exception of monitoring symptoms (α = 0.70), internal consistency of these 
domains was not established in the LAYHFQ and Factor analysis failed to support the 
existence of these theoretical divisions. Despite the lack of support for these self-care 
domains, individual behaviours could be analysed for frequencies. Total self-care scores 
were used in determining relationships between beliefs and self-care.  
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From the survey data, total self-care was high which is consistent with that described by 
the interview participants. This high score may reflect the fact that the population was 
drawn from a service with specialist HFN input where participants might reasonably be 
expected to have had greater educational input and enhanced support for self-care. Social 
desirability may also be operating with participants wanting to present themselves in a 
positive light by agreeing with recommended behaviours.  
 
Adherence to all recommended lifestyle behaviours was reportedly high. Those 
behaviours for which there was with the highest agreement were not smoking and drinking 
alcohol within government recommended limits. Those behaviours with lowest reported 
adherence were restricting fluid intake and taking regular exercise, although this was not 
statistically significant.  
 
Not smoking and drinking alcohol within recommended limits might be considered 
behaviours recommended as part of a general healthy lifestyle and not necessarily illness-
related. This is consistent with the interview findings where healthy lifestyle behaviours 
were reported but not those specifically related to heart failure. Restricting fluid intake, 
which is perhaps the most illness-specific behaviour, was less frequently reported. Van de 
Wal and Jaarsma (2007) also found that adherence to a fluid restriction was infrequently 
practiced. This finding seems to support the suggested lack of a clear illness identity and 
coherence in that, whilst those behaviours considered part of the overall public health 
agenda, hence, applicable to the whole population are practised, those behaviours 
specific to heart failure, such as restricting fluid, lack meaning and so are infrequently 
practiced. Taking regular exercise was not generally reported by either the interview or 
survey sample and might be expected given the age of the population, the presence of co-
morbidities and the symptom of reduced exercise tolerance, resulting in a limited ability to 
exercise. Similarly, taking regular exercise was reported by just 27% of patients in the 
study by Morgan (2008).   
 
Adherence to medication was high with limited non-adherence reported. This result is 
consistent with that described in the qualitative sample and findings by Morgan (2008), 
who, using the EHFScBS, found that adherence to medication was reported by 94% of 
participants. Other self-report measures of medication adherence (Ekman et al, 2006; Van 
de Wal et al, 2004 and Granger et al, 2005) also found high adherence to medication. 
However, it has been suggested by some authors that different levels of adherence may 
apply to different medications. For example, Albert (2008) found that adherence to ACEI 
was only 39%. From the qualitative data, some participants reported omitted specific 
tablets due to concerns about side-effects (aspirin) or the belief that they were no longer 
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necessary (statins). Hence, an overall estimate of medication adherence may mask 
individual levels of adherence for different medications. 
 
Intentional non-adherence by omitting tablets or changing doses was infrequently reported 
in this sample. Again, this is consistent with the interview sample where this was 
described by only a minority of participants. Changing the time at which medication was 
taken was more frequently reported and described in both samples. However, this may 
not be an intentional act of non-adherence but a way of managing medication according to 
lifestyle such as taking medication after returning home from shopping, for example. HFNs 
often advocate this practice so this finding perhaps should be viewed as a strategy for 
maintaining adherence rather than an act of intentional non-adherence. 
 
Unintentional non-adherence through forgetfulness was more frequently reported. 
Forgetting to take tablets was also described by some interview participants although the 
fact that this happened on rare occasions was stressed. Dosette® Boxes were used as a 
strategy to aid memory and manage the medication regime, promoting adherence. 
However, cognitive deficits, common in heart failure and advancing age may put patients 
at greater risk of unintentional non-adherence through forgetfulness.  
 
Monitoring deteriorating symptoms such as signs of fluid overload, particularly changes in 
breathing and the development of a cough were commonly cited. Less specific changes 
including changes in sleep pattern were less well recognised. Monitoring the effects of 
medication was the least commonly practised monitoring behaviour. This may be because 
some patients find it difficult to differentiate between symptoms of heart failure and the 
effects of medication, as reported by some participants in the interview sample, as well as 
the belief that monitoring the effects of medication is the responsibility of the doctor or 
nurse. The practice of regular weighing was reported but less frequently than some other 
behaviours. This is higher than that reported by either Morgan (2008) or Van de Wal et al 
(2004) who found that weighing at least once a week was only carried out by 14% and 
52% of patients respectively. Again, the rationale for regular weighing is likely to be 
dependent on a having a clear understanding the nature of the condition, or the illness 
identity, which may be lacking, as previously discussed. 
 
In contrast to the survey data, the interview findings suggested an overall lack of symptom 
monitoring. It may be that „recognising‟ changes, as defined in the LAYHFQ is a different 
concept from actively monitoring symptoms as discussed in the interviews and the 
intended interpretation of this self-care behaviour. In the interview sample, monitoring the 
illness and the effects of medication was seen as the responsibility of health 
professionals. This might explain why, on discussion of the questionnaires with the clinic 
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patients, the term „checking‟ for signs of deterioration, as in the pilot version of the 
LAYHFQ, were not recognisable to patients, prompting a change in terminology. Although 
further exploration of the concept of symptom monitoring in heart failure is, therefore, 
advocated, it is suggested that active monitoring of symptoms and the effects of 
medication may be less commonly practiced that other aspects of self-care.  
 
In terms of managing symptoms and the social and emotional effects of the illness, resting 
when needed was a commonly reported behaviour. Maintaining a positive outlook was 
also seen as important. Making an effort to see friends and family and going out as much 
as possible were also cited. Participants agreed that they were not as active as they could 
be, although, on reflection, the meaning of this question is ambiguous in that it may 
describe reduced exercise tolerance which is a common symptom of heart failure, rather 
than the intended interpretation which was to assess the degree to which participants 
made an effort to keep active. Furthermore, reversing this question may have made it 
more difficult to understand. The concept of managing symptoms and carrying out 
behaviours aimed at maintaining emotional and social well-being, as described here, was 
largely developed from the qualitative data and is consistent with the CSM and the DH 
(2006a) vision of self-care. That these behaviours are also prevalent in the survey data 
suggests this is an important, yet sometimes overlooked aspect of self-care and may 
reflect strategies to maintain or enhance HRQoL.  
 
Finally, in terms of reporting and seeking help, seeking advice in response to questions or 
concerns was the most prevalent help-seeking behaviour. Other behaviours such as 
checking before taking other medication and reporting the effects of medication were less 
commonly practised, although still highly scored. Reporting any changes to health was 
least specific to heart failure and so perhaps least relevant in this population. It might also 
reflect the desire not to be seen as a „nuisance‟ to health professionals in reporting 
insignificant changes to health, which was a concern of some interview patients.  
 
Overall, these findings describe a reliance on health professionals by heart failure 
patients, especially in terms of managing the emotional effects of the illness by seeking 
reassurance when worried or concerned. This is reflected in the CSM in that this help-
seeking behaviour can be viewed as a coping strategy to manage the emotional effects of 
the illness. The need for a trusting relationship between the patient and the nurse, GP or 
pharmacist is implicit in this behaviour. Such a relationship is described as necessary for 
effective self-care by Sabate (2003) for the WHO.   
 
In summary, adherence to recommended lifestyle behaviours, especially those which can 
be considered part of a healthy lifestyle was reportedly, commonly practiced. The 
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behaviour considered most specific to heart failure, namely, restricting fluids was less 
commonly reported, perhaps reflecting a lack of illness coherence. Medication adherence 
was reportedly high with intentional non-adherence such as omitting tablets or changing 
doses, infrequently reported. Unintentional non-adherence through forgetfulness was 
more frequently reported which may reflect a degree of cognitive impairment due to the 
condition or advancing age in some patients. Recognising changing symptoms was 
reported but recognising the effects of medication was the least frequently described 
monitoring behaviour. This may reflect an inability of some patients to differentiate 
between symptoms and medication effects, as suggested by the qualitative data. 
Managing symptoms, specially resting when needed and managing the emotional and 
social effects of the illness, a theme derived from the qualitative date, was reported which 
reflects a vision of self-care according to the DH (2006a). Reporting and help-seeking 
behaviours were highly scored, especially the need to seek reassurance if worried or 
concerned, again suggesting a powerful need to manage the emotional effects of the 
illness.  
 
7.2 RELATIONSHIPS BETWEEN ILLNESS REPRESENTATIONS, TREATMENT 
BELIEFS, SOCIO-DEMOGRAPHIC FACTORS AND SELF-CARE 
 
According to the CSM, illness representations are not independent but related to each 
other or organised into clusters (Cameron and Moss-Morris, 2004; Leventhal et al, 1997). 
In addition, illness representations are expected to be related to treatment beliefs (Horne, 
1997). In this section, firstly the relationships between beliefs are discussed. As only a 
small number of studies have considered illness representations in heart failure and 
almost none have considered treatment beliefs, few comparisons with published literature 
can be made. Most importantly, the CSM also predicts that beliefs influence behavioural 
outcomes. This addresses the main aim of the research, which was to determine 
relationships between illness representations, treatment beliefs and self-care in heart 
failure.  
 
7.2.1  Relationships between beliefs 
Relationships between individual illness representations and treatment beliefs are first 
discussed, followed by a discussion of the relationships between these two sets of beliefs. 
Relationships were determined using Pearson‟s Correlation Co-efficients (r). 
 
A number of moderate and weak correlations were found which were statistically 
significant. These are shown in Table 6.16 and Figure 6.4. However, Harris and Taylor 
(2008) caution that, in large samples, even small, unimportant correlations may be highly 
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statistically significant. Therefore, in general, weak correlations (r ≤ 0.4) are not discussed 
except where they seem to represent an original or important finding.   
 
The number of symptoms (identity) was positively correlated with a number of other 
representations but was most strongly related with a negative emotional response to the 
illness. This means that the greatest emotional impact was felt by those with the highest 
number of perceived symptoms. From the interview data, for some participants, 
depression, anger and frustration resulted from an inability to carry out the activities that 
were important to them due to the presence of physically debilitating symptoms, 
particularly breathlessness and tiredness, illustrating this relationship between symptoms 
and negative emotions. However, it could also be the case that participants experiencing 
negative emotions, such as anxiety or depression, might attribute more symptoms to heart 
failure. Unlike the IPQ-R (Moss-Morris et al, 2002), the IPQ-R (HF) was unable to 
distinguish between a general somatic effect of negative emotions and specific 
perceptions regarding the illness identity due to the need to simplify the identity sub-scale 
for a heart failure population. A moderate, positive correlation was found between the 
number of symptoms and the belief that the illness had serious consequences. It seems 
that the presence of many symptoms, especially those as diverse and debilitating as 
breathlessness, daytime sleepiness and ankle swelling, for example, leads to the 
development of the belief that heart failure is an illness with serious consequences.  
 
A positive correlation was also found between a negative emotional response to the 
illness and the belief in the illness having serious consequences. Hallas et al (2010) also 
found that patients with more negative beliefs about the consequences of their illness had 
greater levels of depression and anxiety. The belief that the illness had serious 
consequences was also moderately, positively correlated with the belief that heart failure 
was a chronic or long-term condition. This might be expected in that the presence of 
symptoms which have persisted for a long time might reasonably represent a serious 
condition. From this, the duration of the illness might, therefore, be related to a belief in a 
chronic timeline and serious consequences. However, this was not found in this study with 
no correlations found between time with the illness and either timeline or a belief that the 
illness had serious consequences. The lack of any relationships may be because few 
respondents had heart failure of short duration. A picture emerges, then, of a belief 
system in which heart failure is perceived as a long-term condition with serious 
consequences and many symptoms, representing a significant emotional burden.  
 
A number of correlations were found between treatment beliefs as shown in Table 6.16 
and Figure 6.5. A moderate, positive correlation was found between concerns about 
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medication and the belief that medication use impacted on lifestyle. Such a relationship is 
perhaps unsurprising given that the impact of medication use on lifestyle can be 
considered a practical application of medication concerns. That these beliefs are related 
was supported by Factor analysis of the MUHFQ where the item, ‘My tablets disrupt my 
life’ cross-loaded onto the concerns sub-scale and the impact of medication use on 
lifestyle sub-scale. It seems that, for some, the use of medication has a detrimental effect 
on everyday activities, leading to concerns about the use of medication.   
 
Perceived medication knowledge correlated with all other treatment beliefs. Perhaps most 
interestingly, medication knowledge was weakly, negatively correlated with perceived 
social influences on medication use. This means that social influences, either through the 
advice of others or perhaps more importantly their practical help in terms of administering 
medication, had the effect of reducing an individual‟s knowledge about medication. This 
was illustrated in the interview data where wives, in particular, took control of medication 
management with resultant abdication of responsibility for medication management by 
their male partners. For example: 
 
„My wife could tell you all about the tablets I’m on, because, I don’t take much notice 
of that. My wife does it’ [P5] 
 
A significant difference was found between gender and social influences on medication 
use with men reporting greater influence. Although men were less confident in knowledge 
about medication that women, this difference was not statistically significant suggesting 
other factors may also be influencing medication knowledge such as complexity of the 
regime or cognitive abilities, for example.  
 
A high degree of perceived medication knowledge was also related to a belief in the 
necessity of medication, fewer concerns and reduced impact of medication use on lifestyle 
suggesting that confidence in one‟s ability to understand the use of medication creates a 
more positive view of medication, although it is acknowledged that these relationships are 
weak. 
 
A number of statistically significant correlations were found between illness 
representations and treatment beliefs (Table 6.16 and Figure 6.6). Specifically, a 
moderate, positive correlation was found between concerns about medication and a 
negative emotional response to the illness so that fears and anxieties were experienced in 
relation to both the illness and medication. Weak, positive correlations were found 
between the necessity of medication and illness representations.  A high number of 
symptoms and a belief in a chronic timeline correlated with a belief in the necessity of 
205 
 
medication, suggesting that the construction of a model of a long-term illness with 
debilitating symptoms fuels the belief that medication is necessary. Medication knowledge 
was associated with increased illness coherence which represents a consistent finding of 
confidence or high self-efficacy in understanding both the use of medication and the 
illness itself.  
 
In summary, illness representations in heart failure cluster around a model of a long-term 
condition with serious consequences and many symptoms, which represents a significant 
emotional burden for some. The belief that medication use impacts on lifestyle is related 
to more general concerns about medication, as expected. Perceived medication 
knowledge relates to a number of other treatment beliefs, with confidence in one‟s ability 
to understand the actions of medication and how it should be taken, promoting a more 
positive view of medication in terms of a stronger belief that medication is necessary and 
fewer concerns. However, when patients relinquish control of medication management to 
others, this knowledge may be threatened.  
 
Negative emotions such as fear, anxiety and depression in relation to the illness go hand 
in hand with concerns about side-effects of medication and drug interactions, a 
relationship which would be expected.  The view that heart failure is a long-term condition 
with many symptoms leads to the belief that medication is necessary for illness control. 
Self-efficacy is apparent in one‟s confidence in making sense of the illness (coherence) 
and in one‟s ability to understand the use of medication (knowledge). 
 
7.2.2 Relationships between socio-demographic factors, illness representations, 
treatment beliefs and self-care 
 
Socio-demographic factors have been found to enhance self-care in a number of studies. 
Therefore, although not a main aim of the study, the relative influence of socio-
demographic factors and beliefs might usefully be considered here. High levels of social 
support, higher economic status, increased length of time since diagnosis and little co-
morbidity have all been reported to enhance self-care (Wu et al, 2007; Gary, 2006; Van 
der Wal et al, 2006; Carlson et al, 2001; Rockwell and Riegel, 2001; Evangelista and 
Dracup, 2000). The relationship between age and self-care is less clear with the 
suggestion that advancing age limits ability to self-care (Cline et al, 1999). However, 
Chriss et al (2004) and Evangelista et al (2003) found that increasing age was an 
independent, significant predictor of self-care with elderly patients demonstrating greater 
adherence to medication, diet and exercise advice than younger patients. Similarly, 
conflicting findings have been reported by Chung et al (2006b) and Gary (2006) in relation 
to adherence to a low sodium diet.  In terms of gender, Heo et al (2008) found higher 
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perceived control and greater knowledge were associated with better self-care in men, 
whilst in women higher self-confidence and poorer functional status correlated with better 
self-care, perhaps indicating greater motivation.  The presence of specific heart failure 
symptoms of fatigue, sleep difficulties, daytime sleepiness and forgetfulness reduce the 
ability to self-care according to Dickson et al (2007b) and Riegel et al (2007b). Functional 
ability as measured by the NYHA classification has been found to increase self-care in US  
studies by Dickson et al (2008) or decrease it (Wu et al, 2007; Rockwell and Riegel, 2001) 
either through a motivating effect or as a result of a reduced ability to self-care.   
 
In this study, no significant relationships were found between socio-demographic factors 
and self-care. However, it is acknowledged that a number of factors may not have been 
adequately assessed using the SDQ, as this was designed to describe the socio-
demographic characteristics of the sample rather than to determine relationships with self-
care. There may also have been too little variation in the sample with regard to some 
characteristics to produce significant results. Given the disease trajectory, most 
participants were from older age groups so that few younger patients were represented. 
Purposive sampling of younger age groups would be needed to adequately determine the 
relationship between age and self-care. Similarly, as only 25.9% of the sample was 
women, this study may not have been adequately powered to determine the influence of 
gender on self-care. All participants described themselves as of white, British ethnic origin 
so the influence of ethnicity could not be determined. Levels of social support, rather than 
simply the presence of close personal relationships as determined by the SDQ, would 
need to be measured in order to determine the influence of social support on self-care, 
although the influence of others on medication use was considered.  As the question 
assessing income was removed from the final version of the SDQ, economic status was 
determined only by occupation which, considering that most of the sample were retired, 
may not adequately assess this factor. Similarly, since more than half of the sample 
reported having no formal qualifications, there may have been too little variation in terms 
of education to adequately determine the relationship with self-care. Similarly, little 
variation in levels of reported co-morbidity may have meant that the influence of this factor 
could not be accurately determined.  Functional ability as assessed by the NYHA was not 
related to self-care in this study. A more objective measure of illness severity, such as an 
echocardiogram, may be needed in order to determine the influence of this factor. 
Therefore, although it is suggested by this study that socio-demographic factors have 
limited influence on self-care, further research into individual factors is recommended. 
 
From the CSM and studies by Morgan (2008), Cherrington et al (2006) and Voelmeck 
(2006), it would be expected that the belief in a chronic illness with serious consequences, 
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strong personal and treatment control beliefs and high illness coherence would motivate 
individuals to self-care. A strong, negative emotional response to the illness could either 
be a motivating factor or be disabling, here the literature is equivocal. The presence of 
depression has been related to poor self-care in studies by Holzapfel et al (2009), Riegel 
et al, (2007b), Dickson et al (2006) and Lesman-Leegte et al (2006). Non-adherence to 
medication is reportedly three times higher in depressed patients compared to those who 
are not depressed (DiMatteo et al, 2000). However, negative emotions, such as fear or 
worry, may also be motivating factors to self-care. In relation to beliefs about causation, it 
is hypothesised that the belief that the illness was caused by lifestyle factors would result 
in lifestyle changes. The symptom of daytime sleepiness has also been linked to poor self-
care (Riegel et al 2009c).  
 
In this study, a number of weak but statistically significant correlations were found 
between illness representations and self-care. These are presented in Table 6.16 and 
Figure 6.7. A meta-analysis of studies using the IPQ-R found weak to moderate 
correlations between beliefs and behavioural outcomes (Hagger and Orbell, 2003). 
Therefore, the strength of relationships found in this study can be considered comparable 
to similar studies in other illness populations using this theoretical framework.  
 
Illness coherence was most strongly related to self-care, the belief that the illness makes 
sense perhaps enabling an understanding of the rationale for individual self-care 
behaviours. This describes the confidence in one‟s ability to understand the illness and 
the required management, or self-efficacy beliefs (Bandura, 1977). Other hypothesised 
relationships were also supported with the belief that heart failure is a chronic illness, has 
serious consequences and can be controlled by treatment all positively, though weakly, 
correlated with self-care. No statistically significant correlations were found between 
personal control and emotional response to the illness, and self-care.  A limited negative 
emotional response reported by participants in this sample may explain this lack of 
correlation. In addition, that negative emotions may be enhancing or limiting factors in 
different individuals may mean any overall correlation with self-care is cancelled out.  
 
No significant correlations between beliefs about specific causes of heart failure and self-
care were found. An analysis of causative factors revealed general disagreement that the 
listed items caused the illness and few additional causes were suggested in the open 
question. It seems that the cause of the illness is frequently unknown and individuals do 
not seek to attribute the illness to a specific cause so that beliefs about causation may be 
relatively unimportant in terms of behavioural outcomes in heart failure. Only the symptom 
of sexual difficulties was weakly, negatively correlated with self-care. Although sexual 
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dysfunction is a recognized effect of heart failure, no studies have related this to self-care. 
However, the impact of sexual difficulties on emotional status and social relationships, for 
example, seems likely to have a negative effect on well-being and self-care. Given this 
weak relationship, further studies would be needed to explore this further.  
 
In relation to treatment beliefs, according to the extended CSM, a strong belief in the 
necessity of medication enhances adherence while concerns about medication reduce 
adherence. According to Horne (1997) the balance between necessity and concerns (the 
necessity-concerns differential) may be more predictive then either set of beliefs alone. 
From the literature, medication knowledge (Wu et al, 2008; Ekman et al, 2006; Toren et al, 
2006; Cline et al, 1999) is predicted to enhance self-care. However, as perceived rather 
than actual medication knowledge was assessed in this study, findings may not be directly 
comparable to published studies. High levels of social support have been found to 
enhance medication adherence (Chung et al, 2006a), so that it could reasonably be 
assumed that social influences on medication use might also enhance self-care. However, 
the beliefs of others, particularly if these are misconceived may contribute to reduced 
adherence (Furze et al, 2002). Although, aspects of the impact of medication use on 
lifestyle, such as the effects of diuretics, have been described in the literature, their effects 
on medication adherence have not been addressed. It is hypothesised that the belief that 
medication use impacts on lifestyle might result in reduced medication adherence and 
self-care. 
 
In this study, a number of moderate and weak, but statistically significant correlations 
were found between treatment beliefs and self-care (Table 6.16 and Figure 6.7).  
Moderate, positive correlations were found between medication knowledge and beliefs 
about the necessity of medication and self-care, as predicted. This means that the belief 
that medication is necessary for controlling the illness or its symptoms and confidence in 
one‟s ability to understand the use of medication and take it appropriately, enhances self-
care. Presumably this relates to the specific self-care behaviour of medication adherence, 
although this cannot be confirmed using the LAYHFQ as only a total self-care score was 
used. 
 
A weak, negative correlation was found between the impact of medication use on lifestyle 
and self-care. Therefore, the belief that medication use impacts on lifestyle correlates with 
reduced self-care, as predicted. Similarly, concerns about medication also correlated with 
reduced self-care, although this relationship was not significantly significant. This 
suggests that the impact of heart failure medication such as the effects of diuretics, 
difficulty in going out, managing the medication regime and monitoring the effects of 
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medication are more important in predicting medication adherence than more general 
concerns about medication such as drug dependency or worries about side-effects, as 
described in the BMQ.  
 
A weak, negative correlation was found between social influences on medication use and 
self-care. That a high degree of social influence on medication use has been found to 
have a detrimental effect on self-care seems counter-intuitive. However, it was suggested 
by the qualitative data that, where spouses took control of medication management, 
participants had reduced knowledge of medication. This was also found in the survey 
where a weak, negative correlation was found between medication knowledge and social 
influences on medication use. This is in contrast to the findings of Chung et al (2006a) 
who found that patients with a spouse were more knowledgeable about the names and 
doses of medication. Given that medication knowledge was the most highly correlating 
factor with self-care, this finding seems to describe a situation where participants are less 
confident about their knowledge about medication due to the influence of spouses on 
medication management, resulting in a reduced ability to take medication appropriately. It 
is further suggested that this lack of confidence in understanding the use of medication is 
also apparent in terms of the illness as a whole, as illness coherence was the most 
strongly correlating factor with self-care. This means that individuals who lack confidence 
in understanding their illness and its treatment are less able to make decisions about self-
care.  
 
Due to the high number of correlations found in this study, those factors that explained 
most of the variance in self-care behaviour were explored using multiple regression. From 
this analysis, illness representations alone accounted for 23% of the variance in self-care. 
When treatment beliefs were added, 46% of the variance was accounted for. Three 
factors were significant predictors of self-care - medication knowledge, a belief in the 
illness having serious consequences and the impact of medication use on lifestyle (Figure 
6.8). As two of these factors are beliefs about treatment, it is likely that these relate to the 
specific self-care behaviour of medication adherence. 
 
Perceived medication knowledge was the strongest predictor of self-care in this analysis. 
Within the context of the interview data, the statement below illustrates a high degree of 
confidence in medication knowledge which has been shown here, to be predictive of 
effective self-care:  
 
„I know what each of them is supposed to do really. Atorvastatin, that’s for my 
cholesterol, the aspirin’s to keep the blood thin, atenolol, the beta-blocker, that slows 
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my heart down a little bit and then I’m on a couple of other things – I think there’s a 
water tablet in there as well just to help with fluid retention’ [P7]  
 
As no studies have addressed confidence in medication knowledge, further research is 
needed to determine the relative influence of accurate knowledge compared to perceived 
knowledge or confidence in one‟s ability to understand the use of heart failure medication, 
on self-care.  
 
The impact of medication use on lifestyle was also found to be a significant predictor of 
self-care. However, it should be remembered that the internal consistency of this sub-
scale was moderate. Further development and testing of the questionnaire is, therefore, 
advocated. This factor is related to general concerns or worries about medication and so 
is consistent with the necessity-concerns framework of treatment beliefs according to 
Horne et al (1997). Rather than generalized concerns, this factor addresses the specific, 
practical impact of the use of medication on lifestyle, such as the difficulty in adhering to 
the treatment regime when away from home or the effects of medication, for example the 
need for frequent urination due to diuretics, and the work involved in monitoring the effects 
of the medication as illustrated by:  
 
„I am on water tablets but once you’re getting rid of it, you go to the toilet every half 
hour or something like that which is difficult when you are out’ [P3] 
 
‘We used to visit my son in Herefordshire, but I don’t drive there now. It’s not so 
much the driving it’s that I always seem to have an appointment with the nurse or 
doctor to check the effects of the tablets’ [P1] 
 
The disruptive effect of heart failure medication, particularly diuretics, is well documented 
(Cowie et al, 1999). However, the impact this has on self-care has now also been 
demonstrated. Similarly, the concept of work in relation to managing a long-term illness as 
described by Glaser and Strauss (1967) can be applied to heart failure in that 
considerable effort is required, particularly in terms of medication management, with 
resulting negative effects on adherence and self-care.  
 
The only illness representation predictive of self-care was the belief in the illness having 
serious consequences:  
 
‘To me, it’s very serious. The way I feel, it’s bad’ [P10]  
 
A serious model of the illness seems to act as a motivating factor to self-care so that 
actions to negate or minimise these consequences are more likely to be carried out.  
211 
 
 
In summary, a number of correlations between illness representations, treatment beliefs 
and self-care were found suggesting a complex interaction between beliefs and 
behaviour. Self-care was enhanced by the belief that the illness is a long-term condition 
with serious consequences which can be controlled by medication, as predicted by the 
CSM and published literature. The belief that the illness „makes sense‟ also enhances 
self-care, as predicted. Perceived medication knowledge, a belief in the necessity of 
medication, few concerns and, importantly, the belief that medication has limited impact 
on lifestyle was also related to enhanced self-care. Interestingly, social influences on 
medication use reduced self-care which is in contrast to many published findings. As 
medication knowledge was found to be the most significant predictor of self-care, it seems 
that the influence of others reduces this confidence which might explain the detrimental 
influence of family members on the ability of patients to make self-care decisions. The 
importance of confidence or self-efficacy beliefs is also supported by the fact that illness 
coherence was the illness representation most strongly correlated with self-care. There 
was lack of support for some hypothesised relationships, most notably between socio-
demographic factors and self-care, although it may be that there was insufficient variation 
in a number of these factors to establish relationships.  
 
From the regression analysis, illness representations and treatment beliefs together 
accounted for 46% of the variance in self-care. Three factors were significantly predictive 
of self-care, namely, perceived medication knowledge, the impact of medication use on 
lifestyle and the belief that the illness had serious consequences. Strategies aimed at 
enhancing these beliefs and minimising the impact of medication use on lifestyle, may, 
therefore, lead to enhanced self-care, discussed in section 7.6. 
 
7.3 CRITIQUE OF THE METHODOLOGY AND METHODS 
 
This section evaluates the research design, methodology and methods and considers the 
extent to which these were effective in achieving the aims of the research. The purpose of 
using a mixed methods design was not only to develop the questionnaires but also to „add 
value‟. That is, to gain a better understanding of the research problem than if either 
qualitative or quantitative methods had been used alone (Creswell and Plano Clark, 
2007). The interviews provided rich description of the experience of living with heart failure 
from a patient perspective so that the questionnaires could be modified to be meaningful 
and relevant to this population.  
 
The main strength of the survey, using quantitative methods, was the ability to determine 
the relationships between beliefs and behaviour in a larger, representative sample so that 
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the results could be generalised to a wider population of heart failure patients (Kruger, 
2003). In the discussion of these relationships, the qualitative findings have also been 
used to illuminate or help explain the results and provide the context within which beliefs 
and self-care occur. Although methodological triangulation was not the main purpose of 
using mixed methods here, overall agreement between the qualitative and quantitative 
findings, enhanced the reliability of the findings. A small number of contradictions were 
found, particularly in relation to the emotional response to the illness and related concerns 
about medication, which was more prevalent in the interview sample.  
 
However, some dilemmas and tensions were apparent in using a mixed methods design. 
Firstly, given the large volume of data generated by the interviews, the selection of the 
most relevant and important themes to be included in the questionnaires required making 
some difficult decisions. Creswell and Plano Clark (2007) recognise that selecting themes 
for further investigation is difficult in a mixed method, instrument development model. 
Rigorous analysis was therefore required in order to justify the inclusion (or exclusion) of 
themes. For example, from the interview data, the themes of medication knowledge, 
social influences on medication use and the impact of medication use on lifestyle were 
carried through to phase two as they seemed to be frequently described by participants 
and potentially relevant to medication adherence and self-care. The self-care domain of 
managing symptoms and the emotional and social effects of the illness was also 
constructed since this was frequently described by the interview participants and is 
consistent with the DH (2006a) definition of self-care. Furthermore, this theme could be 
visualised according to the CSM in which coping responses are aimed at both the illness 
and emotional response to the illness.  
 
A further dilemma was apparent in drawing conclusions from results which were 
inconsistent between the two phases of the study. For example, a strong, negative 
emotional response to the illness was a prevalent feature of the interview data but this 
was less apparent in the survey. The philosophical paradigm in which the research is 
located is relevant here, in that when a pragmatic stance is taken (Morgan, 2007) the 
findings of one method are not necessarily given priority over the other. This means there 
is freedom to explain the data in different ways. In this example, the negative emotional 
response found in the interview data could be explained as either a result of selection-bias 
in this sample or a limited ability to draw out deep emotions using quantitative methods 
such as the IPQ-R (HF). In relation to illness coherence, the survey results suggested a 
strong belief that the illness made sense. However, when viewed in the context of the 
interview findings, coherence was not demonstrated in relation to other illness 
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representations or behaviour, leading to the conclusion that illness coherence could be 
interpreted in different ways. This is discussed further in section 7.5. 
 
7.3.1 Phase one - the qualitative interviews  
A number of points are raised in relation to the methodology and methods of phase one, 
the qualitative interviews. Firstly, in terms of sampling and recruitment, the purpose was to 
select a diverse range of participants in order to yield rich, descriptive text (Denzin and 
Lincoln, 2003). With this aim, a purposive sample in terms of age and gender was 
achieved as planned. The original intention was to approach patients from across three 
PCTs in order to recruit from a broad geographical area with a potentially more diverse 
population. In the event, recruitment was from one site only (Site A) as determined by 
data saturation which may have limited the diversity of the sample. However, as there 
were few significant socio-demographic differences between Sites A and C in the survey 
sample, it is unlikely that there was much diversity in terms of patient characteristics 
across the three sites. 
 
Personal introduction by the patients‟ HFN was successful in terms of recruiting sufficient 
sample sizes for both the interviews and the survey and was preferable to a postal 
invitation in terms of response rate (De Vaus, 1996). The sample size for the interviews 
was considered to be sufficient given that the final number of interviews was determined 
by data saturation (Polit and Hungler, 2001). Although the HFNs were given careful, 
explicit instructions about the inclusion and exclusion criteria there was no guarantee that 
they did not further pre-select patients. For example, those most compliant with treatment 
may have been selected in order to reflect favourably on the practice of the HFNs. Such 
pre-selection could have been avoided by selecting individual patients from the heart 
failure database before introduction. However, this process would have increased the 
period of data collection considerably as participants would have only been available for 
recruitment at their next home visit or clinic appointment, which may have been some 
weeks away.   
 
In addition to any pre-selection, interview and survey participants also chose to take part 
(self-selection). The effect of this was perhaps most apparent in the interview sample 
where it is suggested that patients who were particularly fearful or anxious may have 
welcomed the opportunity to talk about their illness and so were more likely to consent to 
take part. The likely characteristics of non-responders in the survey have been considered 
in determining the extent to which the sample was representative of the heart failure 
population (section 7.3.2).  
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The lack of pilot interviews meant that the interview schedule and process of conducting 
the interviews were not tested. With hindsight this would have been beneficial especially 
considering that the process of data collection was altered slightly in the course of 
collecting the data in that spouses were asked to only give their views at the end of the 
interview. However, it is acknowledged that the presence of spouses in the room may still 
have influenced the participant‟s responses and introduced some bias (Oppenheim, 
2002). On a positive note, this observed shared illness experience between the participant 
and spouse was an important finding and helped develop the theme of social influences 
on medication use. 
 
From a methodological point of view, Shaw (2002) argues that revealing a true lay 
perspective of illness may not be achievable. Certainly, participants seemed to attempt to 
explain their heart failure in medical terms, often using the same terminology, although not 
necessarily demonstrating full understanding. It could also be argued, however, that in 
western society, the dominance of the biomedical model of health has meant that viewing 
illness in these terms has become the established cultural norm. 
 
In conducting the interviews, the relationship between the researcher and participant was 
recognised as reciprocal. Denzin and Lincoln (2003) assert that it is neither realistic nor 
desirable to view qualitative data as totally objective and free from personal beliefs and 
biases. A major strength of the interviews was the development of a trusting relationship 
so that the beliefs of participants‟ could be explored. This may have been especially 
important in eliciting emotional responses to the illness. However, in order to be able to 
carry out meaningful cross-case analysis, attempts were made to standardise the 
interviews through the use of an interview schedule which also helped ensure that 
important questions were not missed.  
 
Analysis was carried out according to the framework method (Miles and Huberman, 1994) 
using deductive and inductive reasoning, consistent with a mixed method approach.  The 
use of NVivo 7 made the data easier to manage compared to previous experience of 
analysing textual data. Arguably, it also facilitated a more systematic approach to analysis 
as the text could be more easily retrieved and interrogated so that analysis may have 
been more thorough, although this is difficult to confirm. As in the process of collecting 
data, the researcher cannot be viewed as an objective outsider but integral to the process 
of data interpretation and analysis. Field notes, though secondary to the transcripts of the 
audio-tapes, were also useful in developing themes and reviewing the quality of the 
interviews as they were conducted.  
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In determining trustworthiness or „the extent to which the findings of the qualitative data 
represent reality’ (Guba and Lincoln, 1995, p.186), credibility, transferability, dependability 
and confirmability were considered. In terms of credibility, an attempt was made to carry 
out member checks to make sure the interview findings were true to the experience of the 
participants. Although participants were invited to check the accuracy of the transcripts 
and contribute to the analysis by viewing the results, few participants contributed further. 
This might have been because they were completely happy with the accuracy and 
interpretation of the results. However, it is also likely that participants‟ chose not be 
engage with the research process beyond the initial interview which is a common 
experience according to Bryman and Burgess (1994). The transferability of the findings is 
limited by the lack of a representative sample, although qualitative research is not 
primarily concerned with representativeness and therefore, generalisability. Holloway and 
Wheeler (1996) suggest that as long as the characteristics of the sample are described 
accurately and a clear decision trail is given in relation to data analysis, readers can 
determine if the results can be applied to their own setting. Theoretical and 
methodological choices have been discussed throughout which is said to enhance the 
dependability of the findings.  Confirmability has been established by linking quotes from 
individual participants through to the development of themes and conclusions. By 
following these criteria, it has been demonstrated that the findings of the qualitative phase 
may be considered trustworthy.  
 
Ethical principles of autonomy, veracity, informed consent, confidentiality and anonymity 
were applied in all stages of recruitment, data collection, data storage and analysis 
(Guillemin and Gilham, 2004). Equal opportunity of access may have been compromised 
to some extent as those heart failure patients unable to speak or read English were 
excluded from the research. However, given that only 6% of heart failure patients 
registered to the three heart failure services were known to be of BME origin (PCT Trust 
data, 2009) with a similar figure in the County overall (KCC website, 2010), that the 
sample consisted only of patients who described themselves as „white, British‟, could 
reasonably be expected to have occurred by chance.  
 
7.3.2 The pilot study and phase two - the quantitative survey 
In the adaptation or development of the questionnaires, determining what themes to 
measure required a selection process based on the relative strength of the interview 
findings and their relevance to the aims of the study. General principles of questionnaire 
design (Oppenheim, 2002) were followed in the initial development of the questionnaires 
with consideration given to layout, the wording of questions and the response format, for 
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example. Reversed and filler questions were included in order to minimise acquiescence 
bias (Coolican, 2009).  
 
The development of the LAYHFQ using a NGT with an expert group of HFNs was 
effective in determining self-care behaviours in heart failure from a nursing perspective. 
NGT, using a mixed methods approach, was carried out based on a process described by 
Potter et al (2004). The main advantages were that it was easily understood by the HFNs 
and it enabled their views to be determined in a short period of time which was important 
given the limited time available to collect the data. That the behaviours identified were 
generally consistent with self-care behaviours advocated by Riegel et al on behalf of the 
AHA (2009a) supports the adequacy of this method. Determining the relative importance 
of self-care behaviours using a NGT was more difficult as all items were highly scored. 
This was perhaps unsurprising since the remit given to the HFNs was to identity important 
self-care behaviours. The scoring system was, however, useful in excluding those 
behaviours least specific to heart failure or not applicable to all heart failure patients. 
Hence, a healthy diet was least highly scored and subsequently excluded from the final 
questionnaire as it was not specific to heart failure nor recommended advice to heart 
failure patients in the terminal stages of their illness.  
 
The decision to use the interview data as well as NGT in the development of the LAYHFQ 
enabled a patient perspective of self-care to be included. Findings from the NGT indicated 
that the HFNs emphasised adherence to medication and reporting and help-seeking 
behaviours in their definition of self-care, which describes a medically-orientated 
viewpoint. Patients also described the importance of maintaining a positive attitude, 
managing negative emotions and making an effort to maintain social networks. This was 
ultimately developed into the domain of managing symptoms and the emotional and social 
effects of the illness, in the LAYHFQ. In this sense, the patient perspective of self-care 
was more in keeping with the DH (2006a) definition compared to the health professional 
perspective.   
 
The aim of the pilot study was to test the processes of recruitment, data collection and 
analysis and enable further development of the questionnaires in preparation for the main 
survey. In terms of recruitment, the pilot study was effective in establishing that the 
questionnaires could be distributed in sufficient numbers over a reasonable timescale by 
the HFNs. The likely response rate in the main survey was also able to be estimated. A 
limitation of the pilot study was that the process of collecting data by telephone or in a 
face-to-face interview could not be tested as no respondents in the pilot sample chose to 
complete the questionnaires in this way. However, face-to-face completion of the 
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questionnaires was carried out with the clinic patients during member checks which 
enabled some piloting of the procedures to occur. As no difficulties were encountered in 
the collection of the main survey data, the lack of pilot interviews appeared to have had 
limited impact. With hindsight, the pilot study could have been designed to test all 
methods of data collection by only offering one method to different groups of participants. 
However, by doing so, the preferred method of data collection would not have been 
known. 
 
Analysis of the pilot questionnaires meant that those questions which had not been 
answered by a number of respondents (missing data) could be re-designed or omitted in 
the final versions of the questionnaires. The process of going through the questionnaires, 
face-to-face, with a small number of heart failure patients attending a clinic was especially 
useful in identifying ambiguous questions or questions which were difficult to answer. On 
reflection, a second pilot study might have been carried out following these amendments 
so that the final questionnaires could have been more rigorously tested prior to use. 
However, this would have reduced the size of the available sample for the main survey 
and it is likely that a second pilot would have led to yet further amendments.  
 
The process of setting up a pilot data file in SPSS and carrying out anticipated statistical 
analysis was important due to limited prior experience in statistical analysis. The database 
was then easily amended for use with the main data set. 
 
In the main quantitative survey, the sampling strategy was important in terms of 
determining the representativeness of the sample and hence the generalisability of 
findings.  In order to achieve an adequate response rate, recruitment was changed from a 
postal method to a personal, face-to-face introduction by the HFNs. This meant that the 
size of the available population was greatly reduced as it was now limited to those in face-
to-face contact with the HFNs either through home or clinic visits. A probability sampling 
strategy was, therefore, rejected given that the whole population now effectively needed to 
be approached, described by Polit and Hungler (2001) as total or whole population 
sampling.   
 
In order to determine the extent to which the findings can be considered representative of 
the heart failure population, the characteristics of the sample need to be compared to 
those in the wider heart failure population. Data in relation to age, gender, social situation 
and ethnic origin of the heart failure population across the three sites were available from 
the HFN services. Other socio-demographic and illness-related characteristics of 
qualifications, the presence of co-morbidities and NYHA classification were not stored 
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centrally on the Trust databases but only in individual notes and so could not be easily 
retrieved and compared.   
 
Although sample sizes from the three sites were unequal, no significant differences were 
found in terms of age, time with the illness, gender, social situation, qualifications, the 
presence of co-morbidities or NYHA classification between Sites A and C. There were too 
few cases at Site B to carry out similar analysis. Overall, where examined, the samples 
can be considered to come from a single population.  
 
The average age of the heart failure population in the locality is 72.9 years (PCT Trust 
data, 2010). The age of the heart failure population nationally is estimated to be 73 years 
(NICE, 2010). In this sample, the average age was 70.9 years which is slightly younger 
but generally comparable to both the local and national picture. One explanation might be 
that older patients may have been in poorer health and so were not invited to take part in 
the study according to the exclusion criteria. In terms of gender, 31.2% of heart failure 
patients in the locality are female and 68.8% are men. In this sample, 25.9% were women 
and 74.1% were men so that fewer women were included than might be expected. As 
women with heart failure tend to be older (NICE, 2010) they may have been more likely to 
be excluded based on poor health. Only 6% of patients with heart failure in the locality are 
of BME ethnic origin (KCC website, 2010). In this sample, no BME ethnic groups were 
represented which may have occurred by chance or may be partly explained by the 
requirement that participants were able to read and speak a sufficient level of English to 
take part in the study. According to local data, 76.4% of heart failure patients live with their 
spouse or other family member whilst 23.6% live alone. In this sample, 19.3% lived alone 
and 79.5% lived with a spouse or family member. Again, the sample may reasonably be 
considered representative of the heart failure population in terms of living situation. That 
some participants may have needed help in completing the questionnaires might explain 
the slightly lower number of participants living alone than perhaps might be expected.  
 
Finally, it is recognised that the sample was drawn from a population of heart failure 
patients who were managed by a specialist HFN and GP.  Alternative models of service 
delivery exist in this locality and nationally. For example, patients may be managed by a 
GP only, or Community Matron and GP, for example. It might be reasonable to assume 
that patients in this study had greater specialist education which may have resulted in 
fewer misconceptions and had enhanced self-care support compared to those cared for 
according to other service models. However, the involvement of specialist HFNs in care is 
becoming the norm within the NHS (BHF, 2009) so patients in this sample may be typical 
of the heart failure population nationally. In conclusion, the sample can be considered 
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representative of the heart failure population locally and, where it is possible to be 
determined, nationally. Hence, the findings of this study can reasonably be generalised to 
the wider heart failure population, especially those cared for within a shared care model of 
service delivery with specialist nursing input. 
 
In relation to recruitment, fewer questionnaires were delivered than anticipated due to a 
number of unforeseen circumstances. At Site B, staffing pressures meant that far fewer 
envelopes were delivered than anticipated. At Site C, recruitment was limited by the size 
of the available population. However, given the overall response rate of 50.4%, the target 
sample size of 156 respondents was achieved. 
 
As in the qualitative phase, although the HFNs were given careful, explicit instructions on 
the inclusion and exclusion criteria there is no guarantee that they did not further pre-
select participants. However, given that the number of envelopes handed out effectively 
included the total available population, especially at Site C, pre-selection is likely to have 
been minimal.  
 
It is possible that the questionnaires were completed by family members or friends rather 
than the heart failure patients themselves. The degree to which this might have occurred 
is difficult to judge but some involvement of others seems likely given that many of the 
participants were elderly, in poor health and had co-morbidities. The consequences of this 
in terms of the validity of the results may depend on the nature of the involvement. For 
example, where spouses or other family members acted simply as scribes, the influence 
on the results was probably minimal. Alternatively, completion of the questionnaires may 
have been collaborative with participants and their spouses discussing the responses. 
This seems most likely, given that the illness was often viewed as a shared experience by 
patients and spouses in the interview sample. Family members may, alternatively, have 
completed the questionnaires on behalf of the patient without their direct involvement. It is 
difficult to suggest how this could have been avoided as even in the face-to-face 
interviews, which allowed some degree of control by the researcher, the involvement of 
family members in data collection was apparent.  
 
In terms of data analysis, descriptive and inferential statistics were successfully used to 
describe the data and determine relationships between variables, the exception was some 
Chi-squared (X2) analysis where too few cases were available for meaningful analysis. 
Since the aim of this analysis was to determine differences in socio-economic 
characteristics between the three sites, this was not integral in meeting the aims of the 
research.  
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7.4  OVERALL VALIDITY AND RELIABILITY OF THE QUESTIONNARES 
 
The consideration of the validity and reliability of the questionnaires is important in 
determining their overall value and the strength of the findings. The IPQ-R (HF) 
demonstrated good internal consistency both in the questionnaire as a whole and the 
separate domains, demonstrated by Cronbach‟s α ≥ 0.7. In terms of validity, overall, there 
was agreement between the qualitative findings and those of the IPQ-R (HF), for most 
domains, demonstrating concurrent validity. The IPQ-R has also been extensively tested 
for validity and reliability in a variety of illness groups (Moss-Morris et al, 2002) and 
minimal changes were made to this questionnaire in its adaptation to the IPQ-R (HF). The 
strengths of the IPQ-R, therefore, lend support to the conclusion that the IPQ-R (HF) is 
both valid and reliable in a heart failure population.  
 
The MUHFQ, incorporating the BMQ, demonstrated good consistency in four out of the 
five domains (α > 0.7). However, the impact of medication use of lifestyle domain was only 
moderately reliable in this sample (α = 0.56). Further development and testing of the 
reliability of this sub-scale is, therefore, recommended before further use in research or 
used in clinical practice. In terms of validity, concurrent validity was demonstrated by 
general agreement between the findings of the qualitative data and the findings of the 
MUHFQ. Factorial validity, as determined by principal components analysis, was 
supported in that a 5-factor structure was described according to the theoretical domains 
of treatment beliefs. However, the cross-loading of one item on both the impact of 
medication use on lifestyle domain and the concerns domain, again, suggests a need for 
further development and testing of these constructs.  
 
The LAYHFQ demonstrated good internal consistency overall (α = 0.77), but this could not 
be demonstrated in relation to the individual domains (α ≤ 0.7). This meant that only 
relationships with total self-care could be reliably determined. Similarly, factorial validity 
was not established, with principal components analysis failing to support the existence of 
the theoretically derived self-care domains. It is, however, worth noting that the EHFScBS 
also fails to demonstrate factorial validity and uses a total self-care score (Jaarsma et al, 
2003). Given these findings, the usefulness of dividing self-care into separate domains is 
discussed in section 7.5. The LAYHFQ questionnaire was developed and reviewed by 
specialist HFNs and so can be said to have content validity. Findings were consistent 
between the qualitative and survey data, demonstrating concurrent validity.  
 
In conclusion, the questionnaires, overall, can be considered valid and reliable for use in 
this study. However, it is recognised that other measures of reliability and validity such as 
stability, predictive, convergent and discriminant validity might also be tested.  
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7.5 THE USE OF THE THEORETICAL FRAMEWORK 
 
An extended CSM, incorporating treatment beliefs was used to guide data collection and 
analysis. From this analysis, a number of points can be made about the use of the model 
in this study.  
 
As discussed in Chapter four, categorising emotions in the analysis of the qualitative data 
was problematic in that negative emotions could be categorised as an emotional 
response, psychological consequence or coping response, as argued by Ogden (2003). 
However, in-depth interviews, to some extent, overcame this as the context in which the 
emotion was described was known. Similarly, categorising some items as symptoms or 
consequences was, at times, difficult. For example, sexual difficulties could be considered 
a symptom of heart failure or a consequence of it. In general, where items were 
recognised symptoms of heart failure according to the literature, they have been 
categorised as such. Whilst this was relevant in the analysis of the qualitative data in 
order to develop the symptom scale in the IPQ-R (HF), it was less relevant in analysing 
the survey data where the belief that the illness had serious consequences was assessed 
rather than the nature of those consequences. 
 
Coherence was also a difficult concept to analyse as it may be being defined differently 
depending on the methodology used. This conclusion has been drawn from the analysis 
of the qualitative and quantitative data and a review of other published literature. 
Coherence can be defined as a meta-cognition or belief about the extent to which the 
illness makes sense (Moss-Morris et al, 2002), as measured by the IPQ-R and the IPQ-R 
(HF) (Cherrington et al, 2006 and Voelmeck, 2006). In this way illness coherence is 
related to self-efficacy beliefs (Bandura, 1977). Illness coherence may also be 
demonstrated through the accuracy of illness representations and the congruence 
between these beliefs and behaviour when measured by qualitative methods (Horowitz et 
al, 2004). Hence, a strong belief that the illness makes sense is described in studies using 
quantitative methods but limited demonstrated coherence is described in qualitative 
studies.  
 
In relation to treatment beliefs, the necessity-concerns framework proved a useful way of 
describing beliefs about medication. However, this framework was further developed in 
the MUHFQ to include three additional domains. From the interview data, concerns about 
medication were described in practical terms as the impact of medication use on lifestyle. 
Perceived knowledge about medication was described with the actions, names and the 
number of tablets specified. Social influences on medication use were also apparent. 
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Factor analysis supported these constructs and multiple regression analysis confirmed 
that these beliefs were predictors of self-care behaviour. Hence, in heart failure, beliefs 
about medication could be extended beyond the framework proposed by Horne et al 
(1999) to usefully include additional sets of beliefs. 
 
The CSM describes behavioural outcomes as being influenced by illness representations 
and treatment beliefs. Relationships between these beliefs and self-care were 
demonstrated in this study, supporting the use of the CSM in explaining behaviour. 
However, the theoretically proposed constructs of adherence to recommended lifestyle 
advice, adherence to medication, monitoring symptoms, managing symptoms and 
reporting and seeking help (Dickson et al, 2006) were not supported by factor analysis in 
either the LAYHFQ or the EHFScBS (Jaarsma et al, 2003). The additional construct of 
managing the emotional and social consequences of the illness, according to the CSM, 
was also not supported by factor analysis in the LAYHFQ. Rather, self-care seemed to 
consist of a number of unrelated behaviours as also demonstrated by the lack of internal 
consistency. The implications of which are discussed below. 
 
7.6 IMPLICATIONS FOR PRACTICE AND RECOMMENDATIONS FOR FUTURE 
RESEARCH 
 
A number of implications for clinical practice, especially nursing, are suggested. Three 
beliefs were identified which were significantly predictive of self-care - the belief that the 
illness had serious consequences, perceived knowledge about medication and the belief 
that medication use impacts on lifestyle.  It seems likely that treatment beliefs influence 
medication adherence, rather than other self-care behaviours although this cannot be 
confirmed using the LAYHFQ. 
 
Targeted interventions aimed at addressing these beliefs may, therefore, enhance self-
care. An example of such an intervention is described by Petrie et al (2002). In this study 
a brief, in-hospital intervention aimed at changing beliefs was effective in improving 
functional ability in patients following MI. The intervention consisted of three, 30-40 minute 
individual patient sessions conducted by a psychologist. The first session consisted of a 
brief explanation of the pathophysiology of the disease and an explanation of common 
symptoms and terminology. Cardiac and non-cardiac symptoms were discussed. Using 
individual patient scores on the IPQ-R, beliefs about the illness were explored and any 
misconceptions were addressed, particularly the belief that stress was a single causal 
factor in the development of the disease. In this way the patients‟ causal model of the 
illness was broadened to include lifestyle factors. The second session built on these 
beliefs, focusing on developing a plan for minimising future risk by altering risk factors 
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relevant to the individual and increasing beliefs about control of the illness. Highly 
negative beliefs about the consequences of the illness were challenged and a personal 
development plan was devised. In the third session, the action plan was reviewed and 
concerns the patient had about their medication were explored.  The need to take 
medications consistently and the difficulty of relying on symptoms as a guide to 
medication use were discussed.  
 
Many of the features of this type of consultation will be familiar to nurses working with 
heart failure patients and it would seem feasible that a similar approach might be used to 
explore illness and treatment beliefs in heart failure, addressing any misconceptions. In 
particular, the belief that the illness does not have serious consequences might be 
addressed as this was found to impact on self-care. However, high levels of anxiety and 
despair may be present so there is a need to balance a realistic picture of a chronic illness 
with serious consequences against heightened negative emotions. Other specific 
misconceptions such as the belief that the illness is acute and short-lasting or is cyclical in 
nature might be addressed as both were found to be correlated with reduced self-care. 
Similarly, the belief that the illness cannot be controlled by medication may result in 
medication non-adherence. Other beliefs may exist which are unique to the individual. A 
broad discussion of the patient‟s beliefs about the illness and its treatment should elicit 
these views, presenting an opportunity for misconceptions to be challenged.  
 
Knowledge about medication has been shown to be important in terms of the ability to 
take medication appropriately (Ekman et al, 2006; Toren et al, 2006; Cline et al, 1999). 
However, perceived knowledge or the confidence in one‟s ability to understand the use of 
medication and take it appropriately should also be explored. Threats to knowledge, such 
as changing the brand of medication, frequent changes to the medication regime, 
particularly after admission to hospital and the practice of up-titration of many heart failure 
medications should be recognised and avoided where possible. Where changes are 
necessary, efforts should be made to ensure knowledge and confidence are maintained at 
each change in medication or dose. The influence of family members, especially spouses 
on medication management should also be considered as it is suggested that where 
others take control of medication management, the individuals confidence in their ability to 
understand the actions of medication and take it appropriately, may be reduced. Given 
some patients reliance on family members for practical medication management, the loss 
of this support through bereavement, for example, may make this group of patients 
particularly vulnerable to poor self-care, making education a priority in these individuals.  
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The impact of medication use on lifestyle should be recognised and explored and ways in 
which this might be reduced, for example, by altering the timing of medication, should be 
discussed and agreed with the patient. 
 
The intervention described by Petrie et al (2002) is specific to illness and treatment beliefs 
according to the CSM, however, other interventions exist which may differ in their 
theoretical perspective. In a systematic review of interventions designed to change 
maladaptive beliefs in CHD, Goulding et al (2010), suggest that cognitive behavioural and 
counselling/educational interventions can be effective in changing beliefs. What is 
important is that nurses and other health and social care professionals have sufficient 
knowledge, skills and experience in that intervention to effectively explore and address 
beliefs and behaviour, related to heart failure.  Further education may be needed to bridge 
any gaps in their knowledge and skill base. 
 
From a health and social care policy perspective, as found using a NGT, HFNs focused 
on adherence to medication and reporting and help-seeking behaviour in their vision of 
self-care in heart failure. However, government policy (DH, 2006a) encompasses a much 
broader and more inclusive definition of self-care in long-term conditions, including 
maintaining social and psychological well-being. These aspects of self-care were also 
seen as important by patients in this study.  It seems that to truly embed the principle of 
self-care, health professionals need to look beyond adherence behaviour, to a more 
holistic view of the patient and the social context in which the illness occurs.  
 
In terms of further research, although the primary purpose of collecting socio-demographic 
data using the SDQ was to describe the sample rather than to determine relationships 
with self-care, a number of studies, for example, Riegel at al (2007b) suggest 
relationships between socio-demographic variables and self-care. As these variables were 
not fully addressed in this study, further research is needed to determine their relative 
influence on self-care in a UK, heart failure population. No distinction was made in the 
main survey between treatment beliefs and adherence to different medications. The 
interview data suggested that patients may hold different beliefs about different 
medications, for example, doubts about the necessity of statins once cholesterol levels 
have been reduced; concerns about the side-effects of aspirin and the impact of diuretics 
on lifestyle. It might, therefore, be expected that adherence to different medications also 
varies as suggested by Albert (2008). An exploration of beliefs in relation to specific heart 
failure medications would inform the development of interventions addressing potentially 
different beliefs.   
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Although the questionnaires have been shown be reliable and valid in this population, 
further psychometric testing of the questionnaires might be carried out, for example to test 
for concurrent validity and external reliability. Internal consistency of the impact of 
medication use on lifestyle sub-scale in the MUHFQ demonstrated only moderate 
reliability so further exploration of this concept and its relationship to self-care is 
advocated, perhaps through exploratory qualitative methods. 
 
It has been argued here, that individual self-care behaviours are separate and not 
necessarily related to each other according to the theoretical domains of self-care as 
advocated by many authors, including Dickson et al (2006). Therefore, in this study, only 
total self-care can be considered a reliable measure. The LAYHFQ could be used 
clinically as a measure of total self-care as it has been shown to have content validity and 
internal reliability in this population. However, it is recommended that this questionnaire be 
further developed so that each individual behaviour is assessed using three or four items 
as De Vaus (1996) argues that assessing behaviour using multiple items enhances 
reliability.  
 
In terms of the use of the CSM, further research is advocated on the influence of illness 
coherence, either as the self-efficacy belief that the illness makes sense or as 
demonstrated through fewer misconceptions and the congruence between beliefs and 
behaviour. Similarly, the influence of actual medication knowledge and the confidence in 
one‟s ability to understand the use of medication, on self-care might be further explored in 
order to determine whether education alone or in combination with, for example, 
motivational interviewing is most effective in enhancing self-care. Expert Patient 
Programmes (EPP) (DH, 2001), based on the concept of self-efficacy, might be most 
effective in achieving this aim. 
 
Finally, from the literature review, it is recognised that there is limited evidence of 
improved clinical outcomes as a result of carrying out recommended self-care behaviours. 
The assertion of the AHA (Riegel et al, 2009a) that this evidence is needed as an urgent 
priority is echoed here as presently, there is some lack of evidence to support the 
recommendation of individual behaviours. Given this evidence, those specific self-care 
behaviours which improve clinical outcomes can be focused upon. Psychological 
interventions aimed at changing those illness and treatment beliefs which influence self-
care can then be developed. Most importantly, the effect of such interventions on clinical 
outcomes could then be determined.  
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7.7  CONCLUSION 
 
In conclusion, this chapter has discussed the results of the study in relation to the 
literature and the CSM.  The research design, namely mixed methods, has been 
discussed in terms of its strengths and dilemmas. Sampling strategies, data collection and 
analysis methods, employed in the two phases of the study have been evaluated and 
found to be effective in meeting the aims of the research. An analysis of the reliability and 
validity of the questionnaires reveals them to be both valid and reliable in this population, 
although it is acknowledged that the LAYHFQ, in particular, could be further developed. 
The use of the CSM is supported as the illness representation of consequences and 
treatment beliefs of medication knowledge and the impact of medication use on lifestyle 
were found to be significant predictors of self-care.  Finally, the implications for nursing 
and healthcare practice have been considered. In particular, the development of 
interventions aimed at examining illness and treatment beliefs and correcting any 
misconceptions is recommended. The effectiveness of such interventions in enhancing 
self-care behaviour could then be evaluated in further research. Other opportunities for 
future research such as the exploration of illness coherence and medication knowledge 
have also been discussed. The following and final chapter brings the main points of the 
study together in an overall conclusion. 
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CHAPTER EIGHT:   CONCLUSION 
 
This chapter concludes the thesis by first summarising the context of the study and re-
stating the aims and methods. An overview of the main findings in relation to the aims, is 
presented. The use of a mixed methodology and the CSM, as discussed in the previous 
chapter, are evaluated. The implications for practice and suggestions for further research 
are summarised before reflecting on my personal development as a result of undertaking 
this work.  
 
8.1 THE CONTEXT OF THE STUDY AND A REVIEW OF THE AIMS AND 
METHODS 
 
Heart failure is a significant clinical issue which has wide-ranging implications for patients 
and their families, the NHS and society as a whole. The financial cost of heart failure is 
high, accounting for 2% of the total NHS budget (NICE, 2010).  There is a well-established 
evidence base for the medical diagnosis and treatment of heart failure which includes self-
care - a key principle in the management of long-term conditions (DH, 2005a). Self-care in 
heart failure has been conceptualised as a decision-making process involving self-care 
maintenance behaviours such as adherence to medication and self-care management 
strategies such as managing symptoms (Dickson et al, 2006). Published literature 
describes a number of influencing factors on self-care including socio-demographic, 
healthcare system, illness and treatment-related factors. Personal beliefs are also 
expected to influence self-care behaviour, although few studies have previously 
addressed this. The CSM (Leventhal et al, 1980) has proved to be a useful framework for 
exploring illness beliefs and their relationship to health outcomes in other illnesses, and 
was selected as the theoretical framework for this study for this reason. Horne (1997) 
incorporated treatment beliefs into the CSM, which was also applied here. 
 
The aims of the research were to explore illness representations, treatment beliefs and 
self-care in heart failure and to determine any relationships between these beliefs and 
behaviour. 
 
In this study, a mixed methods approach was used (Creswell and Plano Clark, 2007), 
according to a pragmatic philosophical paradigm. The research was conducted in two 
sequential phases. Phase one was the collection and analysis of interview data exploring 
illness representations, treatment beliefs and self-care in a sample of twelve heart failure 
patients. These data were then used to adapt the IPQ-R (Moss-Morris et al, 2002) and the 
BMQ (Horne et al, 1999) in order to make them specific to a heart failure population. An 
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instrument measuring self-care was developed based on the EHFScBS (Jaarsma et al, 
2003), using the interview data and the expert opinion of specialist HFNs. A socio-
demographic questionnaire was also developed in order to describe the characteristics of 
the sample. Following a pilot study, these questionnaires were used in phase two - a 
cross-sectional survey of 169 patients with heart failure which described illness 
representations, treatment beliefs and self-care and enabled relationships between these 
variables to be determined, according to the main aim of the study.  
 
8.2 SUMMARY OF THE FINDINGS  
 
The exploration of illness representations, treatment beliefs and self-care achieved 
through both qualitative and quantitative methods, revealed that heart failure was viewed 
as a long-term or chronic condition with serious consequences and associated with a high 
number of diverse and debilitating symptoms. This cluster of beliefs was related to 
negative emotions such as fear, anxiety and depression. The illness identity was 
problematic with patients finding it difficult to differentiate between heart failure and other 
cardiac conditions, which has implications for understanding the nature of the illness and 
its treatment. Many patients were unable to identify the cause of their heart failure 
although ageing and stress or worry were seen as the most likely causative agents. There 
was a prevalent belief that the illness could be controlled both personally and through the 
use of medication, with medication generally viewed as controlling the illness and its 
symptoms and personal control relating more to managing the emotional consequences of 
the living with heart failure. Although patients agreed that the illness made sense to them 
(coherence), this was generally not demonstrated in the interview sample in relation to 
other illness representations and subsequent behaviour. 
 
There was a strong belief in the necessity of medication but this was balanced against 
some concerns, especially about side-effects and drug interactions. Although related to 
concerns, the concept of impact of medication use on lifestyle was developed which 
addressed the influence of medication use on practical, everyday life, for example, the 
disruptive influence of diuretics, difficulty in taking medication when going out and the 
need for frequent monitoring of the effects of medication. Perceived medication 
knowledge or the confidence in one‟s ability to understand the actions of medication and 
take it appropriately was also a developed theme and, like illness coherence, may be 
related to the concept of self-efficacy. In this sample, perceived medication knowledge 
was high and related to all other treatment beliefs. For some patients, medication use was 
socially influenced, with family members assisting in medication management. This was 
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influenced by gender with men reporting greater social influences. However, it was also 
found that this influence had a detrimental effect on perceived medication knowledge.  
 
Self-care, including medication adherence was reportedly high although those behaviours 
most specific to heart failure such as taking a low salt diet and regular weighing were 
amongst the least commonly reported behaviours. It is hypothesised that, due to the lack 
of a clear illness identity, the purpose of carrying out these behaviours is similarly unclear. 
The reported high level of self-care may reflect the additional educational input and 
support expected as a result of the involvement of a specialist HFN, although a degree of 
social desirability cannot be ruled out.  Managing symptoms and the emotional and social 
consequences of heart failure through resting, making an effort to keep a positive attitude 
and maintaining social networks, were also found to be important aspects of self-care as 
described by patients and suggested in the definition of self-care by the DH (2006a). 
 
In addressing the main aim of the study, as predicted, a number of modest but statistically 
significant, correlations were found between beliefs and behaviour. The strongest 
correlations were found between self-care and medication knowledge and beliefs about 
the necessity of medication. Of illness representations, illness coherence was the most 
strongly correlating factor with self-care. Multiple regression analysis revealed that 46% of 
the variance in self-care could be explained by illness representations and treatment 
beliefs. Three factors were significant predictors of self-care - a belief in the illness having 
serious consequences, perceived medication knowledge and limited impact of medication 
use on lifestyle. Although not a specified aim of the research, no relationships were found 
between socio-demographic factors and self-care although it is acknowledged that there 
may have been insufficient variation in some characteristics in this sample to accurately 
determine such relationships. 
 
The IPQ-R (HF), the MUHFQ and the LAYHFQ can be considered reliable and valid 
measures for use in a heart failure population. The IPQ-R (HF) required minimal 
adaptations from the IPQ-R and demonstrated good internal consistency (α = 0.74). The 
MUHFQ also demonstrated good internal consistency for all domains (α > 0.70), with the 
exception of the impact of medication use on lifestyle scale (α = 0.56). Therefore, 
conclusions drawn in relation to this domain are cautious. Factor analysis supported the 5-
factor structure including the three additional domains developed from the interview data, 
adding support for the trustworthiness of the qualitative data. The LAYHFQ was more 
problematic since although the questionnaire as a whole was internally consistent (α = 
0.77), most sub-scales failed to demonstrate sufficient reliability. As a result only 
relationships between beliefs and total self-care could be considered, which although 
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disappointing, is comparable to other published measures of self-care in heart failure such 
as the EHFScBS (Jaarsma, et al, 2003). This led to the conclusion that self-care might 
best be viewed as a list of individual behaviours rather than in terms of the theoretically 
derived constructs of self-care maintenance and self-care management behaviours.  
 
8.3 SUMMARY OF THE CRITIQUE OF THE METHODOLOGY AND THE CSM 
 
A mixed methodology enabled a patient or lay perspective of beliefs and self-care to be 
incorporated into meaningful, illness-specific questionnaires. An integrated discussion of 
both the qualitative and quantitative results meant that the context and „voices‟ of the 
participants could be retained. In this way a mixed methods approach was believed to 
„add value‟ to the study in that it led to a better understanding of the topic than would have 
been achieved by using any single method. The main difficulty in using mixed methods lay 
in determining the relative strength of the findings where there were differences between 
the qualitative and quantitative results. Here, consideration was given to the most likely 
explanation for the findings.   
 
In applying the CSM, some theoretical difficulties were apparent, especially in the 
qualitative data in categorising some responses. For example, depression could be 
considered a symptom in identity, a co-morbidity or an emotional response. Similarly, 
difficulty in walking may be both a symptom and a consequence of the illness. Perhaps 
most problematic was the concept of illness coherence which seemed to produce different 
results depending on the methodology used with the belief that the illness made sense 
being reported in the quantitative sample and a lack of illness coherence demonstrated in 
the qualitative phase. This was also apparent in other published studies (Cherrington et al, 
2006; Voelmeck, 2006 and Horowitz et al, 2004). It is suggested that the term illness 
coherence may be being used differently according to the methodology. Similarly, in this 
study, a difference was found in the prevalence of negative emotions such as fear and 
depression, between the different samples with strong negative emotions apparent in the 
qualitative sample. This might be explained either as selection bias or suggests that 
interviews are a better method to uncover deep emotions compared to questionnaires.  
 
In terms of treatment beliefs, the necessity-concerns framework (Horne et al, 1999) could 
be applied to this illness population. The impact of medication use on lifestyle was 
identified as a specific and practical concern about medication management. Two 
additional constructs of perceived medication knowledge and social influences on 
medication use were also identified and added to the overall concept of treatment beliefs.  
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There appears to be little empirical evidence to support the existence of the constructs of 
self-care maintenance and self-care management as described by Dickson et al (2006). 
Both the EHFScBS (Jaarsma et al, 2003) and the LAYHFQ suggest that patients view 
self-care as a number of separate behaviours, especially those relating to a general 
healthy lifestyle, such as reduced alcohol consumption and not smoking.  
 
8. 4 IMPLICATIONS FOR PRACTICE AND SUGGESTIONS FOR FUTURE 
RESEARCH  
 
From these findings, a number of implications for practice are suggested. Targeted 
interventions particularly aimed at addressing those beliefs predictive of self-care should 
be developed.  An example of such an intervention by Petrie et al (2002) focuses on 
advancing knowledge and exploring and correcting misconceptions. Such as approach 
seems feasible as many of the features of this type of consultation will be familiar to 
nurses working with heart failure patients. As perceived medication knowledge has been 
found to be a strong predictor of self-care, threats to that knowledge through, for example, 
changing the brand of medication and frequent changes to the medication regime should 
be avoided where possible. Additional educative support may be needed during the 
process of up-titration of medication. The impact of medication use on lifestyle should be 
recognised and explored and ways in which this impact might be reduced, for example, by 
altering the timing of medication such as diuretics, should be discussed and agreed with 
the patient. 
 
In terms of suggestions for future research, further psychometric testing of the 
questionnaires might be carried out, for example to test for concurrent validity and 
external reliability.  The impact of medication use on lifestyle should be further explored as 
this sub-scale demonstrated only moderate internal consistency in the MUHFQ. Although 
the LAYHFQ could be used clinically as a measure of total self-care, it is recommended 
that it is further developed so that each individual behaviour is assessed using a number 
of items which may enhance reliability. Further research is advocated on the concept of 
illness coherence, especially on the different ways in which this term seems to be being 
used. Similarly, the confidence in one‟s ability to understand the use of medication might 
be further explored, especially its relationship to the accuracy of medication knowledge. 
Finally, further evidence is needed in order to fully determine the effects of self-care 
behaviour on clinical outcomes (Riegel et al, for the AHA, 2009). Greater weight might 
then be added to the need for interventions aimed at changing illness and treatment 
beliefs which have been shown here to influence self-care.  
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8.5 PERSONAL REFLECTION  
 
The impetus for this study was to gain deeper understanding of the influence of beliefs on 
behaviour in patients with heart failure, which has, I think, been achieved. However, it has 
now led me to consider further questions, such as what influences the development of 
these beliefs? In undertaking this study, I have come to appreciate the complex jigsaw 
that is the relationship between beliefs and illness behaviour in a social context. In terms 
of the methodology, having been at first sceptical about the use of mixed methods 
(„mixed-up methods‟?), I have come to firmly believe that the use of both qualitative and 
quantitative methods, when used critically, can lead to a much deeper understanding of 
the research question. For me personally, the use of statistical methods has been a steep 
learning curve, but I have now gained much greater confidence in the use of statistics in 
answering fundamental research questions. Finally, undertaking this research has been a 
privilege as I have been able to share, for a brief moment, the experience of patients who 
struggle every day with heart failure.  
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